Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGRP,Agouti-related protein,42296,0.268443790316945,0.00492276943940861,0.258795162215704,0.278092418418186,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN1,CCN family member 1,42047,0.338924626615213,0.00695610751390564,0.325290655887958,0.352558597342468,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.0852302891305537,0.00213468351770724,0.0810463094358475,0.0894142688252599,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,LDLR,Low-density lipoprotein receptor,42170,0.374589411456203,0.00430564940111042,0.366150338630026,0.383028484282379,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFGE8,Lactadherin,42137,0.24357460056113,0.00429221055056834,0.235161867882016,0.251987333240244,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPY,Pro-neuropeptide Y,42262,0.345594109512014,0.00599282520422135,0.33384817211174,0.357340046912288,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,GHR,Growth hormone receptor,39736,0.109639062371434,0.00278704245428229,0.104176459161041,0.115101665581828,1.11253693164298e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCG,Pro-glucagon,41843,0.480666268295304,0.0124038277323868,0.456354765939826,0.504977770650782,1.11395118531753e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPL,Lipoprotein lipase,42145,-0.183738291355037,0.00481034550535625,-0.193166568545535,-0.174310014164539,2.87390201187707e-303
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL27,C-C motif chemokine 27,42145,0.235414961099393,0.00625774060707373,0.223149789509528,0.247680132689257,1.11651013980588e-294
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.12124450152508,0.00322453825153921,0.114924406552063,0.127564596498097,2.19116879096032e-294
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF9,Protein turtle homolog A,39958,0.31867677584119,0.00854457782929985,0.301929403295763,0.335424148386618,2.63088267744358e-287
NMR metabolomics,X23501.Triglycerides in Large VLDL,CES1,Liver carboxylesterase 1,42163,0.314324631017729,0.00853131715383466,0.297603249396213,0.331046012639245,2.65435535355844e-283
NMR metabolomics,X23501.Triglycerides in Large VLDL,F7,Coagulation factor VII,42194,0.114447942231059,0.00311500407694313,0.10834253424025,0.120553350221867,7.73842885834606e-282
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTH,Parathyroid hormone,39649,0.290332131638615,0.00832044597187286,0.274024057533744,0.306640205743486,3.68656658036742e-253
NMR metabolomics,X23501.Triglycerides in Large VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.265657333832917,0.00770448160572819,0.250556549885689,0.280758117780144,7.59679039063126e-248
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.111621119451923,0.0032641670423742,0.10522335204887,0.118018886854976,5.5763629686856e-246
NMR metabolomics,X23501.Triglycerides in Large VLDL,RARRES2,Retinoic acid receptor responder protein 2,42230,0.166775623648966,0.00488431503081273,0.157202366188573,0.176348881109359,2.9082445705467e-245
NMR metabolomics,X23501.Triglycerides in Large VLDL,FURIN,Furin,42181,0.113518272994853,0.00333858625457393,0.106974643935888,0.120061902053818,2.83865688071534e-243
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRAP1,Proline-rich acidic protein 1,39966,0.131176109947574,0.00392344817970619,0.12348615151535,0.138866068379798,7.45202707790376e-234
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.427381271851717,0.0128491502050762,-0.452565606253666,-0.402196937449767,2.38287681386891e-233
NMR metabolomics,X23501.Triglycerides in Large VLDL,INHBC,Inhibin beta C chain,42137,0.13377929793829,0.0040260311301545,0.125888276923187,0.141670318953392,8.18920911273945e-233
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.143450616950348,0.00433742067626086,0.134949272424877,0.151951961475819,8.68325157804791e-231
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCHE,Cholinesterase,39806,0.0888529621903616,0.0027031946506616,0.0835547006750648,0.0941512237056583,2.67885921136782e-226
NMR metabolomics,X23501.Triglycerides in Large VLDL,C9,Complement component C9,39990,-0.189422778578277,0.00579020631423474,-0.200771582954177,-0.178073974202377,1.94258172541728e-224
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.269714009689786,0.00827891744459877,0.253487331498372,0.2859406878812,4.67224183710916e-224
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROC,Vitamin K-dependent protein C,42199,0.0844622436010594,0.00260380660381248,0.0793587826575869,0.0895657045445319,2.12758161675234e-222
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.198427523857011,0.00613946482823012,-0.210460874920342,-0.18639417279368,6.59796495168661e-221
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC39A5,Zinc transporter ZIP5,42119,0.173337844256961,0.00538653086816679,0.162780243755354,0.183895444758568,5.50482435344037e-219
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.273664895199127,0.00852437322799605,0.256957123672255,0.290372666726,7.74930804730232e-218
NMR metabolomics,X23501.Triglycerides in Large VLDL,APCS,Serum amyloid P-component,39870,0.105030444078662,0.00328099907870076,0.0985996858844081,0.111461202272915,2.72721410260146e-215
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADIPOQ,Adiponectin,39979,-0.221142351337677,0.00694144921592167,-0.234747591800883,-0.20753711087447,2.01742136836811e-213
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.470719350929358,0.014852109888167,0.441609215548551,0.499829486310166,1.33539570581565e-212
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRP1,Neuropilin-1,42230,-0.0866113255483795,0.00277898582287134,-0.0920581377612073,-0.0811645133355516,4.71188920803087e-206
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.250291147807697,0.00813897049773227,0.234338765632142,0.266243529983253,9.14131377087166e-201
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLTP,Phospholipid transfer protein,42267,-0.117968929047665,0.00385392605203124,-0.125522624109646,-0.110415233985684,4.35935033468949e-199
NMR metabolomics,X23501.Triglycerides in Large VLDL,TTR,Transthyretin,39862,0.0770775993783177,0.00251091943725453,0.0721561972812988,0.0819990014753365,8.39723144922724e-199
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.265745020626448,0.0086906772310313,0.248711293253626,0.282778747999269,1.3476339733861e-198
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA4,Kallistatin,39802,0.0719688363149376,0.00237102170473452,0.067321633773658,0.0766160388562173,1.49051233375294e-194
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSG2,Desmoglein-2,42137,-0.0831141367189271,0.00275873692058811,-0.0885212610832798,-0.0777070123545744,4.61911679256362e-193
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA5,Plasma serine protease inhibitor,39835,0.0921889621222009,0.00305155657840082,0.0862079112285353,0.0981700130158665,7.81007056483e-193
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN3,Contactin-3,42137,0.0867902940507363,0.00289027849959798,0.0811253481915242,0.0924552399099483,7.60712269738329e-192
NMR metabolomics,X23501.Triglycerides in Large VLDL,MXRA8,Matrix remodeling-associated protein 8,39736,-0.0929348626739263,0.00311710482974231,-0.0990443881402213,-0.0868253372076314,5.46636659011713e-188
NMR metabolomics,X23501.Triglycerides in Large VLDL,AFM,Afamin,39979,0.0608475822987635,0.00204879055053932,0.0568319528197065,0.0648632117778206,9.36941278198361e-187
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD4,T-cell surface glycoprotein CD4,42100,0.087182664647669,0.00296452758319821,0.0813721905846005,0.0929931387107374,2.5913810723015e-184
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL23,C-C motif chemokine 23,42185,0.125473784894182,0.00431760074429902,0.117011287435355,0.133936282353008,3.43551110551807e-180
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.311930333257874,0.0109133731975724,0.290540121790632,0.333320544725116,1.700127639773e-174
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR37,Prosaposin receptor GPR37,41900,0.18813381050583,0.00666722206658564,0.175066055255323,0.201201565756338,3.46820843064178e-170
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLAT,Tissue-type plasminogen activator,42272,0.146602319628337,0.00524089781386542,0.136330159913161,0.156874479343513,1.7330400165062e-167
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.0955919695827142,0.003421083820564,0.0888866452944088,0.10229729387102,3.94060158992628e-167
NMR metabolomics,X23501.Triglycerides in Large VLDL,GH1,Somatotropin,42129,-0.506130845722637,0.0181952826780675,-0.541793599771649,-0.470468091673625,1.19601728898412e-165
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTA3,Glutathione S-transferase A3,41843,0.218014381665824,0.00790284802132948,0.202524799544019,0.23350396378763,6.17589403637069e-163
NMR metabolomics,X23501.Triglycerides in Large VLDL,CKB,Creatine kinase B-type,39966,-0.161283365850297,0.00584807393229614,-0.172745590757597,-0.149821140942997,4.02832167809136e-162
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPM,Carboxypeptidase M,42195,0.094815695784118,0.00348444022959779,0.0879861929341063,0.10164519863413,8.27464235565938e-159
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.344863627203745,0.012711192219156,0.319949690454199,0.36977756395329,6.9066676996422e-158
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.053831852856173,0.00198712160491371,0.0499370945105422,0.0577266112018039,2.01300637592444e-157
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.166281996145019,0.00614639816574744,0.154235055740154,0.178328936549884,6.13840908054711e-157
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHMP6,Charged multivesicular body protein 6,39958,0.158251784087356,0.00584109428774795,0.14680323928337,0.169700328891342,1.07165150803186e-156
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0925394554822921,0.00343660416055474,-0.0992751996369794,-0.0858037113276048,1.12829883349416e-155
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL6,C-X-C motif chemokine 6,42296,0.207836312476088,0.00774311374465419,0.192659809536565,0.22301281541561,1.03074022391111e-154
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUSB,Beta-glucuronidase,42211,0.166608417133749,0.00626808989428207,0.154322960940956,0.178893873326541,8.28727914982712e-152
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0562319715004299,0.00211492321994941,0.052086721989329,0.0603772210115307,9.30069530516881e-152
NMR metabolomics,X23501.Triglycerides in Large VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.186544161075083,0.00704756167497643,0.17273094019213,0.200357381958037,1.49766663434682e-150
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHBG,Sex hormone-binding globulin,39990,-0.126200253394484,0.00478087305923065,-0.135570764590576,-0.116829742198391,4.29432363256712e-149
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.104260787320746,0.00396860930507365,-0.11203926155869,-0.0964823130828013,1.97411445706168e-148
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS15,Enteropeptidase,42070,0.236564179065117,0.00902631798373657,0.218872595816993,0.25425576231324,1.04550497222926e-147
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRIP2,Cysteine-rich protein 2,42016,0.0976279297001845,0.00374288273297189,0.0902918795435596,0.104963979856809,2.41233368513411e-146
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNCA,Alpha-synuclein,39736,0.311460116970621,0.012045305619941,0.287851317955537,0.335068915985706,3.21561076463462e-143
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACY1,Aminoacylase-1,42145,0.166448442110327,0.00646149375980801,0.153783914341103,0.179112969879551,6.6757318615441e-143
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.064572584204004,0.00250996491076971,0.0596530529788954,0.0694921154291126,1.49299958946298e-142
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTA1,Glutathione S-transferase A1,42119,0.223522900851437,0.00871021133268679,0.206450886639371,0.240594915063504,7.491107503025e-142
NMR metabolomics,X23501.Triglycerides in Large VLDL,PON3,Serum paraoxonase/lactonase 3,42185,-0.0771819982553635,0.00301893495983274,-0.0830991107766356,-0.0712648857340913,7.60289302290035e-141
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFH,Complement factor H,39418,0.0613752516375674,0.00239817262903147,0.0566748332846657,0.066075669990469,2.62351321977534e-140
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300LG,CMRF35-like molecule 9,42137,-0.0959020495294666,0.00384347153376842,-0.103435253735653,-0.0883688453232805,2.16305295824577e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCS1,Neuronal calcium sensor 1,42262,0.0722253890995689,0.00291108681618988,0.0665196589398367,0.077931119259301,5.93004821478597e-133
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFPI,Tissue factor pathway inhibitor,42152,0.0795400988562483,0.00321015526471063,0.0732481945374155,0.0858320031750811,1.36349023742769e-132
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLI1,Friend leukemia integration 1 transcription factor,41843,0.283965567103677,0.0114983444784814,0.261428811925853,0.3065023222815,1.09352026171799e-131
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAMR1,Inactive serine protease PAMR1,42137,0.0670371405320899,0.00272439964088053,0.061697317235964,0.0723769638282157,7.94192206518732e-131
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENO3,Beta-enolase,39638,0.158128745927477,0.00643979031431617,0.145506756911417,0.170750734943537,1.11034621446831e-129
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROS1,Vitamin K-dependent protein S,39979,0.0636021386561531,0.00260318896933866,0.0584998882762493,0.0687043890360568,1.53349709035264e-128
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTSS1,Protein MTSS 1,39930,0.27879410493624,0.0114259685434091,0.256399206591159,0.301189003281322,3.35675537585224e-128
NMR metabolomics,X23501.Triglycerides in Large VLDL,UPB1,Beta-ureidopropionase,39958,0.226453165477182,0.00929153157805367,0.208241763584197,0.244664567370167,6.3211141659934e-128
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL16,C-C motif chemokine 16,42310,0.12857133376105,0.00528839027195436,0.11820608882802,0.138936578694081,7.31698981906667e-128
NMR metabolomics,X23501.Triglycerides in Large VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.182765911686179,0.00754329474766256,0.167981053980761,0.197550769391598,5.78147972805649e-127
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFP,Properdin,39979,0.0588313734733489,0.00242827817302053,0.0540719482542286,0.0635907986924691,1.76191474186369e-126
NMR metabolomics,X23501.Triglycerides in Large VLDL,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.18023005332039,0.00745871176440456,0.165610978262157,0.194849128378623,2.6523090202701e-126
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.0801535894649541,0.00332184842483147,0.0736427665522844,0.0866644123776237,5.35375487007955e-126
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELN,Elastin,39958,0.0857139541231533,0.00356348232497965,0.0787295287661932,0.0926983794801134,9.8105185550864e-125
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASGR1,Asialoglycoprotein receptor 1,42016,0.0749440503578032,0.00313219994899457,0.0688049384577738,0.0810831622578325,6.22241549226896e-124
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFI,Complement factor I,39979,0.0476419022861389,0.00199291071145583,0.0437357972916855,0.0515480072805923,2.83942603709015e-123
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.174159871168005,0.00728984128293289,0.159871782253456,0.188447960082553,4.13502106578533e-123
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAT2,Linker for activation of T-cells family member 2,42070,0.30993081091395,0.0130120447928568,0.284427203119951,0.33543441870795,7.27897429148617e-123
NMR metabolomics,X23501.Triglycerides in Large VLDL,F9,Coagulation factor IX,42199,0.0449796786827364,0.00189174511327175,0.0412718582607237,0.048687499104749,1.80137985849283e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINF1,Pigment epithelium-derived factor,39815,0.0642456868604989,0.00269733464942465,0.0589589109476266,0.0695324627733712,2.29237003900991e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUMB,Protein numb homolog,39657,0.20456256236854,0.00860227352907226,0.187702106251559,0.221423018485522,5.9963724741439e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRP,Gastrin-releasing peptide,39638,0.13025827175255,0.00547870205533922,0.119520015724085,0.140996527781015,6.7438744157556e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPIND1,Heparin cofactor 2,39959,0.0709546677016913,0.0029949160621611,0.0650846322198555,0.076824703183527,3.70431308106198e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.141427368152574,0.00601266160459758,-0.153212184897586,-0.129642551407563,6.45073486557075e-120
NMR metabolomics,X23501.Triglycerides in Large VLDL,KDR,Vascular endothelial growth factor receptor 2,42181,0.060840909042886,0.00258858240217038,0.0557672875346321,0.06591453055114,9.08223659626352e-120
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.12576108891493,0.00537801210824515,0.11522018518277,0.136301992647091,1.3060071547222e-118
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLKB1,Plasma kallikrein,39759,0.058785484148655,0.0025189139683246,0.0538484127707388,0.0637225555265712,1.17722854655017e-117
NMR metabolomics,X23501.Triglycerides in Large VLDL,F10,Coagulation factor X,39990,0.0694521342491907,0.00297715021562819,0.0636169198265595,0.075287348671822,1.27405165556858e-117
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.163335080820812,0.007050992645319,0.149515135235987,0.177155026405637,2.09176840247591e-116
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATRN,"Attractin, Isoform 2",39979,0.0397212184777542,0.00171220599995683,0.0363652947178388,0.0430771422376696,2.28776387780436e-116
NMR metabolomics,X23501.Triglycerides in Large VLDL,KYNU,Kynureninase,42296,0.10811788246217,0.00469289398197932,0.098919810257491,0.11731595466685,2.93118712134406e-115
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.0779555820603161,0.00338620608847543,0.0713186181269042,0.0845925459937279,4.65469922394053e-115
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORT1,Sortilin,42129,0.0903666115823949,0.00393933228744771,0.0826455202989974,0.0980877028657925,2.79887702346058e-114
NMR metabolomics,X23501.Triglycerides in Large VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.203276725151756,0.00890597390285717,0.185821016302156,0.220732434001356,8.98395342287808e-113
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF21,Fibroblast growth factor 21,42247,0.282465118067424,0.0124004206127509,0.258160293666432,0.306769942468416,9.33376762784893e-113
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYH9,Myosin-9,39966,0.265991830415022,0.011687474022499,0.243084381330924,0.28889927949912,3.69615331009289e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP4,Metalloproteinase inhibitor 4,42137,-0.0933479708854905,0.00411812156517357,-0.101419489153231,-0.0852764526177503,1.10782882427279e-111
NMR metabolomics,X23501.Triglycerides in Large VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.153928469172889,0.00679070570038165,0.140618686000141,0.167238252345637,2.70105857635896e-111
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTYMK,Thymidylate kinase,39958,0.156657726071976,0.00692067551133228,0.143093202069765,0.170222250074187,5.33349560793099e-111
NMR metabolomics,X23501.Triglycerides in Large VLDL,YES1,Tyrosine-protein kinase Yes,42070,0.266202238745419,0.0117945746447946,0.243084872441622,0.289319605049217,9.57491869175601e-111
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0604813987735241,0.00268672026789595,0.055215427048448,0.0657473704986001,3.45846473285369e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOS3,"Nitric oxide synthase, endothelial",41839,0.117760858583736,0.0052347322214047,0.107500783429782,0.128020933737689,5.16580345720918e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA1,Ephrin type-A receptor 1,42162,0.0747433050214455,0.00333461660496991,0.0682074564757044,0.0812791535671865,2.72296159039579e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAPIN,SNARE-associated protein Snapin,39934,0.134727521781257,0.00600236271221249,0.122962890865321,0.146492152697194,3.31026868744572e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,LATS1,Serine/threonine-protein kinase LATS1,39657,0.200149490202583,0.0089192681839128,0.182667724562114,0.217631255843053,4.26635040707261e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPPC,C-type natriuretic peptide,42119,0.121830093324842,0.0054442268128213,0.111159408771712,0.132500777877972,6.08551129272866e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.0957579947800888,0.00427912483901538,0.0873709100956187,0.104145079464559,6.17264992447575e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0454168222290492,0.00203051997073125,0.041437003086416,0.0493966413716825,7.30798603758178e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,EEF1D,Elongation factor 1-delta,39958,0.209717947193413,0.0093879907698842,0.19131748528444,0.228118409102387,3.2476359310711e-108
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL13,C-X-C motif chemokine 13,42249,0.131868279016341,0.00594490326728908,0.120216268612454,0.143520289420228,3.9867875240221e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPY,Pancreatic prohormone,42089,0.235975913505416,0.0106396703946731,0.215122159531857,0.256829667478976,4.45809809531888e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.0504162203593274,0.00227021446704386,0.0459666000039214,0.0548658407147333,5.95122346165744e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADH1B,All-trans-retinol dehydrogenase,39736,0.174042328039473,0.007852566397026,0.158651297901302,0.189433358177644,1.51658799943229e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.0725290542661461,0.00328734347108595,0.0660858610628176,0.0789722474694745,5.06401934754716e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.319037683433401,0.0144397538625216,0.290735765862859,0.347339601003943,6.06543095447041e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAP29,Synaptosomal-associated protein 29,42181,0.208212502993361,0.00946775054119705,0.189655711932614,0.226769294054107,2.35798365288923e-105
NMR metabolomics,X23501.Triglycerides in Large VLDL,FYB1,FYN-binding protein 1,42115,0.210342817464317,0.00957792523249552,0.191570084008626,0.229115550920008,4.60684524671066e-105
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDHR2,Cadherin-related family member 2,42070,0.14905809682468,0.00681097688758616,0.135708582125011,0.162407611524349,2.35293274243897e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,SARG,Specifically androgen-regulated gene protein,39915,0.248298478350826,0.0113353751928863,0.226081142972769,0.270515813728884,3.36520862361576e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,MLN,Promotilin,42119,0.201512585997927,0.00925093423743557,0.183380754892554,0.219644417103301,2.00320683830294e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,OXT,Oxytocin-neurophysin 1,42249,0.326132825403983,0.0150007856813763,0.296731285468485,0.35553436533948,4.6632050230721e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.128955121713821,0.00591997984880399,0.117351961210165,0.140558282217477,4.88341290660282e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP5,Retinol-binding protein 5,42070,0.125757576007142,0.00582516003937126,0.114340262329974,0.13717488968431,1.20101478460387e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGR3,Anterior gradient protein 3,41827,0.132122359749076,0.00612872606684119,0.120110056658067,0.144134662840084,2.45375432970693e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAA80,N-alpha-acetyltransferase 80,39649,0.273355315563014,0.0127045247228226,0.248454447106281,0.298256184019746,1.25004736577559e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAMDC4,Apical endosomal glycoprotein,39919,0.125417449312951,0.00583344325337328,0.113983900536339,0.136850998089562,1.58063381620483e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOMO1,Nodal modulator 1,42137,0.051690500180605,0.00241062200843316,0.046965681044076,0.056415319317134,2.46693043565729e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEG1,Protein HEG homolog 1,39736,0.061003620198949,0.00284199136978328,0.0554333171141737,0.0665739232837242,3.48179408720104e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,HJV,Hemojuvelin,39934,0.0931146551398164,0.0043395108181906,0.0846092139361628,0.10162009634347,3.77048221147357e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.0656777761180343,0.00306866846039879,0.0596631859356527,0.071692366300416,1.15555909762595e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEP,Leptin,42145,0.153791161536908,0.00720515353219953,0.139669060613797,0.167913262460019,1.88663309504225e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL2,Angiopoietin-related protein 2,42140,0.0873479257761679,0.00409799541677637,0.0793158547592863,0.0953799967930496,3.49983449448509e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.14389971762931,0.00675726890874606,0.130655470568167,0.157143964690452,5.65316477576936e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOST,Sclerostin,42129,0.0852793835347845,0.00401232189513932,0.0774152326203114,0.0931435344492576,1.22166114176773e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,FN1,Fibronectin,39979,0.0598114952480558,0.00281069488841816,0.0543025332667562,0.0653204572293554,1.43012460761105e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,TJAP1,Tight junction-associated protein 1,42181,0.182496306710805,0.0086076804422755,0.165625253043945,0.199367360377665,3.57402755377542e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.149491760056174,0.00705942322205533,0.135655290540946,0.163328229571403,1.39615474778286e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.232997535608116,0.0110257023928121,0.211387158918204,0.254607912298028,1.50906119007278e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORD,Sorbitol dehydrogenase,42204,0.149825459648034,0.00711617300781729,0.135877760552712,0.163773158743356,7.28651592748139e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTN4R,Reticulon-4 receptor,42262,0.0733833577941114,0.00349293026822494,0.0665372144683905,0.0802295011198323,1.80343363622338e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDHR5,Cadherin-related family member 5,42145,0.0842779194056577,0.00401198742276076,0.0764144240570466,0.0921414147542687,1.9582053618829e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0605861014767644,0.00288513872703264,0.0549312295717804,0.0662409733817484,2.28079140264316e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.212252948617844,0.0101227185526538,0.192412420254643,0.232093476981046,4.37735931576484e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.17209919303198,0.00820076622807844,0.156025691224946,0.188172694839014,5.8732857045567e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLA,Alpha-galactosidase A,39713,0.0846731650375933,0.00404090186839534,0.0767529973755384,0.0925933326996481,1.2030693587001e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD2AP,CD2-associated protein,42145,0.136656480194852,0.00653862619290601,0.123840772856757,0.149472187532948,1.71402807772414e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.21660298787991,0.0103732861478263,0.19627134703017,0.236934628729649,2.53799415080459e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,YTHDF3,YTH domain-containing family protein 3,41913,0.185197230607614,0.00887490424344325,0.167802418290466,0.202592042924763,3.50337924698812e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.119998571353384,0.00577457586738801,0.108680402653304,0.131316740053465,2.04090065116547e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTSS2,Protein MTSS 2,39919,0.215769912732291,0.0103721303558317,0.195440537234861,0.236099288229721,2.34692239924392e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.244115814573841,0.0117619349963739,0.221062421980949,0.267169207166734,6.52308885431397e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.078873871542776,0.00381413354252705,0.071398169799423,0.086349573286129,1.49862056830383e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,KHK,Ketohexokinase,39638,0.134543691759342,0.00650215391748685,0.121799470081067,0.147287913437616,2.37823642440188e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINF2,Alpha-2-antiplasmin,39786,0.0286525390377367,0.00138590374885137,0.025936167689988,0.0313689103854853,3.22679666915941e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF8,Immunoglobulin superfamily member 8,42145,0.0663604555370109,0.00321640326264268,0.0600563051422312,0.0726646059317905,3.81726788169889e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYAP1,Synapse-associated protein 1,39736,0.124933795252118,0.0060453243189833,0.11308495958691,0.136782630917325,3.85811329594553e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,YOD1,Ubiquitin thioesterase OTU1,39575,0.129544128142325,0.00626890740247327,0.117257069633477,0.141831186651172,4.22170767351353e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCN2,Ficolin-2,42116,0.086479011670554,0.00420253571777011,0.0782420416637246,0.0947159816773834,1.13483637864776e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,P4HB,Protein disulfide-isomerase,42073,0.0822368233419483,0.00400215379291647,0.0743926019078321,0.0900810447760646,2.07452895148429e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABL1,Tyrosine-protein kinase ABL1,42070,0.143361292749618,0.00699416050078716,0.129652738168075,0.157069847331161,5.72551207262399e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,CES3,Carboxylesterase 3,42070,0.150180141078164,0.00736671111983935,0.135741387283279,0.164618894873049,5.19453196479823e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,F11R,Junctional adhesion molecule A,42137,0.117496198113711,0.00578233467024345,0.106162822160034,0.128829574067389,1.9069530762424e-90
NMR metabolomics,X23501.Triglycerides in Large VLDL,MME,Neprilysin,42070,0.163663554523673,0.00807390430294679,0.147838702089897,0.179488406957448,5.11050252287807e-90
NMR metabolomics,X23501.Triglycerides in Large VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.209071130112701,0.0103039961037781,0.188875297749296,0.229266962476106,6.1383005967173e-90
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTD,Biotinidase,39979,0.0429818608371746,0.00211971794413057,0.0388272136666787,0.0471365080076705,7.83140122321242e-90
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXLNA,Alpha-taxilin,42016,0.184449511435358,0.00914153939774361,0.16653209421578,0.202366928654935,3.26251434927026e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLUL1,Clusterin-like protein 1,42123,-0.0935031271192012,0.00463548080152385,-0.102588669490188,-0.0844175847482145,3.57712347952406e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFR2,Fibroblast growth factor receptor 2,42181,0.046990366131141,0.0023333637708638,0.0424169731402479,0.051563759122034,6.71097228070349e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.0858841912430383,0.00426526022855417,0.0775242811950722,0.0942441012910045,1.2630212182928e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.18759004733726,0.00934838391509209,0.169267214863679,0.20591287981084,2.85405254101143e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP10,Stromelysin-2,42124,-0.119723825062031,0.00598217618250528,-0.131448890379741,-0.10799875974432,7.824009354325e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.151949255897049,0.00760055016818336,0.13705217756741,0.166846334226689,1.26468457621377e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,AXIN1,Axin-1,42119,0.200308924048418,0.0100223480813019,0.180665121809066,0.219952726287769,1.3301332919329e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP85,Centrosomal protein of 85 kDa,41843,0.134750267417775,0.00675752489810082,0.121505518617497,0.147995016218052,3.41378648029688e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,F13B,Coagulation factor XIII B chain,39925,0.0527262789759476,0.00264840477664337,0.0475354056137266,0.0579171523381686,1.03159265745274e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL4A1,Collagen alpha-1(IV) chain,42145,-0.081066699104598,0.00407777994462949,-0.0890591477960718,-0.0730742504131242,1.03810951892711e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.161081927207914,0.00810836645111343,0.145189528963731,0.176974325452096,2.35276378178348e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,KAZN,Kazrin,39930,0.21483495531326,0.0108399124001802,0.193588727008907,0.236081183617613,5.80036962570742e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,ISM1,Isthmin-1,42119,0.0810720353074909,0.00410220547173231,0.0730317125828956,0.0891123580320863,1.0008679936258e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFX1,Transcriptional repressor NF-X1,39575,0.137542864265219,0.00698245411856472,0.123857254192832,0.151228474337606,6.46581272305843e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCLY,Selenocysteine lyase,42224,0.0992759870503715,0.00504936385670747,0.0893792338912249,0.109172740209518,6.9497907721503e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP3S2,AP-3 complex subunit sigma-2,39929,0.0981299598669272,0.0049877656425942,0.0883539392074426,0.107905980526412,9.2617543412708e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,MASP1,Mannan-binding lectin serine protease 1,41997,0.047034208574217,0.00239617607993003,0.0423377034575541,0.0517307136908798,1.34722881986298e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.172128548899464,0.00876658836392777,0.154946035706165,0.189311062092762,2.13714471017692e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL16,Pro-interleukin-16,42296,0.0859432484404146,0.00439050927413495,0.0773378502631101,0.0945486466177191,3.5727973662405e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.0608554612048918,0.00310570191588321,0.0547682854497607,0.0669426369600229,4.1962800865438e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.106829122876917,0.00546250405386377,0.0961226149313442,0.11753563082249,5.31398205104002e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAB2,Stabilin-2,39966,0.0568894041646897,0.00290746684799704,0.0511907691426155,0.0625880391867639,7.08422558249396e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.134691569668247,0.00689865809102607,0.121170199809836,0.148212939526658,1.02113342670669e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCXR,L-xylulose reductase,42181,0.109811012218035,0.00563243738440593,0.098771434944599,0.12085058949147,1.63254986573915e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.0994129141320111,0.00509970344476444,0.0894174953802728,0.109408332883749,1.77826541079993e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.110946337625872,0.00569138940879221,0.0997912143846398,0.122101460867105,1.84906122389156e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.14733530574262,0.00756936489687623,0.132499350544743,0.162171260940498,2.94607782113033e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANG,Angiogenin,42152,0.0661407870035464,0.00340509884038985,0.0594667932763823,0.0728147807307105,6.45509700359114e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFC,Platelet-derived growth factor C,41843,0.0563568144027783,0.00290145885885022,0.0506699550394319,0.0620436737661247,6.90586955149452e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.104325929034365,0.00538744699899437,0.0937665329163363,0.114885325152394,2.00096345706757e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A4,Protein S100-A4,42181,0.112560685827655,0.00581880583604344,0.10115582638901,0.123965545266301,2.90113474237335e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,BECN1,Beclin-1,39638,0.119138604539323,0.00614997557305492,0.107084652416136,0.131192556662511,3.04801686419661e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTN1,Dynactin subunit 1,42262,0.128303840991243,0.00663426874636676,0.115300674248364,0.141307007734122,3.12558330446802e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,MVK,Mevalonate kinase,41913,0.16564032939394,0.00859151889562335,0.148800952358518,0.182479706429361,1.0334748343229e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPY30,Protein dpy-30 homolog,42216,0.120134267660263,0.00623877278552431,0.107906273000635,0.132362262319891,1.51866508729293e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASAH2,Neutral ceramidase,42016,0.106357755960239,0.0055319691605982,0.0955150964054662,0.117200415515011,2.76917725645394e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.105458931542408,0.00548528563512172,0.0947077716975692,0.116210091387246,2.87469173271146e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,PYY,Peptide YY,39575,0.198673540297551,0.0103465726672877,0.178394257869667,0.218952822725435,7.50535228178723e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.122211475955849,0.00637465072259355,0.109717160539566,0.134705791372132,7.94937321193612e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.162028549225865,0.00846327726916127,0.145440525778308,0.178616572673421,1.21135199704041e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL32,Interleukin-32,42119,-0.0883748779062837,0.00462135324606792,-0.0974327302685768,-0.0793170255439905,1.86348009729493e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,BPIFB1,BPI fold-containing family B member 1,42098,-0.128371053924706,0.0067256170987379,-0.141553263438232,-0.11518884441118,3.67987628536904e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP20,Centrosomal protein 20,41843,0.149051119006781,0.00781339132780473,0.133736872004284,0.164365366009279,4.68605352122674e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,IKBKG,NF-kappa-B essential modulator,42119,0.181197087060862,0.00950130544769229,0.162574528383386,0.199819645738339,4.95083220559647e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOA2,Apolipoprotein A-II,39990,-0.0974825039852829,0.00511168530810282,-0.107501407189164,-0.0874636007814013,7.73857560528299e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,EHBP1,EH domain-binding protein 1,39958,0.147947571754938,0.00775861010663434,0.132740695945934,0.163154447563941,8.04902745328524e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1R2,Interleukin-1 receptor type 2,42100,0.0396297084669092,0.00208095207305303,0.0355510424037253,0.0437083745300931,8.16865506247981e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXNA4,Plexin-A4,42119,0.158948065348016,0.0083659241232187,0.142550854066508,0.175345276629525,1.86314163914712e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMOT,Angiomotin,39736,0.0753173468434444,0.00396653599435181,0.0675429362945149,0.083091757392374,3.77708795990004e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCR,Breakpoint cluster region protein,42119,0.18196045677202,0.00960215794880316,0.163140227192366,0.200780686351674,4.66379301420206e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD63,CD63 antigen,41992,0.0993602575112579,0.00524817980473941,0.0890738250939686,0.109646689928547,6.6051933485102e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARF6,ADP-ribosylation factor 6,39930,0.213174184578358,0.0112493393854828,0.191125479382812,0.235222889773905,7.28771528034521e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.162692755470187,0.00858543779402574,0.145865297393896,0.179520213546477,7.65570190843747e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.20412759195253,0.0108213477936291,0.182917750277017,0.225337433628043,2.30637111105787e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM20A,Pseudokinase FAM20A,39958,0.0549227651802518,0.00291678843474491,0.0492058598481518,0.0606396705123518,6.56450692021366e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOC1,Apolipoprotein C-I,39959,0.0751607124894741,0.00399428327788364,0.0673319172648222,0.0829895077141261,8.29658053112897e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,TARBP2,RISC-loading complex subunit TARBP2,41839,0.15442096046703,0.00822918462950863,0.138291758593193,0.170550162340867,1.47544741459285e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.210879412784012,0.0112826740115618,0.18876537172135,0.232993453846673,8.39870387566471e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBIN,Erbin,42070,0.198471375170285,0.0106501576038103,0.177597066266817,0.219345684073753,1.51369901692846e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4A,C-type lectin domain family 4 member A,42119,-0.0689951982118132,0.00371248809971732,-0.0762716748872592,-0.0617187215363673,3.79271307016694e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKK1,Dickkopf-related protein 1,42249,0.113401190521008,0.00613099443769984,0.101384441423116,0.125417939618899,1.84157255292545e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSNK2A1,Casein kinase II subunit alpha,39934,-0.0854823849362618,0.00461608028923168,-0.0945299023031559,-0.0764348675693677,1.89406395815019e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.143140840599525,0.00774246239423133,0.127965614306831,0.158316066892218,3.56729022674507e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,STC1,Stanniocalcin-1,42249,0.0879427766354474,0.00476586922422988,0.0786016729559569,0.097283880314938,4.06165678726149e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.038029057508153,0.00207263956285405,0.0339666839649591,0.0420914310513469,2.73880465990927e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL10,C-X-C motif chemokine 10,42185,0.125578854461468,0.00685623565313227,0.112140632581329,0.139017076341607,4.79006380882795e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18R1,Interleukin-18 receptor 1,42296,0.0628709648653334,0.00343410428681169,0.0561401204631825,0.0696018092674843,5.4572385823881e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPK9,Mitogen-activated protein kinase 9,42119,0.0816163413789398,0.00445816315868845,0.0728783415879105,0.0903543411699692,5.66769794225731e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNIP1,TNFAIP3-interacting protein 1,39929,0.167881688758151,0.00915938115885692,0.149929301686792,0.185834075829511,5.67545704575204e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDLIM7,PDZ and LIM domain protein 7,42185,0.238674929405502,0.0130411870997263,0.213114202690038,0.264235656120965,6.19813537984954e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAP23,Synaptosomal-associated protein 23,42145,0.164695314116116,0.00903743410999638,0.146981943260523,0.182408684971709,2.51184994264147e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC1B,C-type lectin domain family 1 member B,42249,0.180667113746649,0.00993720664900952,0.161190188714591,0.200144038778708,5.30624606932853e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,FETUB,Fetuin-B,42199,0.0607366590198208,0.00334680507714427,0.054176921068618,0.0672963969710235,9.65022852210759e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.214760189697392,0.0118328197039518,0.191567863077647,0.237952516317137,1.37885466003696e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.0939082256716563,0.00517712238746872,0.0837610657922176,0.104055385551095,1.72330828226369e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.133093763904337,0.00737663045615178,0.11863556821028,0.147551959598395,6.46673579559242e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.201652651397267,0.0111681283356286,0.179763119859435,0.223542182935099,7.1177656533247e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R9B,Neurabin-2,42296,0.177453668864599,0.00985770494432632,0.158132567173719,0.196774770555479,1.26575700828785e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP5,Microfibrillar-associated protein 5,42310,0.0756629940756838,0.00420749322835662,0.0674163073481048,0.0839096808032627,1.75378756042979e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.206547970728211,0.0115149380874433,-0.2291172493796,-0.183978692076822,3.99666230325699e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD6,T-cell differentiation antigen CD6,42284,0.0971115622355322,0.00541950612354106,0.0864893302333917,0.107733794237673,5.42790060212777e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATG16L1,Autophagy-related protein 16-1,39930,0.16029474111771,0.00893783897651061,0.142776576723749,0.177812905511671,6.05621419703665e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPB2,Carboxypeptidase B2,39959,0.0417190540841919,0.00233146065155249,0.037149391207149,0.0462887169612348,1.22088117396831e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACE2,Angiotensin-converting enzyme 2,41900,0.101409070068566,0.00567807829414535,0.0902800366120413,0.112538103525091,1.61345520417765e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAT5B,Signal transducer and activator of transcription 5B,42070,0.25466476753104,0.0142629412043918,0.226709402770432,0.282620132291648,1.71266939845978e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.101615129120438,0.00569337575724156,0.0904561126362445,0.112774145604631,1.9795101605465e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.203875414087028,0.0114168035636533,0.181498479102267,0.226252349071788,2.32984184500443e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.129320751835615,0.00724449508030519,0.115121541478217,0.143519962193013,2.60158104172092e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,BACH1,Transcription regulator protein BACH1,42119,0.139181702599113,0.00781037851616038,0.123873360707439,0.154490044490788,3.13144217669858e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLA2,Src-like-adapter 2,39934,0.197415702243754,0.0110662420540015,0.175725867817911,0.219105536669597,3.17232016329424e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.0895558137716864,0.00503529786829136,0.0796866299498353,0.0994249975935374,8.41545295298565e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.098070307796959,0.00552125479600036,0.0872486483967984,0.10889196719712,1.21474714670288e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.0519918931853288,0.002929067128342,0.0462509216137785,0.0577328647568791,1.49239519950656e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,CMIP,C-Maf-inducing protein,39919,0.153869411970306,0.00870399463494312,0.136809582485818,0.170929241454795,5.22066117494451e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA3F,Semaphorin-3F,42145,0.0489430708013127,0.00277565572324815,0.0435027855837463,0.054383356018879,8.06444472823349e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.163381710522482,0.00931435453943853,0.145125575625183,0.181637845419782,5.51167693869997e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAB2,Disabled homolog 2,42262,0.202006119839561,0.0115389584572171,0.179389761263415,0.224622478415706,7.03556171952085e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.205982110128857,0.011776775764505,0.182899629630427,0.229064590627287,9.41048675061417e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL17,C-X-C motif chemokine 17,42296,0.0774452274464496,0.00443297190346837,0.0687566025156516,0.0861338523772476,1.30340345309378e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.172191909849846,0.00988417878242651,0.15281891943629,0.191564900263402,3.07462291137032e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.10183736462567,0.00585408837212343,0.0903633514163078,0.113311377835032,4.81124196474374e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEP1A,Meprin A subunit alpha,39930,0.137323188561096,0.00788919545632409,0.121860365466701,0.152786011655492,5.46164963536868e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE4,Ribonuclease 4,39645,0.050078223721156,0.00287933437371962,0.0444347283486655,0.0557217190936464,7.31356903774012e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.133661013178305,0.00770017689923702,0.1185686664558,0.14875335990081,1.3064811768354e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT18,"Keratin, type I cytoskeletal 18",42070,0.153271488432064,0.00884116851797602,0.135942798136831,0.170600178727297,1.32476784596401e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOXO1,Forkhead box protein O1,42119,0.156261698127857,0.00903033297834118,0.138562245490308,0.173961150765405,2.26975834730464e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.194538163702031,0.0112342388964669,0.172519055464956,0.216557271939106,2.51261364890077e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,EZR,Ezrin,42249,0.0436935708246004,0.00253226922684622,0.0387303231399818,0.048656818509219,5.16553625218246e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.130560746351727,0.00756593840093813,0.115731507085888,0.145389985617566,7.30219920443362e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0481684833147212,0.00279662673912318,0.0426870949060397,0.0536498717234026,8.85827012400035e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESM1,Endothelial cell-specific molecule 1,42123,-0.0622509594840417,0.0036174347292957,-0.0693411315534613,-0.0551607874146222,1.14388196358613e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGRN,Agrin,42185,0.0642559434340165,0.00373462275836132,0.0569360828276283,0.0715758040404047,1.19713359033567e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.0881657528469703,0.00514116759222601,0.0780890643662073,0.0982424413277333,3.23215888511618e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.182754704554957,0.0106622136800891,0.161856765741983,0.203652643367932,3.57545834802039e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLIN1,Perilipin-1,41839,0.0606342730330403,0.0035377244608001,0.0537003330898721,0.0675682129762085,3.80272826936538e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH2B3,SH2B adapter protein 3,41843,0.175423301187499,0.0102685417881335,0.155296959282757,0.195549643092241,9.70073233059817e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL22,C-C motif chemokine 22,41991,0.0922424764197205,0.00540610500992039,0.0816465106002765,0.102838442239164,1.35378489136898e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCK2,Cytoplasmic protein NCK2,42185,0.189431672158077,0.011134265307008,0.167608512156341,0.211254832159812,3.0198880678035e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINE1,Plasminogen activator inhibitor 1,42310,0.117752340507291,0.00692264508118726,0.104183956148164,0.131320724866418,3.16676491982885e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAXX,Protein PAXX,39736,0.0818000894477319,0.00480508948965727,0.0723821140480037,0.0912180648474602,3.54580727320484e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL5,C-X-C motif chemokine 5,42101,0.199503861476141,0.0117349068529272,0.176503444044404,0.222504278907878,3.75679247597743e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17RB,Interleukin-17 receptor B,41934,-0.0954164506770795,0.0056387705020776,-0.106468440861152,-0.0843644604930074,1.43708514141283e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5E,5'-nucleotidase,42181,0.0947742453279777,0.00560379227739384,0.0837908124642857,0.10575767819167,1.62342274083072e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.123218403821623,0.00728809325234907,0.108933741047018,0.137503066596227,1.83872575892347e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUOM,Fucose mutarotase,39736,0.113231205385676,0.0066941582572278,0.100110655201509,0.126351755569842,2.15450620118141e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFC,Vascular endothelial growth factor C,42181,0.0975063457360677,0.00577118279319753,0.0861948274614005,0.108817864010735,2.15808133101195e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELP,P-selectin,42217,0.0981364843209785,0.00581380847646395,0.0867414197071091,0.109531548934848,2.77986248295465e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM5,Tripartite motif-containing protein 5,42119,0.152732998210257,0.00904903413460374,0.134996891306434,0.170469105114081,2.88120585120761e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,GMPR,GMP reductase 1,42296,0.0836747701536116,0.00495964250158037,0.0739538708505141,0.0933956694567091,3.18807597863438e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLSCR3,Phospholipid scramblase 3,39911,0.101036498927604,0.00599043731785119,0.0892952417846155,0.112777756070592,4.68259253737835e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.12020314902577,0.00712607072978416,0.106236050395393,0.134170247656147,4.74684864080474e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOE,Apolipoprotein E,39979,0.122207560473064,0.00725242464349248,0.107992808171819,0.136422312774309,6.00661784448461e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCTN3,Tectonic-3,39958,0.0532246692336118,0.00315880457347696,0.0470334122695969,0.0594159261976266,6.12159066063064e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,MINK1,Misshapen-like kinase 1,39929,0.162961811884072,0.00968077801221272,0.143987486980135,0.181936136788009,8.01531281803904e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMBP,Protein AMBP,42239,0.0351870778875014,0.0020991341067238,0.0310727750383228,0.0393013807366801,1.92740081215487e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0413540580676938,0.00246702360217662,0.0365186918074276,0.04618942432796,1.93424127230494e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSO,Cathepsin O,42296,0.0532582407177618,0.00318792910182997,0.047009899678175,0.0595065817573485,4.8510257596286e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRPK2,SRSF protein kinase 2,42119,0.148290564835755,0.00887777177526048,0.130890132156245,0.165690997515266,5.159252671553e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0444094224562896,0.00265928747549388,0.0391972190043216,0.0496216259082576,5.39536405578936e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRELD1,Protein disulfide isomerase CRELD1,39736,0.0649845145068677,0.00388964785561297,0.0573608047098663,0.0726082243038691,6.58769407189922e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.146191199596475,0.00876004798913618,0.129021505537768,0.163360893655182,8.67371700406157e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.0704171159085727,0.00422389661936889,0.0621382785346097,0.0786959532825358,1.15089601492975e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.134441295808363,0.00808193056760656,0.118600711895855,0.150281879720872,1.60108446945403e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,OPHN1,Oligophrenin-1,39929,0.186961446397455,0.0112741941259821,0.16486402591053,0.20905886688438,4.8262352377193e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS8,Prostasin,42080,0.0720787857171129,0.0043531563959291,0.0635465991810918,0.0806109722531339,5.61889369028822e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,GASK1A,Golgi-associated kinase 1A,39575,0.0734394555677439,0.00443974323278404,0.0647375588314872,0.0821413523040006,1.00114102850819e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOP2B,DNA topoisomerase 2-beta,39657,0.138066298156552,0.00835293583933544,0.121694543911454,0.154438052401649,1.20684310220868e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.176508052695141,0.0106790004760005,0.15557721176218,0.197438893628102,1.22121515164858e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIT1,ARF GTPase-activating protein GIT1,39657,0.166324017082039,0.0100693653446539,0.146588061006517,0.18605997315756,1.44782669960247e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTBS,Di-N-acetylchitobiase,39860,0.0472669061190341,0.0028624524531746,0.0416564993108119,0.0528773129272563,1.52640424076385e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.181377783307661,0.0109967530356508,0.159824147357786,0.202931419257537,1.59583369749103e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSTN,Growth/differentiation factor 8,41900,0.0927750201388389,0.00562786703243613,0.0817444007552641,0.103805639522414,1.87069469920097e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL5,C-C motif chemokine 5,42217,0.173015961182649,0.010516029774203,0.152404542825211,0.193627379540087,3.06100521232506e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCBP2,Poly(rC)-binding protein 2,39934,0.124916084543369,0.00758618513247486,0.110047161683718,0.139785007403019,3.20105177273693e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,THOP1,Thimet oligopeptidase,42081,0.0537201980641364,0.00326657900700989,0.047317703210397,0.0601226929178758,3.48504496661805e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAT,Linker for activation of T-cells family member 1,42296,0.129876432722855,0.00789910996560407,0.114394177190271,0.145358688255438,3.61146859796719e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.0412019581824407,0.0025060642834149,0.0362900721869475,0.0461138441779339,3.80265028347238e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.114016389042924,0.00693632133916471,0.100421199218161,0.127611578867687,4.05171272809637e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINH1,Serpin H1,39757,0.219809116331931,0.013375955187562,0.19359224416431,0.246025988499553,5.59691710933669e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,HGF,Hepatocyte growth factor,42296,0.0589782669560581,0.00359743153874151,0.0519273011401247,0.0660292327719915,7.76366641989061e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC27,Cell division cycle protein 27 homolog,41843,0.104167400378066,0.00635409528708261,0.0917133736153842,0.116621427140748,8.22127252238574e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.166961406105592,0.0101889697713092,0.146991025353826,0.186931786857358,8.84234253988323e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEFTY2,Left-right determination factor 2,42247,0.0880061538728978,0.00537124657661903,0.0774785105827245,0.0985337971630711,9.14602999951977e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOK2,Docking protein 2,42145,0.209880917276291,0.0128115050039625,0.184770367468524,0.234991467084057,9.60906843414657e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRAP,BRCA1-associated protein,39813,0.187405671696394,0.0114395392903343,0.164984174687339,0.209827168705449,1.25847253561544e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.174133571907002,0.010667711209894,0.15322485793561,0.195042285878395,3.18158689630287e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0658149461398909,0.00404828594834657,0.0578803056811316,0.0737495865986501,7.03668739519763e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.103955245197915,0.00639857831249117,0.0914140317054323,0.116496458690398,8.50229044954511e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNST,Consortin,42145,0.18441600142497,0.0113583974366221,0.162153542449191,0.20667846040075,1.00359712898451e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP43,Centrosomal protein 43,41797,0.11909865377988,0.00733533301661087,0.104721401067323,0.133475906492438,1.03408989121833e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.188833436862702,0.0116696352715099,0.165960951730543,0.211705921994862,2.42776351079889e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0900061955623384,0.00556907541692355,0.0790908077451682,0.100921583379509,3.37870289675049e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPD52L2,Tumor protein D54,39736,0.182986155401554,0.011317063900487,0.1608047101566,0.205167600646509,3.82136133446464e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.132342778955568,0.00819592336808404,-0.148406788757013,-0.116278769154124,4.12056561059075e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.0337225332226781,0.00208914905444767,0.0296278010759606,0.0378172653693955,4.54065691581078e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,C19orf12,Protein C19orf12,41839,0.112454733225002,0.00697053455920758,0.0987924854889549,0.126116980961049,5.34998174980524e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.107163417035293,0.00664809530064588,0.094133150246027,0.120193683824559,6.62143955280214e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEXIM1,Protein HEXIM1,42119,0.135679587643964,0.00842353646114213,0.119169456180126,0.152189719107803,7.83523074759663e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,RABEP1,Rab GTPase-binding effector protein 1,39736,0.128739812800416,0.0080091850436023,0.113041810114956,0.144437815485877,1.71734315453376e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN2,CCN family member 2,42146,0.0944487523011817,0.0058920939904375,0.0829002480799242,0.105997256522439,2.66349628283922e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,AZI2,5-azacytidine-induced protein 2,39934,0.0927154330193258,0.00578242767829789,0.0813818747698619,0.10404899126879,3.14512828085433e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,PXN,Paxillin,41839,0.0857178372872768,0.00535427647125093,0.075223455403625,0.0962122191709286,3.78493020583022e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSIP1,PC4 and SFRS1-interacting protein,42119,0.10983571043939,0.00686386044698666,0.0963825439632962,0.123288876915484,4.1341324420815e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.139684938183971,0.00872909817569656,0.122575905759606,0.156793970608337,4.13985202325406e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYTL4,Synaptotagmin-like protein 4,39958,0.121080928268379,0.0075664906288511,0.106250606635831,0.135911249900927,5.16528391155596e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.17336206070863,0.0108486009008909,0.152098802942884,0.194625318474377,5.80410581983202e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.158525812240808,0.00992677598720525,0.139069331305885,0.17798229317573,7.03471233864614e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH2,Cadherin-2,42145,0.0587006715129949,0.00368084146961954,0.0514862222325406,0.0659151207934492,9.71237608396738e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.157885285972128,0.00990858655174365,0.138464456330711,0.177306115613546,1.21299911353816e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.152357518405327,0.00956364949181057,0.133612765401378,0.171102271409275,1.29052535407127e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSD,Cathepsin D,41225,0.0687706485069425,0.00431794620233263,0.0603074739503705,0.0772338230635144,1.46869037017479e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOM,Apolipoprotein M,42199,0.0470405755939443,0.0029596374479988,0.0412396861958666,0.0528414649920219,2.2412064478605e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEC31A,Protein transport protein Sec31A,39638,0.128019830615326,0.00805248187220631,0.112236966145801,0.14380269508485,2.74347561935336e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.10472363758712,0.00659380601025939,0.0917997778070118,0.117647497367229,2.78554030319737e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,LSP1,Lymphocyte-specific protein 1,42119,0.0669399836474716,0.00422655366327714,0.0586559384674484,0.0752240288274947,5.42323271015236e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP3B1,AP-3 complex subunit beta-1,39930,0.126896595425948,0.008015297775525,0.111186611785919,0.142606579065977,7.44151539035199e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.126733178284774,0.00801986060981775,0.111014251489531,0.142452105080017,1.17081357312964e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,USO1,General vesicular transport factor p115,42070,0.146277391417802,0.00928673665215293,0.128075387579582,0.164479395256022,2.10177425500436e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLK1,Protein delta homolog 1,42310,0.0949454774822037,0.00603799708810832,0.0831110031895114,0.106779951774896,3.11177518311652e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELE,E-selectin,42310,0.0828140072372427,0.00526897816027108,0.0724868100431114,0.093141204431374,3.48921897076273e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.132655275682271,0.00843219447148494,0.11612817451816,0.149182376846381,3.49501003045313e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.0881358274513037,0.00560751933357354,0.0771450895574996,0.0991265653451079,4.46941206350861e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD5,Programmed cell death protein 5,42249,0.09376093033046,0.00597707372947388,0.0820458658206912,0.105475994840229,5.62472544801555e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,AAMDC,Mth938 domain-containing protein,39638,0.0863335466812308,0.0055099258933042,0.0755340919303546,0.0971330014321071,9.60567495407344e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,OTUD7B,OTU domain-containing protein 7B,39934,0.102980304939884,0.00657503373361988,0.0900932388219891,0.115867371057779,1.02377683850812e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.101880285542827,0.00651455410824563,0.0891117594906652,0.114648811594988,1.46443276267196e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.154998676280641,0.00992195970513526,0.135551635258576,0.174445717302706,1.57790555093531e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.170867218577759,0.0109637453775309,0.149378277637798,0.192356159517719,3.43832778991517e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.0521216252743628,0.00334920488069599,-0.0586860668405269,-0.0455571837081986,3.83841797377513e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFRP4,Secreted frizzled-related protein 4,39736,0.0648327359715858,0.0041628368822455,0.0566735756823846,0.072991896260787,4.05260373803159e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGL1,Fibrinogen-like protein 1,39990,-0.104964014326022,0.0067423589244582,-0.11817903781796,-0.0917489908340841,4.33755894394447e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMN,Protein amnionless,41913,0.0765871672870856,0.00493058105542147,0.0669232284184595,0.0862511061557117,6.15572179088159e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.11666291838312,0.00751207456670186,0.101939252232384,0.131386584533856,7.79098232038013e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSME1,Proteasome activator complex subunit 1,42002,0.0587908494248186,0.00379306990870281,0.0513564324037611,0.0662252664458761,1.0213484672568e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFB,Platelet-derived growth factor subunit B,42185,0.138411457088985,0.00894515632631192,0.120878950689414,0.155943963488556,1.50263138449917e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL13,C-C motif chemokine 13,42275,0.109903250494765,0.00710696817423903,0.0959735928732569,0.123832908116274,1.71708598249767e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.1641688720655,0.0106297817924952,0.14333449975221,0.185003244378791,2.35425517975597e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.0387158419793805,0.00250703816508384,0.0338020471758161,0.0436296367829448,2.4008407014957e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUCB2,Nucleobindin-2,42231,0.0603465578962116,0.003910255456493,0.0526824572014853,0.0680106585909379,2.77468636473464e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGCC,Regulator of cell cycle RGCC,39934,0.12288006883095,0.00796797905364409,0.107262829885807,0.138497307776092,4.0435783432439e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.125478485233655,0.00813956802146609,0.109524931911581,0.141432038555729,4.42007322052636e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAS6,Growth arrest-specific protein 6,42236,-0.0405446806255317,0.00263424563520074,-0.0457078020705251,-0.0353815591805383,5.21543521877548e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDLIM5,PDZ and LIM domain protein 5,39934,0.189744493890001,0.0123496358710058,0.16553920758283,0.213949780197173,9.63650172289647e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,NHLRC3,NHL repeat-containing protein 3,39481,0.0515814828871474,0.00336113847345915,0.0449936514791675,0.0581693142951273,1.32848125118438e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.105532479878236,0.00688590014833963,0.0920361155874902,0.119028844168982,1.72317179074343e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM13A,Protein FAM13A,39930,0.108348547528679,0.00707021266999513,0.0944909306954883,0.122206164361869,1.75612032573601e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOLGA3,Golgin subfamily A member 3,39934,0.123820606299744,0.00808272275599388,0.107978469697996,0.139662742901492,1.9065901869028e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPL,N-acetylneuraminate lyase,39958,0.074052941558725,0.00483414122891553,0.0645780247500505,0.0835278583673994,1.91423333035773e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINC1,Antithrombin-III,39959,0.023066595427011,0.0015061866680175,0.0201144695576967,0.0260187212963253,2.03822200097288e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYN,Tyrosine-protein kinase Lyn,42070,0.135196429339902,0.00885720397108728,0.117836309556571,0.152556549123233,3.62739642281534e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNMBP,Dynamin-binding protein,42016,0.0966683718860764,0.00633759046145121,0.084246694581632,0.109090049190521,4.28742736514352e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.0488085945831635,0.00319810368102172,0.042540311368361,0.0550768777979661,4.74898581690647e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0435374782069023,0.00285991495807608,0.0379320448890732,0.0491429115247315,6.66298506176735e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.101359237944845,0.00666453744320568,0.0882967445561618,0.114421731333528,1.00187632977979e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL17,C-C motif chemokine 17,42107,0.144693833283857,0.00955361328148319,0.12596875125215,0.163418915315564,2.14473561211754e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,METAP2,Methionine aminopeptidase 2,42247,0.0880405594806127,0.00581858206409384,0.0766361386349888,0.0994449803262366,2.63890456009114e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.0506463629922274,0.00335046507877528,-0.057213274546627,-0.0440794514378279,3.2733010136915e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,NIT2,Omega-amidase NIT2,39903,0.114918389809219,0.00760222186249679,0.100018034958725,0.129818744659713,3.98439568021001e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRAF2,TNF receptor-associated factor 2,42119,0.109199936352644,0.00724883651960691,0.094992216774214,0.123407655931073,7.17260190951558e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,NIT1,Deaminated glutathione amidase,39638,0.0696299116878687,0.00462214714333545,0.0605705032869312,0.0786893200888062,8.86395264014641e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHACTR2,Phosphatase and actin regulator 2,39934,0.179132714239078,0.0118932996104272,0.155821847002641,0.202443581475515,8.96193569779134e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD1,Sushi domain-containing protein 1,41900,0.0764406591561486,0.00508095298112292,0.0664819913131477,0.0863993269991495,9.79607206993582e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCAM,Cell surface glycoprotein MUC18,42217,-0.0502639129811791,0.00334476670020653,-0.0568196557135839,-0.0437081702487743,1.23203772363617e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,STK11,Serine/threonine-protein kinase STK11,41900,0.114470519043786,0.00761772739834487,0.0995397733430297,0.129401264744542,1.27393489167534e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3GLB2,Endophilin-B2,39929,0.102982776373228,0.0068492913692813,0.089558165289437,0.11640738745702,1.320267697921e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.0799040831585707,0.00532342628771081,0.0694701676346575,0.0903379986824838,1.99363094860434e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.141720022984035,0.00944930811624528,0.123199379076194,0.160240666891876,2.36560232954348e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.166184449381542,0.0110865356627293,0.144454839482593,0.187914059280492,2.59666578620759e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.170777012642825,0.0114147529713835,0.148404096818914,0.193149928466737,3.30955070319102e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB27B,Ras-related protein Rab-27B,39958,0.12865252789198,0.00859543581711323,0.111805473690438,0.145499582093522,3.59541389685376e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH1A1,Retinal dehydrogenase 1,42137,0.0831938960005593,0.00556300391692548,0.0722904083233854,0.0940973836777333,3.64033224303017e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAX1BP1,Tax1-binding protein 1,39929,0.0967468843134852,0.00646570899137062,0.0840740946903988,0.109419673936572,3.85072163841993e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.0727127819861892,0.00486814778499705,-0.0822543516447835,-0.063171212327595,4.74255744932699e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGF,Placenta growth factor,42296,0.0408041197103596,0.00273384519271899,0.0354457831326304,0.0461624562880889,5.55263591213564e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.121459410114137,0.00814806738634493,0.105489198036901,0.137429622191373,8.8431437663225e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAMBP,STAM-binding protein,41997,0.0981023144452797,0.00658686077775891,0.0851920673208722,0.111012561569687,9.06331496824744e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,CMC1,COX assembly mitochondrial protein homolog,39958,0.141867805735013,0.00951894280373164,0.123210677839699,0.160524933630327,9.1927378586012e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.131987223382499,0.00886457690338979,0.114612652651855,0.149361794113143,1.17189087757703e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.0303581928463626,0.00204224331156335,-0.0343609897370268,-0.0263553959556985,1.37170603851628e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEPR,Leptin receptor,42145,-0.0487778116513842,0.00328429996757695,-0.0552150395878351,-0.0423405837149334,1.65950407618881e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,MITD1,MIT domain-containing protein 1,42016,0.149783113200172,0.0101026042746115,0.129982008821933,0.16958421757841,2.43719053219851e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.0854428319097972,0.00577130967747174,0.0741310649419527,0.0967545988776418,3.27590993080161e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPON2,Spondin-2,42070,-0.0539168755973539,0.00364624861958743,-0.0610635228917453,-0.0467702283029626,4.31297172857224e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREH,Trehalase,39966,0.115809550423299,0.00784432367444384,0.100434676021389,0.131184424825209,7.13624586916911e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBNL,Drebrin-like protein,42185,0.142347431131924,0.00968448240481925,0.123365845618478,0.16132901664537,1.55387404524805e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.0806993469954675,0.00550565073595337,0.0699082715529989,0.0914904224379361,2.83219194343012e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBC1D23,TBC1 domain family member 23,42070,0.13787139372798,0.00940771238041715,0.119432277462363,0.156310509993598,2.93664892155682e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,NSFL1C,NSFL1 cofactor p47,42249,0.0960351100295918,0.00656940872432622,0.0831590689299124,0.108911151129271,4.93444183868732e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.0448166164255331,0.00307038213517373,0.0387986674405926,0.0508345654104736,6.96609778641791e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.13099440396069,0.00898288365433135,0.1133879519982,0.148600855923179,9.80085679675726e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,GTPBP2,GTP-binding protein 2,39649,0.12453087779411,0.00856278415159111,0.107747820856992,0.141313934731229,1.76735467074665e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNDP1,Beta-Ala-His dipeptidase,42217,0.0699912346316288,0.00482547772562475,0.0605332982894043,0.0794491709738533,2.55480355726068e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPC5,Glypican-5,42016,0.0854634373667598,0.00589219103233477,0.0739147429433837,0.097012131790136,2.58550282817282e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRKL,Crk-like protein,42143,0.159794603213264,0.0110200209005043,0.138195362248276,0.181393844178252,2.72266202804744e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.129116949332509,0.00890448989425241,0.111664149139774,0.146569749525244,2.78017320254639e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP45,Rho GTPase-activating protein 45,39736,0.125621204218088,0.0086605303497044,0.108646564732667,0.142595843703509,3.03256925901117e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.114388708044668,0.00790218181904801,0.0989004316793341,0.129876984410002,3.90746797746025e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.0736918538255442,0.00509825350046426,0.0636992769646342,0.0836844306864541,5.3622858207202e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.176416843979435,0.0122064251188156,0.152492250746556,0.200341437212313,5.40750216010123e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIP,Gastric inhibitory polypeptide,39638,0.0761440095264393,0.00527243456499861,0.0658100377790421,0.0864779812738366,7.52965878904896e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.136075377089162,0.009423480862721,0.117605354598229,0.154545399580095,7.54234357967624e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,CREG1,Protein CREG1,41960,0.0608895208444573,0.00422113201267555,0.0526161020996132,0.0691629395893013,8.10376313175047e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.133175270934999,0.00924624827955274,0.115052624307075,0.151297917562922,1.27443249117831e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX15,Sorting nexin-15,39736,0.080918094916203,0.00562238465492984,0.0698982209925405,0.0919379688398654,1.51521735528344e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTDH,Protein LYRIC,39657,0.142849556651414,0.00992560348641421,0.123395373818042,0.162303739484786,1.52776459723312e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.073356930203698,0.00509775389175231,0.0633653325758635,0.0833485278315325,1.53690375115064e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDHD2,Phospholipase DDHD2,39934,0.0994435724821019,0.00691213107309866,0.0858957955788286,0.112991349385375,1.60706867702583e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.116175639269907,0.00808291812486192,0.100333119745178,0.132018158794636,1.71045436935017e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGBP1,Immunoglobulin-binding protein 1,39934,0.0898256442969825,0.00624986556039668,0.0775759077986051,0.10207538079536,1.97156086800807e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.109006092741772,0.00760032339468271,0.094109458888194,0.12390272659535,2.60264764734816e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.0556998504201425,0.00389214127402886,0.048071253523046,0.0633284473172391,4.05094040962532e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.0498209148809252,0.00348457616567554,0.0429911455962011,0.0566506841656493,4.90783381605646e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN2L,Ataxin-2-like protein,39934,0.0716111590132037,0.00501274720886526,0.0617861744838277,0.0814361435425796,6.70962730263679e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.093269383444872,0.00653090458727902,0.0804688104538051,0.106069956435939,7.37166643627567e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL3,C-X-C motif chemokine 3,42129,0.141868164940859,0.00996892338934575,0.122329075097741,0.161407254783977,1.25458779877533e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,KITLG,Kit ligand,42145,-0.056771507026905,0.00399065060274749,-0.0645931822082901,-0.04894983184552,1.34331576873082e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXNB3,Plexin-B3,42099,0.0714494972030202,0.00502238984859668,0.0616056130997707,0.0812933813062696,1.34548020405259e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,LBR,Delta(14)-sterol reductase LBR,42249,0.101069438050755,0.00711430497963865,0.0871254002906632,0.115013475810847,1.7605498009018e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTBDN,Retbindin,42070,0.0444594438690931,0.00313185574624997,0.0383210066064431,0.050597881131743,2.064550621858e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,RLN2,Prorelaxin H2,39709,0.0762337381095406,0.00536739491795766,0.0657136440703436,0.0867538321487377,2.18529160850844e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBCC,Tubulin-specific chaperone C,42016,0.119334440659593,0.00841293066695106,0.102845096552369,0.135823784766817,2.42475174743962e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.0984697445750652,0.00694012670804541,0.0848670962272962,0.112072392922834,2.63580261995642e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.125594101490634,0.0088604617570987,0.108227596446721,0.142960606534548,2.76647377225933e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOK1,Docking protein 1,39929,0.202817392788535,0.0143099667241036,0.174769858009292,0.230864927567778,3.26719642135157e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAGK,N-acetyl-D-glucosamine kinase,39627,0.0840239859178161,0.00592857417725627,0.0724039805303939,0.0956439913052384,3.36749830411143e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,EREG,Proepiregulin,41997,0.118831133708751,0.00839406906756743,0.102378758336319,0.135283509081183,3.59969844688688e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAG1,Dystroglycan,42185,0.0702289741277188,0.00496184851817543,0.0605037510320949,0.0799541972233426,3.70380375036914e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOLM2,Protein GOLM2,42249,0.0335610332326523,0.00237808172007943,0.0288999930612966,0.038222073404008,6.56576877963335e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRP14,Signal recognition particle 14 kDa protein,42070,0.0880838290893617,0.00624801230265451,0.0758377249761589,0.100329933202565,8.14595174886288e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRELD2,Protein disulfide isomerase CRELD2,42166,0.0768494776167443,0.00545805767182917,0.0661516845799591,0.0875472706535294,1.04026301817039e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPP,Lipoma-preferred partner,39575,0.0968896982351261,0.00688214886300512,0.083400686463636,0.110378710006616,1.25946919269524e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS8,Galectin-8,42249,0.0894631715482844,0.00636332515421173,0.0769910542460295,0.101935288850539,1.38441503206366e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.122617309772297,0.00873905533216564,0.105488761321252,0.139745858223342,2.36933549223672e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0631053157671134,0.00450091957309883,0.0542835134038397,0.0719271181303871,2.73728012954732e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST13,Hsc70-interacting protein,39736,0.0793328888219841,0.00566753224254116,0.0682245256266035,0.0904412520173648,3.80245381850103e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.0901392243420235,0.0064452877459171,0.0775064603600259,0.102771988324021,4.45384033322853e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGA,Protein O-GlcNAcase,39930,0.104086314615084,0.00744303822465714,0.0894979596947556,0.118674669535412,4.50992074952913e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL3,Angiopoietin-related protein 3,42189,0.0502337409934848,0.00359982149482161,0.0431780908636345,0.0572893911233352,5.935965733561e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,F2,Prothrombin,39979,0.0216025975231234,0.0015506210505878,0.0185633802639713,0.0246418147822755,9.30967671924215e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.10566045437006,0.00760564742630109,0.0907533854145104,0.120567523325611,1.63510923628225e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.0551312508295121,0.00397745345444313,0.0473354420588035,0.0629270596002206,2.16309318396588e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,VNN1,Pantetheinase,39990,0.105814431354802,0.00763005575031461,0.0908595220841852,0.120769340625419,2.22473234554571e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0480307465879755,0.00346711184683518,0.0412352073681785,0.0548262858077724,2.39334128611658e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,IST1,IST1 homolog,39850,0.142348528499048,0.0102714076119049,0.122216569579715,0.162480487418382,2.55556971990353e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPHOSPH8,M-phase phosphoprotein 8,41900,0.111299137174616,0.00803749547753644,0.0955456460386446,0.127052628310587,2.63094926292414e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP3,Metalloproteinase inhibitor 3,42185,0.184888795631089,0.0133575114532772,0.158708073182666,0.211069518079512,2.81324999747306e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,GORASP2,Golgi reassembly-stacking protein 2,39930,0.0690023303415752,0.00498167605492933,0.0592382452739137,0.0787664154092367,2.81542067606373e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADD1,Alpha-adducin,39736,0.100587893873532,0.00727127733085869,0.0863361903050487,0.114839597442015,3.63389162931335e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAVS,Mitochondrial antiviral-signaling protein,41843,0.130639198266747,0.00948227080771951,0.112053947483617,0.149224449049877,6.90507281626764e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDRKH,Tudor and KH domain-containing protein,41839,0.122560224764288,0.00890189950237957,0.105112501739624,0.140007947788952,7.84471572945823e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.0882314461300777,0.00641000935668445,0.0756678277909761,0.100795064469179,8.08556902761842e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBPL,FK506-binding protein-like,39930,0.0852243271527485,0.0061880992646214,0.0730956525940905,0.0973530017114064,8.2715915193312e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF3,Immunoglobulin superfamily member 3,42070,0.0532091610311706,0.00387027355843097,0.0456234248566459,0.0607948972056953,1.01460348606999e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.0587414016106248,0.00427582117744822,0.0503607921028263,0.0671220111184233,1.17006360990521e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT5,ADP-sugar pyrophosphatase,42137,0.0715275790056895,0.00522238685130932,0.0612917007771232,0.0817634572342558,2.0469498124506e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.0380020923409743,0.00277566571535586,-0.0434423971430718,-0.0325617875388768,2.48067282490666e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,GYS1,"Glycogen [starch] synthase, muscle",41900,0.132652860673482,0.00970512793145625,0.113630809927827,0.151674911419136,3.02764526787943e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.103181653959467,0.00757444814671377,0.0883357355919076,0.118027572327026,6.29439601652247e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,STIP1,Stress-induced-phosphoprotein 1,42105,0.0910300818974433,0.00668679497553032,0.0779239637454039,0.104136200049483,6.30135381676876e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.102530362405261,0.00752733653442627,0.0877767827977858,0.117283942012737,6.49895633158971e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,QDPR,Dihydropteridine reductase,42081,0.0599948507846936,0.00440816553955359,0.0513548463271685,0.0686348552422186,6.61132328771757e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,COCH,Cochlin,39958,0.0651208089526764,0.00479099393683417,0.0557304608364814,0.0745111570688713,9.4254052099052e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOF,Apolipoprotein F,39990,-0.0367017584632423,0.00270097125932608,-0.0419956621315214,-0.0314078547949632,9.92306315289698e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD207,C-type lectin domain family 4 member K,41832,0.0553165299821524,0.00407810576182316,0.047323442688979,0.0633096172753258,1.23773572259247e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.0816630365801289,0.00602582467788532,0.0698524202114737,0.0934736529487841,1.43052999961415e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0836980211327486,0.00617993863299347,0.0715853414120814,0.0958107008534158,1.63678087631517e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHSG,Alpha-2-HS-glycoprotein,39990,0.0377387454112736,0.00278776893271309,0.0322747183031559,0.0432027725193912,1.96987124580528e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.0632907149356647,0.00468054142688264,0.0541168537389747,0.0724645761323547,2.17975971712717e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERMAP,Erythroid membrane-associated protein,39657,0.0628785064891077,0.00464848128761862,0.0537674831653752,0.0719895298128402,2.31990769853452e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMMD1,COMM domain-containing protein 1,39638,0.0860690128747403,0.00636355374440357,0.0735964475357093,0.0985415782137713,2.36589981442895e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,DGKA,Diacylglycerol kinase alpha,39657,0.0780060611660655,0.00577272997003711,0.0666915104247927,0.0893206119073382,2.79089511309805e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,MGLL,Monoglyceride lipase,42166,0.123243985457397,0.00912825092775589,0.105352613638995,0.141135357275798,2.83470417326977e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.147210783472076,0.0109134808006889,0.125820361102726,0.168601205841426,3.35757672762164e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.0986582647431451,0.00731788846874105,0.0843152033444126,0.113001326141878,4.2273591481174e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN3,Ataxin-3,39929,0.0858412623286137,0.00637092423100943,0.0733542508358352,0.0983282738213922,4.61099046746675e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.205144510023958,0.0152304839737741,0.175292761435361,0.234996258612556,4.90060891722732e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP2B1,AP-2 complex subunit beta,39649,0.06825579246245,0.00507842832490606,0.0583020729456342,0.0782095119792659,7.34201996083876e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS1BP3,HCLS1-binding protein 3,39638,0.127863115870692,0.00952282318010603,0.109198382437684,0.146527849303699,8.7702603667991e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUC13,Mucin-13,41839,0.0739867740342097,0.00551642188874497,0.0631745871322696,0.0847989609361499,9.47545245798652e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,YJU2,Splicing factor YJU2,39919,0.0463046236279369,0.00345116527570307,0.0395403396875589,0.0530689075683149,9.8261947068095e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0357839475565001,0.00266796801122816,0.0305547302544929,0.0410131648585073,1.06438127763574e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,BID,BH3-interacting domain death agonist,42119,0.0928569836852328,0.00693214966340859,0.0792699703449519,0.106443997025514,1.17270450728387e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARSB,Arylsulfatase B,42070,0.077727194076992,0.00580755750475658,0.0663443813676691,0.0891100067863149,1.36597350064537e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD36,Platelet glycoprotein 4,39657,0.0648307091589748,0.0048531081665845,0.0553186171524692,0.0743428011654804,2.1689403930976e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1S,Complement C1s subcomponent,39979,0.0293834892873597,0.00220173741374269,0.025068083956424,0.0336988946182954,2.52428633173464e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.172514549435737,0.0129423986432766,0.147147448094915,0.19788165077656,2.85187886143566e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLG4,Disks large homolog 4,39929,0.100395723321098,0.00752833223928701,0.0856401921320954,0.1151512545101,2.88464253578286e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,F11,Coagulation factor XI,39822,0.0437025490959467,0.0032816229397753,0.0372705681339871,0.0501345300579063,3.69951998806947e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.114849290994909,0.00862946603065255,0.0979355375748302,0.131763044414988,3.71718919718397e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOXJ3,Forkhead box protein J3,39657,0.0628510037057734,0.00472037454208725,0.0535990696032824,0.0721029378082644,3.86447861074332e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,GHRL,Appetite-regulating hormone,42145,0.115647545077439,0.00869295713829171,0.0986093490863877,0.132685741068491,3.93878236018812e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD226,CD226 antigen,39657,0.0590888064140799,0.0044398251939871,0.0503867490338652,0.0677908637942947,4.18348472655191e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.131031676697572,0.00984646940680222,0.11173259666024,0.150330756734905,4.18527844978106e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM24,Transcription intermediary factor 1-alpha,39735,0.091558119986507,0.00688292149616061,0.0780675938540322,0.105048646118982,4.54077219772651e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CIRBP,Cold-inducible RNA-binding protein,39930,0.133815915828919,0.010061012445704,0.114096331435339,0.153535500222499,4.59282277931631e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,SULT2A1,Bile salt sulfotransferase,42119,0.0818070840886501,0.00615533206332431,0.0697426332445345,0.0938715349327658,4.69043203816117e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,PON2,Serum paraoxonase/arylesterase 2,41900,0.0488273981870117,0.00367792863066336,0.0416186580709116,0.0560361383031119,5.7439979179325e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLB,Beta-klotho,41839,-0.103897507146557,0.00782803429360796,-0.119240454362028,-0.0885545599310851,6.01505029965888e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL4,C-C motif chemokine 4,42148,0.086364533038057,0.00651112485458131,0.0736027283230776,0.0991263377530363,6.62493702529711e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,TWF2,Twinfilin-2,39966,0.117995915615549,0.00889149629565561,0.100568582876064,0.135423248355034,6.78215882569805e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGLN1,Egl nine homolog 1,42119,0.077547313438045,0.00585100415780897,0.0660793452887394,0.0890152815873505,7.61342806292124e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIGYF2,GRB10-interacting GYF protein 2,39934,0.105613149548266,0.0079696382111929,0.0899926586543277,0.121233640442204,8.68767691485676e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUS,RNA-binding protein FUS,41831,0.0550110769721867,0.00415434198444279,0.0468685666826789,0.0631535872616946,9.00745297461415e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA5,Integrin alpha-5,42137,0.0344557246758743,0.00260278473438866,0.0293542665964726,0.0395571827552761,9.34643267905099e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.119007811432389,0.00898527612218049,0.101396670232915,0.136618952631862,9.67427919994739e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGFR,Opioid growth factor receptor,42070,0.0444219922602337,0.0033579161667635,0.0378404765733772,0.0510035079470901,1.05473470172151e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCG2,Secretogranin-2,42193,0.0456473315165874,0.00345088957511167,0.0388835879493685,0.0524110750838063,1.06792543915538e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RL2,Interleukin-1 receptor-like 2,41913,0.0522183404695217,0.00394821431976448,0.0444798404027833,0.0599568405362601,1.10768954870968e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAT2,Signal transducer and activator of transcription 2,39657,0.108490682016067,0.00819820064217423,0.0924222087574051,0.124559155274728,1.12551547938748e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYDGF,Myeloid-derived growth factor,39958,0.137335941616002,0.0103872757303451,0.116976881184526,0.157695002047479,1.29199165909347e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.13512426913299,0.0102299609649885,0.115073545641613,0.155174992624368,1.39105867451615e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0822091330381088,0.00622540473715713,0.0700073397532808,0.0944109263229368,1.44727584235729e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0611381157660111,0.00463264047021296,0.0520581404443937,0.0702180910876285,1.6003884104558e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,PENK,Proenkephalin-A,39736,0.0427276128413359,0.00323551664281329,0.0363860002214218,0.0490692254612499,1.60881094315508e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDUA,Alpha-L-iduronidase,42262,0.0650295556430777,0.00493013523565769,0.0553664905811886,0.0746926207049667,1.74110694418062e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.0707867708212803,0.00536762388241016,0.0602662280117564,0.0813073136308042,2.0141924988452e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSC22D1,TSC22 domain family protein 1,39934,0.0907886809615701,0.00688826169829121,0.0772876880329193,0.104289673890221,2.22171870062929e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH2D1A,SH2 domain-containing protein 1A,42119,0.0824501165199153,0.00626532198519682,0.0701700854289296,0.0947301476109011,2.6086406019751e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.0623137757140373,0.00474041849846603,0.0530225554570439,0.0716049959710307,3.51489937703189e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.0280087044457155,0.00213277001321838,-0.0321889336716236,-0.0238284752198075,3.71127145780638e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA11,Annexin A11,42087,0.0906611914009072,0.00693253367383092,0.0770734254001986,0.104248957401616,7.61350936057043e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.10401895415134,0.00796671668394693,0.0884041894508043,0.119633718851876,1.00916965017563e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAO1,Hydroxyacid oxidase 1,42262,0.168121836036743,0.012929633548893,0.142779754280913,0.193463917792574,1.9928979779707e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0396824253545042,0.00305100856158545,0.0337024485737967,0.0456624021352116,2.12815585810893e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASC3,Protein CASC3,39649,0.0585672193272218,0.0045091261093783,0.0497293321528403,0.0674051065016033,2.70676469170697e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0628801603739594,0.0048458044101376,0.0533823837300897,0.072377937017829,2.823484417277e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOXO3,Forkhead box protein O3,41843,0.130493543466189,0.0100573369422874,0.110781163059306,0.150205923873072,2.9026104569978e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,F12,Coagulation factor XII,39979,0.0559064136531529,0.00430687899487792,0.0474649308231921,0.0643478964831136,2.94035409380441e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPART,Spartin,39736,0.105395428861403,0.00811973640746861,0.089480745502765,0.121310112220042,3.00231296815796e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBKS,Ribokinase,41830,0.0672258532257318,0.00518901337918866,0.057055387002522,0.0773963194489416,3.7350106388441e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,TADA3,Transcriptional adapter 3,39919,0.0547413443303298,0.0042237023048531,0.0464628878128177,0.0630198008478419,3.82542414742667e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASHC3,WASH complex subunit 3,39929,0.102779596853208,0.00793095191760467,0.087234931094703,0.118324262611713,3.88325379975763e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,GET3,ATPase GET3,39958,0.0730926088266821,0.00564387881214602,0.0620306063548759,0.0841546112984883,4.32572685219126e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,GDNF,Glial cell line-derived neurotrophic factor,41839,0.0518862602824322,0.00401167760297072,0.0440233721806096,0.0597491483842548,4.9299079200191e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6AP2,Renin receptor,41843,0.0532638151282127,0.00411883602537615,0.0451908965184754,0.0613367337379499,5.06015576782025e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0703613632716958,0.0054404426788668,0.0596980956211168,0.0810246309222747,5.44367079711885e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,EHD3,EH domain-containing protein 3,39638,0.159223975563308,0.0123245560270109,0.135067845750367,0.18338010537625,6.59627227753206e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBM17,Splicing factor 45,39934,0.103574275546314,0.00802433640186934,0.0878465761986499,0.119301974893978,7.54045089657683e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0764504378085897,0.00592725029277131,0.064833027234758,0.0880678483824215,7.79070490943476e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.0967962036440817,0.00752023959398644,0.0820565340398683,0.111535873248295,1.0825677287814e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.0345854964202927,0.00268928063875968,0.0293145063683237,0.0398564864722617,1.24657010427613e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICA1,Islet cell autoantigen 1,41913,0.107365398542711,0.00836994585253122,0.0909603046717495,0.123770492413672,1.91636274829402e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.0977223485061949,0.00762042432475549,0.0827863168296742,0.112658380182716,1.99472474406566e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIAE,Sialate O-acetylesterase,42147,0.0623496515083984,0.00486409906017136,0.0528160173504625,0.0718832856663343,2.13478969927052e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.106437628542994,0.00830767246951289,0.0901545905027492,0.12272066658324,2.34216468661298e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.038692286692448,0.00302055290242772,0.0327720030036897,0.0446125703812064,2.65302095117017e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.118590967557119,0.00926001055150639,0.100441346876166,0.136740588238071,2.71994839081526e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDC,Nuclear migration protein nudC,42296,0.084994670001501,0.00664279062765026,0.0719748003713065,0.0980145396316955,2.85691399011698e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEXN,Nexilin,39990,0.0932105064161179,0.00728152659996819,0.0789387142801802,0.107482298552056,2.92406659001177e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMPACT,Protein IMPACT,39929,0.0724569038285784,0.00566195109964131,0.0613594796732814,0.0835543279838754,3.07804574279086e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53,Cellular tumor antigen p53,41843,0.0594690696100809,0.0046565683849175,0.0503421955756426,0.0685959436445192,3.94131577235054e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,HYOU1,Hypoxia up-regulated protein 1,42310,0.0306207032158593,0.00239814341249534,0.0259203421273685,0.0353210643043502,3.9998709937776e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGF,Pro-epidermal growth factor,42081,0.138818583117445,0.01089225030262,0.11746977252431,0.16016739371058,5.45307516836154e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.0501328257745755,0.00393635474515417,0.0424175704740734,0.0578480810750777,6.10310765798116e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRAP2,GRB2-related adapter protein 2,42145,0.172024538098334,0.0135147557763354,0.145535616776717,0.198513459419952,6.66790451176826e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,RFC4,Replication factor C subunit 4,39919,0.0294502712749054,0.00231466340604155,0.024913530999064,0.0339870115507468,7.83777401692014e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAX,Protein max,41839,0.141432284339588,0.0111234174666805,0.119630386104895,0.163234182574282,8.03050446075508e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.0561731453540075,0.00441850505982312,0.0475128754367542,0.0648334152712608,8.08181400424635e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CETN2,Centrin-2,41839,0.0903820501739679,0.00713280339434809,0.0764017555210456,0.10436234482689,1.39030995213931e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP5,Fatty acid-binding protein 5,42218,0.0883268104929296,0.00697215981999415,0.0746613772457411,0.101992243740118,1.42130604867043e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.109356038051926,0.00863670209578307,0.092428101944191,0.126283974159661,1.55073835037641e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,A1BG,Alpha-1B-glycoprotein,39979,0.0218596590539414,0.00172629451469756,0.0184761218051342,0.0252431963027486,1.67576800419263e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK10,Kallikrein-10,42138,0.0540207158482585,0.00427787340922828,0.045636083966171,0.0624053477303459,2.3739537889097e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.0768051465928544,0.00608865781061371,0.0648713772840515,0.0887389159016573,3.12082387469842e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,RWDD1,RWD domain-containing protein 1,42249,0.0821976279156448,0.00652087006016719,0.0694167225977171,0.0949785332335725,3.14121664076267e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.0580367178995453,0.00460507852362395,0.0490107639932424,0.0670626718058483,3.2812656305199e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT4,Vascular endothelial growth factor receptor 3,42181,0.0448883177669593,0.00356205447894887,0.0379066909882196,0.0518699445456991,3.29012059853579e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,HPSE,Heparanase,39866,0.12567997702412,0.00997505978016003,0.106128859855006,0.145231094193234,3.72735145458963e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELOA,Elongin-A,42070,0.0708286371907811,0.00562956791474279,0.0597946840778853,0.081862590303677,4.25676682635845e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.11427398762516,0.00911297890644598,0.0964125489685263,0.132135426281795,7.17977055829846e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAG4,BAG family molecular chaperone regulator 4,39657,0.0662614663915574,0.00528158930793368,0.0559095513480074,0.0766133814351075,7.35740090097975e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,RILPL2,RILP-like protein 2,39958,0.12939003339302,0.0103238608058147,0.109155266213623,0.149624800572416,8.48457451626792e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNPY4,Protein canopy homolog 4,42070,0.0985169361906006,0.00786580892954373,0.0830999506886949,0.113933921692506,8.65505724945624e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0639750396164342,0.00511134472975278,0.0539568039461188,0.0739932752867497,1.0622172991265e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEP1B,Meprin A subunit beta,42145,0.150134597943292,0.0120055135028171,0.12660379147777,0.173665404408813,1.09691671157405e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHMP1A,Charged multivesicular body protein 1a,42016,0.103934801460573,0.00831579807622884,0.087635837231164,0.120233765689981,1.20180081100268e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.0995995190851034,0.00797214839855852,0.0839741082239287,0.115224929946278,1.27312149490095e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0387360144106026,0.00310696859921851,0.0326463559561343,0.0448256728650708,1.7494628829464e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMVK,Phosphomevalonate kinase,41832,0.141870584356395,0.0113889111318078,0.119548318538052,0.164192850174739,2.02597981760723e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRAS,Ras-related protein R-Ras,39649,0.17132742720307,0.0137480234039398,0.144381301331348,0.198273553074792,2.08121796740903e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAMP8,Vesicle-associated membrane protein 8,39657,0.11444098717262,0.00918463221195,0.096439108037198,0.132442866308042,2.13030489258495e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,GMPR2,GMP reductase 2,39736,0.0864455799320839,0.00693991793163216,0.0728433407860849,0.100047819078083,2.22335596025684e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.102844836637967,0.00825806427009235,0.0866590306685857,0.119030642607348,2.3029374199714e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.0734005418833303,0.00590262063112949,-0.0849696783203441,-0.0618314054463165,2.8968524968406e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0646384583432656,0.00519935650746273,0.0544477195886386,0.0748291970978925,2.99759174894208e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRG2,Bone marrow proteoglycan,39966,-0.0665546234219857,0.00535628396496964,-0.0770529399933262,-0.0560563068506452,3.21587932705677e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.0365348760242558,0.00294778027521854,0.0307572266848275,0.0423125253636841,4.37269057213404e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0458092193003038,0.0036956253291767,0.0385657936551175,0.0530526449454902,4.66407425996977e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST3,Cystatin-C,42184,0.037095213452236,0.0030023377815072,0.0312106314004819,0.0429797955039901,7.00714705499207e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFA,Vascular endothelial growth factor A,42253,0.0732229843677658,0.005927389468423,0.0616053010096567,0.0848406677258749,7.17626726879538e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,CETN3,Centrin-3,39930,0.101516589714033,0.00821491497913866,0.0854153563549215,0.117617823073145,7.43029662182537e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPT1,Angiopoietin-1,42085,0.108026392488652,0.00875001217850391,0.0908763686187848,0.12517641635852,7.90827538928357e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,APPL2,DCC-interacting protein 13-beta,39736,0.145609267346795,0.0117956852353975,0.122489724285416,0.168728810408174,8.82629130442808e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R2,Protein phosphatase inhibitor 2,42145,0.103841567369497,0.00843645698155265,0.0873061116856543,0.120377023053341,1.24567856002657e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP25,Rho GTPase-activating protein 25,41843,0.0782224894310341,0.00636496675359682,0.0657471545939843,0.0906978242680839,1.58965299029902e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP2,Retinol-binding protein 2,42070,-0.100254479857888,0.0081594194690703,-0.116246942017266,-0.0842620176985106,1.62865445720851e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.0738468454540222,0.00601225227095958,0.0620628310029414,0.085630859905103,1.87350795624053e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.0526271458572273,0.00428736974321202,0.0442239011605318,0.0610303905539229,2.06044975954729e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.0853964456373421,0.00696405639879238,0.071746895095709,0.0990459961789751,2.39622281305849e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNLR1,Interferon lambda receptor 1,42119,0.0466812972854081,0.0038140064533912,0.0392058446367614,0.0541567499340549,2.90487280710905e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCT5,T-complex protein 1 subunit epsilon,41843,0.0579542340186992,0.00473933111949081,0.0486651450244972,0.0672433230129012,3.35335167516945e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.0754186627986184,0.00616884462983643,0.063327727324139,0.0875095982730978,3.43243760335578e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.107822601246137,0.00882674226857884,0.0905221863997229,0.125123016092552,3.92364289014755e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.0778020482685516,0.00637017266309613,0.0653165098488832,0.09028758668822,3.97632411019828e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.122523980000577,0.010035243671986,0.102854902403485,0.14219305759767,4.18860982268093e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,LARP1,La-related protein 1,39919,0.0794781802143336,0.00650620877035543,0.066726011024437,0.0922303494042303,4.19820645190424e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL7,Interleukin-7,42119,0.0825842291962522,0.0067669458983587,0.0693210152354691,0.0958474431570352,4.46758917241973e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0617027919232029,0.00505350865697602,0.0517979149555299,0.0716076688908759,4.49961362112419e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP2,Microtubule-associated protein 2,39929,0.0597400178331932,0.00489413002940155,0.0501475229755661,0.0693325126908202,4.69651892227855e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINE2,Glia-derived nexin,39958,0.0827307484599134,0.00677847403263508,0.0694449393559487,0.0960165575638782,4.77915195030445e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.102199241510602,0.00837821598576985,-0.118620544842711,-0.0857779381784932,4.79298727658663e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,UROD,Uroporphyrinogen decarboxylase,39736,0.0864054874261656,0.00708291255791289,0.0725229788126564,0.100287996039675,5.17565812378519e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,STK24,Serine/threonine-protein kinase 24,41839,0.0794651577374271,0.00651788848954605,0.0666900962979168,0.0922402191769374,5.22641871775222e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.0353954262317927,0.0029101083527896,0.0296916138603251,0.0410992386032603,7.35319799237598e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.05771910463644,0.00474791438559846,0.048413192440667,0.067025016832213,7.94385917855014e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRY2,Protein sprouty homolog 2,41913,0.118234061140566,0.00972615261304118,0.0991708020190055,0.137297320262127,8.02303180281603e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL11,Eotaxin,42296,0.0475125907590527,0.003912281649428,0.0398445187261738,0.0551806627919316,9.1526771753916e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK13,Kallikrein-13,41839,0.0570539068821497,0.00469990379978046,0.0478420954345799,0.0662657183297194,9.86812068132003e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD69,Early activation antigen CD69,42082,0.111344890299183,0.00917307621167909,0.0933656609242917,0.129324119674074,9.93260853502085e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.0734457580971304,0.00605330553036311,0.0615812792576187,0.0853102369366421,1.0580127933455e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.0495730748128686,0.00409078647033068,0.0415551333310204,0.0575910162947167,1.26085395119908e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP7,Caspase-7,39929,0.107063800665081,0.00883444021589181,0.0897482978419332,0.124379303488229,1.35308002648513e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.0641154789491756,0.0052938035130452,0.0537396240636071,0.0744913338347442,1.37100535285085e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.059910666889164,0.00494771126955574,0.0502131528008348,0.0696081809774932,1.52891409061275e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,PF4,Platelet factor 4,39914,0.123208215191616,0.0101947275711392,0.103226549152183,0.143189881231049,2.0240144740524e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKG1,cGMP-dependent protein kinase 1,39736,0.159459456350291,0.0131953044616339,0.133596659605488,0.185322253095093,2.06200249689324e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF19,Fibroblast growth factor 19,42185,0.0981662205713408,0.00813784472997064,0.0822160449005983,0.114116396242083,2.45405446349233e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.0926832908034319,0.00767967214426397,0.0776311334006745,0.107735448206189,2.50630828185707e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.140791587194554,0.0116945277986041,0.11787031270929,0.163712861679818,3.29980775014637e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED8,Protein TMED8,39930,0.130008054418213,0.0107949004694329,0.108850049498125,0.151166059338302,3.34766637227059e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA12,Serpin A12,41751,0.13672792585196,0.011358352832714,0.11446555429984,0.158990297404079,3.36640097690141e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,BIN2,Bridging integrator 2,42137,0.112313506698172,0.00935098962236821,0.0939855670383301,0.130641446358014,4.58743715429685e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFA,Platelet-derived growth factor subunit A,42310,0.0903996997874552,0.00752715503611255,0.0756464759166746,0.105152923658236,4.62345805018703e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESYT2,Extended synaptotagmin-2,39929,0.104714862598366,0.00871495900423551,0.0876335429500643,0.121796182246667,4.67584687704533e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP10,Caspase-10,41839,0.0897056058727151,0.00747591541737194,0.0750528116546661,0.104358400090764,5.31496858375387e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.067331299905142,0.00561908042744693,0.056317902267346,0.0783446975429379,6.44206995020918e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMT,Catechol O-methyltransferase,41740,0.104427201821387,0.00872071141976123,0.0873346074386546,0.121519796204119,7.15558467081063e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.0704637689720432,0.00588199709049418,0.0589350546746747,0.0819924832694118,7.18373197831078e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNRD2,Protein ZNRD2,39930,0.0872624083547476,0.0072900340426581,0.0729739416311378,0.101550875078357,8.03755380625815e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,DIABLO,"Diablo homolog, mitochondrial",42107,0.136939208105399,0.0114739033352028,0.114450357568402,0.159428058642396,1.13711955879403e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH9,Protocadherin-9,39930,0.0422031642804466,0.00353685433934267,0.035270929775335,0.0491353987855583,1.25797980580265e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS2,Trypsin-2,42217,0.0712408895956818,0.00598763542420073,0.0595051241642484,0.0829766550271152,1.75585122402224e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNM3,Dynamin-3,39934,0.0685161917774678,0.00575867619786746,0.0572291864296475,0.079803197125288,1.89286299526209e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEMIP2,Cell surface hyaluronidase,39657,0.0402285924947883,0.00338335352293912,0.0335972195898276,0.046859965399749,2.09765587326363e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.085608391956652,0.00720783078367414,0.0714810436206506,0.0997357402926533,2.24629527428504e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,GDF2,Growth/differentiation factor 2,42145,0.0439784718109215,0.00370296506189826,0.0367206602896009,0.051236283332242,2.26813150395154e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.122811586136767,0.0103437262205051,0.102537882744577,0.143085289528957,2.53985770359383e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD5,T-cell surface glycoprotein CD5,42239,0.0441311292831847,0.00372537508903585,0.0368293941086744,0.0514328644576949,3.24334976447478e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.0936972966140701,0.00790653230112236,0.0782004933038703,0.10919409992427,3.34752268168154e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBXN1,UBX domain-containing protein 1,39736,0.0851346838960838,0.0071958101490512,0.0710308960039434,0.0992384717882241,4.19376269355481e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTF1,Cardiotrophin-1,41900,0.104689613238678,0.00885366063093767,0.0873364384020404,0.122042788075316,4.22540256427827e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.0869496010617464,0.00736030247943948,0.0725234082020451,0.101375793921448,4.78303291262631e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,TTF2,Transcription termination factor 2,39649,0.0615064292328395,0.0052067428521137,0.0513012132426967,0.0717116452229824,5.21874154886115e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.113328652374598,0.00959982816044738,0.094512989180121,0.132144315569075,5.26381394810535e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.0605337959856827,0.00512583482919365,0.0504871597204632,0.0705804322509023,5.42284128893735e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,TALDO1,Transaldolase,39948,0.054549676359699,0.00462148672599253,0.0454915623767536,0.0636077903426443,5.75760513019634e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.129118263203741,0.0109499262308819,0.107656407791213,0.15058011861627,6.66576964929077e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0700683422356925,0.00594925012465358,0.0584078119913715,0.0817288724800135,7.29071786405911e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0827677780371929,0.00702559365591937,0.0689976144715909,0.0965379416027949,7.56615171371108e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.0947638037210834,0.00805085903281752,0.078984120016761,0.110543487425406,7.90396445030237e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPARC,SPARC,42181,0.0861590710586398,0.00732206259746441,0.0718078283676095,0.10051031374967,8.23508939650029e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,FMNL1,Formin-like protein 1,41839,0.0777407235004376,0.00662936778236002,0.0647471626470119,0.0907342843538632,1.33265904992739e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMP6,Bone morphogenetic protein 6,41886,0.049187011937546,0.00419604766473407,0.0409627585146672,0.0574112653604248,1.40273990596315e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.104302523291129,0.00890209196246909,0.0868544230446891,0.121750623537568,1.59173583608166e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIFBP,KIF-binding protein,42070,0.101252446883021,0.00864759300501007,0.0843031645932014,0.118201729172841,1.63400855043756e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,ORM1,Alpha-1-acid glycoprotein 1,39922,0.0245784869404242,0.00209883030854316,0.0204647795356796,0.0286921943451688,1.70912057054808e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.120965823439861,0.0103397757443588,0.100699862980917,0.141231783898804,1.97866260086162e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB9,Serpin B9,42016,0.040225613401453,0.00344325639481036,0.0334768308676247,0.0469743959352814,2.22385343815618e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,NACC1,Nucleus accumbens-associated protein 1,39919,0.0676101931387966,0.00579140236707405,0.0562590444993315,0.0789613417782618,2.60861291314902e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4G,C-type lectin domain family 4 member G,42119,0.0409149320798272,0.00350655793074807,0.034042078535561,0.0477877856240934,2.62021620623371e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA11,Integrin alpha-11,42119,-0.0413988981158129,0.0035499460173877,-0.0483567923098928,-0.034441003921733,2.81876960996828e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSNL1,Visinin-like protein 1,39929,0.047192059264398,0.00405325121251764,0.0392476868878634,0.0551364316409326,3.74622785154405e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.0902207164534422,0.0077523598740514,0.0750260911003015,0.105415341806583,4.00257365863192e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUOX,"Sulfite oxidase, mitochondrial",39934,0.077193101813292,0.00663568908073966,0.0641871512150423,0.0901990524115417,4.20529115331852e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.0962715817953399,0.00828199544219838,0.080038870728631,0.112504292862049,4.37503547538083e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPBP,Platelet basic protein,39908,0.10395973266704,0.00896183975252312,0.0863945267520948,0.121524938581985,6.14727115856702e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,THPO,Thrombopoietin,41900,0.0471639215465823,0.00408405101828059,0.0391591815507524,0.0551686615424123,1.05453872519463e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBCB,Tubulin-folding cofactor B,42016,0.121093318017326,0.0104921478086167,0.100528708312437,0.141657927722215,1.13963652084896e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.0454461604007972,0.00394280941358519,0.0377182539501702,0.0531740668514241,1.35801711280418e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBC1D5,TBC1 domain family member 5,42119,0.0941393277931511,0.00817652005278153,0.0781133484896993,0.110165307096603,1.56777539755424e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUB1,NEDD8 ultimate buster 1,42119,0.10147020303726,0.00882145793364046,0.0841801454873242,0.118760260587195,1.77304035994717e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNMA1,Paraneoplastic antigen Ma1,39638,0.0687993170657991,0.00598716504166424,0.0570644735841372,0.080534160547461,2.1757727458363e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,DYNLT1,Dynein light chain Tctex-type 1,39649,0.0954410848701438,0.00830566507999586,0.0791619813133519,0.111720188426936,2.17619867177965e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.0778692393772662,0.00678318827326566,0.0645741903616655,0.0911642883928669,2.29929189894923e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOD,Apolipoprotein D,39468,-0.0509678923584647,0.00443773109576625,-0.0596658453061665,-0.0422699394107628,2.34499009999372e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPB1,Heat shock protein beta-1,41949,0.0843699936596446,0.00735081121144,0.0699624036852222,0.098777583634067,2.37153465602372e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATG4A,Cysteine protease ATG4A,41843,0.069852669298068,0.00609894371597106,0.0578987396147648,0.0818065989813713,3.14327674505217e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF23,Fibroblast growth factor 23,42250,0.0605535329772262,0.00529414509957629,0.0501770085820566,0.0709300573723957,3.71201557574335e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,FIS1,Mitochondrial fission 1 protein,42125,0.0918707074083776,0.00803931571970586,0.0761136485977541,0.107627766219001,4.17998744749397e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.103927724293509,0.0090931918986433,0.0861050681721679,0.12175038041485,4.39693284146079e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0783152658442536,0.00685521570902796,0.0648790430545588,0.0917514886339484,4.68014560030611e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0791490936022025,0.00693998995596058,0.0655467132885198,0.0927514739158852,5.83484970418385e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,PQBP1,Polyglutamine-binding protein 1,41843,0.0675344582803395,0.00592738708519354,0.0559167795933601,0.0791521369673188,6.20070315291077e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYO9B,Unconventional myosin-IXb,41913,0.0786609072411365,0.00691063277791225,0.0651160669964285,0.0922057474858445,7.01770777230004e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA4D,Semaphorin-4D,42249,0.0358902099173583,0.00315344458557359,0.029709458529634,0.0420709613050825,7.06847688207008e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.118217739696583,0.0104154619903772,0.0978034341954441,0.138632045197723,1.00835888861067e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNMT,Histamine N-methyltransferase,41961,0.0569963563005635,0.0050237845782179,0.0471497385272564,0.0668429740738706,1.06994295866857e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLG,Plasminogen,39742,0.0259378599577104,0.00228618822695642,0.0214569310328759,0.030418788882545,1.13613871419426e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,REEP4,Receptor expression-enhancing protein 4,39934,0.0739305227109032,0.00652211626527994,0.0611471748309545,0.0867138705908519,1.26553325425283e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLOD4,Glyoxalase domain-containing protein 4,42106,0.0407415693877026,0.00359611522542116,0.0336931835458771,0.0477899552295281,1.27767652461895e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.0621026039177494,0.00547909722368345,0.0513635733593298,0.0728416344761689,1.2867491532161e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFASC,Neurofascin,42296,0.0345647777803138,0.00305335277241343,0.0285802063463835,0.0405493492142442,1.40946562038444e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0768496330523126,0.00679027266302737,0.0635406986327789,0.0901585674718462,1.45403842498981e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,POSTN,Periostin,39966,-0.0447936581672808,0.00395790059447594,-0.0525511433324536,-0.0370361730021079,1.54600816285891e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0665044066476163,0.00588322995484573,0.0549732759361186,0.0780355373591139,1.69429779506007e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0772191505294166,0.00683767548986886,0.0638173065692736,0.0906209944895596,1.93308652786413e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC3B,Tetranectin,39726,0.0248206257734264,0.00219697864491756,0.020514547629388,0.0291267039174648,1.94989016288478e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERP29,Endoplasmic reticulum resident protein 29,39736,0.141319238951533,0.0125235409721303,0.116773098646158,0.165865379256909,2.26461259395113e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDC4,Syndecan-4,42145,0.0559647871786527,0.00496362205645063,0.0462360879480094,0.0656934864092959,2.35668935043988e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.0793641762386292,0.00704243964654293,0.0655609945314051,0.0931673579458533,2.52641637772757e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPA1,Carboxypeptidase A1,42310,0.0763927101958404,0.00678270098586609,0.0630986162635429,0.089686804128138,2.69117135474257e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP2,Caspase-2,42119,0.0807042675255106,0.00716602529173765,0.0666588579537049,0.0947496770973164,2.72699246522808e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSPN,Persephin,42119,0.102047647602148,0.00906581478074489,0.0842786506318882,0.119816644572408,2.90926197838659e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53I3,Quinone oxidoreductase PIG3,39513,0.0624651501035263,0.00555525120941693,0.0515768577330691,0.0733534424739835,3.57181280013866e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX1,Peroxiredoxin-1,41742,-0.108351975034886,0.00964444774268335,-0.127255092610545,-0.0894488574592264,3.74204050432508e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,VASP,Vasodilator-stimulated phosphoprotein,39990,0.0861001256656691,0.00766258574326402,0.0710814576088716,0.101118793722467,3.84339631726156e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,THTPA,Thiamine-triphosphatase,39897,0.10305392351255,0.00917977940547034,0.0850615558778277,0.121046291147271,4.32287557066062e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB33A,Ras-related protein Rab-33A,39575,0.0779017095912242,0.0069494927647286,0.0642807037723562,0.0915227154100923,5.25174348880617e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM172A,Cotranscriptional regulator FAM172A,39638,0.0716270164233772,0.0063914946777428,0.0590996868550014,0.0841543459917531,5.42456181817244e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRADD,Death domain-containing protein CRADD,41997,0.087704186444689,0.00783276793373973,0.0723519612945591,0.103056411594819,5.66591058875606e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,DFFA,DNA fragmentation factor subunit alpha,42296,0.0783223015743635,0.00699808045999717,0.0646060638727691,0.092038539275958,5.96113996946363e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL1,Growth-regulated alpha protein,42117,0.109003108423659,0.00975177436052276,0.089889630677034,0.128116586170283,7.0121696112991e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPB1,Carboxypeptidase B,42310,0.0726973911117116,0.00650479065755799,0.059948001422898,0.0854467808005253,7.12495139170696e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMG3,Proteasome assembly chaperone 3,42119,0.0579197416832616,0.00518296662469115,0.047761127098867,0.0680783562676563,7.23078950055716e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.066410401755399,0.00594370272172141,0.054760744420825,0.078060059089973,7.37410713295255e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.0640959428212653,0.00574440029899591,0.0528369182352333,0.0753549674072973,8.7821404212874e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,NID1,Nidogen-1,42189,0.0421267584169756,0.00377726998021341,0.0347233092557573,0.0495302075781939,9.25988442323113e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATOX1,Copper transport protein ATOX1,42181,0.0830194906906527,0.00744773303012027,0.0684219339516169,0.0976170474296884,9.87411647181519e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.125465242219671,0.0112873614607476,0.103342013756605,0.147588470682736,1.48100683644775e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,RILP,Rab-interacting lysosomal protein,42224,0.0682034112037196,0.00614004884126344,0.0561689154748433,0.080237906932596,1.5216359786952e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.0543586634030876,0.00490056880799685,0.0447535485394138,0.0639637782667614,1.91462844925717e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0430968558658851,0.00388626626592753,0.0354797739846671,0.050713937747103,1.97549898045769e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.0597688219677195,0.00539006870625199,0.0492042873034656,0.0703333566319734,2.00965173056028e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACYBP,Calcyclin-binding protein,39713,0.120302914208265,0.0108516083438575,0.099033761854304,0.141572066562225,2.06265389067057e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,OTUD6B,Deubiquitinase OTUD6B,39930,0.0671169607512222,0.00606268661227301,0.0552340949911671,0.0789998265112773,2.43696094627006e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX6,Peroxiredoxin-6,42262,-0.0695795398107355,0.00629329063480331,-0.08191438945495,-0.057244690166521,2.69836590728606e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0322953225258397,0.00292176277119379,0.0265686674942999,0.0380219775573795,2.78051155422819e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,WDR46,WD repeat-containing protein 46,39919,0.042351677624709,0.00383043631474938,0.0348440224478003,0.0498593328016178,2.84111840311556e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0536443758796487,0.00485727475013919,0.0441241173693759,0.0631646343899215,3.08195606896692e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNCG,Gamma-synuclein,42016,0.0773676243517185,0.00701034273154924,0.063627352597882,0.091107896105555,3.37926165561136e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0309494557643172,0.00280581697198299,0.0254500544992305,0.0364488570294038,3.78550688585474e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP3,Stromelysin-1,42137,-0.0574139641202707,0.00521223338342447,-0.0676299415517826,-0.0471979866887587,4.24727206111504e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.0497036703760818,0.00451404316077461,0.0408561457809636,0.0585511949712001,4.46572506457209e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLMAP,Sarcolemmal membrane-associated protein,39930,0.0960538355517975,0.00872830685030436,0.0789463541252009,0.113161316978394,5.019223522625e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,MICALL2,MICAL-like protein 2,39649,0.078813012849815,0.00717173526790497,0.0647564117247212,0.0928696139749087,5.99664556597388e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,YWHAQ,14-3-3 protein theta,39736,0.0851366995706348,0.00775647243495095,0.069934013598131,0.100339385543139,6.91001624372718e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLB1,Beta-galactosidase,42016,0.0495963038193195,0.00452391177543288,0.040729436739471,0.0584631708991679,7.5432329446726e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0828586347029839,0.00756546953078616,0.068030314422643,0.0976869549833248,8.53314097979578e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.0737339983031442,0.00673506646598197,0.0605332680298195,0.0869347285764688,9.37803193303203e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGCT,Gamma-glutamylcyclotransferase,39952,0.0542770845970748,0.00497333222200591,0.0445293534419432,0.0640248157522063,1.36017307958539e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.073645222020705,0.00675770561754629,0.0604001190103143,0.0868903250310958,1.54281945823269e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.0525433197850313,0.00482042282918394,0.0430952910398308,0.0619913485302318,1.58447399410735e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0557277109027094,0.00511817289340687,0.0456960920316319,0.0657593297737869,1.79430832462581e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.0585271324878827,0.00538000339882497,0.0479823258261858,0.0690719391495796,1.98891865370584e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,VCAM1,Vascular cell adhesion protein 1,42199,-0.0316195101686399,0.00290825213683179,-0.0373196843568302,-0.0259193359804496,2.02445518585386e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,STXBP1,Syntaxin-binding protein 1,39934,0.0886898862983016,0.008156351885449,0.0727034366028216,0.104676335993782,2.09989451672812e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEPH,Hephaestin,39958,0.0317319156374439,0.00292008394996045,0.0260085510955214,0.0374552801793664,2.26255795214201e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.106552477811625,0.00982247632938623,0.0873004242060283,0.125804531417222,2.65112213342708e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSNAX,Translin-associated protein X,39575,0.0445528565456949,0.00411047183001497,0.0364963317588656,0.0526093813325243,3.09405192744083e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0783110409392079,0.00722861235339273,0.0641429607265582,0.0924791211518577,3.27952650890216e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2L1,Bcl-2-like protein 1,39929,0.112897782925523,0.0104295653576163,0.0924558348245946,0.133339731026451,3.56756373218508e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.107224216136454,0.00990724869459599,0.087806008695046,0.126642423577862,3.64561713161555e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.0950370023842983,0.00880852561985145,0.0777722921693894,0.112301712599207,5.02134407338345e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.0757268210508619,0.00701781853552473,0.0619718967212335,0.0894817453804904,5.195035038629e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUGT1,Protein SGT1 homolog,41843,0.0902639270090149,0.00837605413473991,0.0738468609049247,0.106680993113105,5.75460275082661e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD22,B-cell receptor CD22,42296,0.0481291540687742,0.00446985233966786,0.0393682434830252,0.0568900646545232,6.28167154704913e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMEM106A,Transmembrane protein 106A,39919,0.0807413178242214,0.00750009042329918,0.066041140594555,0.0954414950538878,6.76824775362975e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.0602724015410385,0.00560613513441341,0.0492843766775882,0.0712604264044888,7.88369967111845e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.0908335938269974,0.00844899806444291,0.0742735576206893,0.107393630033306,7.97012428342241e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.10209722119308,0.00949697789876946,0.0834831445114916,0.120711297874668,8.00142289269491e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.0688451672107494,0.00640731417546329,0.0562868314268414,0.0814035029946575,8.50499886146977e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARA5,Scavenger receptor class A member 5,42249,0.0343623562322712,0.00320062562479823,0.0280891300076667,0.0406355824568757,8.80878534219774e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB1,Leukocyte elastase inhibitor,42093,0.100716948565798,0.00939380059725419,0.0823050993951794,0.119128797736416,1.03203855340564e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL8,C-C motif chemokine 8,42239,0.0678967909852659,0.00634980539437695,0.0554511724122871,0.0803424095582448,1.40275124415017e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,CERT,Ceramide transfer protein,41839,0.0688222822878201,0.00644334887137005,0.0561933184999348,0.0814512460757054,1.59949417143636e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0411732369579676,0.00385733708410954,0.0336128562731129,0.0487336176428223,1.79922166741931e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.061680423500477,0.00579450501027128,0.0503231936803453,0.0730376533206087,2.47671641111963e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.0555676541287531,0.00522324089891685,0.0453301019668761,0.0658052062906302,2.51880630256255e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.0355028148790016,0.00333720355607882,0.0289618959090871,0.0420437338489161,2.64523301412689e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.0370652678418812,0.00348774202563777,0.0302292934716312,0.0439012422121313,2.81700265020469e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.04788941995656,0.00451054225752828,-0.0567300827813154,-0.0390487571318046,3.13835387163129e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.0475928852728805,0.00449186914886829,0.0387888217410987,0.0563969488046624,3.95849549065516e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,JAM3,Junctional adhesion molecule C,39736,0.0564069202504343,0.005321784454681,0.0459762227192595,0.0668376177816091,4.00015173278182e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.141669432198112,0.0133683693184395,0.11546742833397,0.167871436062253,4.06069243165866e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.0745948516143921,0.007043759209504,0.0607890835637643,0.08840061966502,4.18512101100113e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL2,C-C motif chemokine 2,41992,0.0576647828063006,0.00544519501322364,0.0469922005803823,0.068337365032219,4.20404675226602e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB6,Serpin B6,42216,0.0649565293473459,0.00614034683126163,0.0529214495580731,0.0769916091366187,4.72453801560517e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.100034170840359,0.00945274724798629,0.0815067862343064,0.118561555446413,4.78259541644985e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0638490316176947,0.00604435372264709,0.0520020983213064,0.075695964914083,5.5861060044707e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.0515624749733739,0.00488048995525851,0.0419967146610672,0.0611282352856806,5.75796747295822e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.0642448485854227,0.00609457786842835,0.0522994759633031,0.0761902212075423,7.06085055473705e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL18,C-C motif chemokine 18,42020,0.077476308342229,0.00736299569870789,0.0630448367727616,0.0919077799116965,8.58447252762169e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1R,Complement C1r subcomponent,39979,0.0207042911739225,0.00196784086810338,0.0168473230724399,0.0245612592754051,9.04636966503391e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDT,D-dopachrome decarboxylase,39966,0.0447257327731302,0.00425861643669659,0.0363788445572048,0.0530726209890555,1.10379303532563e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CIAPIN1,Anamorsin,42181,0.0674711750800744,0.00642774975473487,0.0548727855607941,0.0800695645993547,1.11982779189457e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0762033662565523,0.00725871006098358,0.0619762945370244,0.0904304379760801,1.16476070468139e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,FEN1,Flap endonuclease 1,41843,0.0707890896317693,0.00674643005781505,0.0575660867184519,0.0840120925450868,1.17503702266374e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCRG1,Scrapie-responsive protein 1,39958,0.0299782954036046,0.00286083255479134,0.0243710635962135,0.0355855272109956,1.412959708856e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0524356546608848,0.00501096726949651,0.0426141588126716,0.0622571505090979,1.6487186852881e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.105225190585988,0.01006401438754,0.0854997223864096,0.124950658785566,1.72688991272018e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,GMFG,Glia maturation factor gamma,39958,0.0786961794366661,0.00753819582014663,0.0639213156291787,0.0934710432441535,2.12882619272946e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,MESD,LRP chaperone MESD,42137,0.133253702764634,0.0127853939751831,0.108194330573275,0.158313074955993,2.44499517630228e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,RASSF2,Ras association domain-containing protein 2,41843,0.062364136589347,0.00598792866288509,0.0506277964100922,0.0741004767686018,2.6529774100382e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAP,Prolyl endopeptidase FAP,42310,0.0299503747557276,0.00288732113275288,0.024291225335532,0.0356095241759233,4.0722442883589e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,JPT2,Jupiter microtubule associated homolog 2,39930,0.0954317939585205,0.00919832733141191,0.0774030723889531,0.113460515528088,4.1776996978043e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBLN4,Cerebellin-4,42262,0.0344711180254453,0.00332818757315341,0.0279478703820646,0.040994365668826,4.79858904388448e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.132112193102606,0.0127608917764583,0.107100845220748,0.157123540984464,5.03529573274494e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP3,Caspase-3,42310,0.0955968454417459,0.00923482676798407,0.0774965849764971,0.113697105906995,5.07902547105375e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18,Interleukin-18,42069,0.0480864413218147,0.00464995106797743,0.038972537228579,0.0572003454150505,5.68380794201077e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.038797893201381,0.00375294731218548,-0.0461536699332645,-0.0314421164694974,6.12318301918586e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTRB1,Chymotrypsinogen B,42137,0.0632457539218069,0.00612973605444014,0.0512314712551042,0.0752600365885095,7.233907496225e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.101468313939609,0.00983484233798881,0.0821920229571511,0.120744604922067,7.28885995315389e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL3,C-C motif chemokine 3,42119,0.064219073250888,0.00622769839868367,0.0520127843894681,0.076425362112308,7.69952895194484e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,MENT,Protein MENT,39736,-0.0256602107740435,0.00248808736924748,-0.0305368620177686,-0.0207835595303185,7.9406023520352e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.121814896262369,0.0118355204060588,-0.145012516258245,-0.0986172762664941,9.43355088651815e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOL1,Apolipoprotein L1,39990,0.0575301477517738,0.00558828265715454,0.0465771137437509,0.0684831817597967,9.54813248022795e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.122657547715317,0.0119212133279989,0.0992919695924392,0.146023125838195,9.73168938141284e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.0688065438937855,0.00668785152243972,0.0556983549098037,0.0819147328777674,1.02657344354739e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,FRMD4B,FERM domain-containing protein 4B,39575,0.075642952302945,0.00735872758976329,0.0612198462270089,0.090066058378881,1.12953156803271e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,APP,Amyloid-beta precursor protein,42112,0.0712991269752738,0.00694225668097533,0.0576923038805621,0.0849059500699854,1.18146309308328e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIF1,Allograft inflammatory factor 1,41843,0.0562892472408398,0.00548308864890168,0.0455423934889925,0.0670361009926871,1.24054017117054e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G4A,Cytosolic phospholipase A2,42185,0.0949920780756904,0.00925419707062404,0.0768538518172673,0.113130304334114,1.24950370877527e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.042560027867227,0.00414874687206817,-0.0506915717364806,-0.0344284839979734,1.33346739898962e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,C2,Complement C2,42199,0.0242259775638085,0.00237042653572257,0.0195799415537922,0.0288720135738247,1.97535880105098e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.109012050110434,0.0106623631030156,0.0881138184285236,0.129910281792345,1.98902705026539e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,MIF,Macrophage migration inhibitory factor,42105,0.0717957438421819,0.00702726327272334,0.0580223078276442,0.0855691798567197,2.04712464635813e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.119882468719766,0.0117393329156564,0.0968733762050793,0.142891561234452,2.15490331680401e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC37,Hsp90 co-chaperone Cdc37,42181,0.0894406163911135,0.0087748861685202,0.0722418395008139,0.106639393281413,2.61197979504014e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRGN,Neurogranin,39990,0.0985191139631771,0.00967039663117824,0.0795651365660678,0.117473091360286,2.85923611995098e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNAS,Neuroendocrine secretory protein 55,39934,0.0921943490573356,0.00904992281842432,0.0744565003332239,0.109932197781447,2.87410933634364e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.115345694904188,0.0113464926130965,0.0931065693825189,0.137584820425857,3.61935505830342e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHRDL2,Chordin-like protein 2,42145,0.0487070850518533,0.00479638330860103,0.0393061737669953,0.0581079963367113,3.84304096951702e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRLF1,Cytokine receptor-like factor 1,42185,0.0264801065669472,0.00260990941630456,0.0213646841109903,0.0315955290229042,4.20783152864461e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,C3,Complement C3,39445,0.0489204621090768,0.00482103502000333,0.0394712334698702,0.0583696907482833,4.3637754462977e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.0949536945159204,0.00937991815582965,0.0765690549304942,0.113338334101346,5.5164207100779e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,PARK7,Parkinson disease protein 7,42137,0.053764669918378,0.00531314732889696,0.04335090115374,0.0641784386830161,5.52810976467522e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.127825154225663,0.0126329180554179,0.103064634837044,0.152585673614282,5.56684349298259e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA3,Annexin A3,42224,0.0736585478221208,0.00729070485431144,0.0593687663076704,0.0879483293365712,6.49943910641592e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,XCL1,Lymphotactin,42262,0.0577668253533979,0.00572062804837636,0.0465543943785802,0.0689792563282156,6.83938658659196e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0269041639232837,0.0026656038096481,0.0216795804563734,0.032128747390194,7.47187553720398e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,STXBP3,Syntaxin-binding protein 3,41843,0.0460155118872825,0.00456098166300854,0.0370759878277857,0.0549550359467792,7.53960098854409e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,LBP,Lipopolysaccharide-binding protein,42217,-0.0619918172505233,0.00615119007596872,-0.074048149799422,-0.0499354847016246,8.37447250515755e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPPB,Natriuretic peptides B,41900,-0.148185236277878,0.014712986688483,-0.177022690187305,-0.119347782368451,8.96421125817115e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.0628024275229595,0.00623349684113264,0.0505847737143395,0.0750200813315795,9.0094622347778e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.0922001794689276,0.00915545127403365,0.0742554949718217,0.110144863966034,9.42450865567726e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMOX2,Heme oxygenase 2,41839,0.0505152081655269,0.00501936813077922,0.0406772466291996,0.0603531697018542,9.69439574952125e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTX3,Pentraxin-related protein PTX3,42119,-0.0525076169110794,0.00521977157372746,-0.0627383691955852,-0.0422768646265735,1.0122451120564e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD164,Sialomucin core protein 24,42137,0.0284750887474749,0.00283515329034404,0.0229181882984006,0.0340319891965492,1.18647901237661e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTD,Deoxycytidylate deaminase,39736,0.100583825862015,0.0100291352514044,0.080926720769262,0.120240930954767,1.42854667981995e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKD2,Polycystin-2,39575,0.0613497005302312,0.00612376136678225,0.0493471282513379,0.0733522728091244,1.59827635178307e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.0411339864610318,0.00410670969754845,0.0330848354538368,0.0491831374682267,1.61849443868585e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.0326763506253242,0.00327150862517465,-0.0390885075306665,-0.0262641937199819,2.12246874584073e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX8,Syntaxin-8,42119,0.0501412627021947,0.00502213201613847,0.0402978839505633,0.0599846414538261,2.15690151344438e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCS,Copper chaperone for superoxide dismutase,42016,0.0485246929477217,0.00486609963581412,0.038987137661526,0.0580622482339174,2.43713111296812e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPI,Glucose-6-phosphate isomerase,39990,0.0499369231280637,0.00500652441638614,0.0401241352719469,0.0597497109841805,2.45993761757692e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.0244110015285032,0.00245010117691617,0.0196088032217475,0.0292131998352589,2.64862181647439e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0549457758423139,0.00552267089249227,0.0441213408930291,0.0657702107915988,3.1859801189522e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.0654798802295848,0.00658454202705258,0.0525741778565617,0.0783855826026079,3.2015626550309e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFT20,Intraflagellar transport protein 20 homolog,39649,0.0454416068028547,0.00457142773781688,0.0364816084367336,0.0544016051689758,3.47610356917086e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCRIB,Protein scribble homolog,39638,0.0910478464176707,0.00916766836761001,0.0730792164171551,0.109016476418186,3.80041296681817e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,LACTB2,Endoribonuclease LACTB2,42145,0.0686137617713649,0.00691586221705631,0.0550586718259346,0.0821688517167953,4.0365018418501e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.078563983019488,0.00793258923061568,0.0630161081274813,0.0941118579114947,4.96305482249329e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD244,Natural killer cell receptor 2B4,42296,0.0285588282336085,0.00288662893612649,0.0229010355188006,0.0342166209484165,5.30615299769193e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPP1,Osteopontin,42286,-0.0456931006115549,0.00461861992638157,-0.0547455956672628,-0.036640605555847,5.32007182575666e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOA1,Apolipoprotein A-I,39979,-0.0283671575455029,0.00287242614250098,-0.0339971127848048,-0.0227372023062009,6.56080505740661e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPI,Mannose-6-phosphate isomerase,42070,0.0880387289908541,0.00893092629199249,0.0705341134585488,0.105543344523159,7.58272151362004e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL7,Angiopoietin-related protein 7,42262,0.0379585708932614,0.00385543069869974,0.0304019267238099,0.0455152150627129,8.53765991149093e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSZ,Cathepsin Z,42168,0.0333026716537849,0.00338410398435571,0.0266698278444477,0.0399355154631221,8.94231500294098e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBN1,Drebrin,39657,0.0524946331416826,0.00533889863292933,0.0420303918211411,0.0629588744622241,1.01092825378398e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.0435929136038431,0.00443702455286902,0.0348963454802199,0.0522894817274664,1.09065929384203e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0544545421739912,0.00554531321097889,0.0435857282804725,0.0653233560675098,1.1381053813978e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFAT5,Nuclear factor of activated T-cells 5,39657,0.0876534186399051,0.00892761368408031,0.0701552958191077,0.105151541460703,1.16305857487272e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3BP1,SH3 domain-binding protein 1,39930,0.0507684979120296,0.00517323339693719,0.0406289604540327,0.0609080353700265,1.210051849192e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKN3,Serine/threonine-protein kinase N3,39757,0.0755203869611288,0.00770177533942619,0.0604249072958535,0.0906158666264042,1.31456782912907e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD2,Sushi domain-containing protein 2,42137,-0.0291505524476224,0.00297713820497998,-0.0349857433293832,-0.0233153615658617,1.4556351269071e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.10106997004852,0.0103193293532216,0.0808440845162054,0.121295855580834,1.46398986805573e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.0376254041565283,0.00384566335856766,0.0300879039737356,0.0451629043393209,1.57106049756918e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0773127587940761,0.00790597413389389,0.0618170494916441,0.0928084680965082,1.70024076195092e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0672792256675588,0.00688326514584634,0.0537880259817,0.0807704253534177,1.78041202553155e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINT2,Kunitz-type protease inhibitor 2,42185,0.0404480794741944,0.00414376734038817,0.0323262954870336,0.0485698634613552,1.95782699011118e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.0287693430583436,0.00294782253786253,0.022991610884133,0.0345470752325541,2.07139131610288e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTGR1,Prostaglandin reductase 1,39958,0.0852909425064265,0.00876118642679632,0.0681190171099057,0.102462867902947,2.6111777608679e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.0592535630072052,0.00608864300476529,0.0473198227178652,0.0711873032965452,2.62038362374742e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.0568712515145733,0.0058552280394717,0.0453950045572088,0.0683474984719379,3.13970964125684e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOD1,Superoxide dismutase [Cu-Zn],41874,0.0482956680388439,0.00497351366663855,0.0385475812522324,0.0580437548254555,3.22234222665888e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.0652106551271446,0.00672010232398256,0.0520392545721388,0.0783820556821504,3.54256594714508e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT16,U8 snoRNA-decapping enzyme,39915,0.0890272394274994,0.00917817446323156,0.0710380174795655,0.107016461375433,3.68162596967077e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,AFP,Alpha-fetoprotein,41976,0.0663855941103395,0.00684798037210346,0.0529635525810167,0.0798076356396622,3.77478873492844e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.0736923663334993,0.00760851669799208,0.0587796736054349,0.0886050590615638,4.23015018058481e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0410906327936804,0.00424661009253179,0.0327672770123181,0.0494139885750427,4.50356325990175e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,OPLAH,5-oxoprolinase,39638,0.0703502622908103,0.00726859548163373,0.0561038151468082,0.0845967094348124,4.54653284721728e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.0845343864790484,0.00874871586323702,0.0673869033871039,0.101681869570993,5.29051498031436e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,GZMA,Granzyme A,42296,0.034367577392836,0.0035586775950907,0.0273925693064582,0.0413425854792138,5.37438557094227e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.0584961812436126,0.00606359477952256,0.0466115354757483,0.0703808270114768,5.95754885010094e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA4,Protein disulfide-isomerase A4,39966,0.0619497273514888,0.00642041994543602,0.0493657042584341,0.0745337504445434,6.0327738335443e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMTN,Smoothelin,39897,0.0936231628066592,0.00970438745961446,0.0746025633858148,0.112643762227503,6.11926103747998e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.120749390281347,0.012529873638141,0.0961908379505901,0.145307942612103,6.56326775447894e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCA,Calcitonin,41997,0.0702642201623401,0.00729742047311401,0.0559612760350366,0.0845671642896435,7.1248195841048e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.0620870460405879,0.00644741205834176,0.0494501184062381,0.0747239736749378,7.25617367110032e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.100833177282961,0.0104793230467832,0.0802937041112662,0.121372650454656,7.81553857976288e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,UNC79,Protein unc-79 homolog,39560,0.0561081926930614,0.005838198786588,0.044665323071349,0.0675510623147739,8.79509264175152e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.0404351333095976,0.00420956431117112,0.0321843872597022,0.048685879359493,9.16499301381795e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,NBN,Nibrin,41913,0.0547739876910975,0.00570435064006308,0.0435934604365739,0.0659545149456212,9.21005929783713e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,MIA,Melanoma-derived growth regulatory protein,42181,0.037233290837149,0.00387984210707196,0.029628800307288,0.04483778136701,9.68442978604423e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYBB1,Beta-crystallin B1,39958,0.0664834051890989,0.00692931007631355,0.0529019574395244,0.0800648529386735,1.01902755266062e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN4,CCN family member 4,42262,0.039340261163699,0.00410386138579909,0.0312966928475328,0.0473838294798653,1.06987345034787e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX4,Syntaxin-4,42070,0.0593339694553339,0.00618993685591952,0.0472016932177316,0.0714662456929362,1.0785135253278e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRK5,G protein-coupled receptor kinase 5,41900,0.0517116588316035,0.00539797263612219,0.041131632464804,0.062291685198403,1.14186501065423e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.083075017101602,0.00869031045747686,0.0660420086049474,0.100108025598257,1.38455462171502e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACYP1,Acylphosphatase-1,39701,0.0651677445402764,0.00681486029081701,0.051810618370275,0.0785248707102777,1.39061479323965e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.024504582575627,0.00256356826541373,0.0194799887754161,0.0295291763758379,1.39446548658346e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPAG1,Sperm-associated antigen 1,39934,0.0584434046087645,0.00611758950176015,0.0464529291853146,0.0704338800322144,1.51366080569349e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.0463706499648579,0.00485541099860222,0.0368540444075975,0.0558872555221182,1.51715152991139e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRP2,Neuropilin-2,42137,-0.02819298655996,0.00295323675895131,-0.0339813306075046,-0.0224046425124154,1.56851789989586e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAG3,BAG family molecular chaperone regulator 3,41992,0.0406845297511781,0.00426354755310919,0.0323279765470841,0.0490410829552721,1.63344644421232e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.0397829674534437,0.00417442450249652,0.0316010954285506,0.0479648394783369,1.82997362791069e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.0503366152490881,0.005281901087771,0.039984089117057,0.0606891413811193,1.83259565286123e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,TF,Serotransferrin,39979,0.0214017547146705,0.00224501675060969,0.0170015218834755,0.0258019875458655,1.83744926764897e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFB,Complement factor B,39794,0.0326919633419322,0.00343378578508957,0.0259617432031566,0.0394221834807078,2.07335834390908e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD99L2,CD99 antigen-like protein 2,42137,0.024510303720883,0.00258235771915436,0.0194488825913404,0.0295717248504255,2.65398164627462e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIPC3,PDZ domain-containing protein GIPC3,39930,0.0982136220673032,0.0103583711323977,0.0779112146478037,0.118516029486803,3.00283369515115e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.103078272160535,0.0108914048633191,0.08173111862843,0.124425425692641,3.54213590264458e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.0367456515487456,0.00388632113850145,0.0291284621172828,0.0443628409802085,3.74902637847367e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.0860609124492035,0.00910059863802588,0.0682237391186728,0.103898085779734,3.80577939551402e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL16,C-X-C motif chemokine 16,42295,0.0231110594964634,0.00244828075421195,0.018312429218208,0.0279096897747188,4.33246166914354e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMPER,BMP-binding endothelial regulator protein,39736,0.022851947277387,0.00242052521290376,0.0181077178600956,0.0275961766946783,4.43066878683054e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAG6,Large proline-rich protein BAG6,41900,0.0365589400406602,0.00387439734078739,0.0289651212527169,0.0441527588286035,4.50572619511433e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.0368263599250256,0.00390946636493845,0.0291638058497462,0.0444889140003049,5.40997499717698e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,PVR,Poliovirus receptor,42249,0.036903336719399,0.00392596995461936,0.0292084356083451,0.044598237830453,6.32335914538094e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0601708351750632,0.00640569282497243,0.0476156772381172,0.0727259931120092,6.73053057390338e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,DYNLT3,Dynein light chain Tctex-type 3,39919,0.0430981277479518,0.004594998936865,0.0340919298316964,0.0521043256642072,7.89850026810496e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,ING1,Inhibitor of growth protein 1,41820,0.0469536473887998,0.00500787406630654,0.037138214218839,0.0567690805587606,7.9543512898627e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTN6,Dynactin subunit 6,41839,0.0711430663915013,0.00758887346508534,0.056268874399934,0.0860172583830685,8.05134797683396e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB10,Ras-related protein Rab-10,39958,0.0525044903853442,0.0056008779761827,0.0415267695520261,0.0634822112186623,8.27582592340268e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP170,Centrosomal protein of 170 kDa,39638,0.0757395155503861,0.00809096460588666,0.0598812249228483,0.091597806177924,9.42737902699713e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,POMC,Pro-opiomelanocortin,39638,0.0718284287475926,0.00768872546758577,0.0567585268311245,0.0868983306640607,1.12619942493353e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0364737888694966,0.00390574284466016,0.0288185328939627,0.0441290448450305,1.15893764933145e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC5A,C-type lectin domain family 5 member A,42107,-0.029821122205763,0.00319469345305319,-0.0360827213737473,-0.0235595230377788,1.16993770048983e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL10RB,Interleukin-10 receptor subunit beta,42185,0.0291223932063025,0.00312827261345012,0.0229909788839403,0.0352538075286648,1.47969933154293e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.026693881016791,0.00286696398604178,0.0210746316041491,0.0323131304294329,1.50739168160769e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.117132347852473,0.0126096677718854,0.0924173990195781,0.141847296685369,1.79044139443544e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,BGLAP,Osteocalcin,39966,0.0819788591567704,0.00882362195980797,0.0646845601155468,0.099273158197994,1.80866484199724e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPA,Apolipoprotein(a),39775,-0.177458018086665,0.0191252917725647,-0.214943589960892,-0.139972446212438,2.03086882455839e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,RP2,Protein XRP2,42070,0.0414421012750511,0.00447006077641606,0.0326807821532756,0.0502034203968266,2.11981927920947e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP7,Matrilysin,41881,0.050286196064672,0.00544311901264328,0.0396176827998912,0.0609547093294528,2.87491853422048e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMB1,Laminin subunit beta-1,39638,0.030377716302297,0.00328710201542575,0.0239349963520625,0.0368204362525315,2.87615554125015e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0368850975660077,0.00399296684313474,0.0290588825534636,0.0447113125785518,2.90215272181078e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,BPIFB2,BPI fold-containing family B member 2,39927,0.0593235426670069,0.00642153212984299,0.0467373396925146,0.0719097456414991,2.95199580205433e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.0305940798256841,0.00331402369874524,0.0240985933761434,0.0370895662752247,3.05360442183732e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAP18,Chromatin complexes subunit BAP18,39929,0.0659411347778724,0.00714139734368876,0.0519439959842425,0.0799382735715024,3.07986670089353e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,BDNF,Brain-derived neurotrophic factor,39966,0.0812253530943617,0.00879927343679424,0.063978777158245,0.0984719290304784,3.15712333079056e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAP25,Synaptosomal-associated protein 25,39586,0.0464891702266235,0.00504019916093514,0.0366103798711906,0.0563679605820564,3.39498153394436e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRA1,GDNF family receptor alpha-1,42247,0.0275419226486104,0.00299544417496793,0.0216708520656732,0.0334129932315475,4.30117125877065e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLIT2,Slit homolog 2 protein,41839,0.0498825763987524,0.00542956285549554,0.0392406332019811,0.0605245195955236,4.62380642157679e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS1,Galectin-1,42145,0.0337653805803466,0.00367543124429891,0.0265615353415207,0.0409692258191725,4.62821203028654e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0513301128149157,0.00559656387240552,0.0403608476250009,0.0622993780048305,5.33444722966232e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCN1,Ficolin-1,39978,0.0534833498217289,0.00584021639318563,0.0420365256910851,0.0649301739523728,6.20150344752429e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANSC1,MANSC domain-containing protein 1,42181,-0.0267013843911006,0.00291737956845526,-0.0324194483452729,-0.0209833204369283,6.34483478519055e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPPK1,Epiplakin,39638,0.0708501957126071,0.00775662680501337,0.0556472071747809,0.0860531842504333,7.74081735627021e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM4,Intercellular adhesion molecule 4,42119,-0.0502013624628293,0.00551760276426631,-0.0610158638807913,-0.0393868610448673,1.04319144720216e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.029061846566061,0.00320079523746384,0.0227882879006319,0.0353354052314901,1.23782583689401e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNGR2,Interferon gamma receptor 2,42016,0.0503556030937101,0.0055486618511249,0.0394802258655053,0.0612309803219149,1.29000836867202e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA2,Annexin A2,39492,0.0670381590910661,0.00738676812222282,0.0525600935715094,0.0815162246106228,1.32689267277839e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.0321109836232161,0.00353988358126882,0.0251728118039292,0.039049155442503,1.37081041959793e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.040742684106376,0.0044943244835442,0.0319338081186293,0.0495515600941226,1.44943323513225e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS3BP,Galectin-3-binding protein,39979,0.0296321578894242,0.00327207974416317,0.0232188815908644,0.0360454341879841,1.57232267774258e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.0673862805924102,0.00744413516452367,0.0527957756699438,0.0819767855148766,1.62804015844682e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,C7,Complement component C7,39722,-0.0316544233741935,0.0034976079754281,-0.0385097350060326,-0.0247991117423544,1.66256776566698e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLITRK2,SLIT and NTRK-like protein 2,42262,0.0384541252725585,0.00425684083789957,0.0301107172302753,0.0467975333148416,1.88298544362199e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGFL7,Epidermal growth factor-like protein 7,41843,0.0367121330623016,0.004072439426821,0.0287301517857324,0.0446941143388707,2.24031859929113e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,F2R,Proteinase-activated receptor 1,42166,0.0542226223851759,0.00601794737099319,0.0424274455380292,0.0660177992323225,2.32921386616751e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.0372026101178721,0.0041295736961758,0.0291086456733675,0.0452965745623766,2.41547713753503e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITPA,Inosine triphosphate pyrophosphatase,39575,0.0633697831031239,0.00704177747193406,0.0495678992581332,0.0771716669481147,2.64976632856375e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12A_IL12B,Interleukin-12,42070,0.0726498733008756,0.00808140524802205,0.0568103190147524,0.0884894275869988,2.80405260037565e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,PARD3,Partitioning defective 3 homolog,39757,0.0697806576434342,0.00776733820022402,0.0545566747709952,0.0850046405158733,3.03396230783586e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.0535883935006285,0.00597889379623217,-0.0653070253412435,-0.0418697616600135,3.5712861528631e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX16,Syntaxin-16,41843,0.0537132231711017,0.00599319794721018,0.0419665551945698,0.0654598911476337,3.59856744388668e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.0284377792917272,0.00317526727060466,0.0222142554413421,0.0346613031421123,3.79990319474793e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD93,Complement component C1q receptor,41654,-0.0295366927545155,0.00330080054451414,-0.0360062618217632,-0.0230671236872678,4.09044524799602e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLNK,B-cell linker protein,39657,0.039161511942759,0.00438055376747868,0.0305756265585008,0.0477473973270172,4.51531015015086e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,MZT1,Mitotic-spindle organizing protein 1,41843,0.0492455420460882,0.00551871625517516,0.0384288581859448,0.0600622259062315,5.11103920754012e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLF4,Krueppel-like factor 4,39586,0.0379202947488161,0.00424948606160107,0.029591302068078,0.0462492874295542,5.23413071037399e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASS1,Argininosuccinate synthase,39575,0.0722813079631736,0.00810066104121768,0.056404012322387,0.0881586036039602,5.26367561848335e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAG3,Lymphocyte activation gene 3 protein,42070,-0.0379785424601636,0.00426692541637811,-0.0463417162762647,-0.0296153686440625,6.25156945827442e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,DXO,Decapping and exoribonuclease protein,39929,0.0422284763728877,0.00475024404045508,0.0329179980535958,0.0515389546921797,7.04958915882728e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.0387098403560176,0.00435658952732267,0.0301709248824652,0.04724875582957,7.36300130620737e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBI,Acyl-CoA-binding protein,42085,0.072631566706141,0.00817837648069405,0.0566019488039807,0.0886611846083013,7.45929371666832e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,RARRES1,Retinoic acid receptor responder protein 1,41843,0.0293885362892706,0.0033204029640501,0.0228805464797325,0.0358965260988088,9.77264980295605e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.0333664423752528,0.00376992358465337,0.0259773921493322,0.0407554926011734,1.0031235969487e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLO1,Lactoylglutathione lyase,41900,0.052406208546741,0.00593014728758664,0.0407831198630712,0.0640292972304108,1.10289625977384e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0537919378504573,0.00609462541951494,0.041846472028208,0.0657374036727065,1.21633426449867e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADM,Pro-adrenomedullin,42262,0.0242339115637652,0.00274667367165306,0.0188504311673252,0.0296173919602052,1.24797139602431e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLMH,Bleomycin hydrolase,42310,0.0285938211240395,0.00324578176025979,0.0222320888739303,0.0349555533741487,1.40592873697553e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,TST,Thiosulfate sulfurtransferase,41809,0.0698170703678468,0.00793590491063144,0.0542626967430092,0.0853714439926845,1.56912890864326e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLC,Galectin-10,42119,-0.0619920718332745,0.00705483947734935,-0.0758195572088793,-0.0481645864576698,1.71666206601752e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.0343628910539634,0.00391238507133651,0.0266946163141438,0.042031165793783,1.82441239726197e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP4,Dipeptidyl peptidase 4,41948,0.025706588706495,0.00293181436512641,0.0199602325508473,0.0314529448621428,2.03380788597115e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.056845972431485,0.00648264150865511,0.044139995074521,0.069551949788449,2.06763734571056e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP6,Platelet glycoprotein VI,42115,0.0810217683650215,0.00925571679586282,0.0628805634451304,0.0991629732849127,2.30711715609318e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.0260250428655123,0.00297396379131011,0.0201960738345445,0.0318540118964801,2.36097448705474e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,C4BPB,C4b-binding protein beta chain,42181,0.0350726418448697,0.00401089961295061,0.0272112786034865,0.0429340050862529,2.50425818501552e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLRX,Glutaredoxin-1,42057,0.0509431922804229,0.00583766955813295,0.0395013599464824,0.0623850246143635,2.92918701012358e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD72,B-cell differentiation antigen CD72,39736,0.0396173306738716,0.00455109594722559,0.0306971826173094,0.0485374787304338,3.62249747106586e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLTA,Clathrin light chain A,41900,0.0426759654823673,0.00491291249431788,0.0330466569935043,0.0523052739712304,4.1703726004749e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP5,Platelet glycoprotein V,39736,0.0333133332593595,0.00383403443963528,0.0257986257576743,0.0408280407610446,4.1727952690985e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0675873506965902,0.00779624146253921,0.0523067174300134,0.0828679839631671,4.85205797144954e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA14,Carbonic anhydrase 14,42262,-0.0333915405025402,0.00385363268016353,-0.0409446605556607,-0.0258384204494197,5.01965667819765e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.0270253497547387,0.00311986274250865,0.0209104187794218,0.0331402807300557,5.14638492814567e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBCA,Tubulin-specific chaperone A,39736,0.0762648711182229,0.00880749783733361,0.059002175357049,0.0935275668793968,5.41038237086018e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSS,Cathepsin S,39358,0.0221326999965112,0.00255695417347762,0.0171210698164951,0.0271443301765273,5.58846213680257e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLR2,Folate receptor beta,42249,-0.0263513220402852,0.00305206866037498,-0.0323333766146201,-0.0203692674659502,6.57889435170198e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL24,C-C motif chemokine 24,42166,0.0746843656432752,0.0086509430617221,0.0577285172422999,0.0916402140442505,6.63090337093106e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.0297581764934956,0.00345819193339692,-0.0365362326829536,-0.0229801203040377,8.6237557456807e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARFIP1,Arfaptin-1,39934,0.062428623864841,0.00725527893191203,0.0482082771582934,0.0766489705713885,8.66766459299527e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCOF1,Treacle protein,39958,0.0292690642263472,0.00340228948238403,0.0226005768408745,0.0359375516118199,8.80338459258901e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,HRG,Histidine-rich glycoprotein,39925,0.0280406648795258,0.00326190771740902,0.0216473257534041,0.0344340040056475,9.30456302283753e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDNF,Cerebral dopamine neurotrophic factor,42070,0.0295782562320112,0.00344209415416515,0.0228317516898475,0.0363247607741749,9.38900176631786e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA13,Carbonic anhydrase 13,41967,0.0949959858739714,0.0110580500669314,0.0733222077427858,0.116669764005157,9.59671843019158e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.0303917231271087,0.00354361259884548,-0.0373372038208458,-0.0234462424333715,1.1087857013477e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB2B,Ras-related protein Rab-2B,39919,0.0558986051279326,0.00653431570000071,0.0430913463559313,0.068705863899934,1.33462988795688e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.0219804195998063,0.00257482648195952,-0.0270270795044469,-0.0169337596951656,1.52554343707895e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAM,Integrin alpha-M,42137,-0.0282948841234966,0.00331857281568127,-0.0347992868422319,-0.0217904814047613,1.67094521951431e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARF2,Scavenger receptor class F member 2,42249,-0.0254584506799579,0.00298820331014103,-0.0313153291678343,-0.0196015721920815,1.76652061957167e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CES2,Cocaine esterase,42070,0.0497810619230072,0.00584515515194822,0.0383245578251886,0.0612375660208257,1.81522037561028e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSC2,Desmocollin-2,41984,-0.0314542280985043,0.00369519399379961,-0.0386968083263515,-0.024211647870657,1.88688599138155e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,AK2,"Adenylate kinase 2, mitochondrial",39929,0.0955992420231317,0.0112291378145776,0.0735901319065595,0.117608352139704,1.90014551485799e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH7,Protocadherin-7,39930,0.0311208697044166,0.0036562049850694,0.0239547079336805,0.0382870314751526,1.92805691976081e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,NGRN,Neugrin,39929,0.0199921873439713,0.00235043404160964,0.0153853366224164,0.0245990380655262,2.03071342401782e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA4,Carbonic anhydrase 4,42310,-0.0216518152194251,0.00254863273292956,-0.026647135375967,-0.0166564950628831,2.17283328308498e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0553778667558927,0.00653154314912099,0.0425760421836156,0.0681796913281699,2.51251853889423e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,MATN2,Matrilin-2,42144,0.0262851440119591,0.00311400638002682,0.0201816915071066,0.0323885965168117,3.46505538006591e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.0237062262357655,0.00280976685429406,0.0181990832013492,0.0292133692701819,3.65913614274848e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.0440190382505086,0.00522248030794779,0.033782976846931,0.0542550996540863,3.84279633335349e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN9,Septin-9,42070,0.0254109026021576,0.00302017304020155,0.0194913634433625,0.0313304417609526,4.36904498020222e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPA2,Carboxypeptidase A2,42205,0.0587463637979961,0.00698759289388385,0.0450506817259838,0.0724420458700085,4.61175698879155e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMOTL2,Angiomotin-like protein 2,39882,0.0429795918559841,0.00511999448277264,0.0329444026697497,0.0530147810422184,5.23857857576589e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX9,Sorting nexin-9,42145,0.0598969833105438,0.00713923122536445,0.0459040901088295,0.0738898765122581,5.34642747573179e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.077835826516279,0.00928331239309411,0.0596405342258145,0.0960311188067434,5.71225418428397e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.0669614091547299,0.00798875815228842,0.0513034431762446,0.0826193751332152,5.81823683116849e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL1A1,Collagen alpha-1(I) chain,42310,-0.0206589844787388,0.00246689959284224,-0.0254941076807096,-0.015823861276768,6.08119471280098e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTN2,Dynactin subunit 2,42070,0.0833195652092542,0.00996432909997733,0.0637894801732986,0.10284965024521,6.77974101565598e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0405187945611861,0.00484526111862031,0.0310220827686903,0.0500155063536819,6.87296046464659e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL7,C-C motif chemokine 7,42119,0.0493100482803172,0.00590477544091055,0.0377366884161325,0.0608834081445019,7.43014962982519e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF2,Fibroblast growth factor 2,42119,0.0605920358293861,0.00726156322926741,0.046359371900022,0.0748246997587502,7.8589093873164e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF6,SLAM family member 6,41843,0.0338539964044816,0.00406159955599877,0.025893261274724,0.0418147315342392,8.49855119584528e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOM3,Myomesin-3,39736,-0.0847239326087227,0.0101673372566216,-0.104651913631701,-0.0647959515857443,8.80977494492939e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SBSN,Suprabasin,39954,-0.0309962264985627,0.00372436384887208,-0.0382959796423519,-0.0236964733547734,9.59265948706831e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD40LG,CD40 ligand,42296,0.0692188500359505,0.00831968403119061,0.0529122693348169,0.0855254307370841,9.63055591237521e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.0636076208155155,0.00764758091267431,0.0486183622266739,0.0785968794043572,9.85620747171493e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.0289422612303092,0.00348811986692257,0.022105546291141,0.0357789761694775,1.1639249026633e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.0842682363123972,0.0101574095829147,0.0643597135298844,0.10417675909491,1.1995295539921e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS27,Serine protease 27,42107,0.0349715809725145,0.00422131609678032,0.0266978014228251,0.0432453605222039,1.29676806538974e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIF22,Kinesin-like protein KIF22,39575,0.107705911668439,0.0130185595890241,0.0821895348739519,0.133222288462926,1.4541058504112e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.0750356902456691,0.00907885852738818,0.0572411275319883,0.09283025295935,1.52804933241186e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL4,Angiopoietin-related protein 4,42166,-0.0387063503526942,0.00468601984457968,-0.0478909492480703,-0.029521751457318,1.59120091076969e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.0460504213297165,0.00558628983253158,0.0351012932579546,0.0569995494014784,1.82658060687954e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP1,Rho GTPase-activating protein 1,41843,0.0403313450307267,0.0048936934638328,0.0307397058416144,0.049922984219839,1.85966616053985e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0562982493968032,0.00683924021492731,0.0428933385755456,0.0697031602180607,2.0172451968942e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSCAM,Down syndrome cell adhesion molecule,39934,0.0313041091056531,0.00380682257808596,0.0238427368526046,0.0387654813587016,2.19806058840376e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0256126578911481,0.00311569428773394,0.0195058970871896,0.0317194186951066,2.2460188210591e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF7,SLAM family member 7,42119,-0.05139661348701,0.00627374070035611,-0.063693145259708,-0.0391000817143121,2.79060204238977e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAP3,Cytosol aminopeptidase,41913,0.0413004650589032,0.00504349766024119,0.0314152096448305,0.0511857204729759,2.87598037318166e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGS10,Regulator of G-protein signaling 10,39934,0.0510135706805069,0.00623933861761002,0.0387844669899912,0.0632426743710225,3.2432154984133e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPXM1,Probable carboxypeptidase X1,42181,0.0589973686466998,0.00722450050144252,0.0448373476638724,0.0731573896295271,3.4589610939406e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFC1,Cryptic protein,41843,0.0410607380966052,0.00502831538681056,0.0312052399384566,0.0509162362547539,3.4774353639182e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.0366305814672106,0.0044870946634509,-0.0454252870075743,-0.0278358759268468,3.54068893504959e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.076184414191217,0.00934243001348555,0.0578732513647853,0.0944955770176487,3.81327044105084e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK7,Kallikrein-7,39475,0.0338455158573335,0.00414986195246199,0.025711786430508,0.041979245284159,3.84965621480393e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,PER3,Period circadian protein homolog 3,39657,0.104895880985382,0.0128741359795832,0.0796625744653987,0.130129187505365,4.10493957796751e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROK1,Prokineticin-1,42119,0.0425369113963453,0.00522579819470051,0.0322943469347323,0.0527794758579583,4.30371585982215e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPMT,Thiopurine S-methyltransferase,41843,0.0611807389794687,0.00751646887611038,0.0464484599822924,0.0759130179766451,4.31945691955933e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.0263531336566644,0.00323801859016759,0.0200066172199359,0.0326996500933928,4.41417367212247e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS9,Galectin-9,42129,0.026843582050973,0.00329994551477,0.0203756888420238,0.0333114752599222,4.49274446737072e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPL14,60S ribosomal protein L14,39638,0.0332888746780809,0.00409396135663567,0.025264710419075,0.0413130389370868,4.70455279660363e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.0597834693639738,0.00735761739891738,0.0453625392620958,0.0742043994658519,4.92285505377448e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH15,Cadherin-15,42230,0.0589679605348295,0.00726876052824697,0.0447211898994654,0.0732147311701936,5.37953716006587e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.0562384018959587,0.00693381639030231,0.0426481217709661,0.0698286820209512,5.45625966595821e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP1,Guanylate-binding protein 1,39911,0.0550005036860861,0.00678011875077562,0.0417114709345659,0.0682895364376063,5.49202663664649e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.0505014994321439,0.00622742124791889,0.0382957537862229,0.062707245078065,5.60397461895416e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,EBI3_IL27,Interleukin-27,42247,-0.0260147637824298,0.00321649932552609,-0.0323191024604609,-0.0197104251043986,6.57851216323971e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.027465073995844,0.00339607429327015,0.0208087683810345,0.0341213796106535,6.71915474127781e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMIGO2,Amphoterin-induced protein 2,42070,0.0198523907020246,0.00246005387071052,0.015030685115432,0.0246740962886172,7.62801842435091e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGH,Gamma-glutamyl hydrolase,41933,0.028808357667322,0.0035713572131223,0.0218084975296023,0.0358082178050417,7.84877864969699e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGR,Tyrosine-protein kinase Fgr,41839,0.0497563726979569,0.00617420817898803,0.0376549246671403,0.0618578207287734,8.36529037204547e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA9,Serpin A9,42025,0.0611638219272748,0.00759334297884665,0.0462808696887354,0.0760467741658143,8.61959572256583e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0449722835921171,0.00558987581014683,0.0340161270042293,0.0559284401800049,9.4830380686422e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERI1,3'-5' exoribonuclease 1,39757,0.0289327950425092,0.00359860248670377,0.0218795341685698,0.0359860559164486,9.88973258088474e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL19,C-C motif chemokine 19,42249,0.0952455827959655,0.0118659128733233,0.0719883935642517,0.118502772027679,1.08158450465579e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.0827133829009175,0.0103053508251002,0.0625148952837212,0.102911870518114,1.08738409026947e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH5,Cadherin-5,42310,-0.0256127105508334,0.00319223885663552,-0.031869498709839,-0.0193559223918277,1.11135201223096e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.0367742728714958,0.00458776952034899,0.0277822446116118,0.0457663011313798,1.20232716078982e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL15,C-C motif chemokine 15,42310,0.0366199177966469,0.00457453912156698,0.0276538211183756,0.0455860144749181,1.28856921437901e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD248,Endosialin,39966,-0.0339602206048095,0.00424638370399058,-0.0422831326646311,-0.025637308544988,1.39327995648947e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARF1,Scavenger receptor class F member 1,42310,0.0356758471951655,0.00446397314265957,0.0269264598355528,0.0444252345547783,1.43376550840557e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,OMD,Osteomodulin,42185,-0.0344327860485984,0.00431277633810595,-0.0428858276712861,-0.0259797444259108,1.53105263707391e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTC,Probetacellulin,41843,0.0613760136086748,0.00770891477580175,0.0462665406481034,0.0764854865692462,1.83464451756697e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,VGF,Neurosecretory protein VGF,39934,0.025169214997116,0.00316346478646909,0.0189688240156366,0.0313696059785955,1.94242306215901e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFRP1,Secreted frizzled-related protein 1,41968,0.0359622430993064,0.00452470086546173,0.0270938294030014,0.0448306567956114,2.04692934313935e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0297753473872338,0.00374830842564818,0.0224286628729634,0.0371220319015043,2.15160119576308e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,DENR,Density-regulated protein,39657,0.0478536850160384,0.00602463509204435,0.0360454002356314,0.0596619697964453,2.16468659702661e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARSA,Arylsulfatase A,42137,0.0376518408267253,0.00474211159260768,0.0283573021052143,0.0469463795482364,2.18226532845949e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,0.0323453432770583,0.00407610455031739,0.0243561783584362,0.0403345081956804,2.26110788257126e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SWAP70,Switch-associated protein 70,39930,0.0303716951283251,0.00384295425465865,0.0228395047891941,0.037903885467456,2.96949767095455e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC10A,C-type lectin domain family 10 member A,42016,-0.0302537900299086,0.00384391085093853,-0.0377878552977481,-0.022719724762069,3.79965750440312e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.0300687664721175,0.0038199895170113,0.0225815870187753,0.0375559459254596,3.83352243163466e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.0697944617664976,0.00886755270798149,0.0524140584588539,0.0871748650741414,3.84535514055852e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.059682664977602,0.00758731379666263,0.0448115299361433,0.0745538000190608,3.93737871986969e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPM1F,Protein phosphatase 1F,39958,0.0440148837267427,0.00559584787957018,0.0330470218827851,0.0549827455707002,4.00474180572911e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.0422668001180226,0.00537773154177979,-0.052807153939911,-0.0317264462961342,4.14271755169696e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNM1,Dynamin-1,39930,0.0953215679639851,0.0121295726923243,0.0715476054870295,0.119095530440941,4.23539243933862e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.0366606683262621,0.00466757860017755,0.0275122142699141,0.0458091223826101,4.39127277657273e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0522147828047231,0.0066504852257822,-0.0652497338472562,-0.03917983176219,4.42271169223812e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.0403236039525,0.00513915582247974,0.0302508585404397,0.0503963493645602,4.66804782196852e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0397593915491599,0.00507362895553565,0.0298150787963101,0.0497037043020098,5.04802853503463e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.0273823776476096,0.00349596721046439,0.0205302819150994,0.0342344733801198,5.1346089789242e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.0470027943488903,0.0060142883226792,0.0352147892364391,0.0587907994613416,5.89888625606449e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTSL2,ADAMTS-like protein 2,39966,0.0283193490761097,0.0036389235128976,0.0211870589908304,0.035451639161389,7.73576701377415e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.0328518622299251,0.00422163118415267,0.0245774651089858,0.0411262593508643,7.77236341133202e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,LONP1,"Lon protease homolog, mitochondrial",39638,0.0715595660969457,0.00920287279044189,0.0535219354276796,0.0895971967662118,8.16497498499608e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.0256354016054081,0.00330300280303057,-0.032109287099348,-0.0191615161114682,9.02220965523739e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12B,Interleukin-12 subunit beta,42296,0.0446428503329976,0.00575588535656997,0.0333613150341205,0.0559243856318748,9.37949125790223e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,FADD,FAS-associated death domain protein,42145,0.0621670162936824,0.00801875684272107,0.0464502528819491,0.0778837797054157,9.63542031821739e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNC,Tenascin,42217,-0.0392918822810198,0.00507528786825599,-0.0492394465028015,-0.029344318059238,1.0490677446792e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD276,CD276 antigen,42123,-0.0291985295505903,0.00377643568117816,-0.0366003434856995,-0.0217967156154811,1.13532103972674e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD84,SLAM family member 5,42119,0.0258766159588318,0.00335007842870937,0.0193104622385615,0.0324427696791022,1.20473339742049e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CORO1A,Coronin-1A,41883,0.0719782058531144,0.00931844047814634,0.0537140625159476,0.0902423491902812,1.20529751387547e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.0359008541519545,0.00464936959099406,0.0267880897536061,0.0450136185503028,1.24484251078536e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL26,C-C motif chemokine 26,42119,0.07286994969091,0.00944020227986301,0.0543671532223785,0.0913727461594415,1.25344224093782e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,LACRT,Extracellular glycoprotein lacritin,39895,0.0367722759034374,0.00476922488232328,0.0274245951340838,0.0461199566727911,1.36025311732163e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHGA,Chromogranin-A,39966,-0.0687535037735642,0.00891866029854806,-0.0862340779587184,-0.05127292958841,1.37422835654829e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCAM2,Neural cell adhesion molecule 2,42137,-0.0218288225688033,0.00283260353269773,-0.0273807254928908,-0.0162769196447157,1.38535685979591e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC80,Coiled-coil domain-containing protein 80,42145,0.0284403002547663,0.00369692839125719,0.0211943206079022,0.0356862799016303,1.53680894548243e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,DHPS,Deoxyhypusine synthase,39919,0.0325057370125633,0.00422584590851606,0.0242230790318718,0.0407883949932547,1.56707235005183e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.0701918380510365,0.00912563845399438,0.0523055866812075,0.0880780894208655,1.57385804605495e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0365139606634489,0.00477423058988214,0.0271564687072799,0.0458714526196179,2.17720363750366e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSL3,Insulin-like 3,39929,0.0721212796389691,0.00944549733924538,0.0536081048540482,0.0906344544238901,2.42986336048418e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAGED1,Melanoma-associated antigen D1,41843,0.0385499619738492,0.00507168355751543,0.0286094622011189,0.0484904617465794,3.13537815747979e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXNB2,Plexin-B2,42255,0.0194848451962015,0.00257122471035031,0.0144452447639149,0.0245244456284881,3.7336018202975e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSL5,Insulin-like peptide INSL5,39930,0.0812866652903103,0.0107383357858386,0.0602395271500665,0.102333803430554,4.02907730387878e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.0543362478429988,0.00718332582634307,0.0402569292233663,0.0684155664626312,4.15902181996108e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.0175560743403315,0.00232264520469441,-0.0221084589415325,-0.0130036897391304,4.33874484584548e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.0377952596341125,0.00501345970500834,0.0279688786122961,0.0476216406559289,5.10666588709138e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENO2,Gamma-enolase,42249,0.0515319702037895,0.00684346132350208,0.0381187860097254,0.0649451543978536,5.38775967989224e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEK7,Serine/threonine-protein kinase Nek7,39757,0.058548544322343,0.00777619758156818,0.0433071970624694,0.0737898915822166,5.49888527711521e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMS,Spermine synthase,39586,0.0506635142687043,0.00673619083735726,0.0374605802274841,0.0638664483099245,5.85578109298565e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.0538981800499293,0.0071728272951337,0.0398394385514673,0.0679569215483914,6.16316181083687e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.0225026176263824,0.00299577987168925,-0.0283743461748934,-0.0166308890778715,6.21379364844457e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.024989055370514,0.00332679311054074,0.0184685408738542,0.0315095698671739,6.21478301628725e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,0.0544375185482829,0.00725714121578628,0.0402135217653418,0.068661515331224,6.80659209939874e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42249,0.0273130853981174,0.00364313885632085,0.0201725332397286,0.0344536375565063,6.92463227124856e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,BPIFA2,BPI fold-containing family A member 2,39281,-0.0871474879648515,0.0116231824204001,-0.109928925508836,-0.0643660504208672,7.00815288155303e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,NADK,NAD kinase,42145,0.0430018327017039,0.00574582860381757,0.0317400086382215,0.0542636567651863,7.65307563205815e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.0389469624188927,0.0052038842463202,0.0287473492961051,0.0491465755416803,7.7575054068166e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAA4,Serum amyloid A-4 protein,39979,0.0258586111727145,0.00345640135748246,0.0190840645120489,0.0326331578333801,7.89677715807677e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSE,Cathepsin E,39736,0.0415945711743584,0.00556583129673979,0.0306855418327484,0.0525036005159683,8.4133560476653e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,DGKZ,Diacylglycerol kinase zeta,41913,0.0283424271825455,0.00379568937365768,0.0209028760101764,0.0357819783549145,8.71396854938828e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.0483265078798194,0.0064848168545723,0.0356162668448577,0.0610367489147811,9.74149878939139e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,FRZB,Secreted frizzled-related protein 3,41973,0.0193570217282595,0.00259792032007238,0.0142650979009177,0.0244489455556014,9.83395741413458e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.0762261124786154,0.0102307539829455,0.0561738346720422,0.0962783902851887,9.85405056481888e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,NID2,Nidogen-2,42137,0.0570871650158848,0.00766553732891848,0.0420627118512046,0.072111618180565,1.01066636849072e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGFR,Epidermal growth factor receptor,42310,0.0124958221158621,0.00167827884935286,0.00920639557113044,0.0157852486605937,1.0224310945166e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.0646956738318423,0.00869483668027723,0.0476537939384989,0.0817375537251857,1.0619257003305e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABHD14B,Protein ABHD14B,41976,0.0437438328279241,0.00588113448699605,0.0322168092334118,0.0552708564224364,1.08450277594982e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.0270326196005593,0.00363495779253534,-0.0341571368739286,-0.01990810232719,1.09428397343309e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDZD2,PDZ domain-containing protein 2,39575,0.045934629933264,0.00617762352861971,0.0338264878171693,0.0580427720493586,1.11813448736332e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA2,Carbonic anhydrase 2,42103,0.0517332153204025,0.00697478192938689,0.0380626427388042,0.0654037879020008,1.26771734166494e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.0268312850567913,0.00361786817958777,0.0197402634247993,0.0339223066887834,1.27607731011414e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,F3,Tissue factor,42174,-0.0202864992712776,0.00274546148921276,-0.0256676037901346,-0.0149053947524206,1.56453141353779e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA2,Integrin alpha-2,39736,0.0268350366268023,0.00363093528707951,0.0197184034641265,0.0339516697894781,1.56559059195988e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREML2,Trem-like transcript 2 protein,42137,0.026741389835985,0.00362419337786768,0.0196379708153644,0.0338448088566057,1.69304335182807e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,MET,Hepatocyte growth factor receptor,42158,-0.0148677725581389,0.00201605708754382,-0.0188192444497248,-0.0109163006665531,1.74297362870046e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC16A1,Monocarboxylate transporter 1,41839,0.0427773832065283,0.00580262013816361,0.0314042477357276,0.054150518677329,1.77955350649779e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0508773613751801,0.00690029215609982,0.0373527887492245,0.0644019340011358,1.78162363685228e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGXT,Serine--pyruvate aminotransferase,42145,0.0593210662692935,0.00806796226619951,0.0435078602275425,0.0751342723110446,2.05430248621935e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.0309546757811659,0.00421247003982253,0.0226982345031137,0.039211117059218,2.14936145574976e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACTN2,Alpha-actinin-2,39575,-0.0497293852514737,0.00677298751622587,-0.0630044407832764,-0.036454329719671,2.24801411026434e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROBO2,Roundabout homolog 2,42249,0.0174628066646437,0.00237950666204779,0.0127989736070301,0.0221266397222574,2.27630838467028e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.0277802088786912,0.00379314862986692,0.0203456375641521,0.0352147801932304,2.57863060909338e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBLIF,Cobalamin binding intrinsic factor,42129,0.0587493184429636,0.00802480449187415,0.0430207016388902,0.0744779352470369,2.60087452858743e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,APLP1,Amyloid-like protein 1,42145,-0.0390916526564073,0.00534325497396247,-0.0495644324053737,-0.0286188729074408,2.69683689519521e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDK2,Protein sidekick-2,39736,0.0300968142645609,0.00412755111493373,0.0220068140792908,0.038186814449831,3.2685677166352e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,VIT,Vitrin,39958,0.0293870435571997,0.00403324725670614,0.0214818789340557,0.0372922081803437,3.39945676453868e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.0268891877756949,0.0036948351643993,0.0196473108534722,0.0341310646979175,3.58548569092132e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNAR1,Interferon alpha/beta receptor 1,39930,0.018774590148551,0.00257973590181433,0.0137183077809949,0.023830872516107,3.61961120053489e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDF1,Endothelial differentiation-related factor 1,39934,0.0506660532646161,0.00696292867235328,0.0370187130668037,0.0643133934624286,3.65101701581299e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,C5,Complement C5,39979,0.0114688989464869,0.00157647456312208,0.00837900880276762,0.0145587890902062,3.69107584649851e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNF,Tumor necrosis factor,41880,0.0277806152990904,0.00382229072103883,0.0202889254858543,0.0352723051123265,3.85077280791567e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDA,Cytidine deaminase,39946,0.0363354674955306,0.00499996620188756,0.026535533739831,0.0461354012512303,3.91268857972322e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR3,Toll-like receptor 3,42296,0.0466324183073601,0.00642224504444878,0.0340448180202405,0.0592200185944797,4.04724978414854e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,C7orf50,Uncharacterized protein C7orf50,39929,0.0173539784854666,0.0023920228832888,0.0126656136342205,0.0220423433367126,4.28079975150622e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.03637024119592,0.00501473508961408,-0.0461991219715636,-0.0265413604202764,4.30590640682003e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.067194438271092,0.00926948741813844,0.0490262429315407,0.0853626336106434,4.47204883773071e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD1C,T-cell surface glycoprotein CD1c,42181,0.0188099235854278,0.00259986581512706,0.0137141865877788,0.0239056605830768,4.90629653012121e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.0474510448841639,0.00657347709309223,0.0345670297817031,0.0603350599866246,5.59929191141089e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDGF,Hepatoma-derived growth factor,42243,0.0692833903234928,0.00960047385703397,0.0504664615637062,0.0881003190832794,5.60923340414715e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP1,Metalloproteinase inhibitor 1,42032,0.0218469835900872,0.00302784659399869,0.0159124042658498,0.0277815629143246,5.66786221334953e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAPK2,Death-associated protein kinase 2,39657,0.0418583214607556,0.0058049782997783,0.0304805639931901,0.0532360789283211,5.92728514827337e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,OCLN,Occludin,39934,0.0334543121552146,0.00464113864345959,0.0243576804140338,0.0425509438963954,6.02952998118247e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMSB10,Thymosin beta-10,42137,0.0575171614422131,0.00799091358871355,0.0418549708083346,0.0731793520760917,6.44056510298642e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA6,Carbonic anhydrase 6,42103,-0.0473766007873396,0.00658397449009646,-0.0602811907879287,-0.0344720107867505,6.53977525691909e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFDC1,WAP four-disulfide core domain protein 1,39699,0.0409136098074859,0.00569247404205483,0.0297563606850584,0.0520708589299133,7.03195064660512e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.0227906808299731,0.00317326574561061,0.0165710799685763,0.0290102816913699,7.22384966082427e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.0324998481059133,0.00452960014859856,0.0236218318146602,0.0413778643971665,7.69474815221181e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM3,Intercellular adhesion molecule 3,42310,-0.020417467079671,0.00284675432245172,-0.0259971055516764,-0.0148378286076656,7.75898121220996e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,DMD,Dystrophin,39638,0.0386511708493776,0.00539591890200335,0.028075169801451,0.0492271718973041,8.39340816453631e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,STK4,Serine/threonine-protein kinase 4,42145,0.0657937171026967,0.0091879483564095,0.0477853383241341,0.0838020958812593,8.42998201689586e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.0420545538099267,0.00588555438859095,0.0305188672082884,0.0535902404115649,9.53170116299268e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA9,Carbonic anhydrase 9,42262,-0.0350486502941587,0.00490656873518014,-0.0446655250151117,-0.0254317755732056,9.57908556970729e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIMAP7,GTPase IMAP family member 7,39736,-0.024085213555858,0.00337618683720092,-0.0307025397567718,-0.0174678873549442,1.03657876604265e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX7,Syntaxin-7,39657,0.03665254396972,0.00514432674306683,0.026569663553309,0.0467354243861309,1.10678620289995e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1RL,Complement C1r subcomponent-like protein,39958,0.0147189895881031,0.0020693597135042,0.0106630445496349,0.0187749346265714,1.20527337646871e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.0418566303931279,0.0058912988803929,0.0303096845875578,0.053403576198698,1.27786779865809e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,RABEPK,Rab9 effector protein with kelch motifs,41843,0.0431115667041261,0.00606994066728383,0.0312144829962498,0.0550086504120024,1.28804933085648e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACRBP,Acrosin-binding protein,39919,0.0297053504659874,0.0041884238566384,0.0214960397069761,0.0379146612249986,1.39815902971248e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4M,C-type lectin domain family 4 member M,39945,-0.036879480397368,0.00520139924918402,-0.0470742229257687,-0.0266847378689674,1.41773159564597e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA1,Carbonic anhydrase 1,41890,0.0419434440457261,0.00592480546403527,0.0303308253362169,0.0535560627552352,1.52165518890548e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP3R1,Calcineurin subunit B type 1,42016,0.0300637415893488,0.00424807952544093,0.0217375057194846,0.0383899774592131,1.54603370097152e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,XRCC4,DNA repair protein XRCC4,41839,0.0274317601078816,0.00388445178608884,0.0198182346071474,0.0350452856086157,1.72391769327397e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,C2orf69,UPF0565 protein C2orf69,39649,0.043687409908951,0.00619098954501513,0.0315530704007213,0.0558217494171806,1.80829432454588e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,BGN,Biglycan,41820,-0.0875225930871972,0.0124082477001121,-0.111842758579417,-0.0632024275949775,1.83045193490222e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIMAP8,GTPase IMAP family member 8,39560,0.0370291304175533,0.00525707391041083,0.0267252655531481,0.0473329952819585,1.98455523221497e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPT,Dermatopontin,42310,0.0187991181514805,0.00266960023161374,0.0135667016975176,0.0240315346054434,1.9863436903148e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA6,Integrin alpha-6,42119,0.0376912960090983,0.00535578164809704,0.0271939639788281,0.0481886280393685,2.05155334639927e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCRN1,Secernin-1,42119,0.0409437466953343,0.00582168541501569,0.0295332432819036,0.0523542501087651,2.11898180261531e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.0280269999290216,0.00398467395987145,-0.0358369608903697,-0.0202170389676736,2.12710073431754e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.0307555995860373,0.00437346583226678,0.0221836065547944,0.0393275926172802,2.13101329306373e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,-0.0243400901778692,0.00346289251287233,-0.031127359503099,-0.0175528208526394,2.18236826007646e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKD2,Serine/threonine-protein kinase D2,39575,0.0321911077193908,0.00458451556627141,0.0232054572094988,0.0411767582292828,2.32135736287793e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.0515425204760579,0.00734892163284854,0.0371386340756748,0.065946406876441,2.45696399557834e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPK1,Thiamin pyrophosphokinase 1,39958,0.0205812045099293,0.0029361515992672,0.0148263473753656,0.0263360616444931,2.52572084328954e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAS2,Growth arrest-specific protein 2,39757,0.0383080693277128,0.00546532372169559,0.0275960348331894,0.0490201038222361,2.53343711424566e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CX3CL1,Fractalkine,42016,-0.0246397593198024,0.00351664845295728,-0.0315323902875986,-0.0177471283520061,2.55824677919834e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD101,Immunoglobulin superfamily member 2,39930,0.0317673979969942,0.00453439893368638,0.0228799760869689,0.0406548199070195,2.59376524800889e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEK,Angiopoietin-1 receptor,42181,0.0162862138766295,0.0023268414661739,0.0117256046029287,0.0208468231503303,2.69355266762525e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.0530613658862288,0.00758534252546103,0.0381940945363252,0.0679286372361324,2.77438214969472e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFCAB2,Dynein regulatory complex protein 8,39757,0.0259014135946295,0.00370340973835547,0.0186427305074528,0.0331600966818062,2.82566936493445e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAT,Catalase,39827,0.0383818226279603,0.0054900472292137,0.0276213300587014,0.0491423151972191,2.88083895730574e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAL,Integrin alpha-L,39657,0.031985473035378,0.00458315414623691,0.0230024909087537,0.0409684551620024,3.14479468473579e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0539934408100893,0.00774622922237599,0.0388108315342324,0.0691760500859463,3.31277622643717e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN1,Tetraspanin-1,41900,0.0532126690209915,0.00765583615767212,0.0382072301519541,0.0682181078900288,3.80686672805345e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL6R,Interleukin-6 receptor subunit alpha,42114,0.0249021678929581,0.00358780575996843,0.01787006860342,0.0319342671824962,4.07725672421629e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSNK1D,Casein kinase I isoform delta,39657,0.0468288008736476,0.00674573685253335,0.0336071566426822,0.060050445104613,4.08290727565122e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMBS,Porphobilinogen deaminase,42262,0.0293041367055279,0.00422522759343592,0.0210226906223935,0.0375855827886624,4.22937277316499e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.0409785220908931,0.00591069871114595,0.029393552617047,0.0525634915647391,4.31201117964426e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0233907735620244,0.00337849558779923,-0.0300126249141109,-0.0167689222099379,4.60709840386614e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.0294649061988234,0.00425545301352095,0.0211242182923224,0.0378055941053245,4.62686080554644e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1F,V-type proton ATPase subunit F,41820,0.0485403585616203,0.00702437973750558,0.0347725742761094,0.0623081428471312,5.05899148081919e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.0139737207036322,0.00202244043809876,-0.0179377039623057,-0.0100097374449586,5.08543556272077e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSHB,Thyrotropin subunit beta,42145,0.0493607633302825,0.00715958638774742,0.0353279740102976,0.0633935526502674,5.65044997154366e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPM3,Tropomyosin alpha-3 chain,39575,-0.0334683848482041,0.00485504457176884,-0.042984272208871,-0.0239524974875371,5.74126731156045e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.0410601415369366,0.00595772010409166,0.0293830101329169,0.0527372729409563,5.75347302878282e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL11,C-X-C motif chemokine 11,42249,0.056341086612452,0.00820860868979507,0.0402522135804537,0.0724299596444504,7.00165007976128e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDCP1,CUB domain-containing protein 1,42016,0.0404217141103975,0.00589346586420999,0.0288705210165459,0.0519729072042491,7.25170096508732e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPING1,Plasma protease C1 inhibitor,39959,0.0133267915828883,0.00194278777796392,0.00951892753807899,0.0171346556276976,7.26292275569389e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0428044054293161,0.00624599822939742,0.0305622488996971,0.055046561958935,7.6010539014927e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMOX1,Heme oxygenase 1,42007,-0.0354591105558869,0.00518428399888512,-0.0456203071937017,-0.025297913918072,8.27815583585065e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD274,Programmed cell death 1 ligand 1,42016,0.0242879055576261,0.00355183304292573,0.0173263127934917,0.0312494983217606,8.37048660516164e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.0292789744500069,0.00428584617361966,-0.0376792329503014,-0.0208787159497124,8.8291589607936e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK6,Kallikrein-6,42158,0.0221723923820648,0.00324707767861039,0.0158081201319884,0.0285366646321411,8.9514012302456e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCT,Secretin,39649,0.0345228073545751,0.00505541137179687,0.0246142010658533,0.044431413643297,9.00706033237724e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,WAS,Wiskott-Aldrich syndrome protein,41913,0.0470163732052939,0.00689948322131833,0.03349338609151,0.0605393603190778,9.86774695268782e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,RANBP1,Ran-specific GTPase-activating protein,39638,0.036853923381873,0.00540872750482374,0.0262528174724184,0.0474550292913275,1.00011921934564e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.0635679047605897,0.00936439575117168,0.0452136890882932,0.0819221204328862,1.19267623683519e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTN,Pleiotrophin,41900,0.035451684113015,0.00523391447106516,0.0251932117497272,0.0457101564763027,1.31029112207609e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMPA1,Inositol monophosphatase 1,42016,0.043576197023913,0.0064339780624391,0.0309656000215323,0.0561867940262936,1.31553941358804e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,41843,0.0253878788332491,0.00375564589839467,0.0180268128723956,0.0327489447941027,1.43848159307677e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42115,0.0571102921106044,0.00847001420387066,0.0405090642710179,0.0737115199501909,1.6184653167533e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSR,"Glutathione reductase, mitochondrial",39949,0.0162084979638004,0.00240708742595864,0.0114906066089215,0.0209263893186794,1.73439130153593e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0444968275241358,0.0066139692122663,0.0315334478680939,0.0574602071801778,1.80639143194142e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB6,Integrin beta-6,41913,0.0217275474171292,0.00323063011384298,0.015395512393997,0.0280595824402615,1.8215585635316e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN5,CCN family member 5,42137,0.0268445181211494,0.00399296802434337,0.0190183007934364,0.0346707354488624,1.85220650003425e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSDE1,Cold shock domain-containing protein E1,39575,0.0850126217428125,0.01264783310926,0.060222868848663,0.109802374636962,1.88761497047372e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.0161367477129604,0.00240405288449752,0.0114248040593453,0.0208486913665755,1.99183909146774e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP1,Interstitial collagenase,41693,0.0636162279738037,0.00947992388769762,0.0450355771539163,0.082196878793691,2.01766670895166e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17D,Interleukin-17D,41913,0.0240443368993658,0.00358444539785867,0.0170188239195628,0.0310698498791688,2.053298234336e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFTPD,Pulmonary surfactant-associated protein D,42145,0.0476580811993372,0.0071074299563588,0.033727518484874,0.0615886439138005,2.08832745230044e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALM2,Paralemmin-2,39929,0.0272636308914071,0.00406882232298346,0.0192887391383596,0.0352385226444547,2.17378165481303e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH1,Protocadherin-1,42264,0.0144918537540835,0.00216488119017703,0.0102486866213365,0.0187350208868304,2.25526032004273e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPR,Nucleoprotein TPR,39575,0.0343095132536315,0.00512450284832153,0.0242654876709213,0.0443535388363417,2.25908961512145e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASAH1,Acid ceramidase,39876,0.0332173225565335,0.00496233801586622,0.0234911400454358,0.0429435050676313,2.27633841877921e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYM,Ketimine reductase mu-crystallin,39586,0.0530888351239243,0.00793482775497638,0.0375365727241706,0.068641097523678,2.33051755853114e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.0718903191500825,0.0107478111120464,0.0508246093704715,0.0929560289296935,2.33879433546174e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL14,C-C motif chemokine 14,42152,0.0284301114547441,0.00425134174872059,0.0200974816272517,0.0367627412822365,2.36191820510784e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.064904570774083,0.00971870883223581,0.0458559014629008,0.0839532400852652,2.53013791513196e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD6,Programmed cell death protein 6,42145,-0.0494688964065689,0.00742159032684,-0.0640152134471753,-0.0349225793659625,2.73903268979095e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,41930,0.031945040702173,0.0047929073189028,0.0225509423571235,0.0413391390472224,2.74952207307137e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCF2,Neutrophil cytosol factor 2,42097,0.0582061829905273,0.00874484854513483,0.041066279842063,0.0753460861389915,2.9214189962452e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNLIP,Pancreatic triacylglycerol lipase,39990,0.0463774261938033,0.00697014949297994,0.0327159331875626,0.0600389192000439,2.98878167478794e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,FES,Tyrosine-protein kinase Fes/Fps,41843,0.0331805483032003,0.00498894331487504,0.0234022194060452,0.0429588772003553,3.02912916832958e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPO,Erythropoietin,42119,0.0509804392314026,0.0076709277673406,0.035945420807415,0.0660154576553901,3.12860043939359e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMM2,Phosphomannomutase 2,39575,0.0418147247243522,0.00629464400262557,0.0294772224792061,0.0541522269694983,3.22110223882888e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.0483288824564739,0.00727677811425896,0.0340663973525263,0.0625913675604214,3.22372424717268e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELOB,Elongin-B,39575,0.0272986473841333,0.00411448875542269,0.0192342494235048,0.0353630453447617,3.4033216976626e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.0327705162406614,0.00494477849510032,0.0230787503902648,0.0424622820910581,3.57803271970155e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRDT,Bromodomain testis-specific protein,39575,0.0254146791430947,0.00383722961277226,0.0178937091020611,0.0329356491841284,3.67977398986702e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.0439812098570964,0.00666869920428282,0.0309105594167021,0.0570518602974908,4.40897573920315e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMMT,MICOS complex subunit MIC60,39919,0.0308600696850613,0.00467924332916894,0.0216887527598902,0.0400313866102324,4.43902727445925e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRD1,Natural killer cells antigen CD94,42296,0.0326689566728567,0.00495756234284813,0.0229521344808744,0.0423857788648391,4.56765135477501e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.0372764220125302,0.00566721594660979,0.026168678757175,0.0483841652678853,4.99849543069083e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGT,Angiotensinogen,39990,0.0150020219913644,0.00228450328047691,0.0105243955616297,0.0194796484210992,5.36215768279089e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,HPCAL1,Hippocalcin-like protein 1,42296,0.0507800610740957,0.00773627361220945,0.0356169647941652,0.0659431573540262,5.43085408904559e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,SF3B4,Splicing factor 3B subunit 4,42070,0.0498891572746073,0.0076131801205166,0.0349673242383948,0.0648109903108199,5.84443179854907e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.0180233068978416,0.0027523818545189,-0.0234179753326986,-0.0126286384629845,6.0774280417152e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTRK3,NT-3 growth factor receptor,42249,-0.0146064403522042,0.00223122597434937,-0.0189796432619289,-0.0102332374424794,6.10579052956069e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,APRT,Adenine phosphoribosyltransferase,42002,0.0324110722863862,0.00495226117353264,0.0227046403862622,0.0421175041865102,6.17828284280335e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPM1A,Protein phosphatase 1A,41843,0.0215617592744452,0.00329775317797259,0.0150981630456189,0.0280253555032714,6.44963983098146e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL2A1,Collagen alpha-1(II) chain,39638,0.0539676561879765,0.00826667491181425,0.0377649733608206,0.0701703390151324,6.9421012780397e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS22,Brain-specific serine protease 4,39657,0.023705265310066,0.00363175720269861,0.0165870211927767,0.0308235094273552,6.99359428367427e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.0322431622133409,0.00494575873638388,0.0225494750900285,0.0419368493366533,7.31699384733765e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.0355773191086968,0.00545753035680997,0.0248805596093492,0.0462740786080443,7.32879818821967e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFHR5,Complement factor H-related protein 5,39864,0.0284862629819601,0.00437721736376947,0.0199069169489719,0.0370656090149482,7.94710509785841e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0283790128812782,0.00436272597771115,-0.036929955797592,-0.0198280699649643,8.04622888812476e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTNB,Dystrobrevin beta,39900,0.031039559991231,0.00477177712990094,0.0216868768166252,0.0403922431658369,8.10703048711152e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP9,Caspase-9,39657,0.0435543955251625,0.0066959429797634,0.0304303472848262,0.0566784437654987,8.12660355288897e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAA10,N-alpha-acetyltransferase 10,39575,0.034520757464396,0.00531887383946948,0.0240957647390358,0.0449457501897562,8.93958345764646e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTA,Lymphotoxin-alpha,42119,0.0273246916865725,0.0042118805617746,0.0190694057854943,0.0355799775876507,9.02946720026151e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,-0.0171175026766654,0.0026445938163769,-0.0223009065567641,-0.0119340987965666,9.95814702795368e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.0299676235554037,0.004631751616442,0.0208893903871774,0.0390458567236301,1.02148294780969e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD209,CD209 antigen,42171,-0.0264217077857146,0.00409926111175382,-0.0344562595647521,-0.0183871560066771,1.1912976418457e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.0252604766673174,0.00392566500480588,0.0175661732578979,0.0329547800767369,1.28712452886253e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSB,Cathepsin B,42153,-0.0343321890766133,0.00534007709217619,-0.0447987401772787,-0.023865637975948,1.32613830900272e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.0158104578106873,0.00246338777952537,-0.020638697858557,-0.0109822177628175,1.42496603131942e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA1,Alpha-1-antitrypsin,39795,-0.00550455899552348,0.000858727453878307,-0.00718766480512497,-0.003821453185922,1.51237246463884e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.0222473584762166,0.00347363614437214,0.0154390316332472,0.029055685319186,1.55739035022072e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPCAM,Epithelial cell adhesion molecule,42125,-0.0628843834824043,0.0098418797933854,-0.0821744678774397,-0.0435942990873689,1.71916838207825e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGF1R,Insulin-like growth factor 1 receptor,42070,0.0143978399050119,0.00225374664089625,0.00998049648885528,0.0188151833211686,1.73139081100326e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.0271188821507429,0.00424960241803841,0.0187896614113876,0.0354481028900982,1.82364453635841e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0253123733656405,0.00396855258840873,0.0175340102923594,0.0330907364389217,1.86113817307635e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL7R,Interleukin-7 receptor subunit alpha,42137,-0.034844980708713,0.00548357969759949,-0.045592796916008,-0.024097164501418,2.15911877599592e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,LXN,Latexin,41960,-0.0458835373715514,0.00722330897501961,-0.0600412229625898,-0.031725851780513,2.19208813305355e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPME1,Protein phosphatase methylesterase 1,42070,0.0387724964172762,0.00611286699102997,0.0267912771148575,0.050753715719695,2.32884731691407e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.0414734756055452,0.00655516674089716,0.0286253487933867,0.0543216024177036,2.59917117465109e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.0161494420533845,0.00256173155704772,0.0111284482015709,0.021170435905198,2.98891778861961e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOM2,Myomesin-2,39575,-0.0368087674670363,0.00584709613919451,-0.0482690758998576,-0.0253484590342151,3.1868126638407e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.0206372048579369,0.00329031804073304,0.0141881814981002,0.0270862282177737,3.67050240143155e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.0356380574758897,0.00568299124841019,0.0244993946290057,0.0467767203227737,3.69643088082361e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,UMOD,Uromodulin,42274,-0.0354689306470723,0.00566008465772127,-0.046562696576206,-0.0243751647179386,3.80326332893045e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPE,Ribulose-phosphate 3-epimerase,39757,0.0470056080448678,0.00750937595140727,0.0322872311801095,0.061723984909626,4.00164137130918e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.0286119873398975,0.00457352269536008,0.0196478828569917,0.0375760918228032,4.07118794309509e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG1A,Lithostathine-1-alpha,42105,-0.0328060384918659,0.00524532503873885,-0.0430868755677941,-0.0225252014159378,4.11238958648934e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.0367875196539615,0.00588674873931179,0.0252494921249104,0.0483255471830127,4.2783779115439e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.0352290437265396,0.00563871345787785,0.024177165349099,0.0462809221039802,4.2905227159546e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.0290546097958625,0.00465596962276536,0.0199289093352424,0.0381803102564826,4.52739759430342e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CENPF,Centromere protein F,39757,0.0352704811814875,0.00565372099720773,0.0241891880269603,0.0463517743360146,4.57922872454584e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.0317618397275239,0.00509487475626436,0.0217758852052458,0.0417477942498021,4.68271325688544e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.0151840327749565,0.00243626142530508,0.0104089603813586,0.0199591051685545,4.75264288863796e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,FST,Follistatin,42166,0.031842406541213,0.00512502032370414,0.0217973667067529,0.0418874463756731,5.34585983737655e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100P,Protein S100-P,41900,0.0349310002391816,0.00562675804339365,0.02390255447413,0.0459594460042331,5.52531502823642e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,BOLA1,BolA-like protein 1,39586,0.0354356650504858,0.00571979799563968,0.024224860979032,0.0466464691219395,6.02698433370196e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLU,Clusterin,39979,0.0195437791595621,0.00315985932798947,0.0133504548767027,0.0257371034424214,6.42271775406309e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,AOC3,Membrane primary amine oxidase,42217,-0.0192908651504053,0.00311954642277331,-0.025405176139041,-0.0131765541617696,6.43374177173652e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD27,CD27 antigen,42181,-0.0277493249635999,0.00449103123437895,-0.0365517461829827,-0.0189469037442172,6.64227566028409e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,FXN,"Frataxin, mitochondrial",42262,0.047099062014534,0.00764073908405972,0.0321232134097769,0.062074910619291,7.28322351238156e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0171790659525513,0.00278964237829616,0.0117113668910908,0.0226467650140118,7.56571216966347e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB2A2,Mammaglobin-A,39575,-0.0200910984891721,0.00326685708967649,-0.026494138384938,-0.0136880585934062,8.01909452117562e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX5,Sorting nexin-5,39638,0.0192211124911193,0.00312594950101462,0.0130942514691307,0.025347973513108,8.07263016146085e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESAM,Endothelial cell-selective adhesion molecule,42310,0.0210402413230605,0.00342292243598548,0.014331313348529,0.0277491692975921,8.12204031452628e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCN2,Transcobalamin-2,42286,-0.0194464358669599,0.00318332555660382,-0.0256857539579034,-0.0132071177760164,1.03075670654839e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFHR2,Complement factor H-related protein 2,39904,0.0365926050741582,0.00598928928485846,0.0248535980758356,0.0483316120724808,1.03120285511682e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYZL2,Lysozyme-like protein 2,39560,0.0232780103537403,0.00381508421985194,0.0158004452828305,0.0307555754246501,1.08578206596215e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST5,Cystatin-D,41846,0.0360877791379568,0.00592338713800684,0.0244779403474634,0.0476976179284502,1.1429673129367e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.0400847423211727,0.00658550027831968,0.0271771617756661,0.0529923228666792,1.18921938484148e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA4,Annexin A4,42088,0.0463932737400713,0.00762401250495247,0.0314502092303645,0.0613363382497781,1.19532989894564e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM3C,Protein FAM3C,42129,0.0194541959180817,0.00319739413563851,0.0131873034122302,0.0257210884239332,1.20090730571798e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.0246811386428864,0.00406523994370858,0.0167132683532176,0.0326490089325552,1.30302398574737e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.076390989245521,0.0125939226207286,0.0517069009088929,0.101075077582149,1.35569895518506e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.0454904506189803,0.00751787239039667,0.0307554207338028,0.0602254805041578,1.48526887811805e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QA,Complement C1q subcomponent subunit A,42230,-0.0142214597989736,0.00235232937134186,-0.0188320253668036,-0.00961089423114354,1.52655420336936e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CIT,Citron Rho-interacting kinase,39649,0.029080805288018,0.00481231076544274,0.0196486761877502,0.0385129343882857,1.56150629777005e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PON1,Serum paraoxonase/arylesterase 1,39990,-0.0171676277459806,0.00284490634217499,-0.0227436441766435,-0.0115916113153176,1.64399605453643e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0311891116114381,0.00519019709021886,0.0210163253146092,0.0413618979082671,1.91185318667171e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,AK1,Adenylate kinase isoenzyme 1,42145,0.0387443456291218,0.00647032241303956,0.0260625136995642,0.0514261775586793,2.17802372713552e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSL,Cathepsin L1,42145,0.015396817990577,0.00257425493913219,0.0103512783098779,0.0204423576712761,2.272512658549e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,RCOR1,REST corepressor 1,41900,0.0280700742473501,0.00469389154987591,0.0188700468095933,0.0372701016851068,2.28680175736602e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0690278332596815,0.0115443466469161,0.046400913831726,0.091654752687637,2.29634939146885e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.0384377179485339,0.00642922619781256,0.0258364346008213,0.0510390012962465,2.30768183615735e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX6,Syntaxin-6,41843,0.0412252746328872,0.00690057006560224,0.0277001573043068,0.0547503919614676,2.37178161359766e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0717986185067116,0.0120328578534803,0.0482142171138902,0.095383019899533,2.49064240032224e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDHB,Succinate dehydrogenase,39930,0.041047573498791,0.00688927480979836,0.0275445948715863,0.0545505521259958,2.6263738823519e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.0163570661759409,0.00274551587180087,0.0109758550672112,0.0217382772846706,2.63353091133665e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTSL4,ADAMTS-like protein 4,39638,0.015448433410038,0.00259378860767819,0.0103646077389888,0.0205322590810873,2.66472873428707e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPOCK1,Testican-1,42016,0.0163709378428816,0.00274989647283929,0.0109811407561166,0.0217607349296466,2.69365000705924e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAFA5,Chemokine-like protein TAFA-5,42070,0.0229847436799666,0.00386382826351699,0.0154116402834733,0.0305578470764599,2.76988459394378e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKK3,Dickkopf-related protein 3,42310,-0.0184411227815257,0.00310134960485722,-0.0245197680070459,-0.0123624775560056,2.81180915700601e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42135,-0.0331337833015517,0.00557520665190924,-0.0440611883392938,-0.0222063782638095,2.8662970166591e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGER,Advanced glycosylation end product-specific receptor,42093,0.0256450429608398,0.00432009340592425,0.0171776598852283,0.0341124260364513,2.98822166448073e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINI2,Serpin I2,39930,0.0359892735346237,0.00606516150429853,0.0241015569861985,0.0478769900830488,3.04716497399422e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,NXPH1,Neurexophilin-1,41839,0.0242447521933348,0.00408939074173295,0.0162295463395382,0.0322599580471314,3.12955490659617e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECE1,Endothelin-converting enzyme 1,41839,0.0220303918952108,0.00372093852167473,0.0147373523927284,0.0293234313976933,3.28606023656949e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.0146524441102654,0.00247487595274909,0.00980168724287721,0.0195032009776537,3.28793175440269e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS7_LGALS7B,Galectin-7,42076,0.0273736676909509,0.00462571674923247,0.0183072628624553,0.0364400725194466,3.34374914695335e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFNA4,Ephrin-A4,41992,0.0201425714130011,0.0034039304632536,0.0134708677050241,0.0268142751209782,3.3497041738694e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHB4,Ephrin type-B receptor 4,42310,-0.0157776021554558,0.0026682784073635,-0.0210074278338883,-0.0105477764770234,3.43868065699827e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAM,Basal cell adhesion molecule,42137,-0.0152569049521684,0.00258322869336188,-0.0203200331911577,-0.0101937767131791,3.58621863158338e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.0260413958248796,0.00442209258787406,0.0173740943526465,0.0347086972971128,3.98086542732686e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUCA2A,Guanylin,42083,-0.0217420039857673,0.00370422680463835,-0.0290022885228584,-0.0144817194486761,4.47351952399287e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD46,Membrane cofactor protein,42107,0.0176606357419686,0.00301447239869895,0.0117522698405187,0.0235690016434185,4.77611122842439e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSC,Dipeptidyl peptidase 1,42123,0.0273225158011205,0.00466785100460944,0.018173527832086,0.036471503770155,4.92967519390539e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,0.0231939331641742,0.00396572911521062,0.0154211040983614,0.0309667622299871,5.09814490280145e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,GC,Vitamin D-binding protein,39979,0.0158321498866686,0.00271177132432539,0.0105170780909909,0.0211472216823464,5.41750167198422e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBS,Cystathionine beta-synthase,39638,0.0316216743535248,0.00542814458314809,0.0209825109705545,0.042260837736495,5.85311214973073e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.0126906054875013,0.00218572927742866,0.00840657610374117,0.0169746348712615,6.53785876062418e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0240231798612396,0.00414751524495366,0.0158940499811304,0.0321523097413488,7.13528245364492e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK4,Kallikrein-4,42262,-0.0380931724336617,0.00658214375556732,-0.0509941741945737,-0.0251921706727497,7.30742246033725e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXADR,Coxsackievirus and adenovirus receptor,42119,0.0297594592742617,0.0051527433585712,0.0196600822914621,0.0398588362570612,7.84316008556296e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0262729186534967,0.00455091278021855,-0.0351927077027251,-0.0173531296042684,7.95316228461135e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,WIF1,Wnt inhibitory factor 1,42262,-0.0203866199111546,0.00353869292196516,-0.0273224580382063,-0.0134507817841029,8.53891494512766e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEL1L,Protein sel-1 homolog 1,39638,0.01899958426863,0.00329860155407576,0.0125343252226415,0.0254648433146185,8.64167632094909e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMPD3,AMP deaminase 3,39929,0.0416567460755821,0.00723293783197409,0.0274801879249129,0.0558333042262513,8.66540249185873e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB6A,Ras-related protein Rab-6A,42119,0.0268884104927175,0.00467043797686304,0.0177343520580659,0.0360424689273691,8.74044888708322e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CILP,Cartilage intermediate layer protein 1,39966,0.0334038708717485,0.00580229758198239,0.022031367611063,0.044776374132434,8.78340473716592e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPC2,NPC intracellular cholesterol transporter 2,39820,0.0199832623101851,0.00347129311959751,0.013179527795774,0.0267869968245962,8.80125126253214e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGMN,Legumain,42185,0.021944734342396,0.00382001930832031,0.0144574964980882,0.0294319721867038,9.40768652381962e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECI2,Enoyl-CoA delta isomerase 2,39575,0.0366513725817308,0.00638432605044154,0.0241380935228654,0.0491646516405962,9.67083334030762e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.0213815068553226,0.00372644315611947,0.0140776782693285,0.0286853354413168,9.79894007981847e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY75,Lymphocyte antigen 75,42119,0.0233229326694008,0.00407158018137739,0.0153426355139011,0.0313032298249004,1.03647679410972e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.0342094235539174,0.00598224036083143,0.0224842324466878,0.0459346146611471,1.10230773324045e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0301299474905334,0.00527001464294696,0.0198007187903574,0.0404591761907094,1.10603869041395e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOB,Apolipoprotein B-100,39990,0.013675232441958,0.00239348925323039,0.00898399350562643,0.0183664713782896,1.13441467746075e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.0285576175553961,0.00500354702890405,0.0187506653787442,0.0383645697320481,1.17541485500735e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.0250557274077507,0.00439134522512161,-0.0336627640489891,-0.0164486907665124,1.18816846346452e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.0227075053009951,0.00398274190331449,0.0149013311704987,0.0305136794314915,1.21258556880707e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRSF1,G-rich sequence factor 1,39486,0.0497488982688985,0.00872941354603624,0.0326392477186674,0.0668585488191295,1.23645574379349e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN4,Contactin-4,42137,-0.0140930569812651,0.00247340616202134,-0.0189409330588269,-0.00924518090370325,1.23866934623477e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.0300097746408679,0.0052686102775762,0.0196832984968186,0.0403362507849173,1.257368474603e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,LIPF,Gastric triacylglycerol lipase,39638,0.0375656740555135,0.00659674341136754,0.0246360569692332,0.0504952911417939,1.26835727117563e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAST,Gastrin,39929,0.078245645262112,0.0137413884799653,0.05131252384138,0.105178766682844,1.27065257199321e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLIC5,Chloride intracellular channel protein 5,39649,-0.0188387244350979,0.00330975709612986,-0.0253258483435125,-0.0123516005266834,1.2885163438946e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,AFAP1,Actin filament-associated protein 1,39736,0.0499136505430779,0.00877731918869969,0.0327101049332265,0.0671171961529293,1.32807572075562e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM1,Intercellular adhesion molecule 1,42126,0.0173811509192838,0.00306274189840396,0.011378176798412,0.0233841250401556,1.41510444200195e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENAH,Protein enabled homolog,41913,0.028757684536933,0.00506893838359702,0.0188225653050828,0.0386928037687832,1.42977621055815e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0243520369563419,0.00429872212129156,0.0159265415986104,0.0327775323140733,1.50136453307139e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSF,Cathepsin F,42181,0.0240070052533902,0.00423982672307585,0.0156969448761616,0.0323170656306189,1.52417948492034e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL3,Myosin light chain 3,39638,-0.0466917547470444,0.00824619352029714,-0.0628542940468268,-0.030529215447262,1.53159728120283e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A12,Protein S100-A12,41910,0.0435899577896953,0.00772266478766536,0.0284535348058712,0.0587263807735195,1.69124293938168e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0378318744987237,0.00670340779190136,0.0246931952265971,0.0509705537708504,1.70559275539727e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.0403156514436799,0.00714700439511975,0.0263075228292452,0.0543237800581146,1.72546237862993e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPHS1,Nephrin,39657,0.0197002583997258,0.00349314486527522,0.0128536944637863,0.0265468223356652,1.74536556033382e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.0264654349821609,0.00470042082923132,0.0172526101568675,0.0356782598074542,1.84031962508282e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD99,CD99 antigen,42137,-0.0118085600760768,0.00209755617748044,-0.0159197701839385,-0.00769734996821518,1.84136905637143e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDM1,Nuclear protein MDM1,39649,0.0185730661056647,0.003305159610139,0.0120949532697923,0.0250511789415371,1.9624428621e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,REN,Renin,42145,-0.0478469628489495,0.00853966386635844,-0.0645847040270121,-0.031109221670887,2.14891926776578e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.0195526056141163,0.00349606848383907,0.0127003113857917,0.0264048998424409,2.27800940887416e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA12,Carbonic anhydrase 12,42070,-0.0192120308488694,0.00344279419857961,-0.0259599074780855,-0.0124641542196534,2.44652278102194e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.0218987046952993,0.00392375817737294,0.0142081386676484,0.0295892707229503,2.44697672464631e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL15A1,Collagen alpha-1(XV) chain,39966,0.0158205124531843,0.00283670189743623,0.0102605767342093,0.0213804481721593,2.50177957251708e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSR1,Macrophage scavenger receptor types I and II,42249,0.0277208736803169,0.00497565793981129,0.0179685841182868,0.037473163242347,2.57631633046659e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.0342467319354271,0.00614708277226668,0.0221984497017845,0.0462950141690698,2.5888410435188e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,HGFAC,Hepatocyte growth factor activator,39897,0.0158239580505984,0.00284174643173638,0.0102541350443951,0.0213937810568017,2.62975034263532e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTGES2,Prostaglandin E synthase 2,39579,0.0325535562102775,0.0058502787875183,0.0210870097867417,0.0440201026338134,2.69154791643721e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0303337101077222,0.00545598805759025,0.0196399735148453,0.0410274467005991,2.75450931261471e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB37,Ras-related protein Rab-37,41913,0.0472603531421519,0.00854387740748973,0.0305143534234721,0.0640063528608318,3.23515332027397e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN8,Tetraspanin-8,39930,0.0553158840590184,0.0100135497492681,0.0356893265504529,0.074942441567584,3.38484123853184e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMA4,Laminin subunit alpha-4,42185,0.0198680634511416,0.00359865176012904,0.0128147060012887,0.0269214209009945,3.43309780204092e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN4B,Sodium channel subunit beta-4,39638,0.0250953840902235,0.00456778495200863,0.0161425255842866,0.0340482425961604,4.01661792524004e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXN,Thioredoxin,39854,0.0247592989863597,0.00451329433943545,0.0159132420810663,0.0336053558916532,4.20364390439222e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPL,Periplakin,39657,0.0185452108176814,0.00338755040098771,0.0119056120317455,0.0251848096036174,4.48282826430793e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.0307393317440567,0.00561690920205502,0.0197301897080288,0.0417484737800845,4.51302155049051e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0301348946560637,0.00550999050550612,0.0193353132652717,0.0409344760468557,4.62088540746893e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEZ6L2,Seizure 6-like protein 2,42070,-0.0138939002464302,0.00254478211394096,-0.0188816731897545,-0.00890612730310593,4.85223216273749e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0233998465538188,0.00428905847085732,-0.0318064011566991,-0.0149932919509385,4.964174295022e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD83,CD83 antigen,42119,0.0198082217387018,0.00363251832627721,0.0126884858191985,0.0269279576582052,5.03891933209254e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.0291701510837554,0.00535528392787274,0.0186737945851248,0.0396665075823859,5.21415582862795e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.0328426481226621,0.00603551404807812,0.021013040588429,0.0446722556568952,5.39430529476677e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.022971747104961,0.00422532076113206,0.0146901184131421,0.0312533757967798,5.52423474016316e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.0137745362211151,0.00253462311797245,0.00880667490988913,0.0187423975323411,5.588574184127e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CABP2,Calcium-binding protein 2,39649,0.0372477904793075,0.00687559024597471,0.023771633597197,0.0507239473614179,6.17422493183409e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MILR1,Allergin-1,41913,-0.029103050995175,0.00538143191533478,-0.0396506575492311,-0.0185554444411188,6.48150832162073e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEO1,RNA polymerase-associated protein LEO1,39934,0.016525588380023,0.00305638012366535,0.0105350833376389,0.0225160934224071,6.54206610079014e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.0228011205943825,0.00421823355105396,0.0145333828343167,0.0310688583544482,6.59855671290964e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTP1,Glutathione S-transferase P,41759,-0.0397620481003897,0.00736414438778931,-0.0541957711004568,-0.0253283251003227,6.80207167094578e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTB,Lymphotoxin-beta,39919,0.0194943798241349,0.00361184382337002,0.0124151659303297,0.0265735937179402,6.89977990752746e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNU13,NHP2-like protein 1,39575,0.0357048795346256,0.00662136197469616,0.0227270100642211,0.0486827490050301,7.09740484443987e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLYR1,Putative oxidoreductase GLYR1,39919,0.0326962248248225,0.00608603286989477,0.0207676003998288,0.0446248492498163,7.92625496788527e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIT,Mast/stem cell growth factor receptor Kit,42199,-0.0164421568688137,0.00306156106696798,-0.0224428165600709,-0.0104414971775564,7.9804055184272e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL1,Fc receptor-like protein 1,42145,0.0258361293195691,0.00482066460015514,0.016387626703265,0.0352846319358732,8.48415692680647e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.0232204136069646,0.00433719000181381,0.0147195212034095,0.0317213060105196,8.75378827048344e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWC2,Brorin,41973,0.0230514339019847,0.00431156062884452,0.0146007750694494,0.0315020927345199,9.11833700615714e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.0366730501556693,0.00686692539029695,0.0232138763906872,0.0501322239206513,9.45241932914715e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA7,Carbonic anhydrase 7,39757,-0.0187887860892493,0.00352018369456057,-0.025688346130588,-0.0118892260479106,9.61133839025766e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.0252079318047667,0.00473009651613122,0.0159369426331495,0.0344789209763839,1.00201023096815e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.0201600215265602,0.00379690386607191,0.0127180899490593,0.0276019531040611,1.12014510228852e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.029895624118493,0.00563869672696567,0.0188437785336403,0.0409474697033457,1.16408907632663e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.0282672685906264,0.00534543432486279,0.0177902173138954,0.0387443198673575,1.25490624406912e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.0245133661217758,0.00463586267725476,0.0154270752743564,0.0335996569691951,1.26183386414139e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP13,Collagenase 3,41839,-0.0178792012752326,0.00340014888032835,-0.0245434930806761,-0.011214909469789,1.47609503602544e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0297471317491983,0.00566178298241975,0.0186500371036556,0.040844226394741,1.51516694044352e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.0171896339533522,0.00327310387512593,-0.023604917548599,-0.0107743503581054,1.53455411731891e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSME2,Proteasome activator complex subunit 2,41955,0.0194877283881814,0.00371318579755276,0.012209884224978,0.0267655725513849,1.55902144960344e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRCAM,Neuronal cell adhesion molecule,42145,0.0158632939581118,0.00302301315195468,0.00993818818028065,0.021788399735943,1.56494470473136e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADA,Adenosine deaminase,42296,0.0195858312690616,0.00373360896298894,0.0122679577016032,0.0269037048365199,1.57909763174016e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL34,Interleukin-34,41814,0.0201897390600851,0.00384984057464004,0.0126440515337906,0.0277354265863796,1.59293428790147e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH1,Cadherin-1,41697,0.0221817138143757,0.0042297931665835,0.0138913192078721,0.0304721084208794,1.59440112833245e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0236422016328167,0.00452881096494978,0.0147657321415152,0.0325186711241183,1.81224402582307e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.0533351086738907,0.010252207729101,0.0332407815248526,0.0734294358229287,2.00381399708369e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK14,Kallikrein-14,42262,-0.0253296735263117,0.004871813349867,-0.0348784276920511,-0.0157809193605724,2.03004748790155e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM3B,Protein FAM3B,42070,0.0192376531293164,0.00370065135363373,0.0119843764761943,0.0264909297824385,2.03896490135086e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREML1,Trem-like transcript 1 protein,39990,0.0288079539612155,0.00556480266950387,0.017900940728988,0.0397149671934431,2.29552096900846e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,0.0235679591137518,0.00455885566057862,0.0146326020190177,0.0325033162084858,2.37796434167762e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0244066524868737,0.00472474607306211,-0.0336671547900755,-0.015146150183672,2.42906254909295e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0380751405071526,0.00739284058694611,0.0235851729567383,0.052565108057567,2.64544923488955e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFD,Vascular endothelial growth factor D,42275,-0.0208686714181994,0.00405892843213606,-0.0288241711451861,-0.0129131716912128,2.76428068045141e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPQ,Carboxypeptidase Q,39960,0.0202003753552592,0.0039326747379912,0.0124923328687965,0.027908417841722,2.84467990423696e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSTB,Cystatin-B,41959,0.02337595775591,0.00456237936731006,0.0144336941959823,0.0323182213158378,3.03882870172676e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,HLA_E,,42119,0.0158211429284336,0.00308896465185634,0.00976677221079518,0.021875513646072,3.06752459710893e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRPX,Sushi repeat-containing protein SRPX,39958,-0.0207279126549633,0.00404845918858069,-0.0286628926645815,-0.0127929326453452,3.1061809398672e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP8,Caspase-8,42224,0.0328517823923675,0.00642460446679578,0.0202595576374477,0.0454440071472872,3.20648005050237e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF21,Immunoglobulin superfamily member 21,39638,0.0215406157204564,0.00422191961680529,0.013265653271518,0.0298155781693948,3.41505403333365e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CR2,Complement receptor type 2,42217,0.0250215728709399,0.00490950317412689,0.0153989466496512,0.0346441990922286,3.50517223394691e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARB2,Lysosome membrane protein 2,41777,0.0177310564639236,0.00347917574437446,0.0109118720049497,0.0245502409228975,3.51081078919277e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SATB1,DNA-binding protein SATB1,39934,0.015561337729566,0.0030728967796184,0.00953846004151394,0.0215842154176181,4.16869251018599e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,DGCR6,Protein DGCR6,39586,0.0220941188106284,0.00439528927308929,0.0134793518353734,0.0307088857858835,5.06665862201761e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYAR,Cell growth-regulating nucleolar protein,41843,0.028143162022297,0.00561291046561612,0.0171418575096894,0.0391444665349046,5.39980124896801e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP6,Gastrotropin,41881,0.0299613553789629,0.00597792385560507,0.018244624621977,0.0416780861359489,5.45607564786941e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300LF,CMRF35-like molecule 1,42262,0.0316225696492358,0.00631611860866193,0.0192429771762584,0.0440021621222131,5.60769785401378e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.018537763784588,0.00370320689597648,0.0112794782684741,0.0257960493007019,5.63019043847114e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.0202568242874214,0.00404842533233732,0.0123219106360403,0.0281917379388026,5.7132465052001e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALB2,Calretinin,41839,0.0154790892170972,0.00309913269234404,0.00940478914010294,0.0215533892940916,5.96931569148887e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.0315630585296788,0.00633376336672838,0.0191488823308912,0.0439772347284664,6.32714673532859e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRG3,Proteoglycan 3,39966,-0.0260446960562655,0.00522696983038266,-0.0362895569238155,-0.0157998351887155,6.36089368343259e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPARCL1,SPARC-like protein 1,42169,-0.0143168098177693,0.00287752070408745,-0.0199567503977807,-0.00867686923775792,6.5911365057308e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMOD1,Leiomodin-1,39934,-0.0181191557611718,0.00364211099995809,-0.0252576933210896,-0.0109806182012539,6.62374899537146e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0193355221382624,0.00388710080485673,-0.0269542397157816,-0.0117168045607432,6.62944503678814e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFF3,Trefoil factor 3,42143,-0.0187797655264802,0.00379725981028928,-0.0262223947546472,-0.0113371362983132,7.6815948212034e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0135144174364694,0.00273476871065166,0.0081542707635922,0.0188745641093467,7.83721452340089e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZBP1,Z-DNA-binding protein 1,39657,0.0214297855009272,0.00433925514129837,0.0129248454239823,0.029934725577872,7.98415050035449e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRTAP,Cartilage-associated protein,39649,0.025596340224261,0.0051843434369256,0.0154350270878868,0.0357576533606351,8.03946304308433e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST1,Cystatin-SN,38503,0.0552475919002378,0.0111957655371919,0.0333038914473418,0.0771912923531339,8.15870302378195e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,RALY,RNA-binding protein Raly,39919,0.0249069345287087,0.00505216486497471,0.0150046913933583,0.0348091776640592,8.34160699868011e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.00834820282808077,0.00169798057047022,0.00502016090995914,0.0116762447462024,8.91032938498984e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB8,Serpin B8,42296,0.0301967621384302,0.00614699195708414,0.0181486579025452,0.0422448663743151,9.09863807585003e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD302,CD302 antigen,42070,0.0160880595457648,0.00327596905871523,0.00966716019068296,0.0225089589008467,9.17081270984915e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0130110118808392,0.00265347741572134,0.0078101961460254,0.0182118276156531,9.52932193136095e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,0.0174820080384511,0.00356830239932518,0.0104881353357737,0.0244758807411284,9.73148174535111e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0348457708814711,0.00711334532672435,0.0209036140410913,0.0487879277218508,9.76051199022546e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.027544395928462,0.00563354066884691,0.016502656217522,0.0385861356394019,1.02553286740065e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.0250379944326492,0.0051362770989923,0.0149708913186243,0.0351050975466741,1.10471367868006e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,COPB2,Coatomer subunit beta',39575,0.0220006462018985,0.00451755685947369,0.0131462347573301,0.030855057646467,1.13137174619591e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0262409258414412,0.00540383445513449,-0.0368324413735048,-0.0156494103093776,1.21127399085928e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL8,Interleukin-8,42035,0.0346166911577449,0.00713435449109307,0.0206333563552025,0.0486000259602873,1.23524547584861e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX2,Sorting nexin-2,39919,0.0435105199051274,0.00897120570571451,0.0259269567219269,0.0610940830883278,1.25093071874558e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBC1D17,TBC1 domain family member 17,41839,0.0219903836145727,0.0045382983255963,0.013095318896404,0.0308854483327415,1.2771614531322e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,THBS4,Thrombospondin-4,42189,0.0231521793886038,0.00478244206176303,0.0137785929475483,0.0325257658296594,1.30556709839777e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL6A3,Collagen alpha-3(VI) chain,42310,0.0182564306956117,0.00377141089682418,0.0108644653378363,0.0256483960533871,1.30764651354975e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42137,-0.0227939888322679,0.00471031922603231,-0.0320262145152912,-0.0135617631492445,1.31826727941993e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,VIM,Vimentin,41900,0.0584149913844235,0.012082494246875,0.0347333026605484,0.0820966801082985,1.3485156638774e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.0199530329743338,0.00412884257024775,0.0118605015366482,0.0280455644120194,1.36576118220702e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0231548688649313,0.00480150127971735,-0.0325658113731773,-0.0137439263566853,1.43350035426864e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.0259997906690067,0.00539984924274169,0.015416086153233,0.0365834951847804,1.48894024440601e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECTIN2,Nectin-2,42129,0.0156321173330954,0.00325507927654056,0.00925216195107587,0.0220120727151149,1.58472914742828e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFA,Protransforming growth factor alpha,42119,0.0228418443661469,0.00476383427317091,0.0135047291907319,0.0321789595415618,1.64535860729122e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIF1C,Kinesin-like protein KIF1C,39575,0.0175414569221492,0.00366085959170412,0.0103661721224091,0.0247167417218892,1.67605980183145e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENSA,Alpha-endosulfine,39919,0.0266344421373507,0.00556630525347309,0.0157244838405434,0.0375444004341579,1.73198773453569e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.0188752398634556,0.003948533372927,0.0111361144525187,0.0266143652743925,1.77291970665737e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.0274359434354332,0.00574243114428076,0.0161807783926429,0.0386911084782235,1.79542533428161e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,UROS,Uroporphyrinogen-III synthase,39649,0.0331366506222579,0.00694806099170694,0.0195184510785123,0.0467548501660035,1.8732875171548e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX3,Syntaxin-3,39929,0.0190969591004803,0.00400520512418766,0.0112467570570724,0.0269471611438881,1.88347926612696e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,BST2,Bone marrow stromal antigen 2,42249,0.0255233921501868,0.00536675835679285,0.0150045457708728,0.0360422385295008,1.99653422528517e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPE,Carboxypeptidase E,42134,-0.0195390896494479,0.00411051562069478,-0.0275957002660096,-0.0114824790328861,2.02042917333439e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.0150948092514746,0.00317562197365071,0.00887059018311923,0.02131902831983,2.02606974171216e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.0333957933509525,0.00705925611242434,0.0195596513706008,0.0472319353313042,2.2645144084206e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A13,Protein S100-A13,39657,0.0176690106280472,0.00373720466076794,0.010344089492942,0.0249939317631523,2.29691750906036e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.0183052760568759,0.00387217788849776,0.0107158073954203,0.0258947447183315,2.29694361301412e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADA2,Adenosine deaminase 2,42096,-0.021786508186077,0.00461737745455477,-0.0308365679970044,-0.0127364483751497,2.40123478570165e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.0146429538442367,0.00310877118779722,0.00854976231615417,0.0207361453723193,2.50505415193164e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.0256567240842033,0.00546212831281578,0.0149509525910843,0.0363624955773222,2.66398880993827e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSTN2,Calsyntenin-2,42296,-0.0197619897048517,0.0042109752380207,-0.0280155011713722,-0.0115084782383311,2.7187087856475e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TK1,"Thymidine kinase, cytosolic",39757,0.0231853613872689,0.0049511980947898,0.0134810131214809,0.0328897096530569,2.86351172733243e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUC16,Mucin-16,42070,0.0940012447239882,0.0200864023659063,0.0546318960868119,0.133370593361165,2.89888062705442e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,LUZP2,Leucine zipper protein 2,39919,0.0220349259304339,0.00472000664990097,0.012783712896628,0.0312861389642398,3.07027025446152e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,AZU1,Azurocidin,41751,0.0369733701563392,0.00792850005711996,0.0214335100443841,0.0525132302682943,3.14164585093828e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASGR2,Asialoglycoprotein receptor 2,39990,0.0129416435984094,0.00277576796747844,0.00750113838215163,0.0183821488146671,3.16147051224057e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR15L,Protein GPR15L,39930,0.030523908402969,0.00654846580946374,0.0176889154164201,0.043358901389518,3.17910763416511e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF5,Fibroblast growth factor 5,41913,-0.0167171074989455,0.00358798820733745,-0.0237495643853269,-0.00968465061256411,3.20536242470669e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGMB,RGM domain family member B,42249,0.0137180807613873,0.00295098575467381,0.00793414868222667,0.019502012840548,3.37254465972392e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.0163914560373745,0.00352663243995735,0.00947925645505805,0.0233036556196909,3.38457301959e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRR3,Small proline-rich protein 3,39929,0.0307619308664863,0.00661805973293183,0.01779053378994,0.0437333279430327,3.38657154577644e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH3,Cadherin-3,42249,0.0180118006998773,0.00387699496696009,0.0104128905646355,0.0256107108351191,3.41901858621774e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOBR,Apolipoprotein B receptor,39638,-0.0209482680092497,0.00450899094756988,-0.0297858902664867,-0.0121106457520128,3.42532301233175e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,GDF15,Growth/differentiation factor 15,42310,-0.0223446422995346,0.00481722296247309,-0.0317863993059818,-0.0129028852930873,3.54208227673118e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFIC,Nuclear factor 1 C-type,39934,0.0222741752384923,0.00480281253957067,0.0128606626609338,0.0316876878160508,3.56186818958575e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0231873900331622,0.00500470316860276,-0.0329966082436236,-0.0133781718227007,3.6355570880167e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD28,T-cell-specific surface glycoprotein CD28,41843,0.0181210074421996,0.00391730288558071,0.0104430937864614,0.0257989210979378,3.76528934438586e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,BOC,Brother of CDO,41900,-0.0112989234915706,0.00244629586896061,-0.0160936633947334,-0.00650418358840782,3.89606212699615e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC1A,C-type lectin domain family 1 member A,41900,-0.0165600484738346,0.00358580296590744,-0.0235882222870131,-0.00953187466065599,3.90662106811231e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLAU,Urokinase-type plasminogen activator,42137,-0.0138733676544101,0.0030066816655245,-0.0197664637188381,-0.00798027158998205,3.98273702663755e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUC2,Mucin-2,39966,0.0448606386086933,0.00974649215810912,0.0257575139787994,0.0639637632385871,4.21471318593084e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN3,Neuronal-specific septin-3,39934,-0.0378368243905094,0.0082228481713893,-0.0539536068064324,-0.0217200419745864,4.24162495181297e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWF,von Willebrand factor,42310,-0.0357332974480303,0.00779345009099771,-0.0510084596263858,-0.0204581352696748,4.57908352233418e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIGR,Polymeric immunoglobulin receptor,41987,0.0178965662110519,0.00390656685266398,0.0102396951798305,0.0255534372422733,4.66601801622986e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.0230339805066257,0.00502808708292032,0.0131789298241019,0.0328890311891496,4.6771725775932e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G15,Phospholipase A2 group XV,42181,0.0131626726692735,0.00289213264905545,0.00749409267712486,0.0188312526614222,5.3803732043648e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDK,Midkine,42129,0.0244751350615151,0.0053848089233712,0.0139209095717075,0.0350293605513226,5.53537587727326e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRH,Corticoliberin,41830,0.0408818140975066,0.00902543915931972,0.02319195334524,0.0585716748497733,5.96065223367615e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSV,Cathepsin L2,42200,0.0190771271038642,0.00421312115144232,0.0108194096470373,0.0273348445606911,6.00427305427336e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDHR1,Cadherin-related family member 1,41839,0.0197157069971959,0.00435946414278272,0.0111711572773417,0.02826025671705,6.16423659682551e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGBL1,Integrin beta-like protein 1,39966,0.0186999922632186,0.0041379166962231,0.0105896755386213,0.0268103089878159,6.27062095336529e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,STC2,Stanniocalcin-2,42113,0.0114065388797884,0.00252641472167043,0.00645476602531439,0.0163583117342625,6.38788313469315e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.0436507775509976,0.00966728060394825,0.0247029075672591,0.0625986475347362,6.38791194470244e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.0111352181982015,0.00247918001128946,-0.0159944110203289,-0.00627602537607417,7.14439976925671e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ODAM,Odontogenic ameloblast-associated protein,41814,0.0254732478930585,0.00567415219717557,0.0143519095865943,0.0365945861995226,7.20457475775225e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH6,Cadherin-6,42145,-0.018390052672063,0.0040972567674882,-0.0264206759363398,-0.0103594294077861,7.23580866332719e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLL1,Delta-like protein 1,42181,-0.0143897578263897,0.00322986463156743,-0.0207202925042619,-0.00805922314851758,8.44771572635533e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPP1,Tripeptidyl-peptidase 1,42057,0.0221874500438109,0.00498706264241791,0.0124128072646718,0.0319620928229501,8.6962677902508e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,0.0202598402949287,0.00456364871190305,0.0113150888195987,0.0292045917702587,9.09377999374901e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0303849201465049,0.00684959092381815,0.0169597219358214,0.0438101183571885,9.25025353675351e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.0128910146042014,0.00290797260345291,0.00719138830143375,0.0185906409069691,9.38323815629472e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.0176802933875372,0.0039946659313014,0.0098507481621865,0.025509838612888,9.69272726847448e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PADI4,Protein-arginine deiminase type-4,41814,0.0339703422544883,0.00770141696142537,0.0188755650100946,0.049065119498882,1.03745851980354e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROCR,Endothelial protein C receptor,39575,-0.0160230789439635,0.00363682549333455,-0.0231512569108992,-0.00889490097702778,1.06400150500962e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RHOC,Rho-related GTP-binding protein RhoC,41963,0.0544965841004905,0.0123826158770091,0.0302266569815526,0.0787665112194283,1.08560583159578e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0163118188970409,0.00370825461307469,-0.0235799979386672,-0.00904363985541446,1.09684173101391e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX2,Peroxiredoxin-2,39819,0.0277583832029471,0.00634846115976891,0.0153153993298,0.0402013670760941,1.23962302373134e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,0.0173212120526401,0.00396378420938319,0.00955219500224909,0.0250902291030312,1.25263415405525e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.0224539040469892,0.00513885576906037,-0.0325260613543475,-0.0123817467396309,1.25492097652051e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0391451189524915,0.00896196110271138,0.0215796751911772,0.0567105627138058,1.26389708921918e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,HLA_DRA,,42060,-0.0166757087350769,0.00382914940199428,-0.0241808415629857,-0.00917057590716812,1.34088508171228e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.0127383479825322,0.00292800835989013,0.00699945159714755,0.0184772443679168,1.36834285436918e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN3,CCN family member 3,42299,0.0154838457587839,0.00357571637442556,0.0084754416649098,0.022492249852658,1.49979674997537e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0263289274648563,0.00608689237278026,0.014398618414207,0.0382592365155057,1.53268411488233e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKK4,Dickkopf-related protein 4,41992,0.0209599605484796,0.0048598716821055,0.0114346120515528,0.0304853090454064,1.62307793257526e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHRDL1,Chordin-like protein 1,42166,0.0148442049520497,0.0034434028888865,0.00809513528983219,0.0215932746142673,1.637300556382e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,COLEC12,Collectin-12,42123,0.0124149087998473,0.00288261664581749,0.00676498017404505,0.0180648374256496,1.66786795826049e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL5,Fc receptor-like protein 5,42137,-0.0267897635813778,0.00622637753631052,-0.0389934635525464,-0.0145860636102092,1.69971518974113e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCC,Netrin receptor DCC,39649,0.010107571390197,0.00235013009989829,0.00550131639439632,0.0147138263859976,1.716010954618e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPTLC1,Serine palmitoyltransferase 1,39929,0.0174655520907721,0.00406264446784332,0.00950276893379918,0.025428335247745,1.72958729038435e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL1,Angiopoietin-related protein 1,41920,0.0129859161884914,0.00302499150980394,0.0070569328292757,0.0189148995477072,1.77620034644067e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA7,Thyroxine-binding globulin,39979,0.00828026669815755,0.00192881287983455,0.00449979345368182,0.0120607399426333,1.77787644048228e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0255115449265027,0.00595374136847818,0.0138422118442855,0.03718087800872,1.84040962529044e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSH,Pro-cathepsin H,41865,0.0336580115307132,0.00785648498172196,0.0182593009665382,0.0490567220948883,1.84768451582447e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.00825442410195974,0.00192826488296993,0.00447502493133867,0.0120338232725808,1.87788638920733e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,0.0124412955570141,0.00290698971105777,0.00674359572334087,0.0181389953906873,1.88354595519246e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0138817430034511,0.00325319745282204,0.00750547599591989,0.0202580100109823,1.99629422312862e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICOSLG,ICOS ligand,42070,0.00858205251458983,0.00201212894165388,0.00463827978894823,0.0125258252402314,2.01121413471068e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRELP,Prolargin,42123,0.010495341573861,0.00246517678051448,0.0056635950840526,0.0153270880636694,2.08176754968453e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PVALB,Parvalbumin alpha,42208,0.0498859123822943,0.0117521895192305,0.0268516209246025,0.0729202038399861,2.20220852531225e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,XG,Glycoprotein Xg,42261,0.0154548503387253,0.00364522177918366,0.00831021565152529,0.0225994850259252,2.25234151144874e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE3,Eosinophil cationic protein,42081,0.0484945617564136,0.0114683042683536,0.0260166853904406,0.0709724381223865,2.36729362063785e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.0326007224022688,0.00774662103429663,0.0174173451750474,0.0477840996294902,2.58866312908469e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOD3,Extracellular superoxide dismutase,39990,-0.0268014966384719,0.00637896160397366,-0.0393042613822603,-0.0142987318946836,2.67119455130867e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLVRB,Flavin reductase,42137,0.0281643877493931,0.00670858838812676,0.0150155545086647,0.0413132209901216,2.70694460677493e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FBLN2,Fibulin-2,39966,-0.0141576817352684,0.00337636526083327,-0.0207753576465016,-0.00754000582403518,2.77165125301424e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.0085177700673205,0.00203483309667483,-0.0125060429368032,-0.00452949719783783,2.86074294572427e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPT2,Angiopoietin-2,42262,-0.0164356422258566,0.00392829297735043,-0.0241350964614634,-0.00873618799024976,2.88322592970559e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA11,Serpin A11,42310,-0.0183688186430468,0.00439693833370703,-0.0269868177771126,-0.00975081950898104,2.96375337305925e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL20,C-C motif chemokine 20,42296,0.037975066143372,0.00910167303079641,0.020135787003011,0.055814345283733,3.03377555074764e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.0225052594278551,0.00540403699708722,-0.0330971719421461,-0.0119133469135642,3.13949271234096e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA3,Protein disulfide-isomerase A3,39736,0.0107536364547425,0.0025826376447408,0.00569166667105055,0.0158156062384345,3.15325087855453e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIL1,Nucleotide exchange factor SIL1,39638,0.0143168097641712,0.00344496904546398,0.00756467043506183,0.0210689490932806,3.26510607756483e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.0194762711501499,0.00469143165042243,0.0102810651153219,0.0286714771849779,3.32844946523719e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.0221471226728909,0.00533809858036364,0.0116844494553782,0.0326097958904037,3.36626747701472e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITM2A,Integral membrane protein 2A,42119,-0.0269936596429509,0.0065352104241431,-0.0398026720742714,-0.0141846472116304,3.64158699846212e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,39904,0.0197871558794414,0.00479692395381875,0.0103851849299567,0.0291891268289262,3.73441549499965e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERC2,ERC protein 2,39649,0.0319521280033811,0.00775106619912766,0.0167600382530909,0.0471442177536714,3.77868647463714e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0204001108722638,0.00495219876496838,0.0106938012929258,0.0301064204516019,3.82165060770687e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAM,Signal transducing adapter molecule 1,39919,0.0156244125855794,0.00379911360598401,0.00817814991785071,0.023070675253308,3.93913492184438e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSM,Oncostatin-M,42051,0.0298574404837541,0.00727235966700379,0.0156036155364266,0.0441112654310815,4.0563923756742e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGA,Glycoprotein hormones alpha chain,42137,-0.0267423452919176,0.00651427599790251,-0.0395103262478065,-0.0139743643360287,4.06351847327422e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSG3,Desmoglein-3,42196,0.0151378311046607,0.00369591683836167,0.00789383410147183,0.0223818281078496,4.23102675663005e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.0270694673143395,0.00661836938991884,0.0140974633100986,0.0400414713185805,4.34307500502905e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PODXL,Podocalyxin,42070,0.00649696268452069,0.00159271415236356,0.00337524294588812,0.00961868242315326,4.54555913320428e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTF4,Neurotrophin-4,41843,0.016242733727747,0.00398685503659432,0.00842849785602218,0.0240569695994719,4.64674241528151e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,-0.0308136301491352,0.00759228122823521,-0.0456945013564762,-0.0159327589417942,4.9710583151123e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.0128090316540575,0.00316110551267664,-0.0190047984589037,-0.00661326484921129,5.10456251228146e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF16,Fibroblast growth factor 16,39657,0.0197786315391993,0.00488123915802453,0.0102114027894712,0.0293458602889274,5.11356587447082e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRISP3,Cysteine-rich secretory protein 3,39889,-0.0115578347165197,0.00286505282866633,-0.0171733382607057,-0.00594233117233365,5.5179131121203e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.0147750394577085,0.00366384760337451,0.0075938981550945,0.0219561807603226,5.54520664540032e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.0133124299506596,0.00330486760325398,0.00683488944828181,0.0197899704530374,5.65993494223627e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRN,Progranulin,42077,0.0106431473754628,0.00264642002552591,0.00545616412543198,0.0158301306254936,5.80908596352558e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,JCHAIN,Immunoglobulin J chain,41913,-0.0259351502026058,0.00645152436003152,-0.0385801379482676,-0.013290162456944,5.85179284180059e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.0146103030600024,0.00363783998666529,0.00748013668613847,0.0217404694338664,5.95253855613839e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRD1,Bromodomain-containing protein 1,39757,-0.0128067942200149,0.00319363623470177,-0.0190663212400303,-0.00654726719999938,6.1088998214101e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1B,Interleukin-1 beta,41825,0.0237685101514632,0.00593805942615326,0.0121299136762028,0.0354071066267236,6.29546462527686e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOC,Myocilin,42137,-0.0188070482539085,0.00470951056139802,-0.0280376889542487,-0.00957640755356839,6.5471474964078e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL25,C-C motif chemokine 25,42296,0.0205608276394942,0.00516675944794256,0.0104339791215268,0.0306876761574617,6.94327136148615e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS11D,Transmembrane protease serine 11D,39906,0.0160060788487749,0.00402781859122856,0.0081115544099669,0.0239006032875828,7.11496177051757e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOSB,Protein fosB,41839,0.0161037668627471,0.00405503403979476,0.00815590014474932,0.0240516335807448,7.18588819381407e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.0154800135640023,0.00390326866464784,-0.0231304201467121,-0.00782960698129257,7.35807075033057e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.0116642011176123,0.00294439551535165,0.00589318590752304,0.0174352163277015,7.48600062551779e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.079858866131703,0.0202202174915648,0.040227239848236,0.11949049241517,7.87272753740054e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,0.0163133630527532,0.00413488496980325,0.0082089885119388,0.0244177375935675,8.01923852150408e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAFB2,Scaffold attachment factor B2,39934,0.0112877577704101,0.00286176661352708,0.00567869520789702,0.0168968203329232,8.05047349531583e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHCHD6,MICOS complex subunit MIC25,39919,0.0120035079127371,0.00304979568828088,0.00602590836370656,0.0179811074617676,8.3402177655847e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A14,Protein S100-A14,39934,0.0213909178224651,0.00543921267010207,0.0107300609890651,0.0320517746558652,8.44892288153525e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPEP1,Dipeptidase 1,41997,-0.0190217958582988,0.00483960113617629,-0.0285074140852043,-0.00953617763139326,8.52142848172349e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTA4H,Leukotriene A-4 hydrolase,42262,-0.0246185958890721,0.00626733025363639,-0.0369025631861994,-0.0123346285919448,8.60466172295113e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0338089366875663,0.00863406107172285,0.0168861769869895,0.0507316963881431,9.06604960174899e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.011901840976146,0.00304129294194798,-0.017862775142364,-0.00594090680992793,9.14493354187798e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASET2,Ribonuclease T2,42258,0.011032967872494,0.00282302032911818,0.00549984802742238,0.0165660877175657,9.34295971666585e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFHR4,Complement factor H-related protein 4,39945,0.0299961160054867,0.00768459220369654,0.0149343152862415,0.0450579167247319,9.53953879444549e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL3,Fc receptor-like protein 3,41913,0.0219881869377467,0.00563704603703878,0.0109395767051507,0.0330367971703427,9.64032182319808e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,THBD,Thrombomodulin,42145,0.0121329084800645,0.00311168565557348,0.00603400459514046,0.0182318123649885,9.69992412284201e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGLC2,Immunoglobulin lambda constant 2,39963,-0.0104657502016968,0.00268834466210596,-0.0157349057394245,-0.00519659466396911,9.95745206948729e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17A,Interleukin-17A,41877,-0.0174351573571302,0.00451663343259096,-0.0262877588850085,-0.00858255582925196,0.000113825979622364
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD200,OX-2 membrane glycoprotein,42119,-0.011005578484359,0.0028637607781079,-0.0166185496094505,-0.00539260735926756,0.000122070207543296
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,-0.011480147752501,0.00298785100265241,-0.0173363357176998,-0.00562395978730232,0.00012244824229096
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFHD1,EF-hand domain-containing protein D1,39934,0.0145248022526195,0.00378079066875386,0.00711445254186192,0.0219351519633771,0.000122832893105002
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP5,Rho GTPase-activating protein 5,39560,0.0306717390405743,0.00798901181921757,0.0150132758749079,0.0463302022062407,0.000124109561624597
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMS1,PMS1 protein homolog 1,39649,0.0199410529298912,0.00519711975799369,0.00975469820422355,0.0301274076555588,0.000125268756897289
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEG1,Protein LEG1 homolog,39398,-0.0284294004290942,0.00742179703390753,-0.0429761226155529,-0.0138826782426354,0.000128592415194797
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.0124848777143319,0.00326712267170341,0.00608131727779316,0.0188884381508705,0.000133440456541129
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100G,Protein S100-G,39934,-0.0196315522519027,0.00513770843641287,-0.029701460787272,-0.00956164371653352,0.000133582824898166
NMR metabolomics,X23501.Triglycerides in Large VLDL,JAM2,Junctional adhesion molecule B,42249,0.0109869190461552,0.00287639447316537,0.00534918587875107,0.0166246522135593,0.000134214289841567
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROBO4,Roundabout homolog 4,39638,-0.00731228086952542,0.00191593846106002,-0.0110675202532031,-0.00355704148584779,0.000136068003527016
NMR metabolomics,X23501.Triglycerides in Large VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.0137355189655596,0.00360272609452905,0.00667417582028264,0.0207968621108365,0.000138275865533933
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD109,CD109 antigen,42137,-0.013696172213888,0.00359318310704341,-0.0207388111036931,-0.00665353332408292,0.000138620094076697
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNG,Interferon gamma,41913,0.0457346342068802,0.0120214409710937,0.0221726099035366,0.0692966585102239,0.000142771386424759
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUSP3,Dual specificity protein phosphatase 3,41839,0.0344297461090257,0.00905394415177456,0.0166840155715475,0.0521754766465038,0.000143750214742246
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY96,Lymphocyte antigen 96,42016,-0.0146413654749609,0.0038513596441386,-0.0221900303774726,-0.00709270057244924,0.000144395391956587
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0314127159001694,0.00826976729905662,0.0152039719940184,0.0476214598063204,0.000146224760111657
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDI2,Protein DDI1 homolog 2,39736,0.0298580168983787,0.00787101440810891,0.0144308286584853,0.0452852051382722,0.000149376119079645
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.034773325122548,0.00916847751408695,0.0168031091949376,0.0527435410501584,0.000149814826978664
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECTIN1,Nectin-1,39657,0.0131263067469414,0.00346443476339606,0.00633601461068509,0.0199165988831976,0.000152134306930181
NMR metabolomics,X23501.Triglycerides in Large VLDL,HCG22,Protein PBMUCL2,39575,-0.023084626525826,0.0061000791711629,-0.0350407817013053,-0.0111284713503467,0.000154951857820426
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.012429336054773,0.00328958195558458,-0.0188769166877188,-0.00598175542182723,0.000158677838675786
NMR metabolomics,X23501.Triglycerides in Large VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.0142500702024913,0.00377533501694055,-0.0216497268356948,-0.00685041356928782,0.000160997712916576
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLASP1,CLIP-associating protein 1,39560,0.0297787704340745,0.00789035305833995,0.0143136784397282,0.0452438624284208,0.000161450367760933
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,39638,0.0125270316263362,0.00332295672099829,0.00601403645317952,0.0190400267994928,0.000164200565079494
NMR metabolomics,X23501.Triglycerides in Large VLDL,KEL,Kell blood group glycoprotein,41839,0.0143731580194217,0.00381551093759347,0.00689475658173853,0.0218515594571049,0.000165914565074124
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRR4,Proline-rich protein 4,39652,-0.0281095153579779,0.00746564129789506,-0.0427421723018522,-0.0134768584141036,0.000167288766906505
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRUNE2,Protein prune homolog 2,39757,0.0114093022807486,0.00303146986504157,0.00546762134526708,0.01735098321623,0.000168329307290532
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFR4,Fibroblast growth factor receptor 4,39736,0.0207101714023957,0.0055109439839782,0.00990872119379846,0.031511621610993,0.000172146003074936
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.0119568314528277,0.00318379411837733,0.00571659498080816,0.0181970679248473,0.000173716583753952
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL9A2,Collagen alpha-2(IX) chain,39757,0.0175836257795657,0.00468306052521533,0.00840482715014368,0.0267624244089878,0.000174410267942768
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMEM25,Transmembrane protein 25,39934,-0.0184617679244041,0.0049222037927363,-0.0281092873581673,-0.00881424849064098,0.000177211485381295
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,0.016042464929813,0.00428426673148317,0.00764530213610595,0.02443962772352,0.000181504224346638
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS53,Serine protease 53,39929,0.0150232097337453,0.0040130918497216,0.00715754970829098,0.0228888697591996,0.000182336076639312
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB2,Integrin beta-2,42079,-0.0113206760084629,0.0030266732257659,-0.017252955530964,-0.00538839648596169,0.000184559800603211
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOH,Beta-2-glycoprotein 1,42137,-0.014381947575686,0.00385380429782435,-0.0219354039994218,-0.00682849115195033,0.000190831031475712
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTT2B,Glutathione S-transferase theta-2B,39929,0.0944020673111844,0.0253507405966032,0.0447146157418421,0.144089518880527,0.000197167919864692
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH12,Protocadherin-12,39934,0.00997273114641978,0.00267810359361949,0.00472364810292558,0.015221814189914,0.000197195036299683
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECM1,Extracellular matrix protein 1,39720,0.0142251175441592,0.00383279253183687,0.00671284418175897,0.0217373909065595,0.000207102255442908
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.0219690167057646,0.00592175999014529,0.0103623671250799,0.0335756662864494,0.000208349205634326
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACHE,Acetylcholinesterase,39736,0.0133470832312519,0.00359920219771307,0.00629264692373425,0.0204015195387695,0.000209631591966632
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGR2,Anterior gradient protein 2 homolog,41740,0.03906931298619,0.0105689649483653,0.0183541416873941,0.059784484284986,0.000219388436993883
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0145581267964265,0.00394416052258415,-0.0222886814206914,-0.00682757217216157,0.000224200512914069
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17C,Interleukin-17C,41913,-0.0275352170785407,0.00746267462768308,-0.0421620593487995,-0.0129083748082818,0.000225391327534047
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,0.0161626563783914,0.00438075949640535,0.00757636776543689,0.0247489449913459,0.000225779089931008
NMR metabolomics,X23501.Triglycerides in Large VLDL,BSG,Basigin,42284,0.00809143489103385,0.00219747193210931,0.0037843899040996,0.0123984798779681,0.000232159438835919
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSAP,Prosaposin,39886,0.0109935560000458,0.00299921535710521,0.00511509390011956,0.016872018099972,0.000248010149520992
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.013324339673889,0.00363956317320286,0.0061907958544114,0.0204578834933666,0.0002522280190967
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA3,Alpha-1-antichymotrypsin,39951,-0.0057192812790067,0.001562962392224,-0.00878268756776573,-0.00265587499024766,0.000254093794367552
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYGD,Gamma-crystallin D,39929,0.0376489699529376,0.0103015538948797,0.0174579243189734,0.0578400155869018,0.000258658236012905
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.0138817246790943,0.00379854065727966,-0.0213268643673625,-0.00643658499082621,0.000258669067718105
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.0143662015357699,0.0039405223027439,0.00664277782239185,0.022089625249148,0.000267829811990623
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB1A1,Uteroglobin,42165,0.020531563098203,0.0056420874892535,0.00947307161926615,0.0315900545771399,0.000274713826158412
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA7A,Semaphorin-7A,42272,0.0109214656321897,0.00300666175688422,0.00502840858869664,0.0168145226756828,0.000281800380692132
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.014091343591057,0.00388080491661065,0.00648496595450012,0.0216977212276139,0.00028334475849668
NMR metabolomics,X23501.Triglycerides in Large VLDL,LIFR,Leukemia inhibitory factor receptor,42119,-0.00917392874011651,0.00252864536723931,-0.0141300736599056,-0.00421778382032747,0.000286675970468305
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG1B,Lithostathine-1-beta,42310,-0.0217867111804814,0.00600636289864826,-0.033559182461832,-0.0100142398991308,0.000287471303698635
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA4C,Semaphorin-4C,42070,-0.010606047036906,0.00293093393666252,-0.0163506775527645,-0.00486141652104744,0.00029721920565375
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0292610573127204,0.00810106659175652,-0.0451391478325632,-0.0133829667928776,0.000305154522721179
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB44,Ras-related protein Rab-44,39919,0.0170231048023165,0.00471444238811008,0.00778279772162071,0.0262634118830122,0.000306524475118134
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKD1,Polycystin-1,39958,0.0103017349002296,0.00285892852061753,0.00469823499981928,0.01590523480064,0.000315478725162273
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM26,Tripartite motif-containing protein 26,39560,0.0217098566153298,0.00602964425396188,0.00989175387756448,0.033527959353095,0.000318983895215025
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42249,0.00897254890293834,0.00249471505446537,0.00408290739618622,0.0138621904096905,0.000323514049438424
NMR metabolomics,X23501.Triglycerides in Large VLDL,METAP1,Methionine aminopeptidase 1,41839,0.0110089358874191,0.0030612876354933,0.00500881212185219,0.0170090596529859,0.000324101927717579
NMR metabolomics,X23501.Triglycerides in Large VLDL,CENPJ,Centromere protein J,39757,0.0265069582573328,0.00737657293241891,0.0120488753097917,0.0409650412048738,0.000327800004767975
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAPG,Macrophage-capping protein,42015,0.0222195655874797,0.00619401397473237,0.0100792981970042,0.0343598329779551,0.0003353546218057
NMR metabolomics,X23501.Triglycerides in Large VLDL,VCAN,Versican core protein,42249,-0.0113444496960338,0.00316785531846014,-0.0175534461202156,-0.00513545327185188,0.000343321800065943
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRTG,Protogenin,42262,0.00924908474132568,0.00258534353771619,0.00418181140740195,0.0143163580752494,0.000348086625581099
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSTN3,Calsyntenin-3,39929,0.0113650149521143,0.00317932232647782,0.00513354319221776,0.0175964867120108,0.000352134092791026
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0147310737242174,0.00412833173364758,-0.0228226039221667,-0.00663954352626818,0.000360601467160781
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.0265541605360889,0.00744431866302793,0.0119632959565542,0.0411450251156237,0.000362553212456559
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.00967106262762703,0.00271366909308396,0.00435227120518246,0.0149898540500716,0.000366750183653623
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.0165433417446209,0.00465260888965671,0.00742422832089376,0.0256624551683481,0.000378530358923187
NMR metabolomics,X23501.Triglycerides in Large VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,0.0104197734803833,0.00293562469352021,0.0046659490810837,0.0161735978796829,0.000387380376922722
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.0133759279897137,0.00376877652894984,-0.0207627299864554,-0.005989125992972,0.000388091436676111
NMR metabolomics,X23501.Triglycerides in Large VLDL,MARCO,Macrophage receptor MARCO,42145,0.00964451591417218,0.00272051691963342,0.00431230275169068,0.0149767290766537,0.0003937812181113
NMR metabolomics,X23501.Triglycerides in Large VLDL,OPTC,Opticin,42070,-0.0169261835060783,0.00477676792825571,-0.0262886486454594,-0.00756371836669708,0.000396282120905684
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTSL5,ADAMTS-like protein 5,39958,-0.0149135528456374,0.0042168725543679,-0.0231786230521984,-0.00664848263907626,0.000406869680790363
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.014784484354533,0.00418969038701954,0.0065726911959747,0.0229962775130913,0.000418870127130164
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300A,CMRF35-like molecule 8,39736,0.0113178850294273,0.00321345165031926,0.00501951979480154,0.017616250264053,0.000429964066355494
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.0123897958619104,0.00351980487161821,0.00549097831353875,0.0192886134102821,0.000433202905101153
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTPN,Myotrophin,41900,0.012012958090811,0.00342001276017807,0.00530973308086203,0.0187161831007601,0.000445304707546594
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC11A,C-type lectin domain family 11 member A,42118,-0.0179240849776892,0.00511001670890388,-0.0279397177271408,-0.00790845222823756,0.000453573052742831
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1R1,Interleukin-1 receptor type 1,42113,-0.00872236575906726,0.00251250445402448,-0.0136468744889552,-0.00379785702917929,0.000519017936638744
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.012034532014547,0.00346859890585043,-0.0188329858700139,-0.00523607815908017,0.000523273563717868
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROBO1,Roundabout homolog 1,42144,0.00873354262700264,0.00252262073176118,0.00378920599275073,0.0136778792612545,0.000537650170162221
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.0327153631159305,0.00946068245012652,0.0141724255136825,0.0512583007181785,0.00054580180670378
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.0104492780249809,0.00302173029729578,0.00452668664228114,0.0163718694076806,0.000546105657670463
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.0154960598773888,0.00448655625542313,0.00670240961675948,0.0242897101380182,0.000554287992640392
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.0154669507461161,0.00448377379635677,-0.0242551473869754,-0.00667875410525689,0.000563656083543315
NMR metabolomics,X23501.Triglycerides in Large VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.00981235407473398,0.002849910684264,0.00422652913357655,0.0153981790158914,0.000577294809426284
NMR metabolomics,X23501.Triglycerides in Large VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,0.00991543070141214,0.00288509351541822,0.00426064741119242,0.0155702139916319,0.000590437400780784
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,-0.00964415695383022,0.00281612832105169,-0.0151637684630915,-0.00412454544456891,0.000617504663830996
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALB1,Calbindin,42070,0.0163097716765154,0.00476290908946921,0.00697446986115581,0.0256450734918751,0.000618153841614674
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.00878575041885408,0.00257477898408309,0.00373918361005122,0.0138323172276569,0.000646568885600398
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.0164995325626708,0.0048494525161527,0.00699460563101149,0.0260044594943301,0.000670476812060342
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEO1,Neogenin,39934,0.00806137905261886,0.00237296572451768,0.00341036623256421,0.0127123918726735,0.000683195637526211
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC12A2,Solute carrier family 12 member 2,39575,-0.00940012021688326,0.00277441352778507,-0.014837970731342,-0.00396226970242452,0.000706139760077195
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRAL,GDNF family receptor alpha-like,39574,-0.022494199687441,0.00664197220801245,-0.0355124652151454,-0.00947593415973664,0.00070993527450085
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOS1,"Nitric oxide synthase, brain",41839,-0.0209050045506766,0.00619589817234493,-0.0330489649684726,-0.00876104413288049,0.000742949828349275
NMR metabolomics,X23501.Triglycerides in Large VLDL,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.00921403993528862,0.00273876996114433,-0.0145820290591315,-0.00384605081144572,0.000770016148607512
NMR metabolomics,X23501.Triglycerides in Large VLDL,C9orf40,Uncharacterized protein C9orf40,39930,0.027454261535308,0.00816811359201724,0.0114447588949542,0.0434637641756618,0.000778750029191707
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARG1,Arginase-1,42015,0.0177956556320575,0.00531960515769144,0.00736922952298225,0.0282220817411327,0.000824201393119355
NMR metabolomics,X23501.Triglycerides in Large VLDL,ART5,Ecto-ADP-ribosyltransferase 5,39586,-0.0217594796867214,0.00650985426874896,-0.0345187940534694,-0.00900016531997345,0.000832911771155173
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.0100241140333275,0.00299949605115982,-0.0159031262936007,-0.0041451017730542,0.000834241355332283
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,0.019599103606828,0.00587748769950496,0.00807922771579829,0.0311189794978577,0.000857034927730698
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.0122873708411052,0.00369491589367568,0.00504533568950082,0.0195294059927095,0.000885469751269584
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGN,Secretagogin,41913,-0.0155308375287096,0.00467686760935182,-0.0246974980430392,-0.00636417701438007,0.000900084321883429
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMP4,Bone morphogenetic protein 4,41992,-0.0165370993594284,0.0049890250256532,-0.0263155884097087,-0.00675861030914819,0.000919865786732307
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHCY,Adenosylhomocysteinase,42145,0.0234564665905241,0.00708126135359533,0.00957719433747728,0.037335738843571,0.000927181867920203
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX18,Sorting nexin-18,39930,0.0151818972746079,0.0045950144467887,0.0061756689589021,0.0241881255903138,0.000956137350657638
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPESP1,Sperm equatorial segment protein 1,39958,0.0116385226586718,0.00352550365478277,0.00472853549529754,0.018548509822046,0.000965564904978766
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.0357831639877447,0.0109085571202264,0.0144023920321008,0.0571639359433885,0.00104023847698883
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS3,Galectin-3,42196,0.0102271851700056,0.00311882596627414,0.00411428627610824,0.0163400840639029,0.00104371634334094
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUK1,Guanylate kinase,39575,-0.013835170762026,0.00422797261392389,-0.0221219970853169,-0.0055483444387352,0.00107008079544173
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0182982386238125,0.00560424182299876,0.00731392465073492,0.0292825525968901,0.00109709116611134
NMR metabolomics,X23501.Triglycerides in Large VLDL,NLGN2,Neuroligin-2,39586,-0.0159922995112005,0.0049106945501461,-0.0256172608294869,-0.00636733819291414,0.00113086446484715
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.0177720313229995,0.00546319430981658,0.00706417047575896,0.02847989217024,0.00114509021770305
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,0.013553583334457,0.00417946188190478,0.00536183804592364,0.0217453286229904,0.00118602386975617
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.0224659589159173,0.00692848216591685,-0.0360457839611143,-0.00888613387072024,0.00118750944834213
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.00818788878476985,0.00252534577413664,0.00323821106746204,0.0131375665020777,0.00118861176931815
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.0227943707365388,0.00704841045900208,0.00897948623689477,0.0366092552361829,0.00122380228759117
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.0193668489662936,0.00599104957244066,0.00762439180430991,0.0311093061282773,0.00122956331750244
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.0342582112564273,0.0106306159567624,-0.0550942185316817,-0.0134222039811729,0.001274042272853
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,0.0170398021639353,0.0053015253971175,0.00664881238558505,0.0274307919422856,0.00131206012516922
NMR metabolomics,X23501.Triglycerides in Large VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.0130563040314453,0.00407230913642743,0.0050745781240475,0.021038029938843,0.00134922030324534
NMR metabolomics,X23501.Triglycerides in Large VLDL,TERF1,Telomeric repeat-binding factor 1,39657,-0.00977677392546775,0.00305295830859288,-0.0157605722103098,-0.0037929756406257,0.00136676608544094
NMR metabolomics,X23501.Triglycerides in Large VLDL,PEPD,Xaa-Pro dipeptidase,39990,0.00886549922658796,0.00277089784521658,0.00343453944996347,0.0142964590032125,0.00138041354572091
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA1,Annexin A1,39699,0.0149424990448667,0.00467184259596389,0.0057856875567775,0.024099310532956,0.0013857251686367
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP4,Guanylate-binding protein 4,41839,0.016510402266549,0.00517075973053266,0.006375713194705,0.026645091338393,0.0014111659373594
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.0207902309731216,0.00651129982952898,-0.0335523786389984,-0.00802808330724478,0.00141220989268227
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN2,Ataxin-2,39586,0.0354310613781302,0.0111346389490207,0.0136071690380496,0.0572549537182108,0.00146639874877595
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDK1,Cyclin-dependent kinase 1,39560,0.0121676338711626,0.00383193616057434,0.00465703899643685,0.0196782287458883,0.00150084356196564
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAYN,Layilin,41997,-0.0119765454589686,0.00377210999000115,-0.0193698810393709,-0.00458320987856635,0.00150162527858212
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.0183839903445696,0.00582093498407579,0.00697495777578107,0.0297930229133582,0.00159140482431215
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCUN1D2,DCN1-like protein 2,39560,-0.0263607351274269,0.00838206721462401,-0.04278958686809,-0.00993188338676382,0.00166589507529772
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.0234832494507748,0.00747500570233566,-0.0381342606273527,-0.00883223827419694,0.00168477703021897
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBPMS,RNA-binding protein with multiple splicing,39657,0.0211761692764757,0.00677139024483598,0.0079042443965972,0.0344480941563542,0.00176877525669455
NMR metabolomics,X23501.Triglycerides in Large VLDL,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.00968798181625116,0.0031024107712435,0.00360725670461389,0.0157687069278884,0.00179646328030521
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL15,Interleukin-15,42119,0.0108310995633359,0.00346925781351744,0.00403135424884172,0.0176308448778301,0.00179992226676176
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG4,Regenerating islet-derived protein 4,42144,0.0167463470898309,0.00537056654257506,0.00622003666638381,0.0272726575132781,0.00182358243165868
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.00987572875803484,0.00316802876023043,0.0036663923879832,0.0160850651280865,0.00182977720855734
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELENOP,Selenoprotein P,39979,0.00740014787980424,0.00237687555002991,0.00274147180174562,0.0120588239578629,0.00185408249076707
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A16,Protein S100-A16,41814,-0.0199675425034411,0.00641889348573474,-0.0325485737354812,-0.00738651127140106,0.00187013160148103
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.0132410849193891,0.00425832582036693,-0.0215874035273083,-0.00489476631146996,0.00187910768256281
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.00913753778795909,0.00294291804562021,-0.0149056571573747,-0.00336941841854348,0.00190717323691903
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,0.0208190439185518,0.00670800061726735,0.00767136270870781,0.0339667251283958,0.0019164343269015
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP9,Fatty acid-binding protein 9,42119,0.0184173967724276,0.00593720251599006,0.00678047984108712,0.0300543137037681,0.0019259253811841
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRD3,Bromodomain-containing protein 3,39575,0.0154455562585989,0.00498939182559905,0.00566634828042476,0.025224764236773,0.00196857227661484
NMR metabolomics,X23501.Triglycerides in Large VLDL,MB,Myoglobin,42310,-0.0182252903408446,0.00590679423882734,-0.0298026070489461,-0.00664797363274298,0.00203629198640957
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRTN,Neurturin,41913,0.0160719825511463,0.0052175244891099,0.00584563455249088,0.0262983305498017,0.00207154810548905
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4D,C-type lectin domain family 4 member D,42119,0.0200526291933696,0.00651879952271656,0.00727578212884511,0.032829476257894,0.00210130153623084
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2,Apoptosis regulator Bcl-2,39930,0.017248132636304,0.00560726693660486,0.00625788944055847,0.0282383758320495,0.00210275233684604
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP152,Centrosomal protein of 152 kDa,39560,0.0135776247877731,0.00441661466027249,0.00492106005363906,0.0222341895219072,0.00211575827386854
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACE,Angiotensin-converting enzyme,39990,-0.00871040077812492,0.00283887514982586,-0.0142745960717836,-0.00314620548446623,0.00215816485513149
NMR metabolomics,X23501.Triglycerides in Large VLDL,FMR1,Synaptic functional regulator FMR1,41843,0.0116303246244152,0.00380492892636356,0.00417266392874258,0.0190879853200877,0.0022427355234257
NMR metabolomics,X23501.Triglycerides in Large VLDL,MST1,Hepatocyte growth factor-like protein,39854,0.0216503310632399,0.00708849558288223,0.00775687972079074,0.0355437824056891,0.00226120200622309
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFB,Vascular endothelial growth factor B,39657,0.00945585259398056,0.00310125496427858,0.00337739286399455,0.0155343123239666,0.00230116179844164
NMR metabolomics,X23501.Triglycerides in Large VLDL,OLFM4,Olfactomedin-4,39347,0.03975491605734,0.0130432892943004,0.0141900690405112,0.0653197630741688,0.00230990253785396
NMR metabolomics,X23501.Triglycerides in Large VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.0106358341418225,0.00349299623041697,-0.0174821067534398,-0.00378956153020529,0.00233306623730823
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.0147459972525542,0.00484896432857292,0.0052420271685513,0.0242499673365572,0.00236285197300956
NMR metabolomics,X23501.Triglycerides in Large VLDL,REXO2,"Oligoribonuclease, mitochondrial",39575,-0.01485057359467,0.00489177955648845,-0.0244384615253873,-0.00526268566395258,0.0024044306742441
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNLY,Granulysin,42137,0.0172421921769181,0.00568279615651873,0.00610391171014135,0.0283804726436948,0.00241709139583407
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G1B,Phospholipase A2,42299,-0.0142102381752153,0.00469202962874244,-0.0234066162475505,-0.00501386010288011,0.00246154582680136
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.0170806561246517,0.00564799776781965,-0.0281507317495782,-0.00601058049972516,0.00249872525248176
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL5A1,Collagen alpha-1(V) chain,39736,-0.0130387009298402,0.00431277289511183,-0.0214917358042594,-0.00458566605542101,0.00250623506148288
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECTIN4,Nectin-4,42181,-0.0106281926032613,0.00353888208326441,-0.0175644014864595,-0.00369198372006301,0.00267588183379015
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFDN2,Prefoldin subunit 2,41839,0.0174732884943007,0.00581843170196191,0.00606916235845535,0.028877414630146,0.00267750386979542
NMR metabolomics,X23501.Triglycerides in Large VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.0202324515815534,0.00676058637671471,0.00698170228319262,0.0334832008799143,0.00277109507168666
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALM,Paralemmin-1,39859,0.00962605417976473,0.00321661525305352,0.00332148828377982,0.0159306200757496,0.00277208684144242
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A11,Protein S100-A11,42027,0.0145689968789701,0.00487569592856514,0.00501263285898247,0.0241253608989578,0.00281238543639586
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA5,Protein disulfide-isomerase A5,39560,0.0193086911154319,0.00647381743242009,0.00662000894788853,0.0319973732829753,0.002864571264762
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD80,T-lymphocyte activation antigen CD80,39958,0.010733037962045,0.00360047260085901,0.0036761116643613,0.0177899642597286,0.00287910124133265
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.0174804699434487,0.00586858976314036,0.00597803400769358,0.0289829058792038,0.00290154669780239
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPO,Myeloperoxidase,42137,0.0140917405960206,0.00473772740917505,0.00480579487403751,0.0233776863180037,0.00294111412332299
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDS,Iduronate 2-sulfatase,42296,0.00287689765195213,0.000967956108484021,0.000979703679323449,0.00477409162458081,0.00296249331011847
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPNMB,Transmembrane glycoprotein NMB,41802,0.00910353139058286,0.00306935822648333,0.00308758926667553,0.0151194735144902,0.00302299775985988
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF5,Eukaryotic translation initiation factor 5,39575,0.0132574004657367,0.0044708397670577,0.00449455452230363,0.0220202464091698,0.00303034261982739
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP112,Centrosomal protein of 112 kDa,39575,0.013782263508996,0.00466430356594512,0.0046402285197436,0.0229242984982485,0.00313497296172409
NMR metabolomics,X23501.Triglycerides in Large VLDL,WNT9A,Protein Wnt-9a,41913,-0.00906509364802291,0.0030686688612371,-0.0150796846160476,-0.00305050267999819,0.00314151153912549
NMR metabolomics,X23501.Triglycerides in Large VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.022147001750619,0.00749871149016892,0.00744952722988796,0.0368444762713501,0.00314915243361203
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,0.0161949887371628,0.00549296207454423,0.00542878307105614,0.0269611944032695,0.00320068009340717
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPS10,40S ribosomal protein S10,39575,-0.0128847230209262,0.00438641443483253,-0.021482095313198,-0.00428735072865445,0.0033164804882085
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTF3,Neurotrophin-3,42119,0.0106435428887481,0.00362587171772993,0.00353683432199745,0.0177502514554988,0.00333631541419475
NMR metabolomics,X23501.Triglycerides in Large VLDL,GZMB,Granzyme B,42119,0.0209095826569824,0.00714521608677642,0.00690495912690063,0.0349142061870642,0.00343507962769786
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.0187508882966604,0.0064160404413129,0.00617544903168707,0.0313263275616336,0.00347816529548766
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0317293237126396,0.0109283279648186,0.0103098009015951,0.053148846523684,0.00369845560506602
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCN,Decorin,41900,-0.00702633716312018,0.00242160601953881,-0.0117726849614163,-0.00227998936482411,0.00371966755939633
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,0.0320276291509344,0.0110784492710747,0.010313868579628,0.0537413897222409,0.003846528996374
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.0117889307469965,0.00409313337955752,0.00376638932306379,0.0198114721709293,0.00398095096536432
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNMA2,Paraneoplastic antigen Ma2,39586,0.0134569388070472,0.00467394579713069,0.00429600504467104,0.0226178725694233,0.00399532728024103
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,-0.0126575365396928,0.00440513501061493,-0.0212916011604981,-0.00402347191888756,0.00406886265384957
NMR metabolomics,X23501.Triglycerides in Large VLDL,SULT1A1,Sulfotransferase 1A1,42249,-0.038854418132864,0.0135352034162391,-0.0653834168286927,-0.0123254194370353,0.00410298217048529
NMR metabolomics,X23501.Triglycerides in Large VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00627087556315161,0.00218725292055279,-0.0105578912874351,-0.00198385983886815,0.00415158918543868
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP164,Centrosomal protein of 164 kDa,41913,0.0187553294850238,0.00655356907365504,0.00591033410065996,0.0316003248693877,0.00421833174833207
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42189,-0.00902426754224665,0.00315351402486665,-0.0152051550309853,-0.002843380053508,0.00422079512445693
NMR metabolomics,X23501.Triglycerides in Large VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,-0.00649429006253668,0.00227110978157965,-0.0109456652344328,-0.00204291489064057,0.00425074416215971
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK8,Kallikrein-8,41668,0.0109958565959437,0.00386181519677472,0.00342669881026524,0.0185650143816222,0.0044156574552353
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP2,Metalloproteinase inhibitor 2,39958,-0.00853323521393622,0.00299974951118846,-0.0144127442558656,-0.00265372617200683,0.00445398375485709
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN10,Ataxin-10,41839,0.0219792088065483,0.00773473213599586,0.00681913381999638,0.0371392837931001,0.00449528164633542
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,0.00907030716834596,0.0031970652509514,0.00280405927648123,0.0153365550602107,0.00455964187884228
NMR metabolomics,X23501.Triglycerides in Large VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,-0.00945386145284417,0.00334924729215778,-0.0160183861454734,-0.00288933676021493,0.00476947201323749
NMR metabolomics,X23501.Triglycerides in Large VLDL,CR1,Complement receptor type 1,39970,0.0104648105864814,0.00372906630215046,0.00315584063426654,0.0177737805386963,0.00502020718844713
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.0110338945138734,0.00393429930279617,-0.0187451211473539,-0.00332266788039291,0.00504771199445849
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLPS,Colipase,42115,0.0217342169489276,0.00776934282969844,0.00650630500271863,0.0369621288951365,0.00515832756762366
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.0117255480830231,0.00419416308032913,-0.0199461077204682,-0.00350498844557801,0.00518797423434403
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.016807349405807,0.00601618766975004,0.0050156215730969,0.0285990772385171,0.00521996247675679
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300C,CMRF35-like molecule 6,42249,0.0103608024663634,0.00371049580503751,0.00308823068848988,0.0176333742442369,0.00524082628388264
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.0164895313264845,0.00590854286949072,-0.0280702753506863,-0.00490878730228272,0.00526689596635791
NMR metabolomics,X23501.Triglycerides in Large VLDL,MATN3,Matrilin-3,41992,-0.00969586810562015,0.00347851995957153,-0.0165137672263804,-0.00287796898485996,0.00532151786619401
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.0165842316778459,0.00596717518957917,0.00488856830627075,0.0282798950494211,0.00545785112870826
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINT1,Kunitz-type protease inhibitor 1,42081,-0.00781372281616931,0.00281339809268696,-0.0133279830778358,-0.00229946255450286,0.00548839369461192
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,41839,0.014724460282124,0.00530346117076757,0.00432967638741958,0.0251192441768284,0.00550439722482813
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHI3L1,Chitinase-3-like protein 1,41907,0.024482193869854,0.00882169905767158,0.00719166371681773,0.0417727240228903,0.00552406291579351
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUCA1,Tissue alpha-L-fucosidase,42212,0.0244501823826062,0.00881067924601707,0.00718125106041275,0.0417191137047997,0.00552664442585735
NMR metabolomics,X23501.Triglycerides in Large VLDL,RYR1,Ryanodine receptor 1,39575,-0.00978516418480698,0.00354693613855963,-0.0167371590163839,-0.00283316935323011,0.00581162998400306
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.00886699275228389,0.00321682390236522,0.00256201790364806,0.0151719676009197,0.00585113814448838
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,0.00970564571573492,0.0035267768537606,0.00279316308236414,0.0166181283491057,0.00593129047590684
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0196090250555056,0.00714378046623187,-0.0336108347693201,-0.00560721534169114,0.00606078084043322
NMR metabolomics,X23501.Triglycerides in Large VLDL,QSOX1,Sulfhydryl oxidase 1,39767,0.0114703038176449,0.00418970287063142,0.00325848619120729,0.0196821214440824,0.00619615333631902
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMOD4,Tropomodulin-4,39560,-0.011501141401217,0.00420629197176222,-0.0197454736658709,-0.003256809136563,0.00626190222522173
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEB,Nebulin,39575,-0.0114302846200541,0.00418164599627809,-0.0196263107727591,-0.00323425846734905,0.00627766882071378
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLL4,Delta-like protein 4,39638,0.0252044965057035,0.00926440941041093,0.00704625406129808,0.0433627389501089,0.00652710808450297
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPHA2,Glycoprotein hormone alpha-2,39930,-0.0124696597408534,0.0045854782434921,-0.0214571970980979,-0.0034821223836089,0.00655039904582949
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.00779678339214865,0.00287170096565629,-0.013425317284835,-0.00216824949946232,0.00663696843429527
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHB6,Ephrin type-B receptor 6,41997,0.00935119720920633,0.00345457165692363,0.00258023676163603,0.0161221576567766,0.00679997659499928
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN1,Contactin-1,42310,-0.00760084272705936,0.00281236290780438,-0.0131130740263559,-0.00208861142776278,0.00688731054873962
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAX,Apoptosis regulator BAX,41814,0.0261086010917683,0.00967584541473552,0.00714394407888667,0.0450732581046499,0.0069777348191538
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBR2,TGF-beta receptor type-2,42181,0.00972586526038733,0.00360648589130073,0.00265715291343789,0.0167945776073368,0.00701018412193812
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,-0.00771343799275482,0.00286090807691723,-0.0133208178235126,-0.00210605816199706,0.00702493284641992
NMR metabolomics,X23501.Triglycerides in Large VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42170,0.00765640920489033,0.00284284410969598,0.0020844347498862,0.0132283836598945,0.00708521625696859
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,-0.0170352070866852,0.00632620001150589,-0.0294345591092367,-0.00463585506413366,0.0070942648197853
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPA2,Replication protein A 32 kDa subunit,39657,0.00871148104831879,0.00325129846442222,0.00233893605805123,0.0150840260385863,0.00738666808108251
NMR metabolomics,X23501.Triglycerides in Large VLDL,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.0148571916728183,0.00555243944756347,-0.0257399729900427,-0.00397441035559393,0.00746611959437292
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42185,0.00766505544228834,0.0028667315391657,0.00204626162552357,0.0132838492590531,0.00750877401010248
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.0109606911849877,0.00411586608448504,0.002893593659397,0.0190277887105784,0.00775490166587312
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCAN,Neurocan core protein,42249,0.0104683983079058,0.00394612142705452,0.00273400031087889,0.0182027963049326,0.00799118935827101
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.0155789391613553,0.00588248844075244,0.00404926181748055,0.0271086165052301,0.0080995765014917
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOA4,Apolipoprotein A-IV,39979,0.00955843480724181,0.0036166976496809,0.00246970741386724,0.0166471622006164,0.00823209946789257
NMR metabolomics,X23501.Triglycerides in Large VLDL,TTN,Titin,39575,-0.0192265183148628,0.00727567578438312,-0.0334868428522537,-0.00496619377747186,0.00823950577286701
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,0.0203121683879919,0.00770181461879167,0.00521661173516028,0.0354077250408236,0.00836589685901737
NMR metabolomics,X23501.Triglycerides in Large VLDL,ID4,DNA-binding protein inhibitor ID-4,39757,-0.0116033743663531,0.0044079241431883,-0.0202429056870022,-0.00296384304570404,0.00849033061339657
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.014347692286836,0.00545085804696048,0.00366401051479345,0.0250313740588785,0.00849553940425733
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.0153499127385586,0.00584963624904696,0.00388462569042653,0.0268151997866906,0.00869999285213923
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.00999990194380771,0.00382363905984808,0.00250556938650547,0.01749423450111,0.00892716601645707
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.01384846385549,0.00531201696274105,0.00343691060851758,0.0242600171024625,0.00914602815937764
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB5,Serpin B5,41900,0.0133528095924705,0.00512595085579711,0.00330594591510817,0.0233996732698328,0.00919918208232542
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOP1,DNA topoisomerase 1,39930,0.0329830136768786,0.0126741441250177,0.00814169119184395,0.0578243361619133,0.00926981484794215
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPA4,Carboxypeptidase A4,39518,0.0120215267651921,0.00462387054308998,0.00295874050073568,0.0210843130296484,0.00933808554808214
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.0143567892540174,0.00552293389428921,0.00353183882121057,0.0251817396868243,0.00934842610011818
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD14,Monocyte differentiation antigen CD14,41932,0.0112798515837159,0.00434286579208242,0.00276783463123434,0.0197918685361974,0.00940550942558332
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.0104450753437166,0.00403701335722153,0.00253252916356239,0.0183576215238708,0.00968469967883939
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMNB1,Lamin-B1,39908,0.0165967060120257,0.00642030422310286,0.00401290973474406,0.0291805022893072,0.00974933618864653
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL2,Fc receptor-like protein 2,42229,0.0136140595989578,0.00526875532647916,0.00328729915905869,0.023940820038857,0.00977865905809517
NMR metabolomics,X23501.Triglycerides in Large VLDL,LIF,Leukemia inhibitory factor,41839,0.0135874523626002,0.00527953050971197,0.00323957256356475,0.0239353321616357,0.010075143923585
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSAP,Gamma-secretase-activating protein,41843,0.022802829018235,0.00887318667073853,0.00541138314358747,0.0401942748928825,0.0101848593649059
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.00845276517399637,0.00330017287383396,0.00198442634128181,0.0149211040067109,0.0104406566547792
NMR metabolomics,X23501.Triglycerides in Large VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.0188470272903162,0.00743214444078976,-0.0334140303942642,-0.0042800241863683,0.0112302497367311
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX5,Syntaxin-5,39657,0.0105309982150903,0.00417706061330602,0.0023439594130105,0.0187180370171701,0.0117111262544214
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR101,Probable G-protein coupled receptor 101,39586,-0.0153867099624426,0.00610476286065871,-0.0273520451693337,-0.00342137475555154,0.011734752486942
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF2RB,Cytokine receptor common subunit beta,39657,-0.0112561661073095,0.00446681075158257,-0.0200111151804113,-0.00250121703420767,0.0117509210512573
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.0228483711498919,0.0090742274295021,0.00506288538806782,0.0406338569117161,0.0118183100719547
NMR metabolomics,X23501.Triglycerides in Large VLDL,EXTL1,Exostosin-like 1,39575,0.0125393403270113,0.00500069699715663,0.00273797421258429,0.0223407064414383,0.0121725448959597
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,0.00786124277334551,0.0031360574304081,0.00171457020974563,0.0140079153369454,0.012197329891109
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAMDC2,MAM domain-containing protein 2,39958,-0.00930207367199847,0.00373978519070905,-0.0166320526457882,-0.00197209469820873,0.0128848945797805
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.0389509890926654,0.015685886818936,0.0082066509275508,0.06969532725778,0.0130335601771225
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAD51,DNA repair protein RAD51 homolog 1,39757,0.0136701614149316,0.00551419873496148,0.00286233189440709,0.0244779909354561,0.0131866937515695
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.0302132430275834,0.0121961626258552,0.0063087642809071,0.0541177217742596,0.0132513210876854
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP12,Macrophage metalloelastase,42146,0.0142088701411375,0.00575221970664673,0.00293451951610994,0.0254832207661651,0.0135177045944914
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.00940410677852297,0.00381457808254012,0.00192753373674432,0.0168806798203016,0.0137046605666818
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.00899814783978248,0.00365932515805328,0.00182587052999805,0.0161704251495669,0.0139461341090657
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANK2,Ankyrin-2,39575,-0.0180387780975545,0.00734384151451424,-0.0324327074660024,-0.00364484872910656,0.0140524353237449
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.00747121227379114,0.00304225368768687,0.00150839504592489,0.0134340295016574,0.0140714688794049
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.00830155539471756,0.00339478456757397,-0.0149553331471625,-0.00164777764227259,0.014482399920545
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDRG1,Protein NDRG1,41839,0.0170218787437416,0.00696240837340717,0.00337555833186352,0.0306681991556196,0.0145051389000711
NMR metabolomics,X23501.Triglycerides in Large VLDL,FRMD7,FERM domain-containing protein 7,39649,0.00873193180003438,0.00357495246441161,0.00172502496978762,0.0157388386302811,0.014600240287516
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM2,Intercellular adhesion molecule 2,42310,-0.00840930233957161,0.00344771821056838,-0.0151668300322856,-0.00165177464685759,0.0147368097603042
NMR metabolomics,X23501.Triglycerides in Large VLDL,ULBP2,UL16-binding protein 2,42016,0.010104834694286,0.00414915615739325,0.00197248862579518,0.0182371807627767,0.0148884709012824
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL36G,Interleukin-36 gamma,39624,0.0171605303875952,0.00705601814571895,0.00333073482198607,0.0309903259532044,0.0150297905116676
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPLX2,Complexin-2,39560,-0.00781407839272876,0.0032202648478088,-0.014125797494434,-0.00150235929102351,0.0152598906114101
NMR metabolomics,X23501.Triglycerides in Large VLDL,RCC1,Regulator of chromosome condensation,39919,0.0132873807513601,0.00547827310282036,0.00254996546983223,0.024024796032888,0.0153041610451254
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.0189970274502662,0.00786917809821848,0.003573438377758,0.0344206165227745,0.0157895972740572
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.00918031769521534,0.00381208704630449,0.00170862708445855,0.0166520083059721,0.0160470847681687
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.00831969992922002,0.00348476578949941,0.00148955898180117,0.0151498408766389,0.0169796448318983
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17RA,Interleukin-17 receptor A,42137,0.0111300746879219,0.00467416659046336,0.00196870817061371,0.0202914412052301,0.0172705928920332
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP290,Centrosomal protein of 290 kDa,39757,0.0132484923861479,0.0055693045210342,0.00233265552492086,0.0241643292473749,0.017383869286784
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD58,Lymphocyte function-associated antigen 3,42100,-0.0043439479486627,0.00183478202783749,-0.00794012072322417,-0.000747775174101224,0.0179200587291763
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKCQ,Protein kinase C theta type,41913,0.0106566563023652,0.00450398999748204,0.00182883590730043,0.01948447669743,0.0179933546206262
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.00750975631505241,0.00318421239391369,-0.0137508126071232,-0.00126870002298158,0.0183696155295867
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,0.0153738540503897,0.00651938497975873,0.00259585949006256,0.0281518486107168,0.0183819168457041
NMR metabolomics,X23501.Triglycerides in Large VLDL,NELL1,Protein kinase C-binding protein NELL1,42181,0.0104355392794042,0.00443601199064491,0.00174095577774015,0.0191301227810682,0.0186639029101514
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.00839451725943851,0.00357458610133625,-0.0154007060180576,-0.00138832850081946,0.0188724851929576
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN8,Septin-8,39906,0.00798706449659642,0.00342886235638837,0.00126649427807521,0.0147076347151176,0.0198573746529658
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHNAK2,Protein AHNAK2,39638,0.00762303374851469,0.0032728343635338,0.00120827839598843,0.0140377891010409,0.0198672661357009
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCP2,Non-specific lipid-transfer protein,41843,0.018125249935347,0.00781789720980912,0.00280217140412108,0.0334483284665728,0.0204410965274046
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC1,Sialoadhesin,42185,-0.0101093192289706,0.00437869535269701,-0.0186915621202568,-0.00152707633768447,0.020972312699313
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAMP5,Vesicle-associated membrane protein 5,41900,0.0125940480310358,0.0054570306117705,0.00189826803196558,0.0232898280301059,0.0210223443684196
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL14,C-X-C motif chemokine 14,41913,0.013876343645291,0.00601993144429473,0.00207727801447332,0.0256754092761087,0.0211781413436169
NMR metabolomics,X23501.Triglycerides in Large VLDL,FSTL1,Follistatin-related protein 1,39638,-0.00562453260354114,0.00244270358399266,-0.0104122316281668,-0.000836833578915522,0.0213207160785734
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYO6,Unconventional myosin-VI,39934,0.0090442306804535,0.00393178117944653,0.00133793956873831,0.0167505217921687,0.0214499608890163
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNPY2,Protein canopy homolog 2,41900,0.0147444568330866,0.00641093859683831,0.00217901718328353,0.0273098964828897,0.0214698338105115
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QL2,Complement C1q-like protein 2,39657,0.0103829766572106,0.00452241912654189,0.00151903516918847,0.0192469181452327,0.0217007944152028
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,0.00989285430097137,0.00431235779472544,0.0014406330233095,0.0183450755786332,0.0218017452750182
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPB6,Heat shock protein beta-6,42262,0.00981923720536521,0.00428150379561135,0.00142748976596696,0.0182109846447635,0.0218396093230782
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEBP1,Heme-binding protein 1,41900,-0.012541741690906,0.00547617970407068,-0.0232750539108846,-0.00180842947092748,0.0220232413813479
NMR metabolomics,X23501.Triglycerides in Large VLDL,THY1,Thy-1 membrane glycoprotein,42249,0.00704911634983673,0.00307853451775317,0.00101518869504051,0.0130830440046329,0.0220502110558561
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.0211606568560261,0.00924451165732684,-0.0392798997043868,-0.00304141400766554,0.0220983403192703
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD5,Sushi domain-containing protein 5,39695,-0.00828321018619446,0.00362144212285732,-0.0153812367469948,-0.00118518362539412,0.0221988977149488
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGA,Fibrinogen alpha chain,39735,0.00748268447489164,0.00327223196610812,0.00106910982131972,0.0138962591284636,0.022230741950379
NMR metabolomics,X23501.Triglycerides in Large VLDL,FSHB,Follitropin subunit beta,39638,-0.00982426805506401,0.00431007583929451,-0.0182720167000812,-0.00137651941004677,0.022663934994533
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTX2,Neuronal pentraxin-2,39966,-0.00819497087982466,0.00359898315439048,-0.01524897786243,-0.00114096389721931,0.022803293708819
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCG3,Secretogranin-3,42144,-0.0079774912684668,0.0035059375362324,-0.0148491288394823,-0.0011058536974513,0.022896111956906
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLH1,Glutamate carboxypeptidase 2,39657,0.0248509719847487,0.0109895567532527,0.00331144074837343,0.046390503221124,0.0237584126977911
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSTN1,Calsyntenin-1,41839,0.0120452589999861,0.00534458284363382,0.00156987662646385,0.0225206413735084,0.0242293017883096
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSR,Insulin receptor,39657,0.0040214802882322,0.0017998442444234,0.000493785569162337,0.00754917500730205,0.0254800201620716
NMR metabolomics,X23501.Triglycerides in Large VLDL,NELL2,Protein kinase C-binding protein NELL2,42185,0.00678846667932618,0.00304962619269444,0.000811199341645081,0.0127657340170073,0.0260305497262013
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,0.00794768565552776,0.00357270304719909,0.000945187683017545,0.014950183628038,0.026127487001573
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPC1,Glypican-1,42262,0.00690758797490713,0.00311073839187278,0.000810540726836479,0.0130046352229778,0.0263969709704578
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB39B,Ras-related protein Rab-39B,39575,0.0215178689471356,0.00970120164668541,0.00250351371963217,0.040532224174639,0.0265709826738001
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD82,CD82 antigen,39757,-0.00962339003133388,0.00435170765954989,-0.0181527370440517,-0.00109404301861609,0.0270279687884001
NMR metabolomics,X23501.Triglycerides in Large VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.0104739539129696,0.00473910981697435,0.00118529867169987,0.0197626091542393,0.0271177525650698
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.0078520987289277,0.00355893299356205,0.000876590061546085,0.0148276073963093,0.0273793111611917
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCP1,Plastin-2,39966,0.0110953845027499,0.00503608885373735,0.00122465034942472,0.0209661186560751,0.0276024131809302
NMR metabolomics,X23501.Triglycerides in Large VLDL,NME1,Nucleoside diphosphate kinase A,39657,-0.00506305996151062,0.00230411264470357,-0.00957912074512961,-0.000546999177891623,0.028012468892465
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGA4,Pepsin A-4,39990,0.0173042539713278,0.00787787059369195,0.00186362760769159,0.032744880334964,0.0280716136630292
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNL1,Thioredoxin-like protein 1,39570,0.0233732837038754,0.0106889955126816,0.0024228524990194,0.0443237149087314,0.0287878239724277
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDC1,Syndecan-1,42145,0.0093046466142472,0.00426329762641557,0.000948583266472684,0.0176607099620217,0.0290897758468001
NMR metabolomics,X23501.Triglycerides in Large VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0124205459639103,0.00570246238771542,0.00124371968398802,0.0235973722438325,0.0294160090745957
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.010824198078607,0.00497542060597845,-0.0205760224663248,-0.00107237369088927,0.0296112481181368
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA8,Carbonic anhydrase-related protein,39657,0.0060679295476671,0.00279773117439609,0.00058437644585076,0.0115514826494834,0.0301134095532593
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.0157342489690347,0.00727045550155174,0.00148415618599325,0.0299843417520761,0.0304753259865085
NMR metabolomics,X23501.Triglycerides in Large VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.0122723522866761,0.00567151163533185,0.0011561894814257,0.0233885150919265,0.0304928889402178
NMR metabolomics,X23501.Triglycerides in Large VLDL,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.00620800511945926,0.00286914851942379,-0.0118315362175299,-0.000584474021388637,0.0305039529262641
NMR metabolomics,X23501.Triglycerides in Large VLDL,HRAS,GTPase Hras,39750,0.0224972374592535,0.0104072766893625,0.00209897514810292,0.0428954997704041,0.0306637962560634
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL6,Interleukin-6,42070,-0.0169522150272929,0.00786268503110765,-0.0323630776882639,-0.00154135236632188,0.0310986717603939
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCND2,G1/S-specific cyclin-D2,39757,0.00838838658023122,0.00389924917109858,0.000745858204877999,0.0160309149555844,0.0314753094110649
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPT1,Palmitoyl-protein thioesterase 1,39649,0.0175221753710842,0.00814531901093189,0.0015573501096577,0.0334870006325107,0.0314823681422938
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP1,Caspase-1,41839,0.0156298822043109,0.00726615159575583,0.00138822507662945,0.0298715393319923,0.0314900021941331
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00711340757833042,0.00331237497237392,-0.0136056625241833,-0.000621152632477535,0.0317733313055337
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.0190671417015327,0.0088821221538784,-0.0364761011231344,-0.00165818227993105,0.0318364620287852
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMIGO1,Amphoterin-induced protein 1,39649,0.0114361304935816,0.00533581223949739,0.000977938504166715,0.0218943224829965,0.0321125300810052
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.00683518705347268,0.00319137809251812,-0.0130902881148082,-0.000580085992137163,0.0322335268838906
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.00981722111326063,0.00460089778834309,0.000799461448108168,0.0188349807784131,0.0328801226093996
NMR metabolomics,X23501.Triglycerides in Large VLDL,EVI2B,Protein EVI2B,39560,-0.0089435372724673,0.00419774457078641,-0.0171711166312087,-0.000715957913725931,0.0331477927487886
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST7,Cystatin-F,42148,0.0211573471665898,0.00994337146274832,0.00166833909960309,0.0406463552335765,0.0333729962489851
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACRV1,Acrosomal protein SP-10,39657,0.0237219267758794,0.0111629447078633,0.00184255514846726,0.0456012984032915,0.0336037235870008
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.00701225416874882,0.0033004193880764,-0.0134810761693786,-0.000543432168119072,0.0336375071364249
NMR metabolomics,X23501.Triglycerides in Large VLDL,L1CAM,Neural cell adhesion molecule L1,42181,0.0066386926355846,0.0031255649430479,0.000512585347210717,0.0127647999239585,0.0336883590528479
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS5,Transmembrane protease serine 5,41946,-0.00860410717266821,0.00406334583818157,-0.0165682650155041,-0.000639949329832341,0.0342364543614103
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.00875750246253614,0.00413877072988254,-0.0168694930931059,-0.000645511831966357,0.0343700673910167
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2L15,Bcl-2-like protein 15,39657,0.0125736556112332,0.00594650622944611,0.000918503401518849,0.0242288078209476,0.0344982302872164
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYH4,Myosin-4,39575,-0.0101771858506097,0.00481466149617597,-0.0196139223831146,-0.000740449318104786,0.0345556618478337
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA6,Corticosteroid-binding globulin,39979,0.00341844794185456,0.00162066466579237,0.000241945196901503,0.00659495068680761,0.0349415463167215
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.0129009228919752,0.00614110207575246,0.000864362823500348,0.02493748296045,0.0356816536826999
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.0069920589766353,0.00333344130849364,0.000458514011987758,0.0135256039412828,0.0359677293552523
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCN1,Transcobalamin-1,39806,-0.00784007413931691,0.00374615129407658,-0.015182530675707,-0.000497617602926811,0.0363863759680018
NMR metabolomics,X23501.Triglycerides in Large VLDL,C8B,Complement component C8 beta chain,39979,0.00665006770852582,0.00317858062622525,0.00042004968112434,0.0128800857359273,0.0364471964980311
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3GL3,Endophilin-A3,39690,0.0187146759784381,0.00894860288002315,0.00117541433359267,0.0362539376232834,0.0365192423167963
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPEP2,Dipeptidase 2,42070,-0.00662223231052456,0.00316723846248696,-0.012830019696999,-0.000414444924050118,0.0365598718377143
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD55,Complement decay-accelerating factor,41714,0.00580161604415687,0.00277786464080836,0.00035700134817248,0.0112462307401413,0.0367705091731788
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.00792729184081065,0.00380239286961607,0.000474601816363153,0.0153799818652582,0.0371088757816789
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL9,C-X-C motif chemokine 9,42185,0.0142601974182802,0.00684278858568465,0.00084833179033832,0.0276720630462221,0.0371811206944312
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.0064388836945341,0.00309059125456577,-0.012496442553483,-0.000381324835585194,0.0372394351132146
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSG4,Desmoglein-4,42018,0.0104955565243149,0.00504441471811815,0.00060850367680336,0.0203826093718265,0.0374867840765491
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASPN,Asporin,39958,0.00607922181947758,0.00292599209137588,0.000344277320380857,0.0118141663185743,0.0377629364856063
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.0153201913937745,0.00738074807250722,0.000853925171660374,0.0297864576158887,0.0379406452271238
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.0186802682342946,0.00901127455014361,0.00101817011601315,0.0363423663525761,0.03819647816002
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENDOU,Poly(U)-specific endoribonuclease,39090,0.0122541548741578,0.00594473156989829,0.000602480997157165,0.0239058287511585,0.03929452821825
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,-0.00637916695633718,0.00312925033474824,-0.0125124976124437,-0.000245836300230642,0.0415133812650034
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTKN2,Rhotekin-2,39575,-0.010842439821755,0.00535075588130677,-0.0213299213491163,-0.000354958294393705,0.0427542992132192
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAP1A,Ras-related protein Rap-1A,39657,-0.0147032235264959,0.00726313516273244,-0.0289389684454515,-0.000467478607540348,0.0429567880014507
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC13A1,Solute carrier family 13 member 1,39919,0.0127665260976183,0.00631111102772481,0.000396748483277729,0.025136303711959,0.043110522928885
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDHB15,Protocadherin beta-15,39919,-0.00845759120288049,0.00418723715693426,-0.0166645760304716,-0.00025060637528933,0.0434224580296347
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.00896496964496176,0.00444778308543652,-0.0176826244924173,-0.000247314797506181,0.0438611174376856
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAD2,Glutamate decarboxylase 2,39657,-0.00956889831821014,0.00475804783443255,-0.0188946720736979,-0.000243124562722349,0.0443393792516516
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF7,Fibroblast growth factor 7,39560,-0.0164205604570143,0.00816503139205852,-0.032424021985449,-0.000417098928579631,0.0443410700552762
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLMP,CXADR-like membrane protein,42262,0.00466030950708362,0.00232979959946963,9.39022921231389e-05,0.0092267167220441,0.0454871084634168
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.0171252821023992,0.00857334564113544,-0.0339290395590247,-0.000321524645773744,0.0457952632822189
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEX101,Testis-expressed protein 101,39649,0.0129384483564685,0.00647915423482561,0.000239306056210354,0.0256375906567267,0.0458567555847236
NMR metabolomics,X23501.Triglycerides in Large VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.0199545215391574,0.00999861492076417,0.000357236294459582,0.0395518067838551,0.045988180015171
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHPK,Sedoheptulokinase,39757,-0.00837547001901451,0.0041976979171308,-0.0166029579365909,-0.000147982101438154,0.0460395532609706
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.00660651788096629,0.00331555308073506,0.000108033842725562,0.013105001919207,0.0463274261008135
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,-0.00795937933187183,0.00401198651607412,-0.0158228729033771,-9.58857603665531e-05,0.047287173641965
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK15,Kallikrein-15,39900,0.0109454985040337,0.0055258673528817,0.000114798492385519,0.0217761985156818,0.0476407477934819
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.0119473547666562,0.00603690909830785,-0.0237796965993396,-0.000115012933972791,0.0478351224622547
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMMD9,COMM domain-containing protein 9,39919,0.00828606286714521,0.00418919003491608,7.52503987096979e-05,0.0164968753355807,0.0479570940351713
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,0.00559835260093455,0.00283078582971589,5.00123746914006e-05,0.0111466928271777,0.0479865972457522
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00716513548289233,0.00362706629367868,-0.0142741854185025,-5.60855472821137e-05,0.0482406106139324
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBH,Dopamine beta-hydroxylase,39978,0.0236351644594741,0.0119821207347035,0.0001502078194551,0.047120121099493,0.0485726251400534
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPSAB1,Tryptase alpha/beta-1,42281,0.0108081308488746,0.00548412040398387,5.92548570662495e-05,0.021557006840683,0.0487663340770953
NMR metabolomics,X23501.Triglycerides in Large VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.0167824079835968,0.00851617767972566,9.06997313344995e-05,0.0334741162358591,0.0487888150840133
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.0108795362500963,0.00553370131913153,3.34816645984667e-05,0.0217255908355941,0.0493136413019242
NMR metabolomics,X23501.Triglycerides in Large VLDL,GKN1,Gastrokine-1,41538,0.00587752513711019,0.00298997100182302,1.71819735370711e-05,0.0117378683006833,0.0493492500173366
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.0156361358140792,0.00795721094437782,-0.0312322692650598,-4.0002363098696e-05,0.04943625086285
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.0115397918930845,0.00590198957408118,-2.81076721146238e-05,0.0231076914582836,0.0505759254827914
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMCH,Pro-MCH,39575,-0.0169393891559921,0.00867104632161393,-0.0339346399463554,5.58616343712404e-05,0.0507789193027259
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAV,Integrin alpha-V,42262,-0.00340744272584836,0.00174958188037254,-0.00683662321137853,2.17377596818101e-05,0.0514862396988991
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF3,Granulocyte colony-stimulating factor,41913,0.00982880749313962,0.00505476488958999,-7.85316904567609e-05,0.019736146676736,0.0518605764991044
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.0080891969714609,0.0041709754179484,-8.5914847717963e-05,0.0162643087906398,0.0524772547807858
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.0136585738479684,0.00708060583215895,-0.000219413583063108,0.027536561279,0.053754306505423
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA1549,UPF0606 protein KIAA1549,39757,0.0138638861715288,0.00718731809909167,-0.000223257302690827,0.0279510296457485,0.0537639778200006
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUCL3,Mucin-like protein 3,39560,-0.00863112731852655,0.00447686613449759,-0.0174057849421418,0.000143530305088721,0.053888449998371
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.0256433601398679,0.0133017691342577,-0.000428107363277103,0.051714827643013,0.0538994052425112
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1A,Interleukin-1 alpha,41913,0.0117471682902301,0.00609436547784339,-0.000197788046342927,0.0236921246268031,0.0539329012711415
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMRK2,Nicotinamide riboside kinase 2,39560,-0.00785509981048846,0.00410335869056319,-0.0158976828439923,0.0001874832230154,0.0556065919368552
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC4A1,Band 3 anion transport protein,39966,0.00958087523043566,0.00500754688441801,-0.000233916663023637,0.0193956671238949,0.0557363948978192
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH17,Protocadherin-17,42145,0.00751704017681069,0.00394580951957326,-0.000216746481552888,0.0152508268351743,0.0567922332511883
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPN1,Epsin-1,39757,0.00862558423954889,0.00454329280375819,-0.000279269655817154,0.0175304381349149,0.0576518876729264
NMR metabolomics,X23501.Triglycerides in Large VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.0152611914620009,0.00804413404873038,-0.000505311273510604,0.0310276941975125,0.0578299122516227
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIF20B,Kinesin-like protein KIF20B,39586,0.0148965946612687,0.00785495291986271,-0.000499113061662211,0.0302923023841996,0.0579256103917161
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIRREL1,Kin of IRRE-like protein 1,39586,-0.0110839849105366,0.00586476189554801,-0.0225789182258107,0.000410948404737481,0.0587937271724437
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00613438477293673,0.00325495642929937,-0.000245329828490034,0.0125140993743635,0.0595017300017381
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGFLAM,Pikachurin,39930,0.00611877108792187,0.00324835629153149,-0.000248007243479851,0.0124855494193236,0.0596377228042909
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42181,-0.00547491684279095,0.00290886356700396,-0.0111762894341187,0.000226455748536803,0.0598370487876893
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.00770027678579994,0.00411359054501804,-0.000362360682435421,0.0157629142540353,0.061240894466056
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPHS2,Podocin,39657,-0.0200204855483052,0.0107014939210316,-0.0409954136335272,0.000954442536916848,0.0613975067154246
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTNAP2,Contactin-associated protein-like 2,42119,-0.00845039852378953,0.00452211468579599,-0.0173137433079497,0.000412946260370603,0.0616885495658126
NMR metabolomics,X23501.Triglycerides in Large VLDL,OBP2B,Odorant-binding protein 2b,41979,-0.0112641526497305,0.00603857276897538,-0.0230997552769223,0.000571449977461225,0.0621518912188278
NMR metabolomics,X23501.Triglycerides in Large VLDL,GZMH,Granzyme H,41900,0.0153994440921332,0.00828586370308281,-0.000840848765909157,0.0316397369501755,0.0631172698969392
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE1,Ribonuclease pancreatic,39990,0.00482314653380579,0.00259792150374242,-0.000268779613529361,0.00991507268114094,0.0634023556802338
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.0101876794647243,0.00549012860674983,-0.020948331533954,0.000572972604505359,0.0635322430075923
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARTN,Artemin,41913,0.00883073700140784,0.00476061799749559,-0.000500074273683525,0.0181615482764992,0.0636245996874613
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.00617643578167559,0.00333813569971192,-0.012719181753111,0.000366310189759782,0.0642972424004832
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA6C,Semaphorin-6C,39657,0.00500363490709527,0.00271037386015403,-0.000308697858806635,0.0103159676729972,0.0649036632185133
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.00966066767362499,0.00525220148704303,-0.0199549825882293,0.000633647240979354,0.0658898272936726
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC44A4,Choline transporter-like protein 4,39649,-0.0132677904453215,0.00723844901896055,-0.0274551505224842,0.000919569631841219,0.0668353512607616
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.0084891228210247,0.00463168117614337,-0.0175672179262657,0.000588972284216316,0.0668528677926441
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTK7,Inactive tyrosine-protein kinase 7,41839,0.00738524421230983,0.00403672258434674,-0.000526732053009772,0.0152972204776294,0.0673449831990772
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAN,Brevican core protein,42016,0.00665417479982871,0.0036388310913158,-0.000477934139150265,0.0137862837388077,0.0674731621615434
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.00705537542507017,0.00386556651926346,-0.000521134952686213,0.0146318858028266,0.0679998351425227
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.00692931036333112,0.00380807962688442,-0.0143931464320246,0.000534525705362342,0.0688418407657605
NMR metabolomics,X23501.Triglycerides in Large VLDL,OTOA,Otoancorin,39586,-0.0100377547255346,0.00552117936890586,-0.0208592662885901,0.000783756837520865,0.0690844167139142
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD177,CD177 antigen,42123,-0.0246617786465317,0.0135697776389112,-0.0512585428187977,0.00193498552573424,0.0691772782957638
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX1,ATP-dependent RNA helicase DDX1,39930,0.00919470167734393,0.00506155859679186,-0.000725953172368109,0.019115356527056,0.0693085997284473
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.0131473596637175,0.00724032759989398,-0.00104368243207474,0.0273384017595097,0.069415766405483
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN2B,Sodium channel subunit beta-2,39649,-0.00538663149500945,0.00296746399746144,-0.0112028609300339,0.000429597940014979,0.0695155755924943
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUP50,Nuclear pore complex protein Nup50,39575,-0.00602714191165199,0.00333301626802928,-0.0125598537969894,0.0005055699736854,0.0705849136068908
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYH7B,Myosin-7B,39560,-0.00812812688990597,0.00450602008162853,-0.0169599262498979,0.00070367247008594,0.071284270542261
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALPP,"Alkaline phosphatase, placental type",42070,0.0197716438261711,0.0109725380458971,-0.00173453074378731,0.0412778183961294,0.0715802267330063
NMR metabolomics,X23501.Triglycerides in Large VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.00723659862559876,0.00402040259948797,-0.000643390469397654,0.0151165877205952,0.0718887306212147
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.0130910332428342,0.00728330919066512,-0.0273663192565378,0.00118425277086945,0.0722993026739156
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.0116105863065374,0.00646733274255963,-0.0242865584819542,0.00106538586887952,0.0726387397738937
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA2,Ephrin type-A receptor 2,41614,-0.006108360098997,0.0034058856560426,-0.0127838959848405,0.000567175786846492,0.0729207146722186
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUSP29,Dual specificity phosphatase 29,39649,-0.0126273960559491,0.00708458183231007,-0.0265131764472769,0.00125838433537863,0.0747152169539075
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTR,Methionine synthase,39575,0.0122073910014141,0.00686461597972475,-0.0012472563188464,0.0256620383216746,0.0753812119096499
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNXB,Tenascin-X,42137,-0.0048912370443015,0.00275412017475369,-0.0102893125868187,0.000506838498215745,0.0757601860798006
NMR metabolomics,X23501.Triglycerides in Large VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.0131205229242348,0.00738980177320426,-0.00136348855124551,0.0276045343997152,0.0758392085654097
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.0166301501937024,0.00937297926101577,-0.0350011895452934,0.00174088915788846,0.0760461819146489
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNPEP,Aspartyl aminopeptidase,39929,0.01058368334549,0.00598435322988615,-0.00114564898508682,0.0223130156760669,0.0769943589967925
NMR metabolomics,X23501.Triglycerides in Large VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.0115703254658603,0.00654288509402834,-0.00125372931843524,0.0243943802501559,0.0770244986359328
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMA1,Laminin subunit alpha-1,39575,-0.0095664095862996,0.00543114061838328,-0.0202114451983308,0.00107862602573162,0.078198612478572
NMR metabolomics,X23501.Triglycerides in Large VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.00411155095603477,0.00233839445781381,-0.000471702181280289,0.00869480409334984,0.0787225833973527
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.00453421700257996,0.00257888358789461,-0.000520394829693478,0.00958882883485341,0.0787395739661776
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOC2B,Double C2-like domain-containing protein beta,39649,0.00677423563419044,0.00386083893399955,-0.00079300867644868,0.0143414799448296,0.0793551290326853
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJA4,DnaJ homolog subfamily A member 4,39929,0.0127266439288949,0.00726302640793666,-0.00150888783066097,0.0269621756884507,0.079757741506379
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBM19,Probable RNA-binding protein 19,39575,-0.00884705705997663,0.00505317727435101,-0.0187512845177046,0.00105717039775134,0.0800098627656203
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.0153911886834889,0.00880395006924801,-0.032646930819215,0.00186455345223718,0.0804549400180756
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBM25,RNA-binding protein 25,39560,-0.00853237310101201,0.0049191895638397,-0.0181739846461378,0.00110923844411381,0.0828561224164922
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.00819286372354233,0.00473267537012892,-0.00108318000191036,0.017468907448995,0.0834523531440871
NMR metabolomics,X23501.Triglycerides in Large VLDL,HYAL1,Hyaluronidase-1,42077,-0.00420816381936419,0.00243095178252901,-0.00897282931312106,0.000556501674392679,0.0834609848570025
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYT1,Synaptotagmin-1,39929,0.0072783168191712,0.00421077586614447,-0.000974803878471951,0.0155314375168144,0.0839262615342052
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR158,Probable G-protein coupled receptor 158,39934,0.00629272140851774,0.00364354708701701,-0.000848630882035599,0.0134340736990711,0.0841793540927591
NMR metabolomics,X23501.Triglycerides in Large VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.00827614412461762,0.00481806261989418,-0.0177195468596102,0.00116725861037497,0.0858733655779748
NMR metabolomics,X23501.Triglycerides in Large VLDL,PREB,Prolactin regulatory element-binding protein,41913,0.00512108748213182,0.00298643310788215,-0.000732321409317192,0.0109744963735808,0.086408122662919
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.0136707019584751,0.00797992144826277,-0.0019699440801199,0.0293113479970702,0.0867106758333894
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD70,CD70 antigen,42119,-0.00797663707725958,0.00465702868934669,-0.0171044133083791,0.00115113915385993,0.0867691741187618
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRK1,NKG2-D type II integral membrane protein,39929,0.00848170193801566,0.00495298971766388,-0.00122615790860554,0.0181895617846369,0.0868428206132762
NMR metabolomics,X23501.Triglycerides in Large VLDL,AREG,Amphiregulin,42070,-0.00700970440849594,0.00412298042845535,-0.0150907460482684,0.00107133723127655,0.0891249226168959
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD1,Programmed cell death protein 1,42232,0.00745872069796445,0.00441418124229548,-0.00119307453693469,0.0161105159328636,0.091104818549924
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST6,Cystatin-M,41864,0.00885459813196687,0.00524496842854901,-0.00142553998798919,0.0191347362519229,0.0913947988601992
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.00691931831049415,0.00410253115376426,-0.00112164275088381,0.0149602793718721,0.0917090617623465
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRR5,Proline-rich protein 5,39657,0.00834713788945571,0.0049557700528212,-0.00136617141407385,0.0180604471929853,0.092146691264438
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,0.00632156315999055,0.00375524199482871,-0.00103871114987372,0.0136818374698548,0.0923217296308456
NMR metabolomics,X23501.Triglycerides in Large VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,0.0152471034701453,0.00907668696948191,-0.00254320299003922,0.0330374099303299,0.0930229742668679
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOS2,"Nitric oxide synthase, inducible",39575,-0.00711049315575332,0.00423615112121095,-0.0154133493533268,0.00119236304182015,0.0932727735376757
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.0108219089020157,0.00644792906865419,-0.0234598498765779,0.00181603207254654,0.0933059765624667
NMR metabolomics,X23501.Triglycerides in Large VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.0147042174534501,0.00879769939915271,-0.00253927336888918,0.0319477082757894,0.0946770178000858
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.0143681911101495,0.00859963992113101,-0.0312234853555663,0.00248710313526722,0.094791241086225
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD59,CD59 glycoprotein,41638,0.00415500599663791,0.00248733343512506,-0.000720167536207209,0.00903017952948303,0.0948511984349707
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEX33,Testis-expressed protein 33,39757,-0.00676525422049373,0.00405067530714478,-0.0147045778224975,0.00117406938151004,0.094916819676548
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0216986638948395,0.0130382045900576,-0.00385621710167327,0.0472535448913524,0.096088713432418
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS4,Galectin-4,42123,-0.00984550334145522,0.00594322308360442,-0.0214942205853199,0.00180321390240945,0.0976249338636983
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0115059525883824,0.00695029308074616,-0.0251285270266449,0.00211662184988004,0.0978538392620135
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.0100277975308899,0.00609607059566055,-0.0219760958983846,0.0019205008366048,0.100001029037411
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMNB2,Lamin-B2,39929,0.0049322741355878,0.00301506290016292,-0.000977249148731527,0.0108417974199071,0.101892966787458
NMR metabolomics,X23501.Triglycerides in Large VLDL,TUBB3,Tubulin beta-3 chain,39586,-0.00491689286481404,0.00300768376599737,-0.0108119530461689,0.000978167316540811,0.102124411116454
NMR metabolomics,X23501.Triglycerides in Large VLDL,TG,Thyroglobulin,39919,-0.0179944088419961,0.0110091721121438,-0.0395723861817979,0.00358356849780568,0.102183296124797
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMI,N-myc-interactor,39875,-0.012516032497334,0.00766128624854481,-0.0275321535444818,0.00250008854981383,0.102355560199702
NMR metabolomics,X23501.Triglycerides in Large VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.00684675995066992,0.0042025698367261,-0.00139027692931324,0.0150837968306531,0.103302559689638
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.0050290552392712,0.00309156039052203,-0.00103040312615198,0.0110885136046944,0.103828365284024
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOX9,Transcription factor SOX-9,39649,0.00471219818610167,0.00290715441481216,-0.000985824466930171,0.0104102208391335,0.105068242135516
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00599544479521582,0.00371957067898746,-0.0012949137355996,0.0132858033260312,0.107015208064092
NMR metabolomics,X23501.Triglycerides in Large VLDL,RALB,Ras-related protein Ral-B,39657,0.00500913102092054,0.00311462056052989,-0.00109552527771805,0.0111137873195591,0.107805999383594
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENOPH1,Enolase-phosphatase E1,39919,0.00899333509407415,0.00560304693489067,-0.00198863689831157,0.0199753070864599,0.108504234129431
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B4,Protein ATP1B4,39560,-0.00705864885085946,0.00440014454593197,-0.0156829321608861,0.00156563445916721,0.108701944519704
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.00586929888930914,0.00365964012593403,-0.0130421935361398,0.00130359575752156,0.108783386241976
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAPS,Calcyphosin,39929,0.016001751956512,0.00998543160935172,-0.00356969399781739,0.0355731979108413,0.10907080201978
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSC1,Hamartin,39657,0.0124513946393417,0.00777201979538154,-0.0027817641596061,0.0276845534382895,0.109166566068235
NMR metabolomics,X23501.Triglycerides in Large VLDL,H2AP,Huntingtin-interacting protein M,39560,-0.00847806787050798,0.00529300186489811,-0.0188523515257083,0.00189621578469232,0.109239633480987
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A3,Protein S100-A3,39919,0.00718137758890153,0.00448646250146142,-0.00161208891396286,0.0159748440917659,0.109476372767368
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALPI,Intestinal-type alkaline phosphatase,39657,0.0210679220811829,0.0131673725338644,-0.0047401280851913,0.0468759722475572,0.109625030135854
NMR metabolomics,X23501.Triglycerides in Large VLDL,EXOSC10,Exosome component 10,39575,-0.00975647473294027,0.00612568285310515,-0.0217628131250264,0.00224986365914582,0.111252654556377
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.00782459607897486,0.00491985386232461,-0.0174675096491311,0.00181831749118138,0.111770742154242
NMR metabolomics,X23501.Triglycerides in Large VLDL,TJP3,Tight junction protein ZO-3,39586,-0.00694406806189863,0.00437070809143336,-0.015510655921108,0.00162251979731077,0.112140166083655
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,-0.00813267265691468,0.00512901626662828,-0.0181855445395061,0.00192019922567675,0.112848738500103
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.00591917583869186,0.00373751398195875,-0.013244703243331,0.00140635156594729,0.113280799382427
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB118,Beta-defensin 118,39586,0.00946618009476053,0.00598815062041299,-0.00227059512124893,0.02120295531077,0.113948300186058
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.00984432420497473,0.00625131645523929,-0.00240825604729427,0.0220969044572437,0.115340674951162
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFPI2,Tissue factor pathway inhibitor 2,42142,0.00631149881600711,0.00401829500017469,-0.00156435938433529,0.0141873570163495,0.116277860155351
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRTN3,Myeloblastin,41800,-0.00794983867130198,0.00507184123531829,-0.0178906474925258,0.00199097014992186,0.117034384061231
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.00811024736099673,0.0051776372978287,-0.00203792174274752,0.018258416464741,0.117283087485678
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSN,Gelsolin,39943,-0.00311793952534484,0.00199165723785971,-0.00702158771154988,0.000785708660860195,0.117493598907452
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL4A4,Collagen alpha-4(IV) chain,39743,-0.00879784174121517,0.00562700087932888,-0.0198267634646998,0.00223107998226943,0.11796235257071
NMR metabolomics,X23501.Triglycerides in Large VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.0173749676394238,0.0111337449519957,-0.0391971077453354,0.0044471724664879,0.118654514243551
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL6ST,Interleukin-6 receptor subunit beta,42145,0.0028786178703132,0.00184862224931154,-0.000744681738337424,0.00650191747896382,0.11945365100768
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.00880094976612612,0.00569084392817633,-0.0199550038653517,0.00235310433309949,0.122009971229373
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAPN3,Calpain-3,39919,-0.00633532910918447,0.00410020820616399,-0.0143717371932659,0.00170107897489696,0.122344287662482
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGMA,Repulsive guidance molecule A,42249,-0.00522903037646661,0.00338792481003013,-0.0118693630041257,0.00141130225119244,0.122749262820036
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.00815019273611021,0.00529808923973486,-0.0185344476459905,0.00223406217377011,0.123997141131307
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00544475882003207,0.00355671078198558,-0.0124159119527238,0.00152639431265966,0.125832304677458
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,0.0059521807895939,0.00389869990608499,-0.00168927102633269,0.0135936326055205,0.126857109016467
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFDN4,Prefoldin subunit 4,39560,-0.00841283611892527,0.00554518512179942,-0.0192813989576521,0.00245572671980159,0.1292595468111
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL5,Interleukin-5,41913,0.0219756427898151,0.0145492124775856,-0.00654081366625273,0.0504920992458829,0.1309561434599
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00406132970795493,0.00269158693270796,-0.00933684009606252,0.00121418068015266,0.131353513575687
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD2,T-cell surface antigen CD2,39575,-0.00614050747733321,0.00408937167804799,-0.0141556759663073,0.00187466101164085,0.133235091242112
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR2,Toll-like receptor 2,39757,-0.0036407627694672,0.00243103840908425,-0.00840559805127234,0.00112407251233793,0.13426125633898
NMR metabolomics,X23501.Triglycerides in Large VLDL,PI3,Elafin,41966,0.00886400980791747,0.00592260490673232,-0.00274429580927788,0.0204723154251128,0.134510462486223
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTO1,Protein LTO1 homolog,41913,0.00650857383394198,0.00435015390239517,-0.00201772781475256,0.0150348754826365,0.134632821236808
NMR metabolomics,X23501.Triglycerides in Large VLDL,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.0068685723885574,0.00459181085668594,-0.0158685216676619,0.00213137689054704,0.134726461750008
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF8,SLAM family member 8,41843,-0.00844901594882609,0.00567420406476125,-0.0195704559157581,0.00267242401810596,0.136505329629819
NMR metabolomics,X23501.Triglycerides in Large VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.0076442996798075,0.00513616866149635,-0.0177111902563404,0.00242259089672534,0.136693387715068
NMR metabolomics,X23501.Triglycerides in Large VLDL,NXPE4,NXPE family member 4,39575,-0.00499175793475756,0.00336219606489736,-0.0115816622219564,0.00159814635244127,0.137659485128056
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAG,S-arrestin,39586,-0.00815158664247151,0.00549423142054883,-0.0189202802267472,0.00261710694180419,0.137927093593499
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGS8,Regulator of G-protein signaling 8,41913,-0.00996319073027967,0.00672996757019909,-0.0231539271678699,0.00322754570731055,0.138784378702155
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFAP,Glial fibrillary acidic protein,41820,0.00710192131009313,0.0047986619777017,-0.00230345616620221,0.0165072987863885,0.13890254919252
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.0090734158341579,0.00617926261723634,-0.0211847705639411,0.00303793889562533,0.142033423297167
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPA33,Cell surface A33 antigen,42070,0.020637818044987,0.0140817020575798,-0.00696231798786938,0.0482379540778435,0.142786914011689
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDNRB,Endothelin receptor type B,39657,0.00673157305272794,0.00460285895620177,-0.00229003050142753,0.0157531766068834,0.143639101348381
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.00468133808229318,0.00320894824229743,-0.0109708766371961,0.00160820047260978,0.144637214585348
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.00754372829760999,0.00517237358300686,-0.0176815805203034,0.00259412392508345,0.144736007099619
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.00631860784897768,0.00434489278884234,-0.0148345977151087,0.00219738201715331,0.145902360990586
NMR metabolomics,X23501.Triglycerides in Large VLDL,MBL2,Mannose-binding protein C,39826,-0.0167740308980103,0.0115917457693338,-0.0394938526059046,0.00594579080988401,0.147906126911735
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKLR,Pyruvate kinase PKLR,42143,0.00947898701892728,0.00656226115468743,-0.00338304484426008,0.0223410188821146,0.148630047579523
NMR metabolomics,X23501.Triglycerides in Large VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00702969742328348,0.00487110968704791,-0.00251767756333042,0.0165770724098974,0.149009335336897
NMR metabolomics,X23501.Triglycerides in Large VLDL,NXPH3,Neurexophilin-3,39657,0.00454015392499941,0.00315182254119508,-0.00163741825574294,0.0107177261057418,0.149758470609398
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.0086461699613841,0.00600484965767018,-0.0204156752904177,0.00312333536764946,0.149934227215869
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA4,Ephrin type-A receptor 4,39736,0.00441761878668488,0.00307146540232232,-0.00160245340186688,0.0104376909752366,0.150383508160603
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00382200175734094,0.00266542043969859,-0.00904622581915019,0.0014022223044683,0.151622470009515
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRC1,Macrophage mannose receptor 1,39990,-0.00427822048959523,0.00298664384087232,-0.010132042417705,0.00157560143851451,0.152042279558238
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPM1B,Protein phosphatase 1B,39657,0.00926991683360352,0.0064792934533261,-0.00342949833491563,0.0219693320021227,0.152544840283965
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSMB,Beta-microseminoprotein,42103,-0.0105229292098108,0.00735576077439686,-0.0249402203276286,0.00389436190800703,0.152576688042286
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANPEP,Aminopeptidase N,42187,0.00409857578786195,0.00287273376783192,-0.0015319823970886,0.00972913397281251,0.153684693902651
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP4,Caspase-4,39757,-0.0246845895072896,0.0174323075693116,-0.0588519123431403,0.00948273332856118,0.156795996930529
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP6,Guanylate-binding protein 6,39575,-0.00664967503278621,0.00469877736205697,-0.0158592786624179,0.00255992859684544,0.157040401727444
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,0.00514972508143378,0.0036413026128796,-0.00198722803981023,0.0122866782026778,0.157310504208002
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00438157690574695,0.00310075662587334,-0.00169590608096479,0.0104590598924587,0.15765942257169
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK3,Prostate-specific antigen,39966,0.0169272300744894,0.0120408143495313,-0.00667276605059206,0.0405272261995708,0.159804609608958
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.008090415606429,0.00576986556564021,-0.0193993521150838,0.00321852090222581,0.160888437087036
NMR metabolomics,X23501.Triglycerides in Large VLDL,VASN,Vasorin,41975,-0.00404640238388417,0.00288663607991145,-0.0097042091005106,0.00161140433274227,0.161006883653057
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2RB,Interleukin-2 receptor subunit beta,41913,-0.00534825582540859,0.00383265321260464,-0.0128602561221137,0.00216374447129651,0.162905037771674
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINI1,Neuroserpin,39713,0.00424738084245057,0.00304383842479405,-0.00171854247014577,0.0102133041550469,0.162922271394986
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,-0.0052816248628165,0.0038075613571873,-0.0127444451229036,0.0021811953972706,0.16542601661939
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.0201817953659718,0.0145769035763588,-0.048752526375635,0.00838893564369142,0.166231068032422
NMR metabolomics,X23501.Triglycerides in Large VLDL,DHODH,Dihydroorotate dehydrogenase,39575,0.00670726625589745,0.00488208527637813,-0.00286162088580368,0.0162761533975986,0.169515461148831
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,0.00498362901095439,0.00364352958062229,-0.0021576889670653,0.0121249469889741,0.171396711242992
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTNNA1,Catenin alpha-1,39586,-0.00485532568263819,0.00355364341281791,-0.0118204667717613,0.00210981540648492,0.1718743138258
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC7A,C-type lectin domain family 7 member A,42296,-0.00852705825542611,0.00626172572605428,-0.0208000406784925,0.00374592416764029,0.173291468216623
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.00410927833981421,0.00302330215492871,-0.0100349505634745,0.00181639388384606,0.174105149660299
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK1,Kallikrein-1,42016,-0.0182655214235417,0.013455690539263,-0.0446386748804973,0.00810763203341382,0.174658878202441
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM5,Intercellular adhesion molecule 5,42145,0.00656219338512817,0.00484888942975396,-0.00294162989718959,0.0160660166674459,0.17596979400446
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB6B,Ras-related protein Rab-6B,41839,0.00674827846993015,0.00499553073339062,-0.00304296176751546,0.0165395187073758,0.176762355587876
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGN,Mimecan,42137,0.00614629086510856,0.00455640012339521,-0.00278425337674604,0.0150768351069632,0.177380178278872
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,0.00714465430152094,0.00530512075510469,-0.00325338237848426,0.0175426909815261,0.178089422847634
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB7,Integrin beta-7,42262,-0.00649270280952737,0.0048564929175337,-0.0160114289278934,0.00302602330883868,0.181273680950365
NMR metabolomics,X23501.Triglycerides in Large VLDL,FH,"Fumarate hydratase, mitochondrial",39586,0.0115439715936152,0.0086471283263722,-0.00540439992607433,0.0284923431133047,0.181901917227083
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.00679369666760149,0.00509672109899734,-0.00319587668643329,0.0167832700216363,0.18257441979351
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.0372045277707345,0.0280122849945579,-0.0921086063600679,0.017699550818599,0.184155884438972
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP3,"Fatty acid-binding protein, heart",39958,0.00756653084589801,0.00571780677740014,-0.00364037043780627,0.0187734321296023,0.185753133521331
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHAD,Chondroadherin,39736,0.0065074348764564,0.0049314263611074,-0.00315816079131411,0.0161730305442269,0.187000834929141
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,0.00673254110463044,0.00511955638649365,-0.0033017894128971,0.016766871622158,0.188511276473332
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.00448884520208132,0.00342977503727638,-0.00223351387098038,0.011211204275143,0.190633894036321
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.00810263920684241,0.00620037627989817,-0.004050098301758,0.0202553767154428,0.191303554600561
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYTL1,Cytokine-like protein 1,39966,0.00349965766669127,0.00268425719232571,-0.00176148643026712,0.00876080176364966,0.19233795335358
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALY,Neuron-specific vesicular protein calcyon,39575,-0.00532126377134511,0.00408452357275987,-0.0133269299739545,0.00268440243126423,0.192674861217251
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.00784713328494296,0.00602463482814423,-0.0196554175481057,0.00396115097821974,0.192770216591793
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.00573828622590185,0.00441971670806869,-0.0144009309737165,0.00292435852191278,0.194193146472068
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF9,Fibroblast growth factor 9,39539,0.00562045250248413,0.00432946504497767,-0.00286529898567211,0.0141062039906404,0.194250670618806
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD48,CD48 antigen,42166,-0.00420095534304867,0.00323823328939582,-0.0105478925902645,0.00214598190416713,0.194550544816632
NMR metabolomics,X23501.Triglycerides in Large VLDL,MKI67,Proliferation marker protein Ki-67,39657,0.00553722470800069,0.0042749487374389,-0.00284167481737956,0.0139161242333809,0.195253190413638
NMR metabolomics,X23501.Triglycerides in Large VLDL,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.00899053359448799,0.00694737264594767,-0.0226073839805454,0.00462631679156944,0.195660717237403
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMC3,26S proteasome regulatory subunit 6A,39560,-0.00412675278685635,0.00319955867317182,-0.0103978877862731,0.00214438221256042,0.197151446220204
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.00790797330620417,0.00617351165554161,-0.00419210953865737,0.0200080561510657,0.200237497516179
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOS,Proto-oncogene c-Fos,39539,-0.00484709087092616,0.00379310417220479,-0.0122815750484476,0.00258739330659523,0.201322677375695
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSBP1,Heat shock factor-binding protein 1,39638,0.0129129977377411,0.0101152293133446,-0.00691285171641445,0.0327388471918966,0.201773990459113
NMR metabolomics,X23501.Triglycerides in Large VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.00631647410693307,0.00495377159922968,-0.0033929182275571,0.0160258664414232,0.202305740098775
NMR metabolomics,X23501.Triglycerides in Large VLDL,NME3,Nucleoside diphosphate kinase 3,42144,-0.00320633687922751,0.00251763426491395,-0.00814090003845885,0.00172822628000383,0.202844267778952
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN5,Contactin-5,42170,0.0049460936010855,0.00389971084279557,-0.00269733965079381,0.0125895268529648,0.204704325851681
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGM2,Phosphoglucomutase-2,39649,0.00809278661366666,0.00638569129292966,-0.00442316832047547,0.0206087415478088,0.205063553438477
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.00730385224061703,0.00578277697830733,-0.0186380951180994,0.00403039063686534,0.20660331396702
NMR metabolomics,X23501.Triglycerides in Large VLDL,REST,RE1-silencing transcription factor,39560,-0.0045307471743803,0.00359661356961741,-0.0115801097708304,0.00251861542206983,0.207795091956203
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42123,0.0397121730683159,0.0315519530900753,-0.0221296549882318,0.101554001124864,0.208186439966813
NMR metabolomics,X23501.Triglycerides in Large VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.00911762238994555,0.00724804623129276,-0.00508854822338825,0.0233237930032794,0.208434507863586
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.0087198373039133,0.00693279432741968,-0.0223081141856559,0.00486843957782928,0.208502930705553
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTNL10,Butyrophilin-like protein 10,39560,-0.0052495701333693,0.00419020875420103,-0.0134623792916033,0.00296323902486473,0.210298575516674
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRA2,GDNF family receptor alpha-2,42070,0.00274897970289484,0.00219822195160612,-0.00155953532225315,0.00705749472804283,0.21112154728424
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.00911060766842595,0.00730229637656132,-0.0234231085664861,0.00520189322963425,0.212191017068624
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.00747995251353675,0.0059974816854555,-0.0192350166170295,0.00427511158995603,0.212357107324863
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALM3,Paralemmin-3,39575,0.00993345942361183,0.00796980792964437,-0.00568736411849115,0.0255542829657148,0.212649210244507
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL21,C-C motif chemokine 21,42185,0.00502174388985117,0.00403128781250333,-0.00287958022265536,0.0129230680023577,0.212898892060795
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.00707333219649014,0.00569175832172798,-0.00408251411409671,0.018229178507077,0.21399306511743
NMR metabolomics,X23501.Triglycerides in Large VLDL,UNG,Uracil-DNA glycosylase,39919,0.00459435224230574,0.00370189605873754,-0.00266136403281984,0.0118500685174313,0.214601609847437
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAEP,Glycodelin,42016,-0.0136685536222254,0.0110403688295481,-0.0353076765281397,0.00797056928368897,0.215718346828164
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMCN2,Hemicentin-2,39721,-0.00754878045558609,0.00609939954264073,-0.0195036035591619,0.00440604264798975,0.215880594277595
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.00379927956334792,0.00307018029666135,-0.00981683294480416,0.00221827381810831,0.215931262934082
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDN1,Endothelin-1,39638,0.00381672006671342,0.0030878573855799,-0.00223548040902319,0.00986892054245003,0.216469417471858
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBX2,Chromobox protein homolog 2,39575,-0.00511100378900088,0.00414809436698764,-0.0132412687482966,0.00301926117029488,0.217925817366821
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.00383829538849762,0.00311708396870082,-0.00994777996715123,0.00227118919015599,0.218208666869603
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,-0.00635959460999478,0.005164910407997,-0.0164828190096689,0.00376362978967934,0.218233812134297
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL36A,Interleukin-36 alpha,39657,-0.00734772101464692,0.00603375822011505,-0.0191738871260724,0.00447844509677858,0.223337924232176
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00504742125265555,0.00414985841077385,-0.0131811437377723,0.0030863012324612,0.223901548125144
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIRREL2,Kin of IRRE-like protein 2,41839,0.00509628750852451,0.00420492560572445,-0.00314536667869542,0.0133379416957444,0.225541504732217
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNLZ,DNL-type zinc finger protein,39586,-0.0107481428532929,0.00887588330235386,-0.0281448741259065,0.00664858841932064,0.225945282193179
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP8,Neutrophil collagenase,42224,0.00910240463754655,0.00754020604529763,-0.00567639921123679,0.0238812084863299,0.227382833892355
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA10,Ephrin type-A receptor 10,41839,0.00836589212987522,0.0069353724078161,-0.00522743778944434,0.0219592220491948,0.227737154361783
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.00915310446502997,0.00759244886313532,-0.0240343042367752,0.00572809530671525,0.228015205438365
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXDC2,Plexin domain-containing protein 2,39929,0.00347296727261595,0.00288111532199883,-0.00217401875850176,0.00911995330373366,0.228064607838828
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.00470358995653639,0.00390249237448968,-0.0123524750105362,0.00294529509746338,0.228121388898057
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.00964428202023327,0.00800981465419283,-0.0253435187424512,0.00605495470198468,0.228592676073162
NMR metabolomics,X23501.Triglycerides in Large VLDL,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.00913861800704955,0.00760382991373302,-0.0240421246379663,0.00576488862386716,0.229449847491355
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD7,T-cell antigen CD7,39636,0.00565017288690904,0.00470258322613456,-0.0035668902363147,0.0148672360101328,0.229581511884723
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL9,Interleukin-9,39757,-0.00705559655101267,0.00589780768202558,-0.0186152996077828,0.00450410650575746,0.231601674995601
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA3,Carbonic anhydrase 3,42287,-0.00738282007934517,0.00619221804760923,-0.0195195674526593,0.00475392729396893,0.233174527898374
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMG4,Proteasome assembly chaperone 4,39657,0.00697693053047577,0.00587673599998244,-0.00454147202948981,0.0184953330904413,0.235169578419796
NMR metabolomics,X23501.Triglycerides in Large VLDL,UNC5D,Netrin receptor UNC5D,39657,-0.00325278632252777,0.00274272024096117,-0.00862851799481166,0.00212294534975612,0.235659286135107
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL3A1,Collagen alpha-1(III) chain,39966,0.00293847649410385,0.00247991814458262,-0.00192216306927808,0.00779911605748579,0.23607833625252
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKKL1,Dickkopf-like protein 1,42070,-0.0104296227624563,0.00881926441264495,-0.0277153810112404,0.00685613548632781,0.236990354496934
NMR metabolomics,X23501.Triglycerides in Large VLDL,STEAP4,Metalloreductase STEAP4,39586,0.00903775372359864,0.00765031813983322,-0.00595686983047448,0.0240323772776718,0.23748666920094
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPSG1,Tryptase gamma,39657,0.00324393720008255,0.00275208454026013,-0.0021501484988273,0.00863802289899241,0.238535037580599
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPK13,Mitogen-activated protein kinase 13,39560,0.00539080957119071,0.00458438265567006,-0.00359458043392262,0.014376199576304,0.239657416030031
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCARE,Photoreceptor cilium actin regulator,39586,-0.0102478867437822,0.00874765291374121,-0.027393286454715,0.00689751296715052,0.241422742986177
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,39966,-0.00270935261333213,0.00231320116589836,-0.00724322689849292,0.00182452167182866,0.241520120372699
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.00512376129122343,0.00437654074310277,-0.003454258565258,0.0137017811477049,0.241730673430083
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACAN,Aggrecan core protein,41994,0.00336176812640427,0.00288115836161073,-0.00228530226235275,0.0090088385151613,0.243307356870193
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,-0.00729980518166177,0.0062703753317965,-0.0195897408319829,0.00499013046865938,0.244378819120857
NMR metabolomics,X23501.Triglycerides in Large VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.00780270512177822,0.00672122478282085,-0.0209763056961071,0.00537089545255065,0.245700984446634
NMR metabolomics,X23501.Triglycerides in Large VLDL,FZD8,Frizzled-8,39586,0.00525209540057651,0.00452537266894437,-0.00361763503055445,0.0141218258317075,0.245834510133252
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIF1L,Allograft inflammatory factor 1-like,39638,0.00685253997957319,0.00596262784309442,-0.00483421059289187,0.0185392905520383,0.250478506418254
NMR metabolomics,X23501.Triglycerides in Large VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.00810175302338447,0.00705269839819651,-0.0219250418838496,0.00572153583708069,0.250686121119559
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNPO1,Transportin-1,39757,0.00427789682948413,0.00372671371683134,-0.00302646205550529,0.0115822557144736,0.251034221735893
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,0.00522017548099928,0.00455044225636644,-0.00369869134147895,0.0141390423034775,0.251327469870963
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,0.0052256190457125,0.00455953632711503,-0.00371107215543296,0.014162310246858,0.251783852715927
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.00744817279651395,0.00649947327928224,-0.00529079483087924,0.0201871404239072,0.251834346591103
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00360564403247233,0.00315018295034713,-0.00256871455020805,0.00978000261515271,0.252403442885935
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.0142865804419311,0.0125157065077295,-0.038817365197081,0.0102442043132188,0.253685378135305
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.00838026752900442,0.00734161395625109,-0.00600929582524772,0.0227698308832566,0.253692754757887
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRPB1,Signal-regulatory protein beta-1,42100,0.00573520675246382,0.00503194792380453,-0.00412741117819306,0.0155978246831207,0.254407038625363
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL3RA,Interleukin-3 receptor subunit alpha,41913,0.0037673122683213,0.00331002751073209,-0.0027203416527136,0.0102549661893562,0.255077772157643
NMR metabolomics,X23501.Triglycerides in Large VLDL,PODXL2,Podocalyxin-like protein 2,42181,-0.0034212582105773,0.00300833606487945,-0.00931759689774103,0.00247508047658643,0.255449961816193
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,39575,-0.00427327192129289,0.00375786143379588,-0.0116386803315328,0.00309213648894703,0.255498209931564
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALMS1,Alstrom syndrome protein 1,39757,-0.00527614662878467,0.00466409894076968,-0.0144177805526932,0.00386548729512391,0.257984598978409
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1D,V-type proton ATPase subunit D,42070,0.00308463708960957,0.00273282736166997,-0.00227170453926357,0.00844097871848271,0.259029865859031
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN7,Tetraspanin-7,39586,-0.0115664234003826,0.0102518488900065,-0.0316600472247954,0.00852720042403022,0.2592482617057
NMR metabolomics,X23501.Triglycerides in Large VLDL,JUN,Transcription factor AP-1,41913,-0.00569327650426261,0.00508492531874965,-0.0156597301290119,0.0042731771204867,0.262888179999946
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL13,Interleukin-13,41913,-0.00571430772716976,0.00511841280206133,-0.01574639681921,0.00431778136487045,0.264261767765912
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.00490689653976971,0.00439695412698207,-0.0135249266286546,0.00371113354911514,0.264456554603011
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALLD,Palladin,39657,-0.00446059316123028,0.00400487562165245,-0.0123101493796691,0.00338896305720851,0.265393204940381
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNW1,Interferon omega-1,39575,-0.00412865569761979,0.00370805366603252,-0.0113964408830435,0.00313912948780396,0.265548470244329
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL19,Interleukin-19,41756,-0.00861491598601544,0.00774007874268133,-0.0237854703216708,0.00655563834963997,0.265717204993288
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.00365503276122502,0.00328407233500481,-0.0100918145378345,0.00278174901538442,0.265746307593014
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.00717658601659409,0.00646579205626422,-0.019849538446872,0.00549636641368379,0.267052856483883
NMR metabolomics,X23501.Triglycerides in Large VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,-0.00402406300036263,0.00362666289924252,-0.011132322282878,0.00308419628215271,0.267205486318571
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB1,Integrin beta-1,42167,-0.00245594119478983,0.00222135924460054,-0.0068098053142069,0.00189792292462723,0.268918044630076
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLB1,"Phospholipase B1, membrane-associated",39929,0.00689157518494446,0.00623685484797946,-0.00533266031709529,0.0191158106869842,0.269193436697711
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT8,"Keratin, type II cytoskeletal 8",39586,0.00972616068300415,0.00881646899050203,-0.00755411853837984,0.0270064399043881,0.269972754399277
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.0039755514333005,0.00360487174097622,-0.0110411000456139,0.00308999717901289,0.2701218169317
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.00810157334215943,0.00735529899034594,-0.00631481267891861,0.0225179593632375,0.27071955638498
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,-0.00578263618070737,0.00530878181993625,-0.0161878485477824,0.00462257618636767,0.276063786533083
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOCK9,Dedicator of cytokinesis protein 9,39586,0.0134252869325245,0.0123483444413432,-0.0107774681725081,0.0376280420375572,0.276966312812619
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESPL1,Separin,39560,-0.00609437810851236,0.00560762037355256,-0.0170853140406754,0.00489655782365065,0.277147824719263
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP1,"Fatty acid-binding protein, liver",42123,-0.010870302204846,0.0100187133233027,-0.0305069803185193,0.00876637590882734,0.277941074630445
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM171B,Protein FAM171B,39919,0.00302072146792812,0.0027907622773866,-0.00244917259574962,0.00849061553160586,0.279097825913101
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMBN,Ameloblastin,41913,-0.00309883127747119,0.00288135415352115,-0.00874628541837265,0.00254862286343027,0.282180534642768
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,0.00433749717930832,0.0040361314972918,-0.00357332055538362,0.0122483149140003,0.282542808338585
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAT1,Diamine acetyltransferase 1,39575,-0.00542606113592867,0.00508324330802378,-0.0153892180196553,0.00453709574779795,0.285796326927199
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPVL,Probable serine carboxypeptidase CPVL,42223,0.00460923302519165,0.00432253125105006,-0.00386292822686647,0.0130813942772498,0.286294615475095
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMA1,Proteasome subunit alpha type-1,41843,0.00519978786902413,0.0048772811472068,-0.0043596831795012,0.0147592589175495,0.286386899585969
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,0.00772393597530764,0.00726707602695536,-0.00651953303752487,0.0219674049881401,0.287865232011543
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGBL2,Cytosolic carboxypeptidase 2,39586,0.0102435306996674,0.00965961516462182,-0.00868931502299138,0.0291763764223261,0.288963624354487
NMR metabolomics,X23501.Triglycerides in Large VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00654495047707268,0.00617645282489408,-0.00556089705971972,0.0186507980138651,0.289321886462177
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,39649,0.00721609299415214,0.00681298054442903,-0.00613734887292877,0.020569534861233,0.289546294596837
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL24,Interleukin-24,41913,-0.00535755211111468,0.00507886885905469,-0.0153121350748619,0.00459703085263252,0.291503412630013
NMR metabolomics,X23501.Triglycerides in Large VLDL,BEX3,Protein BEX3,39560,-0.00514961010185048,0.00491470271866673,-0.0147824274304373,0.0044832072267363,0.294755312635328
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.00838261833521042,0.00800144899506393,-0.00730022169511488,0.0240654583655357,0.294824672778263
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP7,Retinoid-binding protein 7,39930,0.00687028528122829,0.00656339719206419,-0.00599397321521754,0.0197345437776741,0.295233763245365
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR4,Toll-like receptor 4,39657,0.00311731153031364,0.00298179932159797,-0.00272701514001838,0.00896163820064566,0.295839529695225
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLK,STE20-like serine/threonine-protein kinase,39757,-0.00862795463120523,0.00829647946580498,-0.024889054384183,0.00763314512177254,0.298383941069315
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCAM1,Neural cell adhesion molecule 1,42217,0.00357423011700162,0.00344686728517374,-0.00318162976193892,0.0103300899959422,0.299777426432254
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMC3,Structural maintenance of chromosomes protein 3,39560,0.00562418867648459,0.0054762748705291,-0.00510931006975244,0.0163576874227216,0.304438452919884
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARB1,Scavenger receptor class B member 1,41839,0.00601380497814265,0.00586013221063633,-0.00547205415470456,0.0174996641109899,0.304805029257471
NMR metabolomics,X23501.Triglycerides in Large VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.00603148504213978,0.00590033014196778,-0.00553316203611706,0.0175961321203966,0.306695374219837
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.00451310587029528,0.00442853749126552,-0.0131930393531757,0.00416682761258515,0.308176498890398
NMR metabolomics,X23501.Triglycerides in Large VLDL,OMP,Olfactory marker protein,39586,-0.00513439511961819,0.00503870652535446,-0.0150102599093129,0.00474146967007655,0.308229817910298
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC51B,Organic solute transporter subunit beta,39575,-0.00776708902555034,0.00762466837319,-0.0227114390370027,0.00717726098590205,0.308377873158595
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTXR,Neuronal pentraxin receptor,42145,0.00364907895795261,0.00359629789741782,-0.00339966492098632,0.0106978228368915,0.310278184561981
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,-0.00227259845860781,0.00226009512670104,-0.00670238490694185,0.00215718798972624,0.314662119331521
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42310,-0.00328361438185632,0.00327424747583964,-0.009701139434502,0.00313391067078937,0.315945736816733
NMR metabolomics,X23501.Triglycerides in Large VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.00725870976104137,0.00724356724795511,-0.00693868204495064,0.0214561015670334,0.31632162926858
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLI2,Zinc finger protein GLI2,39657,-0.0034931849187138,0.00348633806862327,-0.0103264075332154,0.00334003769578782,0.316382950626436
NMR metabolomics,X23501.Triglycerides in Large VLDL,HIP1,Huntingtin-interacting protein 1,39575,0.00345503618134721,0.00346229128599353,-0.00333105473920012,0.0102411271018945,0.318347652636532
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNNI3,"Troponin I, cardiac muscle",41900,0.00879130934417272,0.00884125389143719,-0.00853754828304418,0.0261201669713896,0.320070121265755
NMR metabolomics,X23501.Triglycerides in Large VLDL,PZP,Pregnancy zone protein,39979,0.00346622575487666,0.00348978706872131,-0.00337375689981712,0.0103062084095704,0.320609990623548
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCUN1D1,DCN1-like protein 1,39586,-0.00784550279677061,0.00792284983818641,-0.023374288479616,0.00768328288607475,0.322079869632127
NMR metabolomics,X23501.Triglycerides in Large VLDL,FBN2,Fibrillin-2,39649,0.00625184922850197,0.00632057192525374,-0.00613647174499535,0.0186401702019993,0.322622600627767
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFL4,Insulin growth factor-like family member 4,39657,0.00742499881104833,0.00750823937528667,-0.00729115036451354,0.0221411479866102,0.322727134902816
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUOX2,Dual oxidase 2,41900,0.00730629061309009,0.00740089507253946,-0.00719946372908725,0.0218120449552674,0.323554150208336
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRXN3,Neurexin-3,39649,0.0037328216312472,0.00378349096063828,-0.00368282065160384,0.0111484639140982,0.323856557021568
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGLON5,IgLON family member 5,39560,-0.00957555618953011,0.00973509095272078,-0.0286563344568628,0.00950522207780262,0.325327837664138
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH23,Cadherin-23,39929,-0.00274218729339423,0.00281321823994817,-0.00825609504369264,0.00277172045690417,0.329704600353258
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-0.00372717875028604,0.00382981254696573,-0.0112336113423389,0.00377925384176679,0.330474687292034
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC123,Cell division cycle protein 123 homolog,39560,0.00641661386928814,0.00659546950551911,-0.00651050636152933,0.0193437341001056,0.330633399585986
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP10,Inactive dipeptidyl peptidase 10,42119,0.00375876174705079,0.00386523669123093,-0.00381710216776183,0.0113346256618634,0.33084254062382
NMR metabolomics,X23501.Triglycerides in Large VLDL,B2M,Beta-2-microglobulin,39979,0.00310621392771331,0.00320048526601709,-0.00316673719368018,0.00937916504910681,0.331795697437352
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDAN1,Codanin-1,39929,0.00222065313232432,0.00229811646712439,-0.00228365514323949,0.00672496140788813,0.333918371733136
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARG2,"Arginase-2, mitochondrial",39919,-0.00426426667260748,0.00443244430865358,-0.0129518575175685,0.00442332417235354,0.336041229134585
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00422783157954558,0.00439660341060688,-0.00438951110524392,0.0128451742643351,0.336261534509977
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY6D,Lymphocyte antigen 6D,42041,0.00401869541933776,0.00418474080455573,-0.00418339655759148,0.012220787396267,0.336910844910807
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00479303657616226,0.00499806097985152,-0.0145892360966712,0.00500316294434672,0.337590201650439
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.0034996023374284,0.00365236748144118,-0.00365903792619631,0.0106582426010531,0.337995956478094
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFAP2A,Transcription factor AP-2-alpha,39586,0.00597372554416187,0.00625359946565808,-0.00628332940852796,0.0182307804968517,0.339474353610315
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEDD9,Enhancer of filamentation 1,39657,0.00338089893012669,0.0035565466945709,-0.00358993259123228,0.0103517304514857,0.341821729337335
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.00405279748341649,0.00429098851710734,-0.0043575400101139,0.0124631349769469,0.344939262437824
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL15RA,Interleukin-15 receptor subunit alpha,41913,-0.00344161445991465,0.00365518307993224,-0.0106057732965818,0.00372254437675255,0.346429397443267
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKAP12,A-kinase anchor protein 12,39736,-0.00209214177470987,0.00223485175197373,-0.00647245120857838,0.00228816765915864,0.349219647275185
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSP90B1,Endoplasmin,41774,0.0062650755731343,0.00670377610808154,-0.00687432559870552,0.0194044767449741,0.350032647702196
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL20,Interleukin-20,41913,-0.00457785039119544,0.00491397346216054,-0.0142092383770301,0.00505353759463922,0.351560943066895
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.00416642940473651,0.00447797091728129,-0.0129432524026078,0.00461039359313481,0.352170005445897
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.00471066796659935,0.00506524080408096,-0.00521720400939934,0.014638539942598,0.352392178587589
NMR metabolomics,X23501.Triglycerides in Large VLDL,MN1,Transcriptional activator MN1,39649,-0.00576168359012597,0.00619687497292799,-0.0179075585370648,0.00638419135681288,0.352509228952056
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRLB,Fc receptor-like B,41843,0.00603602327487434,0.00649398745378929,-0.00669219213455267,0.0187642386843014,0.35265797977441
NMR metabolomics,X23501.Triglycerides in Large VLDL,EP300,Histone acetyltransferase p300,39657,0.00299800005760665,0.00323416911299145,-0.00334097140385659,0.00933697151906988,0.35395876103436
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,-0.00849580954197287,0.0091777455536855,-0.0264841908271964,0.00949257174325071,0.354623782820614
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF20,Fibroblast growth factor 20,39657,-0.00419360035420186,0.00453333842782566,-0.0130789436727401,0.00469174296433642,0.35495599846252
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,41879,0.00520003076181357,0.00564795710358397,-0.005869965161211,0.0162700266848382,0.357227809359822
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,0.00291840123384528,0.00318156402110048,-0.00331746424751166,0.00915426671520222,0.359009758270282
NMR metabolomics,X23501.Triglycerides in Large VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00632987347818184,0.00690151565920541,-0.0198568441702244,0.00719709721386076,0.359072602922795
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00379260080838312,0.00413902770224582,-0.0119050951047849,0.00431989348801869,0.359528140775081
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.00565788964078118,0.00618378740222184,-0.00646233366757362,0.017778112949136,0.360235148887563
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,0.00350446873202911,0.00383490686791542,-0.00401194872908513,0.0110208861931433,0.360823464032089
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,-0.00312982049270022,0.00344884491830332,-0.00988955653257473,0.00362991554717428,0.364159574160364
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL4,Interleukin-4,41913,0.00895745630815414,0.00994109729279564,-0.0105270943857253,0.0284420070020336,0.367576399260297
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18BP,Interleukin-18-binding protein,42217,0.00297769001381798,0.00330553481003774,-0.00350115821385598,0.00945653824149194,0.367700261462236
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFF1,Trefoil factor 1,42084,-0.00763161739654399,0.00848017765730843,-0.0242527656048685,0.00898953081178053,0.368170367098406
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17F,Interleukin-17F,41913,-0.00692587879432456,0.00772982604561912,-0.022076337843738,0.00822458025508891,0.370272096464694
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEFL,Neurofilament light polypeptide,41797,-0.00444517711019244,0.00499099549459102,-0.0142275282795908,0.00533717405920597,0.373138904362762
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.00383983968724401,0.00431334380760649,-0.00461431417566472,0.0122939935501527,0.373365125365753
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.00478878029682221,0.00541544103314867,-0.00582548412814918,0.0154030447217936,0.376562731894864
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.00340374479910107,0.00387556206524017,-0.0109998464469718,0.00419235684876967,0.379822051159841
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANSC4,MANSC domain-containing protein 4,39575,0.00625694377011368,0.00714239846720395,-0.00774215722560607,0.0202560447658334,0.381033777383962
NMR metabolomics,X23501.Triglycerides in Large VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,-0.00260335003214209,0.0029833010644772,-0.0084506201185174,0.00324392005423322,0.382874399095579
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELAVL4,ELAV-like protein 4,39586,0.00751242650880579,0.00861444107863295,-0.00937187800531478,0.0243967310229264,0.383187293933321
NMR metabolomics,X23501.Triglycerides in Large VLDL,RELB,Transcription factor RelB,39657,0.00426549248899743,0.00492710518948535,-0.00539163368239385,0.0139226186603887,0.386662625877863
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.00707104042391413,0.00825174887867464,-0.0232444682261164,0.00910238737828816,0.391507834769083
NMR metabolomics,X23501.Triglycerides in Large VLDL,YY1,Transcriptional repressor protein YY1,39657,0.00250913266508784,0.00292992098309231,-0.00323351246177309,0.00825177779194877,0.391804873650253
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK11,Kallikrein-11,42062,0.00289600809473438,0.00339640905717419,-0.00376095365732703,0.00955296984679579,0.393858810589764
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN7,Septin-7,39757,-0.00476208800159414,0.00558876678507382,-0.0157160709003388,0.00619189489715055,0.394186829135114
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOM1,Myomesin-1,39586,0.00437951165114271,0.00514613817458135,-0.00570691917103674,0.0144659424733222,0.394771918667681
NMR metabolomics,X23501.Triglycerides in Large VLDL,POF1B,Protein POF1B,39657,-0.00406053879408302,0.00477368004052438,-0.0134169516735108,0.00529587408534477,0.395004589783794
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42070,0.0071510242386497,0.0084597899390399,-0.0094301640418685,0.0237322125191679,0.397960763538992
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,0.0034214453259854,0.00407421238705211,-0.00456401095263674,0.0114069016046075,0.40104959485427
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL9A1,Collagen alpha-1(IX) chain,42119,-0.0039219922080429,0.00469803970506493,-0.0131301500299702,0.00528616561388436,0.40383684747735
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASQ2,Calsequestrin-2,39575,0.00413697879427215,0.00500070220923773,-0.00566439753583379,0.0139383551243781,0.408096604856334
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORC3,MORC family CW-type zinc finger protein 3,39929,0.00243937986457235,0.0029511977529154,-0.00334496773114184,0.00822372746028654,0.408496632929658
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.00423830812581745,0.00513266541556002,-0.0142983323403151,0.00582171608868019,0.408959426379399
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA11,Carbonic anhydrase-related protein 11,41843,-0.00264612350253943,0.00321511941026932,-0.0089477575466673,0.00365551054158843,0.410508623084534
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL28,C-C motif chemokine 28,42075,0.00510038522164734,0.00620792897528543,-0.0070671555699121,0.0172679260132068,0.411323639541168
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFNB2,Ephrin-B2,39649,-0.00499770183103076,0.0060863722737463,-0.0169269914875735,0.00693158782551199,0.41159003641846
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAL,Galanin peptides,42185,-0.00572715357907691,0.00701371165372941,-0.0194740284203866,0.00801972126223274,0.414191208872341
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXK,Tyrosine-protein kinase TXK,39757,-0.00628005777868357,0.00769143378964702,-0.0213552680063917,0.00879515244902459,0.414231500928106
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL31,Interleukin-31,39657,-0.00472468063795956,0.00583975972462587,-0.0161706096982263,0.00672124842230714,0.41850152651582
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSB,Lupus La protein,41839,0.00500493867094477,0.00621003541638969,-0.00716673074517901,0.0171766080870686,0.420289811217601
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC39A14,Zinc transporter ZIP14,41839,-0.00285920100836377,0.00355821697531909,-0.0098333062799892,0.00411490426326165,0.421672024895008
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,39930,-0.00456698721073376,0.00572278901821453,-0.0157836536864342,0.00664967926496671,0.424866775772424
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNF75D,Zinc finger protein 75D,39757,-0.00511987200868353,0.0064246913767491,-0.0177122671071118,0.0074725230897447,0.425522863592959
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC50,Coiled-coil domain-containing protein 50,39934,0.0062178573398304,0.0078159712627431,-0.00910144633514607,0.0215371610148069,0.426320608733155
NMR metabolomics,X23501.Triglycerides in Large VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00586727695199765,0.00745082255669568,-0.0204708891631212,0.00873633525912589,0.431025522243521
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMMR,Hyaluronan mediated motility receptor,39541,0.00399546163841675,0.00508073609828056,-0.00596278111421314,0.0139537043910466,0.431653584502323
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHH,Sonic hedgehog protein,39657,-0.00351585783423065,0.00448104418773106,-0.0122987044421835,0.00526698877372223,0.432700938797772
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCN15,Lipocalin-15,39934,-0.00499972349902937,0.00637352341480544,-0.017491829392048,0.0074923823939893,0.432791302619956
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZP4,Zona pellucida sperm-binding protein 4,39560,0.00256213805092806,0.00327820439048057,-0.00386314255441386,0.00898741865626998,0.434485668304818
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-0.00268245256070226,0.00344708663944483,-0.00943874237401413,0.0040738372526096,0.436479907027077
NMR metabolomics,X23501.Triglycerides in Large VLDL,HBQ1,Hemoglobin subunit theta-1,42262,-0.00502767434530843,0.00647238390433858,-0.017713546797812,0.00765819810719518,0.437296923710705
NMR metabolomics,X23501.Triglycerides in Large VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.00510657635480922,0.00657650115921749,-0.00778336591725706,0.0179965186268755,0.43747732254956
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFDN6,Prefoldin subunit 6,39649,0.00527445652454378,0.00682270744958312,-0.00809805007663914,0.0186469631257267,0.439495230305785
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,0.00231168606607261,0.00299067497127028,-0.00355003687761714,0.00817340900976236,0.439559368828069
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,-0.00208441432810021,0.00269859190648248,-0.00737365446480588,0.00320482580860546,0.439888845995456
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLR3,Folate receptor gamma,42132,-0.0152524768735057,0.0202151488292429,-0.0548741685788218,0.0243692148318104,0.450557807944259
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHC1,SHC-transforming protein 1,39560,-0.00922855399145292,0.0122925301715756,-0.033321913127741,0.0148648051448352,0.452822329796769
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBR1,TGF-beta receptor type-1,39657,-0.00172264666590633,0.00230914067280275,-0.00624856238459973,0.00280326905278706,0.45567602187454
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP2,Guanylate-binding protein 2,41913,0.0046729218051077,0.00638780943489238,-0.00784718468728138,0.0171930282974968,0.464463816262475
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.00280796204708638,0.0038468786185921,-0.0103478441395269,0.00473192004535413,0.465446869178709
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,0.00210579323241577,0.00289476300693896,-0.00356794226118459,0.00777952872601612,0.466963204110316
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAND5,DAN domain family member 5,39657,-0.00416973686224306,0.00574440130381089,-0.0154287634177124,0.00708928969322629,0.467928679126721
NMR metabolomics,X23501.Triglycerides in Large VLDL,GH2,Growth hormone variant,41843,0.0123807325628822,0.0170769178829642,-0.0210900264877277,0.045851491613492,0.468466021975024
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNL1,Interferon lambda-1,41839,0.00346880062511901,0.00479515570421842,-0.0059297045551491,0.0128673058053871,0.469448874470171
NMR metabolomics,X23501.Triglycerides in Large VLDL,DENND2B,DENN domain-containing protein 2B,39575,-0.00372423781243819,0.0051493638102575,-0.0138169908805429,0.00636851525566651,0.469546437795681
NMR metabolomics,X23501.Triglycerides in Large VLDL,FDX2,"Ferredoxin-2, mitochondrial",39575,0.00418815908096156,0.00580171315778409,-0.00718319870829526,0.0155595168702184,0.470381689292182
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUMF1,Formylglycine-generating enzyme,39657,0.00500560604686501,0.00694000780174742,-0.00859680924455993,0.0186080213382899,0.4707598471112
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCNIP4,Kv channel-interacting protein 4,41839,0.00386780598368081,0.00537201674937403,-0.00666134684509228,0.0143969588124539,0.471542986948186
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.00264140671332275,0.0036966488301574,-0.00988683842043125,0.00460402499378575,0.474905067466457
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSLN,Mesothelin,42048,-0.00436822176050207,0.00612006979085969,-0.0163635585505871,0.00762711502958291,0.475391951346067
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZPR1,Zinc finger protein ZPR1,39586,-0.00720915212293995,0.0101268364307782,-0.0270577515272652,0.0126394472813853,0.476550547028864
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.00327462503777109,0.00460091357609609,-0.0122924156469194,0.00574316557137723,0.47664437647126
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENG,Endoglin,42310,-0.00128717611640399,0.00182008777155289,-0.00485454814864766,0.00228019591583968,0.47945078972243
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXDC1,Plexin domain-containing protein 1,41843,-0.0023995924445847,0.00339332833174289,-0.00905051597480078,0.00425133108563137,0.479485651965672
NMR metabolomics,X23501.Triglycerides in Large VLDL,YAP1,Transcriptional coactivator YAP1,39929,0.00204127218578767,0.00290122324917668,-0.00364512538259863,0.00772766975417396,0.481702488703647
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRC1,Protein regulator of cytokinesis 1,39919,0.00325854487352595,0.00463564907387142,-0.00582732731126203,0.0123444170583139,0.482112745842809
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYTH3,Cytohesin-3,39560,0.0053939052070344,0.00768042917176082,-0.00965973596961681,0.0204475463836856,0.482511894644618
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENO1,Alpha-enolase,42119,-0.00581503625384646,0.00828771581552113,-0.0220589592522679,0.010428886744575,0.482912516622594
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSPN,Claspin,41820,0.00262913145034787,0.00374890664422281,-0.00471872557232884,0.00997698847302457,0.483124293453552
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSAPL1,Proactivator polypeptide-like 1,39930,-0.00370123069678297,0.00528366491603129,-0.0140572139322043,0.00665475253863837,0.483626721974935
NMR metabolomics,X23501.Triglycerides in Large VLDL,MLLT1,Protein ENL,39560,-0.00486707009451159,0.00697148505640719,-0.0185311808050697,0.00879704061604651,0.485104678967855
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,0.00622466498709665,0.00896979698166185,-0.0113561370969606,0.0238054670711539,0.487720289622742
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACTA2,"Actin, aortic smooth muscle",41900,-0.00318357328344492,0.00459265204824354,-0.0121851712980023,0.00581802473111242,0.488203409674109
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHISA5,Protein shisa-5,39966,0.00188845935465116,0.00272964942383115,-0.00346165351605789,0.0072385722253602,0.489056846915341
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCL2,Phosducin-like protein 2,39560,-0.00378904103492727,0.00548670442811941,-0.0145429817140413,0.00696489964418677,0.489840398493655
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.00331600227563795,0.00481505966777083,-0.00612151467319288,0.0127535192244688,0.491040744569504
NMR metabolomics,X23501.Triglycerides in Large VLDL,PXDNL,Peroxidasin-like protein,39919,-0.00413902019600501,0.00601418376698492,-0.0159268203792954,0.00764877998728542,0.491334778144898
NMR metabolomics,X23501.Triglycerides in Large VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.00192843302996421,0.00280230121645602,-0.0035640773542896,0.00742094341421801,0.491366274120342
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,-0.00349442466999342,0.00508350447419067,-0.0134580934394071,0.00646924409942029,0.491842306762511
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAGE2A,G antigen 2A,39560,-0.00471747029291828,0.0068672494345042,-0.0181772791845465,0.00874233859870996,0.492127551545545
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.00258757151730898,0.00376948909427541,-0.00480062710747082,0.00997577014208877,0.492440183323121
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00357357952003491,0.00523158784395084,-0.0138274916941785,0.00668033265410873,0.494572342320264
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-0.00488940110344806,0.00716869995661984,-0.0189400530184229,0.00916125081152681,0.495222437735679
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRISP2,Cysteine-rich secretory protein 2,42262,0.00380198715526814,0.00559036971517881,-0.00715513748648233,0.0147591117970186,0.496455305842933
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,0.00550869845936604,0.00811530502450241,-0.0103972993886587,0.0214146963073908,0.497276514783534
NMR metabolomics,X23501.Triglycerides in Large VLDL,CORO6,Coronin-6,39586,-0.00277278627757875,0.00410313305545226,-0.0108149270662652,0.00526935451110767,0.49919904364027
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORF4L2,Mortality factor 4-like protein 2,39560,-0.00268031483017097,0.00396831373177141,-0.0104582097444429,0.005097580084101,0.499417390728496
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAD1,Glutamate decarboxylase 1,39560,0.00186304101366309,0.00276716283502706,-0.00356059814298995,0.00728668017031613,0.500791273039941
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,0.00197886918348325,0.00293983553759442,-0.0037832084702018,0.00774094683716831,0.500883485727871
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP3,Microfibril-associated glycoprotein 3,41900,0.00338957399651805,0.00503581709101901,-0.0064806275018792,0.0132597754949153,0.500899725547171
NMR metabolomics,X23501.Triglycerides in Large VLDL,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00239446406249073,0.00357055274855427,-0.00460381932467563,0.0093927474496571,0.502479875812885
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPLA2,Acyl-protein thioesterase 2,39586,0.00758458938410816,0.0114178537333864,-0.0147944039333292,0.0299635827015455,0.506528563006483
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,-0.00475896173239481,0.00717107675550518,-0.018814272173185,0.00929634870839535,0.506939318809624
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSLNL,Mesothelin-like protein,39649,-0.00264381683408427,0.00398956084551031,-0.0104633560912845,0.00517572242311594,0.507546991742588
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,0.00310068216501267,0.00469504986428626,-0.0061016155689884,0.0123029798990137,0.509001072651827
NMR metabolomics,X23501.Triglycerides in Large VLDL,RSPO1,R-spondin-1,42016,0.00236530689965717,0.00359317251794384,-0.00467731123551275,0.00940792503482709,0.510370721577576
NMR metabolomics,X23501.Triglycerides in Large VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00337704593446982,0.0051323800935217,-0.00668241904883272,0.0134365109177724,0.510559464877227
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL12,Stromal cell-derived factor 1,41913,0.00273153506479519,0.00415916215139764,-0.00542042275194419,0.0108834928815346,0.511352208027639
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53BP1,TP53-binding protein 1,39657,-0.00592826196603565,0.00903257780476972,-0.0236321144633843,0.011775590531313,0.511631873860609
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,0.00629351048804604,0.00961720713865728,-0.0125562155037222,0.0251432364798143,0.512867186989595
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOP56,Nucleolar protein 56,39575,0.00768389377744056,0.0117723056424418,-0.0153898252817453,0.0307576128366264,0.513957354922294
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT1,Vascular endothelial growth factor receptor 1,42042,-0.00148702877315965,0.00228957579674436,-0.0059745973347786,0.0030005397884593,0.516040654250264
NMR metabolomics,X23501.Triglycerides in Large VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.0052747118398004,0.00812256858042309,-0.0106455225778289,0.0211949462574297,0.516100061056875
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPON1,Spondin-1,42144,0.00219052627450634,0.00343648557212629,-0.00454498544686118,0.00892603799587387,0.523854188536155
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,0.0078716196474531,0.0123905549750821,-0.0164138681037078,0.032157107398614,0.525250857773171
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRN1,Neuritin,39934,0.00231055146667451,0.00365469212939082,-0.0048526451069315,0.00947374804028052,0.527259099082638
NMR metabolomics,X23501.Triglycerides in Large VLDL,TET2,Methylcytosine dioxygenase TET2,39750,-0.0066625953748087,0.0105522930258979,-0.0273450897055686,0.0140198989559512,0.527799544112884
NMR metabolomics,X23501.Triglycerides in Large VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.00316711616414438,0.00508089193260359,-0.00679143202375865,0.0131256643520474,0.533074583914716
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA2,Protein disulfide-isomerase A2,39560,0.00258620087893777,0.00419936447834528,-0.00564455349861899,0.0108169552564945,0.538002813292175
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,-0.0029663432023122,0.00483070655785655,-0.012434528055711,0.00650184165108663,0.539188067903613
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.00227635968702077,0.00371802379668366,-0.00956368632852075,0.00501096695447921,0.540385117147771
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSL4,Early placenta insulin-like peptide,39919,-0.00309216143133589,0.00505938485750137,-0.0130085557520386,0.0068242328893668,0.541097066257342
NMR metabolomics,X23501.Triglycerides in Large VLDL,BSND,Barttin,39560,0.00215046970209966,0.00352571306293715,-0.00475992790125716,0.00906086730545648,0.541914898908511
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.00207817961874974,0.00340732856920252,-0.00875654361438668,0.0046001843768872,0.541930960738195
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDA1,DET1- and DDB1-associated protein 1,39575,0.00249721336143179,0.00411568871652845,-0.00556953652296397,0.0105639632458275,0.544026283839812
NMR metabolomics,X23501.Triglycerides in Large VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00295640004241491,0.00491877962725898,-0.00668440802701269,0.0125972081118425,0.547821059587295
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCP11,T-complex protein 11 homolog,39757,-0.00364690265947171,0.00607526111452487,-0.0155544144439405,0.00826060912499702,0.548326911143597
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP7,Dipeptidyl peptidase 2,42054,0.0039499900633374,0.00662544549886222,-0.00903588311443254,0.0169358632411073,0.551061792256618
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBLN1,Cerebellin-1,39586,-0.00580458000074091,0.00973673896349526,-0.0248885883691916,0.0132794283677098,0.55108572428754
NMR metabolomics,X23501.Triglycerides in Large VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,-0.00211816180823084,0.00361451117652189,-0.00920260371421374,0.00496628009775207,0.55787673432856
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,0.00303806580104945,0.00521723570579615,-0.00718771618231101,0.0132638477844099,0.560367534001088
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,-0.00260532918231308,0.00448431353625589,-0.0113945837133746,0.00618392534874846,0.561260859419366
NMR metabolomics,X23501.Triglycerides in Large VLDL,RUVBL1,RuvB-like 1,41843,0.00605522853205545,0.0104263766779237,-0.014380469756675,0.0264909268207859,0.561411711101007
NMR metabolomics,X23501.Triglycerides in Large VLDL,UGDH,UDP-glucose 6-dehydrogenase,39575,0.00605188919952934,0.0104874225182676,-0.0145034589362752,0.0266072373353338,0.563909655151189
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPB41L5,Band 4.1-like protein 5,39649,0.00375785687048758,0.00654277055662582,-0.00906597342049903,0.0165816871614742,0.565740956442576
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.00238966177816481,0.00417992426502781,-0.0105823133376193,0.0058029897812897,0.567536721424888
NMR metabolomics,X23501.Triglycerides in Large VLDL,PYDC1,Pyrin domain-containing protein 1,39638,-0.00247515867223471,0.00433454053976119,-0.0109708581301666,0.00602054078569721,0.567989996095285
NMR metabolomics,X23501.Triglycerides in Large VLDL,PITHD1,PITH domain-containing protein 1,39539,-0.00459615737227346,0.00811484438619272,-0.0205012523692112,0.0113089376246643,0.571141092845168
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,-0.00156535949760841,0.00277441073387052,-0.00700320453599463,0.00387248554077781,0.572620071736724
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.00354133267114351,0.00628433679594182,-0.0158586327911895,0.00877596744890245,0.573092156123502
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEF,Thyrotroph embryonic factor,39575,0.00249323221734192,0.00450092708361024,-0.00632858486653416,0.011315049301218,0.579632917499068
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC12A,C-type lectin domain family 12 member A,39657,0.00118364637397887,0.00214355127514105,-0.0030177141252976,0.00538500687325534,0.580829730749826
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRA3,GDNF family receptor alpha-3,41989,0.00161761931772218,0.00293258345281577,-0.00413024424979673,0.0073654828852411,0.581230173240532
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTX1,Neuronal pentraxin-1,42137,0.00241336164562411,0.00439990151513681,-0.00621044532404405,0.0110371686152923,0.583355230820157
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDAC8,Histone deacetylase 8,39657,0.00345427393048554,0.00632430677752302,-0.00894136735345958,0.0158499152144307,0.584946271172893
NMR metabolomics,X23501.Triglycerides in Large VLDL,NGF,Beta-nerve growth factor,42016,0.000701089437563518,0.00128413639306612,-0.00181581789284609,0.00321799676797312,0.585101262614954
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPO,Lactoperoxidase,41647,-0.00354447072157158,0.00649463448276614,-0.0162739543077932,0.00918501286465005,0.585244592209938
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL22,Interleukin-22,39919,-0.00403594309386393,0.00740020675877321,-0.0185403483410594,0.0104684621533316,0.585501235975272
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL10,Interleukin-10,41913,-0.00441609160625143,0.00810036817447129,-0.0202928132282151,0.0114606300157123,0.585644556184756
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.0016329576682939,0.00299669616070899,-0.00750648214328352,0.00424056680669573,0.585819669070675
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLR1,Folate receptor alpha,42110,0.00168605664582482,0.00310656797553213,-0.00440281658621816,0.0077749298778678,0.587318238441094
NMR metabolomics,X23501.Triglycerides in Large VLDL,PADI2,Protein-arginine deiminase type-2,41913,-0.00325622699534299,0.00600572822634065,-0.0150274543189707,0.00851500032828467,0.587698853569627
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX1B,Syntaxin-1B,39649,0.0022863820636751,0.00422457056620104,-0.00599377624607895,0.0105665403734291,0.588373393637279
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCNE1,G1/S-specific cyclin-E1,39657,0.00518644117309773,0.00962237300491844,-0.0136734099165424,0.0240462922627379,0.589898988283824
NMR metabolomics,X23501.Triglycerides in Large VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.00453204848756812,0.00840988243490296,-0.0210154180599779,0.0119513210848417,0.589969658184247
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,-0.00427200929395664,0.00794580144872476,-0.0198457801334572,0.0113017615455439,0.590833693463926
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLHL41,Kelch-like protein 41,39934,-0.00295361675601792,0.00551232646058821,-0.0137577766187708,0.00785054310673498,0.592093222874041
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFF2,Trefoil factor 2,42166,-0.00329175503452737,0.0061547012724247,-0.0153549695284798,0.00877145945942504,0.592772119731386
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFRC,Transferrin receptor protein 1,42200,0.00210030820564682,0.00394776384566476,-0.00563730893185611,0.00983792534314974,0.594717521081673
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.00145130564442942,0.00273855052996748,-0.00681886468316568,0.00391625339430683,0.596154217739003
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.00277794462868539,0.00526156664414489,-0.00753472599383858,0.0130906152512094,0.597531443306158
NMR metabolomics,X23501.Triglycerides in Large VLDL,ISM2,Isthmin-2,39966,0.00240385474438118,0.00456477447015854,-0.00654310321712956,0.0113508127058919,0.598474895817945
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERCC1,DNA excision repair protein ERCC-1,39560,0.00184351294371485,0.00351208217781353,-0.00504016812479966,0.00872719401222937,0.599659167917871
NMR metabolomics,X23501.Triglycerides in Large VLDL,NLGN1,Neuroligin-1,39649,-0.0037066055718363,0.00706737048176924,-0.017558651716104,0.0101454405724314,0.599963994949289
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.0026107245619067,0.00497912781202891,-0.0123698150734834,0.00714836594966997,0.600057043105129
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,0.00224821350338713,0.00428965823718156,-0.00615951664148873,0.010655943648263,0.600218599563246
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.00131520615105727,0.00253828575652257,-0.0062902462338415,0.00365983393172697,0.604365548966483
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,0.00320952944831565,0.00622000888979175,-0.00898168797567619,0.0154007468723075,0.605864258369192
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,-0.00336887981332454,0.00656970915433557,-0.0162455097558223,0.00950775012917318,0.608107040177958
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00184899934856456,0.00360751983043302,-0.00522173951908417,0.00891973821621328,0.608283151081409
NMR metabolomics,X23501.Triglycerides in Large VLDL,KDM3A,Lysine-specific demethylase 3A,39657,-0.00476461922989792,0.00931341022417342,-0.0230189032692778,0.013489664809482,0.60895032935507
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,-0.00219293406234438,0.00429450545738395,-0.0106101647588169,0.00622429663412816,0.609613373335433
NMR metabolomics,X23501.Triglycerides in Large VLDL,MERTK,Tyrosine-protein kinase Mer,42296,0.00131343904075084,0.00259740134674069,-0.00377746759886091,0.0064043456803626,0.613093468839029
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLGN,Calmegin,39649,0.00242919803414855,0.00480597147537891,-0.00699050605759412,0.0118489021258912,0.613250004701917
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNF174,Zinc finger protein 174,39657,0.00194794201246665,0.003862770759156,-0.00562308867547912,0.00951897270041241,0.614070317386602
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00345830219579269,0.00686090257034975,-0.0169056712336782,0.00998906684209283,0.614229613592563
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,0.00526475999855475,0.0105391827655972,-0.0153920382220158,0.0259215582191253,0.617407612414785
NMR metabolomics,X23501.Triglycerides in Large VLDL,MELTF,Melanotransferrin,39958,-0.0015781151486384,0.00316309883435975,-0.00777778886398351,0.00462155856670672,0.617849442296445
NMR metabolomics,X23501.Triglycerides in Large VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.00119979841347879,0.00240679496945084,-0.00351751972664485,0.00591711655360243,0.618136410310628
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-0.00281801582223987,0.0056908225688176,-0.0139720280571224,0.00833599641264262,0.620478652638335
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN15,Tetraspanin-15,39575,-0.00260682549147451,0.00528520630163982,-0.0129658298426885,0.00775217885973953,0.621859525312545
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMY2B,Alpha-amylase 2B,41300,-0.00258542934080408,0.00527590469275992,-0.0129262025386135,0.00775534385700536,0.624110705507429
NMR metabolomics,X23501.Triglycerides in Large VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,0.00219374753590725,0.00449306517661955,-0.00661266021026707,0.0110001552820816,0.625379346917788
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP2BP,LRP2-binding protein,39649,-0.00398577145132258,0.00817507206576584,-0.0200089127002236,0.0120373697975785,0.62587698639196
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCIN,Adseverin,39586,-0.00376628029671682,0.00775439324428489,-0.0189648910555152,0.0114323304620816,0.62719217636038
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHP1,Calcineurin B homologous protein 1,39586,0.00376112175730858,0.00775631205385234,-0.011441249868242,0.0189634933828592,0.627749081409409
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMY2A,Pancreatic alpha-amylase,41665,-0.00247202423356978,0.0051507820222441,-0.0125675569971682,0.00762350853002865,0.631283902646566
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD160,CD160 antigen,42296,-0.00244370036215685,0.00509947244928344,-0.0124386663627524,0.0075512656384387,0.631799379033502
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00271434351730045,0.00566599872738997,-0.0138197010229848,0.00839101398838389,0.631906736981913
NMR metabolomics,X23501.Triglycerides in Large VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.0034316479417007,0.00717084636298911,-0.0174865068131594,0.010623210929758,0.632264417785114
NMR metabolomics,X23501.Triglycerides in Large VLDL,UPK3A,Uroplakin-3a,39586,-0.00242767218723828,0.00509077505976894,-0.0124055913043854,0.00755024692990884,0.633459385082578
NMR metabolomics,X23501.Triglycerides in Large VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,-0.00131005293967405,0.00276270886247423,-0.00672496231012354,0.00410485643077544,0.635372818824716
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLIN3,Perilipin-3,42145,0.0021261914751028,0.00451234349677792,-0.00671800177858192,0.0109703847287875,0.637509428722459
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH4,Cadherin-4,39586,0.00228579866786352,0.00488880239551997,-0.00729625402735563,0.0118678513630827,0.64010998024292
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL4,Myosin light chain 4,39638,0.00252048903474141,0.00541806743341987,-0.00809892313476153,0.0131399012042443,0.641796878761864
NMR metabolomics,X23501.Triglycerides in Large VLDL,FZD10,Frizzled-10,39649,0.00290828488962211,0.00627583565940547,-0.00939235300281262,0.0152089227820568,0.643079652968291
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRX,Cone-rod homeobox protein,41900,-0.00523320948872189,0.0113238211641456,-0.0274278989704473,0.0169614799930035,0.643987297463997
NMR metabolomics,X23501.Triglycerides in Large VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,0.0028066009815816,0.00608093621048192,-0.00911203399096296,0.0147252359541262,0.644417971640947
NMR metabolomics,X23501.Triglycerides in Large VLDL,INHBB,Inhibin beta B chain,39736,0.0025104111415357,0.00549141653133695,-0.00825276525988472,0.0132735875429561,0.647570832958475
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBA,Lysosomal acid glucosylceramidase,39649,0.00266534165293377,0.00583389673070112,-0.00876909593924042,0.014099779245108,0.647772329551461
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPBGL,Trophoblast glycoprotein-like,39649,-0.00193734777485817,0.00427607895766297,-0.0103184625318776,0.00644376698216124,0.650509812958871
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALCAM,CD166 antigen,42310,0.000936178328247702,0.00207317867814148,-0.00312725188090959,0.004999608537405,0.651588350671602
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRD2,Bromodomain-containing protein 2,39586,0.00166007655619279,0.0036814501637998,-0.00555556576485481,0.0088757188772404,0.652048854778764
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBQLN3,Ubiquilin-3,39575,0.00266104164352039,0.00590977822077374,-0.00892212366919614,0.0142442069562369,0.652519074004035
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC1A4,Neutral amino acid transporter A,39649,0.00240653097374159,0.00534523158919686,-0.00807012294108425,0.0128831848885674,0.65256054081536
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA10,Annexin A10,41839,-0.00387679231892179,0.00862366847412679,-0.0207791825282103,0.0130255978903667,0.653040454361513
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,-0.00141805279024286,0.00318509464869164,-0.00766083830167847,0.00482473272119274,0.656171465910707
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH17,Cadherin-17,42145,-0.00319173293112305,0.00718636025847643,-0.0172769990377368,0.0108935331754908,0.656950185324061
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGR,Progesterone receptor,39657,0.00464065113848926,0.0105269351648488,-0.0159921417846143,0.0252734440615928,0.659340406487641
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,-0.00160305273724417,0.0036460387046941,-0.00874928859844461,0.00554318312395626,0.660183313848847
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL6B,Myosin light chain 6B,39649,0.00421357590845678,0.00960080359665492,-0.0146039991409869,0.0230311509579004,0.660758940642929
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.00255191253662281,0.00582220948976134,-0.013963443136555,0.00885961806330942,0.661172707468333
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTTG1,Securin,39757,0.00190692134136101,0.00437136140455042,-0.00666094701155781,0.0104747896942798,0.66267791346002
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,39575,0.00213520199164254,0.00489911718821578,-0.00746706769726037,0.0117374716805455,0.66296572297866
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.00292683867128569,0.00677788762334816,-0.0162114984130481,0.0103578210704767,0.665879463190686
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYBB2,Beta-crystallin B2,39929,0.00313818328102075,0.00735235618573807,-0.0112724348430259,0.0175488014050674,0.669513534311427
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAG,Myelin-associated glycoprotein,39649,0.00217940423216221,0.00511827606067378,-0.00785241684675841,0.0122112253110828,0.67025586027543
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC6A,C-type lectin domain family 6 member A,41843,0.00212563263970268,0.00499266900421631,-0.00765999860856128,0.0119112638879666,0.670296386614033
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERVV_1,,39575,-0.00193934502492258,0.00457994378653132,-0.010916034846524,0.00703734479667881,0.671980393054161
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEZ6,Seizure protein 6 homolog,39649,-0.00139165103362273,0.00329451896580918,-0.00784890820660871,0.00506560613936326,0.672731058489583
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORN4,MORN repeat-containing protein 4,39560,0.00345412966673506,0.00822395276787339,-0.0126648177582968,0.0195730770917669,0.674487513002425
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTM4,Glutathione S-transferase Mu 4,39575,-0.00329310894475518,0.00785311804989331,-0.0186852203225461,0.0120990024330357,0.674977510154875
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD4,Sushi domain-containing protein 4,39919,-0.00169240837532123,0.0040501787453987,-0.00963075871630268,0.00624594196566021,0.676057282263187
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACTN4,Alpha-actinin-4,41913,0.00138347920033099,0.00332273348829602,-0.00512907843672921,0.0078960368373912,0.677147606231477
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH22,Cadherin-22,39757,0.00120515350975874,0.00289549490211031,-0.00447001649837747,0.00688032351789494,0.677259401930608
NMR metabolomics,X23501.Triglycerides in Large VLDL,THBS2,Thrombospondin-2,42137,0.00168907005206711,0.00406997286974355,-0.00628807677263025,0.00966621687676447,0.678142848235197
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.00232648802338289,0.00565678245751909,-0.0134137816401203,0.00876080559335452,0.680879593018722
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPSD1,Tryptase delta,39934,0.00157303572498634,0.00384286068383372,-0.00595897121532776,0.00910504266530044,0.682298065583489
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRR1B,Cornifin-B,39757,0.00370238098748568,0.00907546807095124,-0.0140855364315787,0.0214902984065501,0.683314669267363
NMR metabolomics,X23501.Triglycerides in Large VLDL,DIPK1C,Divergent protein kinase domain 1C,39649,0.00179491432866742,0.00442057788291918,-0.00686941832185416,0.010459246979189,0.68472391794955
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300E,CMRF35-like molecule 2,42232,0.00178500908162458,0.00439887767201691,-0.00683679115552857,0.0104068093187777,0.684905194916966
NMR metabolomics,X23501.Triglycerides in Large VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,0.00204220744924289,0.00504034081406368,-0.00783686054632193,0.0119212754448077,0.685358491771917
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPGN,Epigen,39919,-0.00194642292193552,0.00486755183239443,-0.0114868245134286,0.00759397866955756,0.689254523167446
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.00265911101952308,0.00665147376084374,-0.0103777775517306,0.0156959995907768,0.689327894709151
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42070,-0.00164348764649569,0.00414265445663185,-0.0097630903814941,0.00647611508850273,0.691577783448467
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,39894,-0.00157264768003243,0.00402444774356279,-0.00946056525741551,0.00631526989735064,0.695972007750862
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE6,Ribonuclease K6,39937,0.001325217828022,0.00339294678057416,-0.00532495786190336,0.00797539351794735,0.696114903116662
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM171A2,Protein FAM171A2,39934,-0.00636084269489481,0.0164138357905007,-0.0385319608442762,0.0258102754544866,0.69837165683954
NMR metabolomics,X23501.Triglycerides in Large VLDL,FSTL3,Follistatin-related protein 3,42084,0.00132631287814389,0.00344831202173734,-0.00543237868446129,0.00808500444074907,0.700520074262837
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIPR,Gastric inhibitory polypeptide receptor,39657,0.00181567865154701,0.00474395885829167,-0.00748248071070467,0.0111138380137987,0.701923686600075
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD86,T-lymphocyte activation antigen CD86,39930,-0.0012126437652261,0.00319282876064994,-0.00747058813609998,0.00504530060564778,0.704099280008042
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCLRE1C,Protein artemis,39560,-0.00118864963119287,0.00319887141983194,-0.00745843761406347,0.00508113835167774,0.7102097416105
NMR metabolomics,X23501.Triglycerides in Large VLDL,RETN,Resistin,42105,-0.00167776938358126,0.00452804307469274,-0.010552733809979,0.00719719504281651,0.710994494767104
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.0023431216813075,0.00636663628316143,-0.0101354854336889,0.0148217287963039,0.712856956370622
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRL,Prolactin,42249,0.00283615698764954,0.00775201729246367,-0.0123577969055792,0.0180301108808783,0.714474836043417
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,0.00296286140467677,0.00810746154785342,-0.0129277632291159,0.0188534860384695,0.714783535043046
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00267378900331577,0.00735084665918353,-0.0117338704486839,0.0170814484553155,0.716059938948864
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBR1,T-box brain protein 1,39649,0.00183178578005115,0.00504740488051208,-0.00806112778575254,0.0117246993458548,0.716674311315615
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,0.0019816766880867,0.00550447670522294,-0.00880709765415027,0.0127704510303237,0.718845009677226
NMR metabolomics,X23501.Triglycerides in Large VLDL,VNN2,Vascular non-inflammatory molecule 2,42070,-0.0017835420739857,0.00497985795818291,-0.0115440636720242,0.0079769795240528,0.72023578148908
NMR metabolomics,X23501.Triglycerides in Large VLDL,RLN1,Prorelaxin H1,39934,0.00166544785346837,0.00465742626030067,-0.00746310761672094,0.0107940033236577,0.720657014685687
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.0013728557200122,0.00386207167127404,-0.00894251619570932,0.00619680475568491,0.722243311812923
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRRT3,Proline-rich transmembrane protein 3,39638,0.00142456947500753,0.00406812882695473,-0.00654896302582373,0.00939810197583879,0.726211750131549
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRING1,SREBP regulating gene protein,39560,0.00224954431182519,0.0065227190292299,-0.0105349849854654,0.0150340736091158,0.730192475613002
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00164821264268709,0.00477984494538529,-0.0110167087356423,0.00772028345026808,0.730232090110921
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00136433434377702,0.00401602650667197,-0.00923574629685408,0.00650707760930004,0.734072058199983
NMR metabolomics,X23501.Triglycerides in Large VLDL,GHRHR,Growth hormone-releasing hormone receptor,41839,-0.00191651139415449,0.00570395841547955,-0.0130962698884944,0.00926324710018542,0.736878654606684
NMR metabolomics,X23501.Triglycerides in Large VLDL,LHB,Lutropin subunit beta,41843,-0.00312588765964903,0.00932116982639195,-0.0213953805193772,0.0151436052000792,0.737363693191567
NMR metabolomics,X23501.Triglycerides in Large VLDL,NENF,Neudesin,39919,0.00394336044756839,0.0118141430443312,-0.0192123599193208,0.0270990808144576,0.738549473985499
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42095,0.00134051556823065,0.00404236321019825,-0.00658251632375791,0.00926354746021921,0.740183778803062
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,39657,0.00141239667563041,0.00428464694068252,-0.00698551132810734,0.00981030467936816,0.741677241114721
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.00139339640135448,0.00423314868259696,-0.00690357501653557,0.00969036781924452,0.742038676479866
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR1,Toll-like receptor 1,39657,0.000924488938765639,0.00281128290072036,-0.00458562554664626,0.00643460342417754,0.742275684391704
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRNN,Cornulin,41749,-0.00231958723258691,0.0070969590296395,-0.0162296269306803,0.0115904524655065,0.743792279078922
NMR metabolomics,X23501.Triglycerides in Large VLDL,HBZ,Hemoglobin subunit zeta,39958,-0.00368707753023776,0.0112926279935453,-0.0258206283975865,0.018446473337111,0.744049794805356
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.00209995005760073,0.00648564168220873,-0.0148118077547298,0.0106119076395284,0.746106261278274
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL6,Fc receptor-like protein 6,42119,0.00231433276785685,0.00723156817960554,-0.01185954086417,0.0164882063998837,0.748949066664042
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMEM132A,Transmembrane protein 132A,39638,0.00210384706562303,0.00659548899540151,-0.0108233113653639,0.01503100549661,0.749745646863696
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHGB,Secretogranin-1,42210,-0.00142006450568789,0.00445213737184186,-0.0101462537544979,0.00730612474312215,0.749759905667895
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPT,Microtubule-associated protein tau,41839,0.00177600768147606,0.00557331057471674,-0.00914768104496874,0.0126996964079209,0.749987127005851
NMR metabolomics,X23501.Triglycerides in Large VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00216222460448707,0.00683089799176816,-0.0112263354593785,0.0155507846683527,0.75160177683279
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.00147490686477131,0.0046701814475469,-0.00767864877242061,0.0106284625019632,0.752148937386931
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,0.00121643541957249,0.00388285825922137,-0.00639396676850141,0.00882683760764638,0.754071034366668
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL21R,Interleukin-21 receptor,39657,-0.0017666716533665,0.00568715179238934,-0.0129134891664496,0.0093801458597166,0.756078188945886
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC25A,M-phase inducer phosphatase 1,39560,-0.00129762148089669,0.00420889658400589,-0.00954705878554824,0.00695181582375486,0.757856551301217
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB5,Integrin beta-5,42181,-0.00123314432210437,0.0040462904005836,-0.00916387350724822,0.00669758486303948,0.760554209495611
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL3,Interleukin-3,39560,0.00195489089123369,0.00643508077519983,-0.010657867428158,0.0145676492106254,0.761296292475045
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOX2,Transcription factor SOX-2,39915,0.000782031849613841,0.00258068678338751,-0.00427611424582568,0.00584017794505336,0.761870699669457
NMR metabolomics,X23501.Triglycerides in Large VLDL,GM2A,Ganglioside GM2 activator,39733,-0.0012162307777617,0.0040480854238469,-0.00915047820850162,0.00671801665297821,0.763842646104273
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMP,Cartilage oligomeric matrix protein,42042,-0.00105026862411251,0.00350909582098552,-0.00792809643324413,0.00582755918501912,0.76471659827276
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,-0.000924686706653931,0.00310187562427115,-0.0070043629302254,0.00515498951691753,0.765627095146409
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.000939276756000202,0.00315412517674063,-0.00712136210241183,0.00524280859041143,0.765866529258146
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD33,Myeloid cell surface antigen CD33,42181,-0.00248391206507925,0.00836688976659137,-0.0188830160075983,0.0139151918774398,0.766567243852688
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNGR1,Interferon gamma receptor 1,42185,-0.00067456932101124,0.00227841958611575,-0.0051402717097981,0.00379113306777562,0.767181942445298
NMR metabolomics,X23501.Triglycerides in Large VLDL,COPE,Coatomer subunit epsilon,41839,0.00144399580524703,0.00489345726989355,-0.00814718044374433,0.0110351720542384,0.767932019462032
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,0.00104461010158515,0.00354441149366885,-0.0059024364260058,0.0079916566291761,0.768213079110962
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN3B,Sodium channel subunit beta-3,39586,-0.00143451206672664,0.00489582938576764,-0.0110303376628312,0.00816131352937794,0.769522368631516
NMR metabolomics,X23501.Triglycerides in Large VLDL,RASA1,Ras GTPase-activating protein 1,41839,0.00098878025013355,0.00343841218333715,-0.00575050762920726,0.00772806812947436,0.773681290355982
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCNA,Proliferating cell nuclear antigen,39560,0.00194640280171372,0.00677471649941398,-0.0113320415371377,0.0152248471405651,0.773885031013027
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.00442093978158452,0.0154171437654807,-0.0346385415619267,0.0257966619987577,0.774305504602233
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP1,Retinol-binding protein 1,39649,0.00207758951032223,0.00739009580679708,-0.012406998271,0.0165621772916445,0.778614723671685
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,0.000804356695083429,0.00290370181675431,-0.00488689886575503,0.00649561225592188,0.781776136291112
NMR metabolomics,X23501.Triglycerides in Large VLDL,TYMP,Thymidine phosphorylase,42070,-0.00194083302857434,0.0070073248385563,-0.0156751897121447,0.011793523654996,0.781805828343255
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF3,Fibroblast growth factor 3,39657,-0.000859707010437963,0.00311139850308161,-0.00695804807647791,0.00523863405560199,0.782316006513259
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNF830,Zinc finger protein 830,39919,0.00223991492168592,0.00815797666385952,-0.0137497193394787,0.0182295491828506,0.783653580705768
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.000775501019985708,0.00284532320341506,-0.00480133245870782,0.00635233449867923,0.785201095572436
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,-0.00134166653678181,0.00513406472658972,-0.0114044334008977,0.00872110032733404,0.793845725495562
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL11,Interleukin-11,41913,-0.00167401350445883,0.00641675093603385,-0.0142508453390852,0.0109028183301675,0.794187699207393
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM3D,Protein FAM3D,39930,0.00236797191774762,0.00919752163803589,-0.0156591704928027,0.020395114328298,0.796830212173821
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCDC2C,Doublecortin domain-containing protein 2C,39560,0.00170700486190529,0.00667232361785853,-0.0113707494290974,0.014784759152908,0.798084095524974
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHIT1,Chitotriosidase-1,42207,-0.00421128677529618,0.0164987158231085,-0.0365487697885889,0.0281261962379965,0.798534361714762
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP350,Centrosome-associated protein 350,39560,-0.000975787657074463,0.00384100445715314,-0.00850415639309461,0.00655258107894568,0.799465623286955
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00161825992613623,0.00645748734056162,-0.0110384152613645,0.014274935113637,0.802126301908095
NMR metabolomics,X23501.Triglycerides in Large VLDL,SKIV2L,Helicase SKI2W,39575,-0.00104211526598535,0.0041590534604814,-0.0091938600485289,0.0071096295165582,0.802154756410977
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAX,Integrin alpha-X,39757,-0.00135842334774051,0.00542474293542705,-0.0119909195011775,0.00927407280569651,0.802272987933464
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF1,Macrophage colony-stimulating factor 1,42185,-0.00069594050945154,0.00284366229871757,-0.00626951861493799,0.00487763759603491,0.806666188990342
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLNS1A,Methylosome subunit pICln,39649,0.000849093318456968,0.00353398892234842,-0.00607752496934593,0.00777571160625986,0.810129399972645
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNN,Tenascin-N,39966,0.00107059110748149,0.00454625790768386,-0.00784007439157888,0.00998125660654186,0.813833905589098
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.00425594160495248,0.0180882352278315,-0.0311969994415972,0.0397088826515022,0.813989593012731
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4C,C-type lectin domain family 4 member C,42119,0.00119418177038678,0.00510904627101835,-0.00881954892080919,0.0112079124615827,0.815191390331875
NMR metabolomics,X23501.Triglycerides in Large VLDL,FDX1,"Adrenodoxin, mitochondrial",39575,-0.00152262995065206,0.00661968497934328,-0.0144972125101649,0.0114519526088608,0.818084035551882
NMR metabolomics,X23501.Triglycerides in Large VLDL,RANGAP1,Ran GTPase-activating protein 1,41843,-0.00116446343631842,0.00507307374580966,-0.0111076879781053,0.00877876110546852,0.818454298102797
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFD,Complement factor D,39979,-0.000487844680486726,0.00212895843817297,-0.00466060321930575,0.00368491385833229,0.818758694567006
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL33,Interleukin-33,41913,0.00094735147421897,0.00415479770291306,-0.00719605202349062,0.00909075497192856,0.81963896499716
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSCA,Prostate stem cell antigen,39930,0.00610780164028843,0.0273076587955867,-0.0474152095990615,0.0596308128796384,0.823021041777178
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL20RB,Interleukin-20 receptor subunit beta,39657,-0.000981956421868257,0.00440348787379263,-0.00961279265450182,0.00764887981076531,0.823543403415282
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK12,Kallikrein-12,41843,-0.00305564221732877,0.0140545315619593,-0.030602524078769,0.0244912396441115,0.827889609365801
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.00121864679313388,0.00563814910388442,-0.0122694190367473,0.00983212545047958,0.828880249773936
NMR metabolomics,X23501.Triglycerides in Large VLDL,KHDC3L,KH domain-containing protein 3,39560,-0.00150714450571208,0.007050991412318,-0.0153270876738554,0.0123127986624312,0.830746536891946
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00109432863976278,0.00520086623368411,-0.00909936917825808,0.0112880264577836,0.833349437454547
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPT1,Translationally-controlled tumor protein,41913,-0.00141935896772729,0.00674813405869612,-0.0146457017227717,0.0118069837873171,0.833410573520054
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTNAP4,Contactin-associated protein-like 4,39649,-0.00232058015537289,0.0111040659010473,-0.0240845493214256,0.0194433890106798,0.834464015804044
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAPPA,Pappalysin-1,41913,-0.00104138159026567,0.00499647771066217,-0.0108344779031635,0.00875171472263217,0.834901775751875
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL25,Interleukin-25,39510,0.000750636625947657,0.00361046483275511,-0.00632587444625237,0.00782714769814768,0.835306391007669
NMR metabolomics,X23501.Triglycerides in Large VLDL,IKZF2,Zinc finger protein Helios,41843,-0.00193092686696316,0.00936476363074894,-0.0202858635832311,0.0164240098493048,0.836645146864802
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.000977456026991466,0.00476182135290314,-0.0103106258786816,0.00835571382469869,0.837365483680113
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRND,Prion-like protein doppel,39929,0.00104931608005212,0.00513911168220834,-0.00902334281707623,0.0111219749771805,0.838214643773514
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSLP,Thymic stromal lymphopoietin,41900,0.00128329559241268,0.00634163567627346,-0.0111463103330833,0.0137129015179087,0.839638121217578
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB116,Beta-defensin 116,39586,-0.00159028864303114,0.00789021859995876,-0.0170551170989503,0.013874539812888,0.840270774033561
NMR metabolomics,X23501.Triglycerides in Large VLDL,GJA8,Gap junction alpha-8 protein,39560,-0.00130718841725714,0.00655715312177273,-0.0141592085359317,0.0115448317014174,0.841990288885549
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.00149668688090984,0.00785322297907803,-0.0138956301580831,0.0168890039199028,0.84885622209591
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEZ6L,Seizure 6-like protein,42181,-0.0005408089929129,0.00289824523738357,-0.00622136965818469,0.00513975167235889,0.851978019290637
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,0.00125131536389808,0.00674540949663284,-0.0119696872495023,0.0144723179772984,0.852835441146203
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA5,Annexin A5,41780,-0.000593837556707749,0.00320598088583679,-0.00687756009294786,0.00568988497953236,0.85305302679197
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTRC,Chymotrypsin-C,42122,0.00119436356555637,0.00688422464858039,-0.0122987167456612,0.0146874438767739,0.862266666015582
NMR metabolomics,X23501.Triglycerides in Large VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42017,0.001059583803721,0.00617768842413237,-0.0110486855075784,0.0131678531150204,0.863819186934258
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.000928611408607088,0.00542979959692178,-0.0115710186185738,0.0097137958013596,0.864210236984748
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF6,Fibroblast growth factor 6,39657,0.000700983822756362,0.00410427968676639,-0.00734340436330576,0.00874537200881849,0.864389355344108
NMR metabolomics,X23501.Triglycerides in Large VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,0.00267593939523672,0.0158066831680283,-0.0283051596140988,0.0336570384045722,0.865569780354016
NMR metabolomics,X23501.Triglycerides in Large VLDL,DRAXIN,Draxin,42016,-0.00073358826126541,0.0044837569807237,-0.00952175194348386,0.00805457542095304,0.870040499153241
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYB5A,Cytochrome b5,39560,-0.001195007447397,0.00748015601947974,-0.0158561132455773,0.0134660983507833,0.873075424808729
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS11B,Transmembrane protease serine 11B,39586,0.00127325508982865,0.00797738101054897,-0.0143624116908473,0.0169089218705046,0.873192686272301
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.00280343548812912,0.0178204842547312,-0.032124713651144,0.0377315846274022,0.874998715063008
NMR metabolomics,X23501.Triglycerides in Large VLDL,DIPK2B,Divergent protein kinase domain 2B,39736,-0.000479158365396632,0.00314564883933337,-0.00664463009049003,0.00568631335969677,0.878934017780213
NMR metabolomics,X23501.Triglycerides in Large VLDL,HLA_A,,39934,-0.000523064878414348,0.00344916427919151,-0.00728342686562971,0.00623729710880102,0.879465896487174
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.000573111372603515,0.00381034271045544,-0.00689516033988914,0.00804138308509617,0.880444368636206
NMR metabolomics,X23501.Triglycerides in Large VLDL,CADPS,Calcium-dependent secretion activator 1,39649,-0.000644589498583371,0.00429202410562075,-0.00905695674560004,0.0077677777484333,0.88062289783513
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.00084622011127568,0.00564852981480657,-0.0102248983257452,0.0119173385482966,0.880915291583733
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.00062098502283373,0.00425633728968767,-0.0077214360649541,0.00896340611062156,0.884005698701438
NMR metabolomics,X23501.Triglycerides in Large VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,0.000460152673284084,0.00316534282067083,-0.00574391925523073,0.0066642246017989,0.884419636214543
NMR metabolomics,X23501.Triglycerides in Large VLDL,HK2,Hexokinase-2,41900,0.000416248419968243,0.0028744047614919,-0.00521758491255588,0.00605008175249236,0.884861469416149
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRP15,RRP15-like protein,39586,0.00138254658678989,0.00958358182744735,-0.0174012737950069,0.0201663669685867,0.885296237932871
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2RG,Cytokine receptor common subunit gamma,39919,-0.000533433387878445,0.00373937044203008,-0.00786259945425741,0.00679573267850052,0.886566570442503
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSTN,Osteocrin,39649,-0.000598566198016139,0.0042569742969357,-0.00894223582001011,0.00774510342397783,0.888181902301626
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.000942615978439776,0.0067076968958283,-0.0140897018942632,0.0122044699373837,0.888245291724171
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESR1,Estrogen receptor,39657,0.000833265055300637,0.00600363349468949,-0.0109338565942908,0.012600386704892,0.889615891056391
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTN,Neuroplastin,41843,0.00108335866942948,0.00825007655316481,-0.0150867913747735,0.0172535087136325,0.895528133754044
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.000528386810946184,0.00417951862257377,-0.00872024331119078,0.00766346968929841,0.899399065724396
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.000895774343513833,0.00720866629750249,-0.0150247602866187,0.0132332115995911,0.901108453014002
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42016,0.000313393304966402,0.00252430018864584,-0.00463423506477945,0.00526102167471225,0.901197919431243
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNR,Tenascin-R,42016,-0.00053679073552371,0.00441467432688436,-0.00918955241621706,0.00811597094516964,0.903223673733762
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,-0.000763824202625178,0.00636930379027988,-0.0132476596315737,0.0117200112263234,0.904546190134669
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTPP1,dCTP pyrophosphatase 1,42145,-0.000393359564868302,0.00333646165510811,-0.0069328244088802,0.00614610527914359,0.906150841514885
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRTAC1,Cartilage acidic protein 1,42310,-0.000382158208943442,0.00326145383395616,-0.00677460772349752,0.00601029130561064,0.906723736326205
NMR metabolomics,X23501.Triglycerides in Large VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,-0.000529631275265496,0.00462291864565152,-0.00959055182074247,0.00853128927021148,0.908790889801859
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.000650144732354076,0.00578397790426351,-0.0106864519600024,0.0119867414247106,0.910504797590367
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,39649,-0.000431457486123174,0.00386004063730485,-0.00799713713524067,0.00713422216299432,0.911003544176035
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,0.000497634660462958,0.00452364808248403,-0.00836871558120573,0.00936398490213165,0.912405169747615
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNL2,Interferon lambda-2,39586,-0.000622052690161782,0.00615146076313828,-0.0126789157859128,0.0114348104055892,0.919454856182506
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,39560,0.000265040815548765,0.0026700238178261,-0.00496820586739039,0.00549828749848792,0.920929414514879
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,-0.000528170039992345,0.00533701366808322,-0.0109887168294355,0.00993237674945077,0.921168985389897
NMR metabolomics,X23501.Triglycerides in Large VLDL,NINJ1,Ninjurin-1,41843,0.000538529155763528,0.00572348277267685,-0.0106794970786831,0.0117565553902102,0.925038162867137
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLINT1,Clathrin interactor 1,39560,-0.000490510881467139,0.00525111599383738,-0.0107826982293884,0.00980167646645412,0.925578928036664
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGN,Cingulin,39649,0.000362060270567366,0.00393793328229232,-0.00735628896272559,0.00808040950386032,0.926746028745665
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.000559458689589417,0.00623311277202941,-0.0116574423435882,0.0127763597227671,0.92848277596355
NMR metabolomics,X23501.Triglycerides in Large VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,-0.000276518143626514,0.00313783744899096,-0.0064266795436488,0.00587364325639577,0.929779880288964
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAGLN3,Transgelin-3,39560,-0.000522619723155834,0.00630601867228947,-0.0128824163208432,0.0118371768745315,0.93395138380493
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPEP,Glutamyl aminopeptidase,39575,0.000368905805307787,0.00445980231774679,-0.00837230673747593,0.0091101183480915,0.934077302390833
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAP1,Antigen peptide transporter 1,39757,-0.000500141914845395,0.00612823818302476,-0.0125114887535739,0.0115112049238831,0.934956185185232
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,0.000266250838110603,0.00326707607222959,-0.00613721826345939,0.00666971993968059,0.935049390604701
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF12,Fibroblast growth factor 12,39657,-0.000380809799410624,0.00476218520542122,-0.00971469280203622,0.00895307320321497,0.936266262771707
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTLA,B- and T-lymphocyte attenuator,39560,0.000708234507754143,0.00900347867215997,-0.0169385836896794,0.0183550527051877,0.93730265401551
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.000472054679305472,0.00618227060973498,-0.012589305074386,0.0116451957157751,0.939137107082621
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP73,Tumor protein p73,39649,-0.000273419243928087,0.00360550515224946,-0.00734020934233704,0.00679337085448086,0.939552678717056
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCLN,Nicalin,41913,-0.000393887067862584,0.00539393696497129,-0.0109660035192063,0.0101782293834811,0.941788084573901
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAGEA3,Melanoma-associated antigen 3,39757,0.000657994978258943,0.00905120021960069,-0.0170823574521584,0.0183983474086763,0.942048549922772
NMR metabolomics,X23501.Triglycerides in Large VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.000307987434498535,0.00443061894886145,-0.00837602570526991,0.00899200057426698,0.944582204085158
NMR metabolomics,X23501.Triglycerides in Large VLDL,EVPL,Envoplakin,39757,-0.00024354687851682,0.00350750630571643,-0.00711825923772101,0.00663116548068737,0.944643893318337
NMR metabolomics,X23501.Triglycerides in Large VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.000372890301656762,0.0053719738692292,-0.0101561784820325,0.010901959085346,0.944661117839567
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,0.00044018586909339,0.00660609405022274,-0.0125077584693432,0.01338813020753,0.946874846108695
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLGAP5,Disks large-associated protein 5,39934,-0.000334690474136075,0.00519328179940689,-0.0105135228009736,0.00984414185270142,0.948615590630846
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFNA1,Ephrin-A1,42113,0.000190471944461609,0.00310200343388382,-0.00588945478595067,0.00627039867487389,0.951039266909145
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP15,Matrix metalloproteinase-15,39958,-0.000313035697868017,0.00511495352033079,-0.0103383445977164,0.00971227320198032,0.951200922081819
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT17,"Keratin, type I cytoskeletal 17",39575,-0.0002571741304371,0.00424314321188958,-0.00857373482574069,0.00805938656486649,0.95167143462863
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,39929,-0.000191520049771269,0.00321868941621375,-0.00650015130555022,0.00611711120600768,0.952552928061824
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDSN,Corneodesmosin,42246,0.000243151354284622,0.00461030273740187,-0.00879304201102304,0.00927934471959228,0.95793915076091
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEPACAM2,HEPACAM family member 2,39929,-0.000231285529231082,0.00459308417037925,-0.0092337305031744,0.00877115944471224,0.959840248780514
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP9,Matrix metalloproteinase-9,42125,-0.000303614198067939,0.00630445339148753,-0.0126603428453835,0.0120531144492476,0.961590485973519
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,0.000162581475747908,0.00352549694419253,-0.00674739253486945,0.00707255548636526,0.963218710774335
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,-0.00023018458782957,0.00508362980397988,-0.0101940990036301,0.009733729827971,0.963885292753196
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMP10,Bone morphogenetic protein 10,39736,-0.000130565175543319,0.00297317487883222,-0.00595798793805446,0.00569685758696782,0.964973428306673
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN2,Contactin-2,42262,0.000202859186094417,0.00463375880967757,-0.00887930808087362,0.00928502645306245,0.965081574672217
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTF,Ciliary neurotrophic factor,39586,-0.000158680949491867,0.00363126533093968,-0.00727596099813363,0.0069585990991499,0.965145506812808
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,0.000146540966439873,0.00355449391131254,-0.0068202670997327,0.00711334903261244,0.967115707995628
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINT3,Kunitz-type protease inhibitor 3,39930,-0.000714544451862856,0.0174535589063842,-0.0349235199083758,0.0334944310046501,0.967344644252774
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELL,L-selectin,39979,9.93276775487576e-05,0.00244916649710737,-0.00470103865678169,0.00489969401187921,0.967650807707392
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRK1,Protein BRICK1,41839,-0.000190038080746938,0.00479109971752655,-0.00958059352709898,0.00920051736560511,0.968360951774428
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCB,Calcitonin gene-related peptide 2,39929,-0.000166186700665168,0.00427059905514598,-0.00853656084875129,0.00820418744742096,0.968959526614023
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,-0.000198124937162128,0.00522133586440041,-0.0104319432313869,0.0100356933570627,0.969732018388211
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY9,T-lymphocyte surface antigen Ly-9,41960,-0.000119412129775185,0.00320087861783579,-0.00639313422073334,0.00615430996118297,0.970241541018183
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHD,SH2 domain-containing adapter protein D,39554,-0.00031405230762399,0.00866780375835456,-0.0173029476739989,0.0166748430587509,0.971097989983869
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP30,Rho GTPase-activating protein 30,39757,0.000145572230379376,0.00422502190808496,-0.00813547070946714,0.0084266151702259,0.9725151119423
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD5L,CD5 antigen-like,39925,-0.000170498623806231,0.00504833387639288,-0.0100652330215363,0.00972423577392382,0.973058565260683
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA2013,Uncharacterized protein KIAA2013,39919,0.000155250573168629,0.00564603631142821,-0.0109109805972307,0.0112214817435679,0.978063603658394
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,-7.1527051005979e-05,0.00279419268013934,-0.00554814470407908,0.00540509060206712,0.979578075134031
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2,Interleukin-2,41913,-8.36691362678311e-05,0.00336839957842027,-0.00668573230997156,0.00651839403743589,0.980183409904648
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-7.4081450952293e-05,0.00318212872616726,-0.00631105375424012,0.00616289085233553,0.981426959197793
NMR metabolomics,X23501.Triglycerides in Large VLDL,PI16,Peptidase inhibitor 16,39990,5.38304892577618e-05,0.00253763488490789,-0.0049199338851617,0.00502759486367722,0.983076228719019
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC2L,C-type lectin domain family 2 member L,39649,-0.000111707492335993,0.00538756771798167,-0.0106713402195801,0.0104479252349081,0.983457974892822
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA3G,Semaphorin-3G,39736,-6.99177731596795e-05,0.00478659313852995,-0.00945164032467838,0.00931180477835902,0.988345975128933
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLITRK1,SLIT and NTRK-like protein 1,39657,-3.83108307032147e-05,0.00341398900922246,-0.00672972928877924,0.00665310762737281,0.991046752775713
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDAC9,Histone deacetylase 9,39586,6.13383967969716e-05,0.0070114627539378,-0.0136811286009211,0.0138038053945151,0.993020112420664
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMOD2,Leiomodin-2,39586,-3.93855808816551e-05,0.00646200585035512,-0.0127049170475777,0.0126261458858144,0.995137076947341
NMR metabolomics,X23501.Triglycerides in Large VLDL,RSPO3,R-spondin-3,42262,-1.12100368984464e-05,0.00295831465743141,-0.005809506765464,0.00578708669166711,0.996976612927738
NMR metabolomics,X23501.Triglycerides in Large VLDL,CKAP4,Cytoskeleton-associated protein 4,42247,-1.07321359831816e-05,0.00298614758269369,-0.00586358139806281,0.00584211712609645,0.997132482548685
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,-1.15492874893476e-05,0.00434589473633566,-0.00852950297070723,0.00850640439572854,0.997879659266638
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABO,Histo-blood group ABO system transferase,39990,-2.87950227258934e-05,0.0152377013643313,-0.0298946896968153,0.0298370996513635,0.998492253814423
